0001493152-23-007116.txt : 20230309 0001493152-23-007116.hdr.sgml : 20230309 20230309160144 ACCESSION NUMBER: 0001493152-23-007116 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 56 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230309 DATE AS OF CHANGE: 20230309 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RESEARCH FRONTIERS INC CENTRAL INDEX KEY: 0000793524 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 112103466 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-14893 FILM NUMBER: 23719649 BUSINESS ADDRESS: STREET 1: 240 CROSSWAYS PARK DR CITY: WOODBURY STATE: NY ZIP: 11797-2033 BUSINESS PHONE: 5163641902 MAIL ADDRESS: STREET 1: 240 CROSSWAYS PARK DR CITY: WOODBURY STATE: NY ZIP: 11797-2033 10-K 1 form10-k.htm
0000793524 false FY true false REFR 0000793524 2022-01-01 2022-12-31 0000793524 2022-06-30 0000793524 2023-03-09 0000793524 2022-12-31 0000793524 2021-12-31 0000793524 2021-01-01 2021-12-31 0000793524 us-gaap:CommonStockMember 2020-12-31 0000793524 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000793524 us-gaap:RetainedEarningsMember 2020-12-31 0000793524 2020-12-31 0000793524 us-gaap:CommonStockMember 2021-12-31 0000793524 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000793524 us-gaap:RetainedEarningsMember 2021-12-31 0000793524 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000793524 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0000793524 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0000793524 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000793524 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0000793524 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0000793524 us-gaap:CommonStockMember 2022-12-31 0000793524 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000793524 us-gaap:RetainedEarningsMember 2022-12-31 0000793524 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember REFR:CompanyOneMember 2022-01-01 2022-12-31 0000793524 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember REFR:CompanyOneMember 2021-01-01 2021-12-31 0000793524 REFR:CompanyTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000793524 us-gaap:SalesRevenueNetMember REFR:LicenseAgreementMember srt:MinimumMember 2022-01-01 2022-12-31 0000793524 us-gaap:SalesRevenueNetMember REFR:LicenseAgreementMember srt:MaximumMember 2022-01-01 2022-12-31 0000793524 REFR:LicenseAgreementMember 2022-01-01 2022-12-31 0000793524 REFR:LicenseeOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000793524 REFR:LicenseeTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000793524 REFR:LicenseeThreeMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000793524 REFR:LicenseeFourMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000793524 REFR:LicenseeOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000793524 REFR:LicenseeTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000793524 REFR:LicenseeThreeMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000793524 REFR:LicenseeFourMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000793524 REFR:OptionsAndWarrantsMember 2022-01-01 2022-12-31 0000793524 REFR:OptionsAndWarrantsMember 2021-01-01 2021-12-31 0000793524 REFR:EmployeesAndDirectorsMember 2022-01-01 2022-12-31 0000793524 REFR:EmployeesAndDirectorsMember 2021-01-01 2021-12-31 0000793524 us-gaap:FairValueInputsLevel1Member REFR:PutnamShortDurationBondMember 2021-12-31 0000793524 us-gaap:FairValueInputsLevel1Member REFR:PutnamUltraShortDurationIncomeMember 2021-12-31 0000793524 us-gaap:FairValueInputsLevel1Member 2021-12-31 0000793524 us-gaap:FairValueInputsLevel1Member 2021-01-01 2021-12-31 0000793524 REFR:EquipmentAndFurnitureMember 2022-12-31 0000793524 REFR:EquipmentAndFurnitureMember 2021-12-31 0000793524 REFR:EquipmentAndFurnitureMember 2022-01-01 2022-12-31 0000793524 REFR:TradeShowMaterialsMember 2022-12-31 0000793524 REFR:TradeShowMaterialsMember 2021-12-31 0000793524 REFR:TradeShowMaterialsMember 2022-01-01 2022-12-31 0000793524 REFR:AutosMember 2022-12-31 0000793524 REFR:AutosMember 2021-12-31 0000793524 REFR:AutosMember 2022-01-01 2022-12-31 0000793524 us-gaap:LeaseholdImprovementsMember 2022-12-31 0000793524 us-gaap:LeaseholdImprovementsMember 2021-12-31 0000793524 2022-08-16 0000793524 REFR:TaxYear2018To2022Member 2022-12-31 0000793524 REFR:OptionsAndWarrantsMember 2021-01-01 2021-12-31 0000793524 REFR:OptionsAndWarrantsMember us-gaap:SubsequentEventMember 2023-02-01 2023-02-28 0000793524 REFR:SubscriptionAgreementMember 2022-09-14 2022-09-16 0000793524 REFR:SubscriptionAgreementMember 2022-09-16 0000793524 REFR:SubscriptionAgreementMember 2022-01-01 2022-12-31 0000793524 REFR:SubscriptionAgreementMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000793524 REFR:SubscriptionAgreementMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0000793524 REFR:TwoThousandNineteenEquityIncentivePlanMember 2022-12-31 0000793524 REFR:NonEmployeeStockOptionMember us-gaap:WarrantMember srt:MinimumMember 2022-01-01 2022-12-31 0000793524 REFR:NonEmployeeStockOptionMember us-gaap:WarrantMember srt:MaximumMember 2022-01-01 2022-12-31 0000793524 us-gaap:InvestorMember 2022-12-31 0000793524 REFR:NonEmployeeStockOptionMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0000793524 us-gaap:StockOptionMember 2020-12-31 0000793524 us-gaap:StockOptionMember 2020-01-01 2020-12-31 0000793524 us-gaap:StockOptionMember 2021-01-01 2021-12-31 0000793524 us-gaap:StockOptionMember 2021-12-31 0000793524 us-gaap:StockOptionMember 2022-01-01 2022-12-31 0000793524 us-gaap:StockOptionMember 2022-12-31 0000793524 srt:MinimumMember 2022-01-01 2022-12-31 0000793524 srt:MaximumMember 2022-01-01 2022-12-31 0000793524 srt:ChiefExecutiveOfficerMember 2022-01-01 2022-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-K

 

ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) of

THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2022   Commission File Number 000-14893

 

RESEARCH FRONTIERS INCORPORATED

(Exact name of registrant as specified in its charter)

 

delaware   11-2103466

(State or other jurisdiction of

incorporation or organization)

  

(I.R.S. Employer

Identification No.)

 

240 CROSSWAYS PARK DRIVE    
WOODBURY, new york   11797-2033
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code (516) 364-1902

 

Securities registered pursuant to Section 12(b) of the Act:   Name of Exchange
Title of Class   on Which Registered
Common Stock, $0.0001 Par Value   The NASDAQ Stock
    Market

 

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☒

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

 

  Large accelerated filer ☐   Accelerated filer ☐   Non-accelerated filer ☐

 

Smaller reporting company ☒ Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared its audit report. ☐

 

If the securities registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to Section 240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

 

The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant as of June 30, 2022 (the last business day of the registrant’s most recently completed second fiscal quarter), computed based on the closing sale price of $1.74 was $49,488,280. In making this computation, all direct and indirect shares known to be owned by directors and executive officers of the Company and all direct and indirect shares known to be owned by other persons holding in excess of 5% of the Company’s common stock have been deemed held by “affiliates” of the Company, and awards of restricted stock subject to vesting are assumed to have been fully issued and outstanding. Nothing herein shall prejudice the right of the Company or any such person to deny that any such director, executive officer, or stockholder is an “affiliate.”

 

On March 9, 2023, the registrant had 33,509,287 shares of Common Stock outstanding.

 

 

 

   

 

 

PART I

 

ITEM 1. BUSINESS

 

Forward-Looking Statements

 

Information included in this Annual Report on Form 10-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical facts, but rather reflect our current expectations concerning future events and results. We generally use the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “will” and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, those factors set forth in this Annual Report on Form 10-K under “Item 1A. – Risk Factors” below. Except as required by applicable law, including the securities laws of the United States, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this Annual Report on Form 10-K.

 

General:

 

As used herein, “we,” “us,” “our,” the “Company” or “Research Frontiers” means Research Frontiers Incorporated unless otherwise indicated. Research Frontiers operates in a single business segment which is engaged in the development and marketing of technology and devices to control the flow of light (see Note 1 to the Consolidated Financial Statements). We develop and license our patented suspended particle device (“SPD-Smart”) light-control technology to other companies that manufacture and/or market the: (i) SPD-Smart chemical emulsion, (ii) light-control film made from the chemical emulsion, (iii) the light-control panels made by laminating the film, (iv) electronics to power end-products incorporating the film, or (v) lamination services for, and the end-products themselves such as “smart” windows, skylights and sunroofs. Research Frontiers currently has over 40 companies that, in the aggregate, are licensed to primarily serve five major SPD-Smart application areas (aerospace, architectural, automotive, marine and display products) in every country of the world.

 

The Company has entered into a number of license agreements covering its light control technology. During 2022, four licensees accounted for 28%, 23%, 13% and 11% of fee income recognized during the year. During 2021, four licensees accounted for 20%, 18%, 18% and 12%, of fee income recognized during the year.

 

Research Frontiers was incorporated in New York in 1965 to continue early work that Dr. Edwin Land, founder of Polaroid Corporation, and others had done in the area of light-control beginning in the 1930s. Research Frontiers was reincorporated in Delaware in 1989. Since 1965, Research Frontiers has actively worked to develop and license its own SPD technology, which it protects using patents, trade secrets and know-how. Although patent and trade secret protection is not a guarantee of commercial success, Research Frontiers currently has 219 patents that have been issued worldwide. In addition, the Company has current patent applications in the US and other countries that, if granted, would add a significant number of additional patents to its portfolio. The Company has and continues to devote significant resources to develop, license and protect its intellectual property position.

 

SPD-Smart products use microscopic light-absorbing nanoparticles that are typically suspended in a film. These particles align when an electrical voltage is applied, thus permitting light to pass through the film. Adjustment of the voltage to the SPD film gives users the ability to quickly, precisely and consistently regulate the amount of light, glare and heat passing through the window, skylight, sunroof, window shade or other SPD-Smart end-product. This SPD film can be incorporated between two layers of glass or plastic, or combinations of both, to produce a laminate that has enhanced energy efficiency, light-control and security performance properties.

 

 1 

 

 

Research Frontiers believes that the SPD industry is in the initial phase of growth. SPD light-control technology may have commercial applicability in many products where variable light-control is desired. Some existing product applications for SPD-Smart glass or plastic include the following:

 

● Automotive:
   
  sunroofs, sun visors, side windows and rear windows, and head-up displays;
   
● Aerospace and marine:
   
  windows, doors, partitions, sun visors, skylights, and lateral cockpit windows;
   
● Architectural:
   
  commercial and residential windows, doors, skylights, and partitions for new construction, replacement, and retrofit applications.

 

● Information Displays:
   
  SPD-Smart light-control film combined with Transparent OLED displays and PDLC projection systems.

 

In addition to the product applications listed above, SPD-SmartGlass technology may also offer potential benefits in the development of new flat panel displays, light conservation panels, neonatal and other incubators, consumer electronics, eyewear, automotive exterior lighting systems, self-dimming automotive rear-view mirrors and other reflective information displays. However, such products need additional product design, engineering or testing before the commercial potential of such SPD-SmartGlass products can be determined.

 

Some of our licensees consider the stage of development, product introduction strategies and timetables, and other plans to be proprietary or secret. Unless required to disclose such information, the Company may limit its disclosure of licensees’ activities until such licensees, or their customers, make their own public announcements of planned or actual product launches.

 

Some of the early sales and uses of SPD technology were to low volume commercial installations and some have involved concept and test installations by licensees and their customers. Recent progress with regard to market development and commercialization activity has been the result of focused and active efforts by Research Frontiers and its key licensees who have invested in product development and improvements, production facilities, increased production capacity, durability, performance testing, quality control and assurance, and marketing programs.

 

Beginning in late 2011, higher volume sales of SPD products commenced with the launch by Daimler AG of the Magic Sky Control™ all glass roof option on their Mercedes-Benz SLK (subsequently renamed SLC). In early 2012, sales of the Magic Sky Control™ all glass roof option commenced on their Mercedes-Benz SL. In mid-2014, sales of the Magic Sky Control™ all glass roof option commenced on the new S-Class Coupe with other Mercedes-Benz S-Class variants began offering the Magic Sky Control™ all glass roof option in 2015 and 2016. These vehicles were discontinued at the end of their current model lifecycle. In the case of the SLC and SL roadsters, it is expected that the next version of the SL roadster might use a canvas roof instead of the current switchable and static tint glass roofs. It has not been announced whether plans for the next models of the S-Class and Maybach vehicles will include any switchable glass technology in the sunroofs or windows. Subsequent to introduction by Mercedes, other car makers such as McLaren, General Motors, Ferrari and others have introduced SPD-SmartGlass roofs and other products into serial production in various car models, and other new car models using SPD-SmartGlass technology are expected to enter into serial production based upon current development efforts that are underway between the Company’s licensees and these automakers. Increased volumes of products using SPD-SmartGlass technology are also expected in trains, boats, aircraft, and other transportation vehicles, in architectural applications, and in various forms of information displays for the consumer and transportation markets.

 

Research Frontiers believes that with the normal progression of product and manufacturing improvements, and as licensees become more experienced at the lamination, fabrication and installation of SPD-Smart products for various applications, the adoption rates for SPD-Smart products will grow and accelerate, which we expect will increase the stream of royalty income for the Company. Research Frontiers believes the largest and most predictable near and intermediate term market for its technology will be automotive glass.

 

As part of their marketing and branding programs, many of our licensees have developed their own trademarks for SPD-Smart emulsion, film, and end-products and these are listed in their respective press releases, product brochures, advertising and other promotional materials. Research Frontiers uses the following trademarks: SPD-Smart™, SPD-SmartGlass™, VaryFast™, SPD-CleanTech™, SPD Clean Technology™, SmartGlass™, The View of the Future - Everywhere you Look™, Powered by SPD™, Powered by SPD-CleanTech™, Powered by SPD Clean Technology™, SG Enabled™, SPD Green and Clean™, SPD On-Board™, Speed Matters™ and Visit SmartGlass.com - to change your view of the world™.

 

 2 

 

 

In each of the last three fiscal years the Company devoted substantially all of its time to the development of one class of products, namely SPD-Smart light-control technology, and therefore revenue analysis by class is not provided herein. Information about our operations and those of our licensees is included below and in our financial statements and notes thereto.

 

The Company does not believe that future sales will be seasonal in any material respect. The Company does not currently directly manufacture products on its own but rather depends on activities of its licensees and vendors. Due to the nature of the Company’s business operations and the fact that the Company is not presently a manufacturer, there is no backlog of orders for the Company’s products.

 

The Company believes that compliance with federal, state and local provisions which have been enacted or adopted regulating the discharge of materials into the environment, or otherwise relating to the protection of the environment, will not have a material effect upon the capital expenditures, earnings and competitive position of the Company. The Company has no material capital expenditures for environmental control facilities planned for the remainder of its current fiscal year or its next succeeding fiscal year.

 

Employees:

 

On March 9, 2023, the Company had six full-time employees, two of whom are technical personnel, and the rest of whom perform legal, finance, marketing, investor relations, and administrative functions. Of these employees, one has obtained a doctorate in Chemistry and one has extensive industrial experience in electronics and electrical engineering. One employee also has a postgraduate degree in business administration, and one has a doctorate in jurisprudence. Also, the Company’s suppliers and licensees have people on their teams with advanced degrees in a number of areas relevant to the commercial development of products using the Company’s technology. The success of the Company is dependent upon, among other things, the services of its senior management, the loss of which could have a material adverse effect upon the prospects of the Company.

 

Smart Glass Industry Trends:

 

There are favorable converging global trends in the major near-term markets for smart glass and SPD-Smart products. The potential for smart glass products is significant and is expected to attain economies of scale with increasing high-volume production. This increased production is also expected to bring down end product costs and expand market opportunities.

 

In both public and private sectors across the world, there are substantial efforts targeted toward the promotion and use of energy efficient smart glass materials, including those used in automobiles, windows and other architectural glazings, aircraft and boats. Products using SPD-Smart technology continue to be exhibited at trade shows, conferences, and industry events, with such products not only being exhibited by our licensees but also by their customers and by OEMs. While there can be no assurance that these trends will continue, to the extent that they do continue, each is expected to have a beneficial effect on future interest in SPD-Smart technology.

 

In October 2019, MarketsandMarkets issued Smart Glass Market by Technology (Suspended Particle Display, Electrochromic, Liquid Crystal, Photochromic, Thermochromic), Application (Architecture, Transportation, Consumer Electronics), and Geography - Global Forecast to 2023. This market research report concludes that the smart glass market is expected to grow from USD $2.8 billion in 2016 to reach USD $8.35 billion by 2023, with a growth rate of 16.6% between 2017 and 2023. Key conclusions in this report included:

 

● Smart glass, especially active glass, provides a higher control over heat and light at the will of the user, thereby providing considerable electricity cost-savings and conclusively making the construction spaces more environment-friendly.
   
● Smart glass technology has been in existence for the last few decades; however, its demand is gathering momentum on account of improved innovation in raw materials and technologies and the possibility for new applications across various sectors. North America and Europe have been at the forefront of this trend. Smart glass demand is growing in the Asia Pacific region on account of its growing building and construction, electronics, and transportation sectors.

 

 3 

 

 

● One of the biggest hindrances to the growth of smart glass industry demand is its higher cost. The higher cost of raw material and its limited availability is undermining its penetration at a larger scale. Constant innovations are happening in terms of raw material, product design, and work capacity, which will simultaneously attract new users and provide opportunity to manufacturers to rationalize the product cost over the forecast period.

 

In January 2023, MarketsandMarkets issued Smart Glass Market by Technology Smart Glass Market by Technology (Suspended Particle Display, Electrochromic Glass, Liquid Crystals, Micro blinds, NanoCrystals, Photochromic and Thermochromic), Application, Control Mode and Geographic Analysis - Global Forecast to 2027.

 

This market research report concludes that the smart glass market is expected to grow from USD $5.0 billion in 2022 to reach USD $8.2 billion by 2027, with a growth rate of 10.4% between 2022 and 2027. Key conclusions in this report included:

 

●

Electrochromic technology to hold largest share of smart glass market during forecast period: Electrochromic technology held ~49% of the market in 2021—the largest share. This is attributed to the faster switching time of electrochromic glass from a clear to dark state and increasing investments in this technology.

   
● The increased traction of electrochromic technology is primarily attributed to the benefits it offers in a sustainable building design. A majority of the top smart glass manufacturers are focusing on R&D to bring down the prices of smart glass without compromising on quality and thus achieve economies of scale.
   
● Smart glass using electrochromic and SPD technologies is expected to witness huge demand in the coming years since the degree of customization is high in these two technologies, and the cost of these technologies is expected to drastically decrease.
   
● Architecture is projected to register highest CAGR during the Forecast period by application. The marketability of a residential or commercial facility considerably depends on comfort, aesthetics or interior design, and eco-friendliness. Smart glass offers the architecture application energy efficiency and improved aesthetics. Smart glass products have inherent properties that help in market growth. The glare control property of smart glass eliminates unwanted glare from sunlight and can provide bright, clear, and customized lighting levels in the building. Smart glass is also used to adjust the heat levels in buildings. The self-cleaning property of smart glass offers users a superior experience at the low cost of maintenance.
   
● Opportunity: Growing need for sustainable buildings. The world is becoming conscious of climate change, global warming, and its impact on the planet. The pandemic has also shown the need for green buildings and the benefit of having a sustainable living space. As part of the EU (European Union) Green Deal, the European Commission has set a target to make Europe a climate-neutral The EU also issued directives to member states like the “New Energy Performance in Building” in 2018 to promote sustainable buildings. continent by 2050, focusing on sustainable building and energy performance.

 

In June 2019, Grand View Research issued Smart Glass Market Size, Share & Trends Analysis (SPD, PDLC, Liquid Crystal, Electrochromic), By Application (Consumer Electronics, Architectural Transportation), And Segments Forecast, 2019-2025. This market research report concludes that the smart glass market is expected to grow from USD $3.7 billion in 2018 to reach USD $8.6 billion by 2025 reflecting a growth rate of 15.2%. Key conclusions in this report include:

 

  ● Smart glass has gained importance due to its inherent capability of thermal and acoustic insulation, energy conservation, and aesthetic 3D designer proposition.

 

  ■ The automotive and residential applications have witnessed a dynamic phase change in functionalities from legacy weather protection features to seclusion apparatus and advanced energy-conserving.
     
  ■ Architecturally advanced construction philosophies incorporating the installation of large windows in the majority of buildings are projected to drive demand in Europe.

 

  ● The transportation segment accounted for the highest market share in 2018 and is projected to retain its leading position throughout the forecast years. The segment is further categorized into automotive, aircraft, and marine.

 

  ■ Automotive sector is the largest consumer of switchable glass and captured the largest revenue share of more than 70% in 2018.
     
  ■ The technology provides protection from UV rays and controls heat inside the vehicles by limiting energy consumption.
     
  ■ Initiative for reducing CO2 emissions and minimizing energy consumption are encouraging manufacturers to develop anti-heat glass and glazing solutions.
     
  ■ High demand for luxury automobiles, especially in Asia Pacific, is driving the market growth.
     
  ■ Major aerospace manufacturers, such as The Boeing Company, Beechcraft Corporation, Airbus SA, Bombardier Inc., and Embraer S.A., are shifting towards electronically dimmable windows.

 

Automotive Market:

 

In the automotive industry, global trends include the introduction of larger sunroofs and panoramic roof panels in transportation vehicles, and a higher percentage of these vehicles having a sunroof or using more glass in the roof.

 

SPD-SmartGlass has also been shown in armored automotive glass applications, recreational vehicles, and a new market is also beginning to develop for personalized custom conversions of automobiles for owners who wish to express themselves through the design of the cars they own and/or drive.

 

 4 

 

 

Aircraft Market:

 

In the aircraft industry, there is a trend towards larger windows with more passenger control and functionality, and an increased investment in improving the passenger experience. In the “transport category” (primarily large commercial passenger aircraft) segment, the world’s two largest aircraft manufacturers are both promoting the size of the windows in new aircraft platforms already being delivered (e.g. Boeing 787 and Airbus A350). In the “general aviation” category (primarily business jets, private or chartered smaller aircraft) this trend is true as well. For example, Gulfstream is promoting the size of the windows on their G650 platform as well as their upcoming G700 flagship aircraft, and Bombardier highlights the size of the cabin window on the Global 7000 and 8000 platforms. Several OEMs either already offer, or have announced their interest to include, electronically dimmable windows in their aircraft – including Boeing, Airbus, Bombardier, Embraer, Textron-Beechcraft, HondaJet, Airbus Helicopters, Airbus Corporate Jets, Bell Helicopter, Dassault, Epic Aircraft and One Aviation. Electronically dimmable windows for aircraft may use SPD technology or may use other smart window technologies such as liquid crystal or electrochromic technology. A window system using electrochromic technology was introduced in the Boeing 787. There have been concerns raised that this aircraft’s electronically dimmable windows are not dark enough for long haul flights, transmit too much heat into the cabin, and have a switching speed that is too slow.

 

The Company believes its SPD technology offers important performance advantages over other technologies including faster, more uniform response time, superior heat-rejection when the aircraft is parked on the ramp, superior acoustic insulation, an automated dimming system to continuously maintain a constant level of light in the cabin in real-time, weight-savings, and the use of scratch-resistant, lightweight (saving fuel) chemically strengthened glass. Leading companies manufacturing electromechanical pleated window shades have products that incorporate SPD-Smart windows into their designs, and Tier 1 suppliers of other cabin systems (e.g. cabin management systems) are featuring SPD-Smart electronically dimmable windows in mockups.

 

SPD technology is also the only commercially available light-control smart window technology known to have passed the stringent safety and durability tests required by the aviation industry and to have received a Supplemental Type Certificate (STC) from the Federal Aviation Administration. Today, SPD-Smart electronically dimmable windows are flying on over 40 models of various aircraft including those used in commercial aviation, general aviation and military aviation. SPD-Smart products have been selected by aircraft manufacturers as standard equipment on new production platforms including the Honda Aircraft HondaJet, Textron-Beechcraft King Air 250, 350i and C90GTx, Epic Aircraft E1000, and was selected for the One Aviation Eclipse 700, production of which is now discontinued. <One Aviation is now defunct and the 700 was not produced. Should we delete this?>

 

Architectural Market:

 

The architectural community is actively increasing the use of daylight harvesting, green building technologies and building automation systems to more effectively capture and control natural light as part of energy reduction strategies to offset cooling/heating costs and electricity used by artificial lighting. In addition to design, aesthetic and other benefits, the expanded use of glass also supports a growing body of research which finds that the presence of and control over incoming natural light improves an individual’s well-being and productivity. Products using SPD-Smart light-control technology – sunroofs, windows, skylights, partitions and others – can play an important role in supporting these converging global trends.

 

For architectural applications, various market forces and the distinctive features of SPD-SmartGlass are having a positive influence on interest for SPD-Smart products. Many architects are specifying more glass in their designs to satisfy building occupants’ desire for greater connectedness with the outside environment. In addition, there is increasing interest in improving energy efficiency in both commercial and residential buildings. Various studies indicate that buildings in the United States and Europe now account for an estimated 39-40% of total energy use and upwards of 70% or more of electricity consumption. Many architects and building owners are striving for sustainable, “green” buildings that are highly energy-efficient, reduce environmental impact, and improve occupant health and well-being. In addition, the design community is increasingly interested in advanced daylighting systems in buildings that lower electrical lighting usage and reduce heating and cooling loads. Because of this, the ability to control light, glare and heat in these building applications is very important and advanced solutions often are needed to optimize operating efficiencies. SPD-Smart architectural products instantly and precisely provide shading, glare control and heat management solutions for offices and homes, especially when these products are available for new construction, replacement and retrofit projects. These products include insulated glass units, single-panel retrofits, unusually shaped glazings, and products with advanced fabrications such as those with ballistic- and blast-resistant capabilities.

 

In 2015, Research Frontiers’ patented SPD-SmartGlass technology was selected as the exclusive smart glass for the USA Pavilion at the World’s Fair, Expo Milano 2015. The USA Pavilion featured 312 large panels of SPD-SmartGlass manufactured under license from Research Frontiers by Isoclima S.p.A. Each panel measures approximately 1 meter by 3 meters, making the total surface area in the roof more than 10,000 square feet. This is the largest known installation of smart glass in the world for a roof application and was seen by over 6 million people.

 

 5 

 

 

Marine Market:

 

In the marine application, where light-control needs are especially important, many yacht manufacturers currently employ less than ideal glazing solutions as they try to satisfy various shading and solar control objectives. For example, some report having to use as many as five different types of glass in a typical yacht to satisfy diverse glazing needs. SPD-Smart marine products can reduce the number of different types of glass used in these yachts because of their increased functionality, superior performance and versatility. SPD-Smart marine products provide an innovation that allows these operators to manage incoming light, glare and heat while achieving privacy or maintaining one’s view as desired.

 

Historical Background and Recent Developments:

 

1. SPD-Smart Film Production

 

Hitachi Chemical

 

An important material used in SPD-Smart end-products is SPD light-control film that varies the tint of glass or plastic. In early 2007, our licensee Hitachi Chemical began producing its initial SPD-Smart light-control film on its first factory line. During the second half of 2009, Hitachi Chemical announced that it had begun mass production on its new, larger capacity production line and expanded its annual production capacity to 400,000 square meters (over 4.3 million square feet).

 

Hitachi Chemical’s production line is dedicated exclusively to the production of SPD-Smart film. In July 2009, Hitachi Chemical launched its website dedicated to its SPD-Smart light control film and during 2009, Hitachi Chemical outlined in its press releases and public presentations that it plans to “accelerate the use of SPD film, which holds significant potential for growth” and noted that “SPD film is positioned as one of the key emerging products promoted by Hitachi Chemical to become a future leading product for the company.”

 

Hitachi Chemical expanded its SPD film product portfolio by initiating commercial production of a “lighter” version of its film. Both the SPD “dark” and “light” versions of the films provide a high range of visible light transmission. The best-selling SPD “dark” film has a range of approximately 0.5% to 55.0%. This leads to contrast ratios (the ratio of clear to dark light transmission) of up to 110:1. The commercialization of both “dark” and “light” versions of SPD-film provides greater design and performance options for end-product applications.

 

Hitachi Chemical sold its overall business to Showa Denko, and although sales of SPD film by Showa Denko continued through late 2022, it is expected that Showa Denko may reduce or discontinue the sale and branding of SPD film as part of the acquisition of Hitachi Chemical.

 

Gauzy Ltd.

 

In October 2018, Gauzy Ltd. announced that it will be producing SPD-Smart light control film for the entire SPD-SmartGlass industry. The announcement came at a ceremony to celebrate the inauguration of Gauzy’s production line to produce SPD-Smart light control film in Tel Aviv-Jaffa.

 

Gauzy initially announced that its Tel-Aviv film production line has a capacity to produce up to 364,000 square meters of film per year per shift, and that its initial production will be 1.2 meters wide, and in 2019 it planned on expanding its SPD film coating capabilities to 1.5 meters wide rolls, and in 2020 to 1.8 meters wide rolls. In February 2019 Gauzy announced that it would be expanding its SPD film production capacity by having SPD emulsion produced in Tel Aviv and that this emulsion would be coated into SPD-Smart light control film in a new dedicated factory being built by Gauzy in Stuttgart, Germany.

 

In December 2019, Gauzy Ltd. celebrated the opening of its second production facility in Stuttgart, Germany to produce SPD-Smart light control film for the entire SPD-SmartGlass industry. This state-of-the-art facility, with specially designed coating and curing areas, will give Gauzy the capacity to coat over one million square meters of SPD film per year in widths of up to 1.8 meters.

 

In January 2023, Research Frontiers, Gauzy Ltd. and their customers showed over 115 thousand attendees at this year’s CES new ways to benefit from SPD-SmartGlass.

 

 6 

 

 

In April 2020, Gauzy Ltd. announced that it secured Series C investments from Hyundai Motor Company, Blue Red Partners VC, and Avery Dennison. This strategic investment marks the first known equity investment by an automotive OEM in Research Frontiers’ entire industry. As part of the announcement of this investment, Gauzy confirmed that its state-of-the-art material synthesis facility in Israel, and its custom SPD production line strategically located in Germany, are currently operating and producing SPD emulsion and light control film for the automotive, aircraft, and architectural industries, with modified staffing and procedures to protect Gauzy’s employees during the COVID-19 pandemic.

 

Customers for Showa Denko’s and Gauzy’s SPD-Smart film are end-product licensees of Research Frontiers. These licensees receive the film, laminate it between glass or plastic substrates, and then fabricate end-products which are sold into various industries. Most end-product licensees pay Research Frontiers a royalty on the sale of these end-products that typically range from 10-15%.

 

Others

 

Other companies are currently licensed by Research Frontiers to sell SPD-Smart light-control film to licensees of Research Frontiers. None of these other companies has yet announced commercial SPD film for sale.

 

Transportation Vehicle Products:

 

SPD-SmartGlass is used extensively across many vehicle platforms in the transportation industry. With the use of SPD-SmartGlass light-control film, passengers and occupants in cars, boats, trains, RVs and other vehicles can instantly change the tint of their windows, sunroofs and other glazings to help keep out harsh sunlight and heat, and create an open-air feeling even when the window or sunroof is closed.

 

In October of 2022, Gauzy’s Vision Systems discussed their forty-one contracts with transportation OEM and Tier-1 suppliers using SPD-SmartGlass technology, summarized below:

 

● Aerospace Contracts  
  + Helicopter Platforms 5 Contracts
  + Aircraft Platforms 11 Contracts
  + Aircraft Platforms: Airline (Retrofit) 1 Contract
     
● Marine Contracts  
  + Sailing Yacht Platforms 3 Contracts
  + Yacht Platforms 4 Contracts
  + Cruise Ship Platforms 2 Contracts
     
● Railway Contracts  
  + Railway Platforms 3 Contracts
     
● Specialty Vehicle Contracts  
  + Specialty Vehicle Platforms 9 Contracts
     
● Recreational Vehicle Contracts  
  + RV Platforms 3 Contracts

 

2. SPD-Smart Automotive Products:

 

Research Frontiers and its licensees are currently working with multiple automotive manufacturers to introduce SPD-Smart windows, sunroofs and roof systems on both concept and production vehicles. Research Frontiers’ end-product licensees in this sector include industry leaders American Glass Products, Asahi Glass, Custom Glass, Daimler AG, Isoclima, Pilkington Glass, Saint-Gobain, SER, and Vision Systems. The Company’s automotive glass licensees account for the majority of all glass produced for the automotive market throughout the world.

 

Automotive OEMs:

 

In 2011, Daimler AG began using SPD-SmartGlass technology in its Magic Sky Control™ panoramic glass roof as an option on its new Mercedes-Benz 2012 SLK. In 2012, Daimler AG began offering its Magic Sky Control™ panoramic glass roof as an option on its new Mercedes-Benz 2013 SL. These SPD products allow drivers and passengers to change the tint of the car roof from dark to clear quickly with a touch of a button. The SLK and SL are the first large-scale series production vehicles to offer SPD-SmartGlass. The Research Frontiers licensees involved with the production of the Magic Sky Control™ roof for the SLK and SL include Showa Denko, which manufactures the SPD-Smart light-control film in Japan. Automotive glass companies Nippon Sheet Glass in Japan and its subsidiary, Pilkington, in the UK and Germany then process and laminates Hitachi’s SPD film into the glass for the Magic Sky Control™ roof.

 

In late 2014, Daimler AG began offering its Magic Sky Control™ as an option on the new Mercedes-Benz S-Class Coupe. In 2015, other S-Class variants (i.e. Standard Wheel base W222, Long Wheel Base V222, Maybach S600 X222 and the Maybach Pullman Limousine) began offering Magic Sky Control™ as an option. The current Mercedes-Benz S-Class is the third large-scale serial production vehicle to offer Magic Sky Control™ using SPD-Smart technology.

 

The S-Class Coupe offers the largest panoramic Magic Sky Control™ roof ever put into serial production. The surface area of the panoramic roof using SPD-SmartGlass technology on the S-Class is approximately three times the size of the roof glass used on the current SLC and SL roadster. With the addition of the new 2018 S450 and S450 4MATIC S-Class Sedans, a total of 14 Mercedes-Benz model variants have now offered this remarkable panoramic smart glass roof:

 

● S 450 S-Class Sedan
   
● S 450 4MATIC S-Class Sedan
   
● S 560 4MATIC S-Class Sedan

 

 7 

 

 

● AMG S 63 S-Class Sedan
   
● Mercedes-Maybach S 560 4MATIC
   
● S550 4MATIC S-Class Coupe
   
● AMG S63 S-Class Coupe
   
● AMG S65 S-Class Coupe
   
● SLC 300 Roadster
   
● AMG SLC 43 Roadster
   
● SL 450 Roadster
   
● SL 550 Roadster
   
● AMG SL63 Roadster
   
● AMG SL65 Roadster (Standard Equipment)

 

A key factor in the broad adoption of SPD technology in various automotive windows is its cost. Typically, the cost for new technology products decreases as production volumes increase. The price per square foot of SPD-SmartGlass reported by our licensees has gone down over time in the automotive market. Royalties from the Magic Sky Control panoramic roofs generate a royalty of 10% of the selling price of these roofs by our licensees to Daimler. The roofs on the S-Class are approximately two to three times the surface area of the roofs on the SLC and SL vehicles.

 

Research Frontiers believes that the addition of the S-Class car model is also significant because it applies our SPD-Smart light-control technology to the broader class of vehicles by moving beyond roadsters to coupes and passenger sedans. Historically, since its debut over 40 years ago, the S-Class represents the premier platform to introduce new technologies to the customer, which in many cases expand to the other less expensive model lines within the Mercedes-Benz brand.

 

In November 2015 at the Los Angeles Auto Show, Mercedes-Benz launched a refreshed Mercedes-Benz SL. The press release from Mercedes-Benz stated, “Another feature which has been retained is the unique optional extra MAGIC SKY CONTROL: when closed, the panoramic vario-roof automatically changes from dark to transparent or vice-versa within just a few seconds.” The MAGIC SKY CONTROL feature is a carry-over from the previous model. Other new features include a new front end, new headlamps, more powerful engines, and a new transmission, among many others.

 

In January 2016 at the North American International Auto Show in Detroit, Mercedes-Benz premiered the new Mercedes-Benz SLC. The press release from Mercedes-Benz when the SLC was first announced stated, “A feature that continues to be unique to the SLC is the panoramic vario-roof with Magic Sky Control – this glass roof is lightened or darkened at the touch of a button. This means that it provides an open-air feeling at any time, but when required gives welcome shade under a hot sun.” The Magic Sky Control feature, using Research Frontiers SPD-SmartGlass technology, is a carry-over from the SLC’s predecessor model, the SLK roadster.

 

McLaren was the second auto manufacturer to adopt the Company’s SPD-SmartGlass technology for series production in the automotive market. The following new production cars by McLaren Automotive featured SPD-SmartGlass technology in their roofs: the McLaren GT, McLaren 720S Spyder and McLaren Speedtail (which also incorporated SPD-SmartGlass technology in the windshield as a built-in sun visor and also other areas of the car). The McLaren GT and 720S Spyder have been in production for several years, and the McLaren Speedtail was first delivered to customers in January 2020. Since then, McLaren has included SPD-SmartGlass in additional production models.

 

 8 

 

 

General Motors was the third auto manufacturer to announce that it was putting SPD-SmartGlass into series production in the roof of their new electric ultra-luxury flagship vehicle, the Cadillac Celestiq. The SPD-SmartGlass sunroof for the Celestiq gives occupants control over individual segments of the sunroof above them to better customize and enhance the driving experience in terms of comfort, security, and the reduction of heat, light and glare into the vehicle. The Celestiq with its SPD-SmartGlass roof was launched at CES 2021in January 2021.

 

Also in terms of new product development in the automotive industry, in August 2020, Daimay, the world’s largest supplier of automotive sun visors, licensed Research Frontiers’ SPD-Smart light-control film technology for use in automotive sun visors. SPD-Smart light-control film technology will enable Daimay to develop products that automatically and dynamically adjust the sun visor to manage changing light and glare conditions. Daimay is developing this product in conjunction with a specific automotive manufacturer customer.

 

In the Asian automotive market, in April 2020, Gauzy Ltd. announced that it secured Series C investments from Hyundai Motor Company, Blue Red Partners VC, and Avery Dennison. This strategic investment marks the first known equity investment by an automotive OEM in Research Frontiers’ entire industry. As part of the announcement of this investment, Gauzy confirmed that its state-of-the-art material synthesis facility in Israel, and its custom SPD production line strategically located in Germany, are currently operating and producing SPD emulsion and light control film for the automotive, aircraft, and architectural industries.

 

In January 2023, Research Frontiers, Gauzy Ltd. and their customers showed over 115 thousand attendees at the CES new ways to benefit from SPD-SmartGlass, at the prestigious automotive West Hall of the Las Vegas Convention Center. Exhibits included cutting edge LCG® (Light Control Glass) smart glass in applications for passenger vehicles, aircraft and trains, as well as Advanced Driver Assistance Systems (ADAS) / Camera Monitoring Systems (CMS) for long-body on-road vehicles. Innovative new products co-developed with industry-leading automotive and technology Tier 1 original equipment manufacturers (OEMs), such as BOS, LG Display, OSG, and Continental, made their North American debut in Gauzy’s booth to demonstrate how Gauzy delivers solutions to help OEMs achieve their goals. CES was not held in person in 2021 due to concerns about the global pandemic. In January 2022 Gauzy exhibited in the Smart City pavilion at CES various commercial applications for SPD-Smart film produced by Gauzy including electronically dimmable aircraft windows, dual-zone panoramic sunroofs, smart projection systems, and information displays that combine transparent OLED and SPD technology to turn windows into high definition information or entertainment displays that can operate in bright environments and instantly and automatically adjust to changing light conditions to produce a vibrant high-contrast display.

 

In January 2023, Oliver Zipse, Chairman of the Board of Management and CEO of BMW AG, delivered the opening automotive keynote address at the CES. During the address, BMW revealed the i VISION Dee vehicle to showcase how the future of mobility can merge the real and virtual worlds. An integral part of how this was done uses a sophisticated head-up display system utilizing SPD-SmartGlass in the windshield of the car. The full side and rear glass of the i VISION Dee also uses SPD-SmartGlass to enhance the passenger experience and the integration of real and virtual environments. BMW’s implementation of Gauzy and Research Frontiers technology makes this the first vehicle to showcase the full extent that smart glass can be utilized in a passenger vehicle for shading, privacy, and transparent displays, with smart glass being used in all the windows on the front, rear and sides of the vehicle.

 

In June 2022, Research Frontiers announced: “Cool and Coming Soon: Research Frontiers SPD-SmartGlass Technology in Cadillac CELESTIQ Electric Vehicle.” CELESTIQ’s full-glass roof is expected to be one of the first to feature a large four-quadrant panel of SPD-SmartGlass. Using Research Frontiers’ patented SPD-Smart light-control technology, each occupant of the vehicle can set their own level of roof transparency. The driver and front-seat passenger will enjoy a pillar-to-pillar freeform display with active privacy to help mitigate driver distraction, while rear-seat passengers have personalized entertainment screens. Console screens between seats in the front and back will separate individualized comfort settings from entertainment displays to minimize distractions. The Cadillac CELESTIQ will be built on GM’s Ultium Platform, the heart of the company’s EV strategy. The CELESTIQ will be the first production vehicle to be built at GM’s Global Technical Center.

 

In September 2021, Research Frontiers licensee Gauzy Ltd. and their customers showed at the Munich Auto Show (AIA 2021) SPD-SmartGlass, including two new products using SPD light control technology: in collaboration with LG Display, a unique automotive information displays with improved readability and performance, and a SPD-SmartGlass headlight by BMW for its BMWi Vision Circular Showcar. This vehicle utilized SPD-Smart light-control film that is laminated into automotive thin glazed curved glass. As the all-electric car starts, the SPD glass in the dynamic shading headlights switches from dark to transparent, revealing headlights that illuminate surroundings. Gauzy also presented an SPD sunroof with and without invisible segmentation.

 

Other automakers continue to develop and evaluate the use of SPD technology in their windows systems. Such window systems include sunroofs, side-windows, rear-windows and sun visors. Some automakers and their suppliers have incorporated SPD-SmartGlass in concept vehicles, with some of these concept vehicles being exhibited at major auto shows:

 

● March 2019:
   
  At the 2019 Geneva Auto Show, Mercedes-Benz SLC roadster, SL roadster, S-Class Sedan and Maybach vehicles in serial production were presented using the Company’s SPD-SmartGlass technology.
   
● January 2019:
   
  At least four different companies showcased SPD-Smart products at CES 2019 in the automotive and consumer electronics industries.
   
● November 2018:
   
  Two concept electric vehicles debuted at the 2018 Los Angeles Auto Show featured SPD-SmartGlass and were also showcased at various automotive and other major industry trade shows during 2019 and early 2020. These two vehicles are scheduled to be in production in 2020.
   
  At various trade shows beginning with electronics 2018 in Munich in November, Texas Instruments demonstrated a control unit reference design (TIDA-020013) created to more intelligently and efficiently power SPD-SmartGlass electronically dimmable glass using a standard 12-volt automotive battery. The interactive demonstration is paired with gesture control to lighten or tint glass with the SPD-SmartGlass technology.
   
  The SPD-SmartGlass sunroof application gives occupants more control over the lighting in their car, removes unwanted heat, light and glare, and increases the driving range of electric vehicles. It also miniaturizes the electronics package and reduces the cost of the entire system to the auto maker, while also improving power efficiency. Engineers can use the TI reference design to accelerate their own designs using electronically dimmable glass. The design includes TI’s highly efficient power management circuits and a 32-bit C2000™ real-time MCU to help generate the necessary signal to drive and control substantial surface areas.

 

 9 

 

 

● January 2018:
   
  A number of different companies showcased SPD-Smart products at CES 2018. In the automotive industry, Fisker debuted its new Fisker E-Motion with a unique and innovative four-segment SPD SmartGlass roof. In addition to use in its large curved panoramic roof, Fisker says that it plans to offer SPD-SmartGlass technology on the side windows of this new electric vehicle.
   
  Continental Corporation (“Continental”) also showcased its Intelligent Glass Control system using SPD technology at CES 2018 to demonstrate how it makes cars safer, more private and comfortable, lighter and more energy-efficient.
   
● January 2017:

 

Corning introduced a concept car that features an SPD-SmartGlass panoramic roof and rear glass at the 2017 Consumer Electronics Show. This large roof and curved rear glass is made using SPD-SmartGlass light-control film laminated between Corning’s Gorilla® Glass, a special chemically-strengthened thin and lightweight glass.

 

At the 2017 Consumer Electronics Show, Continental Corporation (“Continental”) showcased an advanced version of its SPD-equipped vehicle that it originally showcased at the 2016 Consumer Electronics Show. This vehicle has enhanced and more sophisticated electronics, Continental indicated that its Intelligent Glass Control system increases passenger comfort and lowers CO2 emissions by keeping the interior of the vehicle cooler. As a result, smaller, more efficient and lighter air conditioning units could be used. Calculations showed a reduction in CO2 emissions of four grams per kilometer. Continental also estimates that its Intelligent Glass Control system can increase the driving range of electric vehicles by 5.5%.

 

● January 2016:
   
  Continental Corporation showcased its “Intelligent Glass Control” system on a demonstration vehicle at a special event at the Consumer Electronics Show (CES) in Las Vegas. This vehicle, a Ford Mondeo station wagon, used SPD-SmartGlass technology to enable the glass in all eleven side and rear windows and in the top sun visor portion of the windshield to change its transparency and darken instantly through electric control signals.
   
● March 2015:
   
  The Lincoln Motor Company, the luxury automotive brand of the Ford Motor Company, introduced the Lincoln Continental Concept car using an SPD-SmartGlass electronically tinting sunroof. This Lincoln Continental Concept car featuring SPD-SmartGlass also made its Asian debut at Auto Shanghai in April 2015.
   
● September 2012:
   
  BMW debuted at the Paris Motor Show its new BMW Concept Active Tourer. This vehicle’s entire composite glass roof uses patented SPD-SmartGlass technology.

 

● March 2012:
   
  Mercedes-Benz debuted at the Geneva International Motor Show its public evaluation of the Limited Edition Viano Pearl. This vehicle displays the capabilities and conceptual use of SPD-SmartGlass on the side glass of vehicles from Mercedes-Benz.
   
● December 2011:
   
  Toyota debuted its FS Hybrid Concept at the 2011 Tokyo Motor Show in Tokyo, Japan. The FS Hybrid Concept demonstrated the use of SPD-Smart™ technology inside glass.

 

 10 

 

 

● September 2011:
   
  Audi debuted its A2 concept car at the Frankfurt International Auto Show in Frankfurt, Germany. The A2 is an electric-powered passenger car equipped with a large SPD-Smart™ panoramic glass roof.

 

3. Automotive Aftermarket:

 

While the highest volume market for which SPD-Smart technology is being developed is new car production by the world’s automakers, the aftermarket upgrade market also presents opportunities in the automotive market. Research Frontiers licensee American Glass Products (AGP) is offering its Vario Plus Sky SPD-SmartGlass to the automotive aftermarket as well as to the automotive OEM market for serial production. In March of 2013, Research Frontiers announced that it had added two new licensees, Tint-It JSC and Advnanotech, both of whom are targeting the automotive aftermarket in Russia. In May of 2017, Hanamac International Ltd. acquired a license from Research Frontiers to produce and sell SPD-SmartGlass automotive windows for the South Korean aftermarket.

 

In August 2019, Research Frontiers licensed São Paulo, Brazil based SER Company to make SPD-SmartGlass primarily for the automotive armored glass aftermarket in Brazil. SER Company is a Brazilian leader in the development of technologies and solutions for ballistic cars in the protection and security sector.

 

4. Recreational Vehicles//Motor Homes/Buses and Motorcoaches:

 

Most motorcoach windows use heavily tinted windows to manage excessive light, glare or heat. While this reduces somewhat the time the shade has to be down, it remains ineffective for many conditions. Also, it limits passengers’ experience of views during dusk, nighttime and dawn hours. This is due to the fact that when outside light levels are low, a heavily tinted window blocks or degrades elements of the scene outside. During these hours, the high optical clarity of SPD-SmartGlass in the “clear” state eliminates this problem.

 

Features of SPD-SmartGlass electronically dimmable windows (“EDWs”) for motorcoaches include:

 

  ○ Different zones of an EDW can be independently controlled.
     
  ○ All EDWs can be controlled centrally with a master control, or automatically with light sensors.
     
  ○ The level of noise in the motorcoach is reduced.
     
  ○ The EDWs automatically turn to the darkest state when the motorcoach engine is off, keeping the interior cooler and offering lower air-conditioning consumption and greater energy savings.
     
  ○ An ergonomic SPD-Smart dimmable motorcoach sun visor increases safety.
     
  ○ The electronics are integrated into the EDW, which facilitates OEM and aftermarket installations.

 

● October 2022:

 

At the NBAA trade show, Vision Systems discussed their SPD-SmartGlass contracts for transportation vehicles, which includes three recreational vehicle contracts.

 

● January 2020:

 

Vision Systems exhibited its SPD-SmartGlass technology for the coach marketplace at the UMA Motorcoach Expo in Nashville, TN. Vision Systems showcased an EDW with integrated information display that provides travel information such as time, temperature, remaining distance to the next stop, or service availability. Also at the show, Vision Systems’ unveiled an SPD-SmartGlass solution for the driver environment with an ergonomic SPD-Smart dimmable sun visor integrated into the upper part of the windshield, avoiding the need for the driver to handle a shade, which partially blocks the view.

 

● January 2019:

 

Vision Systems also exhibited its SPD-SmartGlass technology solutions for the coach marketplace at the UMA Motorcoach Expo.

 

 11 

 

 

● May 2017:
   
  At Caravan Salon in Dusseldorf, Germany, premium recreational vehicle supplier Lippert Components, and Knaus, a leading manufacturer of leisure vehicles in Europe, both featured the world premiere of dimmable windows using SPD-SmartGlass technology. These electronically dimmable smart windows, which dramatically improve the recreational vehicle passenger experience, were supplied by Vision Systems, a licensee of Research Frontiers.
   
● September 2014:
   
  Global Caravan Technologies, Inc. unveiled the CR-1 Carbon which features the MagicView™ roof and MagicView™ windshield with SPD-SmartGlass. This special glass, which totals 28 square feet, was jointly developed with Research Frontiers’ licensee Vision Systems. SPD nanotechnology on this vehicle allows infinitely variable control of privacy between blackout and clear and can be controlled by any smart-phone or other smart-devices. In addition to controlling the level of light and glare coming into the RV, the MagicView™ SPD-SmartGlass on RVs offers many other advantages. This technology provides unsurpassed thermal insulation: SPD-SmartGlass substantially rejects solar heat from entering RVs through windows. The SPD-SmartGlass achieves its maximum dark state when the RV is parked/turned off and no power is consumed.
   
● January 2012:
   
  Vision Systems announced that Notin, manufacturer of motorhomes and campers, selected Visions Systems’ Nuance brand of SPD-SmartGlass for the skylight of Notin’s Angara luxury motorhome. In October 2013 at Busworld 2013, Vision Systems showcased a new sun visor using SPD-Smart light-control film technology and a light sensor to automatically and dynamically adjust the sun visor to deal with changing light and glare conditions. Vision Systems indicated that it has been working for almost two years with a major automotive OEM to test the ease of installation, reliability, design and performance of its new sun visor in real world conditions. It further indicated that customer reaction regarding the effectiveness and ease of use of this product has been excellent. The fact that this feature can be installed in the aftermarket should bring these benefits to a wider range of drivers.

 

5. Rail Transport:

 

● October 2022:

 

At the NBAA trade show, Vision Systems discussed their SPD-SmartGlass contracts for transportation vehicles, which includes three railway contracts.

 

● September 2022:

 

● At the InnoTrans trade show, Gauzy showcased its SPD T-OLED in cooperation with LG Display, the world’s industry-leading manufacturer of Transparent OLED, in a railway compliant Insulated Glass Unit (IGU). These use LG Display’s state-of-the-art 55” Transparent OLED display with Gauzy SPD for high contrast and vibrant advertising and messaging in shifting lighting conditions when SPD is tinted, or a transparent window when SPD is on (clear mode).
   
● Also at InnoTrans, Gauzy showed the platinum concept, which Gauzy created for Talgo, the Spain-based railway OEM. They demonstrated a segmented SPD railway compliant IGU which allows passengers to instantly dim entire windows or specific areas for precise shading that increases visual and thermal comfort.
● Also at InnoTrans, Rehau, in collaboration with Gauzy and Research Frontiers, presented as part of the major Deutsche Bahn (DB) “Ideas Train” exhibition. This is an SPD-SmartGlass window system for trains, enabling continuously variable shading of carriage windows. This DB innovation project demonstrates how continuously variable shading using SPD-SmartGlass technology can raise comfort and sustainability to a new level in the trains of the future.

 

● February 2020

 

In February 2020, Vision Systems presented its SPD-SmartGlass marine products at the Middle East Rail show in Dubai, UAE, including a multi-zone SPD-SmartGlass dimmable window, and a dimmable divider with an integrated information display, and a concept of glass partition playing videos. The multi-zone solution exhibited is an SPD-SmartGlass panel that resembles a digital shade, providing tinting control of a chosen zone to protect from unwanted light and glare, for improving the passenger experience. Vision Systems also exhibited an SPD-SmartGlass dimmable divider with an integrated information display that gives travel information such as time, temperature, remaining distance to next stop, or service availability.

 

● September 2018

 

Innotrans, the leading international trade fair for transport technology, was the stage for the world premiere of new EDW solutions using SPD-SmartGlass technology. AGC and Vision Systems launched their respective latest generations of SPD-SmartGlass EDWs for the rail industry. In addition, Continental also new electronic control products for SPD-SmartGlass EDWs at the show.

 

 12 

 

 

Vision Systems at InnoTrans

 

Some of the products using SPD-SmartGlass for the train industry being showcased this week in Berlin include:

 

  ● EDWs with integrated control system electronics (on the passenger window EDW itself), for rapid installation in both new train car production, and retrofitting existing train cars.
  ● SPD-SmartGlass solutions for the driver cabin, to eliminate glare on the dashboard with side and back window EDWs, and/or SPD sun visors integrated into the windshield.
  ● “Info-Vision” window, which integrates an electroluminescent display into SPD-SmartGlass windows. This combines the benefits of the EDW with information available directly on the window, such as time to destination, remaining distance, temperature, service options, and train schedules.

 

In addition to the above information, Vision Systems confirmed at Innotrans that it was working on other high-volume train projects with major commuter train manufacturers and operators.

 

AGC at InnoTrans

 

AGC, a leading Tier 1 supplier of transparencies to the rail industry for over 50 years, is also prominently featuring SPD-SmartGlass EDWs. In a recent article entitled AGC at Innotrans with smart glass for transportation, it was noted, “AGC’s booth will feature AGC’s smart glasses for transportation… Wonderlite light control glazing, that switches from clear to dark at the simple touch of a button.” Wonderlite is AGC’s brand name for its SPD-SmartGlass EDWs.

 

Global Rail News published an article about Continental at Innotrans, noting, “The level of transparency… of the glass can be adjusted via a control system, which can be programmed to respond to external conditions, such as sensor data on sunlight intensity.”

 

Continental at InnoTrans

 

Continental unveiled a number of new innovations, including an intelligent technology for darkening glass panes and a range of individual surface designs. The ‘Intelligent Glass Control’ (IGC) system by Continental provides passengers with the flexibility to adjust the amount of light and the color of their window or other glazed areas to suit their needs. The technology, which was originally developed for the automotive industry, relies on a film sandwiched between two panes of glass and connected to an electronic control unit (ECU).

 

● September 2017:

 

Vision Systems announced to the press in September 2017 that it had just signed a contract to supply SPD-Smart Nuance windows for a new proposed special Shinkansen bullet train which will be put in service for the 2020 Tokyo Olympics.

 

● May 2017:
   
  AGC Asahi Glass announced its light control glass, WONDERLITETM, was adopted for JR East luxury sleeper train, Train Suite Shiki-shima (“Shiki-shima”), which began service on May 1. JR East’s luxury sleeper train Shiki-shima, conceptualized as a train for ‘enjoying changes in time and space’, has been designed with individualized themes for each compartment. Of particular note, the front carriage, containing a special area for enjoying panoramic views of Japan’s landscape, has been outfitted with WONDERLITETM light control glass, which makes it possible to adjust passing sunlight simply with a switch.
   
● September 2016:
   
  Vision Systems, with its customers/strategic partners, exhibited many different types of SPD-Smart products at InnoTrans 2016. Products included:

 

  (a) A full-scale train cabin mockup equipped with many SPD-Smart passenger windows

 

 13 

 

 

  (b) SPD-Smart windows with integrated transparent information displays
     
  (c) SPD-Smart contrast enhancement filters for displays
     
  (d) SPD-Smart windows with multi-zone switching capabilities
     
  (e) Train passenger SPD-Smart windows
     
  (f) Aftermarket driver cabin SPD-Smart windows

 

● September 2014:
   
  In September 2014, Poma (a leading supplier of cable transport systems) showcased at Innotrans 2014 its Cabine H2 cable car. The windows in this cable transport vehicle used Research Frontiers licensee Vision Systems’ “Nuance” SPD solution. Innotrans 2014 is the largest international trade fair for rail transport technology with over 160,000 visitors and is held every two years in Berlin, Germany. At this fair, Bombardier featured its “FLEXITY 2” tram platform using an electronically dimmable window produced by Vision Systems. In addition, AGC, one of the largest producers of flat glass in the world, featured its “WONDERLITE” SPD-SmartGlass train window.

 

6. Automotive Armored Glass Market:

 

Within the automotive market, a potentially additional sector is the armored glass market. Armored glass (sometimes referred to as “transparent armor” and “bullet-resistant glass”) encompasses the military, non-military government, and civilian markets. In addition, SPD-Smart technology in this market not only provides the benefits of light-control and UV blockage, it also enhances security by introducing darker tints and privacy. A number of the Company’s licensees including American Glass Products, Isoclima, and SER are recognized industry leaders in the armored glass market.

 

In August 2019, Research Frontiers licensed São Paulo, Brazil based SER Company to make SPD-SmartGlass primarily for the automotive armored glass aftermarket in Brazil. SER Company is a Brazilian leader in the development of technologies and solutions for ballistic cars in the protection and security sector.

 

7. SPD-Smart Aircraft Products:

 

Multiple aircraft manufacturers and their selected interiors installers have announced that they have selected SPD-Smart dimmable window products as standard or optional equipment for their production aircraft:

 

● Honda Aircraft Company:

 

The HondaJet, with first delivery in December 2015, comes with SPD-Smart electronically dimmable windows as standard equipment on all passenger windows.

 

● Textron-Beechcraft has SPD-Smart electronically dimmable windows as standard equipment on models of its King Air aircraft:

 

  ● The King Air 250, with first delivery during 2015
     
  ● The King Air 350i, with first delivery during 2015
     
  ● The King Air C90GTx, with first deliveries during the first quarter of 2016

 

● ONE Aviation announced the selection of SPD-Smart electronically dimmable windows for its Eclipse 700 platform, production of which is now discontinued.. <This OEM is defunct and the 700 was not produced. Should this be deleted? If it is, the first word of this section needs to change from “four” to “three>
   
●

Epic Aircraft’s E1000, with first delivery in February 2020, comes with SPD-Smart electronically dimmable windows as standard equipment on all passenger windows.

 

Airbus’ ACJ TwoTwenty, the A220 platform for private aircraft, will come with SPD-Smart windows. Airbus, as well as their selected completion center Comlux, feature the EDWs in promotional materials. Airbus shipped the first ACJ TwoTwenty to Comlux in January 2022, for the installation of the interior.

 

In October 2022, Daher showcased its TBM 960 aircraft at the NBAA show, which had SPD EDWs. The TBM 960 comes with SPD EDWs as standard equipment, which a Vision Systems partner publicly confirmed in February of 2023.

 

 

 14 

 

 

● Dassault Aviation:

 

The Falcon 5X was scheduled to come with SPD-Smart electronically dimmable skylights as standard equipment. Subsequently, however, Dassault announced in December 2017 that it was terminating the Falcon 5X program and announced the launch of a new Falcon program featuring the same skylight as the Falcon 5X. This aircraft, the Falcon 6X is scheduled to enter into service in 2023.

 

Other aircraft manufacturers and their suppliers continue to develop and evaluate the use of SPD technology in their window systems. Aircraft manufacturers and SPD product suppliers have incorporated SPD-Smart electronically dimmable windows in mockups, with some of these mockups being exhibited at major aviation shows:

 

● February 2023:

 

Vision Systems partner Verre Industrie published a news item promoting Vision Systems SPD EDW as standard equipment contract for the Daher TBM 960 aircraft. They noted, “Our partner Vision Systems has entrusted us with the manufacture of several hundred thin glasses X-Lite for dimmable windows to be fitted in series in Daher TBM 960 aircraft. This success rewards the joint efforts of recent years including the creation several prototypes before the launch in production.”

 

● October 2022:

 

At the NBAA aircraft show, Vision Systems discussed their SPD-SmartGlass contracts for transportation vehicles, which includes five helicopter contracts, eleven aircraft contracts, and one airline retrofit contract.

 

● June 2022:

 

At the 2022 Aircraft Interiors Expo, Vision Systems unveiled an “ambiance management system” for commercial and private aircraft. This system delivers the ideal atmosphere for each passenger with SPD electronically dimmable windows (EDWs), mood lighting, and large triple-window shades – and all elements of the system can be synchronized to provide an unparalleled passenger experience. Also at this show, Vision Systems unveiled new SPD EDW innovations, for first class and business class passengers on commercial airlines. This included a smart glass partition showing messages, images or videos such as traveling information or advertising. When nothing is displayed, this divider can remain transparent, or opaque (white or dark) to offer privacy between classes.

 

● April 2022:

 

At the Sun ‘n Fun Expo in Florida, OEM Daher showed its TBM 960, which features EDWs. Aircraft EDWs using SPD technology instantly and precisely control the amount of light, glare and heat in the cabin.

 

● October 2020:

 

Airbus launched the ACJ TwoTwenty business jet, a clean-sheet design aircraft based on Airbus’ A220-100, featuring advanced materials and state-of-the-art technologies that include electronically dimmable windows.

 

● November 2019:

 

Vision Systems unveiled its aircraft and helicopter SPD-Smart solutions at the Dubai Airshow in Dubai, UAE. Among the products presented at the show were an SPD-Smart electronically dimmable helicopter window, and a multizone SPD-Smart dimmable aircraft window with an integrated control panel. Vision Systems also unveiled an SPD-Smart partition combining an electronically dimmable system with an information display based on electroluminescent technology. Whether on windows or dividers, this solution can either be set in transparent or dark mode when no information is displayed, or show short travel information. The background opacity can then adjust automatically for perfect contrast and readability.

 

● April 2019:

 

Vision Systems presented its SPD-Smart EDWs at the Aircraft Interiors Expo (AIX) in Hamburg, Germany. Its system delivers important passenger experience benefits including a cooler and quieter cabin due to remarkable thermal and acoustic insulation. The following chart summarizes some of the performance advantages highlighted at the show that Vision Systems’ SPD-Smart EDWs have over electrochromic EDWs:

 

    SPD-Smart EDW   Electrochromic EDW
Switching Speed   0.5 – 3 Seconds   Minutes
         
Uniform Tinting   Yes   No
         
Heat-Blocking When Aircraft on Ramp and Unpowered  

Extremely High:

Switches to Darkest State

  

Poor – Moderate:

Switches to Clearest State

         
Noise Blocking   Extremely High   Poor – Moderate
         
Multizone Tinting   Yes   No
         
Replaces Dust Pane   Yes   No
         
Integrated Electronics   Yes   No
         
Ability to Include PDLC Film For Additional Blackout and Privacy   Yes   No
         
Integrated Information Display   Yes   No
         
Integrated Touch Panel   Yes   No

 

 15 

 

 

● October 2018:

 

Vision Systems presented its second-generation SPD-Smart EDWs, branded Nuance V2, with enhanced optics and a lower cost at the NBAA business aviation show. The solutions on display at Vision Systems’ NBAA included:

 

  ○ Multizone: This Nuance V2 solution allows independent control of light and glare through different “zones” of an SPD-Smart EDW, to any level of tint.
     
  ○ Variable light control with diffused light / privacy control: This SPD-Smart solution enables instant and precise dimming from clear to very dark, plus an opaque white or dark feature for privacy and enjoying soft, diffused daylight through the EDW.
     
  ○ Interactive: Vision System’s Info-Vision is the first smart information window integrating SPD-Smart and electroluminescent technologies. This economical innovation, for use in windows and cabin dividers, provides passengers with travel and other information right on the window. The tint of the Info-Vision EDW can automatically adjust in real-time, providing optimal contrast and readability.
     
  ○ Cabin Divider: The Nuance V2 cabin divider enables adjustable levels of privacy between classes and allows flight attendants the ability to view multiple cabins whenever needed.

 

● April 2018:

 

Fokker Services, in partnership with InspecTech Aero Service, featured their Element EDW brand of SPD-Smart EDWs at the AIX commercial aviation show in Hamburg, Germany:

 

  ○ An Airbus A320 mockup was demonstrated, which includes two Element EDWs integrated into a sidewall. The EDWs replace the inboard “scratch lens” (the surface closest to the passenger), resulting in benefits including improved optical clarity, and the perception of larger windows as the scratch lens panel has a larger surface area than the structural window.
     
  ○ Fokker showcased a Boeing 737 cabin mockup which includes Element EDWs.

 

● April 2018:

 

At the AIX show in Hamburg, Vision Systems unveiled the world premiere of Vision System’s Info-Vision, the first smart information window integrating both SPD-Smart and electroluminescent technologies. This economical innovation, for use in windows and cabin dividers, provides passengers with travel information right on the panel. The tint of the Info-Vision window or divider can automatically adjust in real-time, providing optimal contrast and readability. Other SPD-Smart EDW solutions from Vision Systems featured at AIX in Hamburg include:

 

  ○ Second-generation Nuance V2 and Nuance V2 Ultra-Dark: enhanced optics and lower cost.
     
  ○ Nuance Smart-Shell: a retrofit EDW product covering cockpit side windows.
     
  Nuance Energia: a dimmable sun visor integrating a transparent photovoltaic film for self-power.

 

● October 2017:

 

PPG Aerospace, in partnership with Vision Systems, launched a new product at the National Business Aviation Association Convention and Exhibition in Las Vegas, Nevada. Nuance V2 Ultra Clear is a new product responding to the industry requests for aircraft cabin shading systems that allow for brighter cabin interiors, while providing for more effective shading. This Electronically Dimmable Window (EDW) solution uses patented SPD-Smart light control technology developed by Research Frontiers.

 

● July 2017:

 

ONE Aviation announced the selection of the ALTEOS EDW by PPG for its new Eclipse 700 aircraft. The Eclipse 700 aircraft is an upgraded version of its Eclipse 500/550. The Alteos EDW utilizes the NUANCE V2 shading product by Vision Systems that uses SPD-Smart light-control technology from Research Frontiers. As ONE Aviation stated in the announcement, “A priority at ONE Aviation is to maximize ease of use and passenger comfort. The PPG ALTEOS system provides both with simple and effective control of window shading.”

 

 16 

 

 

● May 2017:

 

Vision Systems and PPG Aerospace announced that they have reached a commercial agreement to work together on developing new applications utilizing Vision Systems’ EDW shading solutions for aircraft. These solutions use Research Frontiers’ SPD-Smart EDW technology and also combine the considerable experience that both PPG Aerospace and Vision Systems have in supplying the aircraft industry with EDW systems. As stated in their press release, “The agreement provides a framework for PPG and Vision Systems to pursue opportunities in commercial, regional, military and general aviation applications that capitalize on each company’s expertise.”

 

● October 2016:

 

At the MRO Europe conference Fokker Services, a division of GKN Aerospace, launched “Element EDW,” a new electronically dimmable window system for commercial airliners. Developed in collaboration with Research Frontiers licensee InspecTech Aero Service, this “smart transparency” controls and manages both beneficial and undesirable outside elements coming into aircraft cabins through passenger windows.

 

Vision Systems exhibited SPD-Smart EDWs at Aircraft Interiors Expo Asia and at the National Business Aviation Association (NBAA) Business Aviation Convention & Exhibition. These products improve the airline passenger experience by controlling light, glare, heat and noise entering the cabin.

 

● May 2016:

 

Easier SPD-Smart EDW control switches from InspecTech Aero Service were featured at the EBACE aircraft show on the newly redesigned King Air 350i and 250 that were on display by Textron-Beechcraft. Also, at EBACE it was reported that the King Air C90GTx (the third King Air to offer SPD-Smart EDWs as standard equipment) has received FAA certification, and Textron highlighted the improved EDWs on its newly redesigned aircraft as an important cabin enhancement.

 

Vision Systems debuted an Acti-Vision interactive aircraft window at the EBACE aircraft show that not only dims but brings the passenger important information such as flight status, moving map, satellite imagery, and even tourist information about what the passenger is looking at out the window via a transparent video touchscreen built into the window.

 

● April 2016:

 

Vision Systems introduced a solution for the light and glare issues commonly experienced in aircraft cockpits at the Aircraft Interiors Expo. Vision Systems’ Nuance Smart Shell, using Research Frontiers SPD-Smart EDW technology, is designed for lateral cockpit windows, which account for a large percentage of light and glare entering cockpits, and are extremely difficult to shade. The Nuance Smart Shell EDW covers the entire window surface area and brings dynamic solar control to aircraft cockpits – providing automated management of intense high-altitude light and glare, and protection from harmful UV radiation.

 

● April 2015:

 

Vision Systems demonstrated its Nuance Touchless SPD-Smart EDW at the 2015 Aircraft Interiors Expo in Hamburg, Germany. The new system allows passengers to use gestures, much like those used to operate a smart phone, to control the tint of their aircraft windows, but without ever having to touch the window or any other aircraft interior component.

 

Isoclima showcased its CromaLite brand of SPD-Smart electronically dimmable windows at the Aircraft Interiors Expo in Hamburg, Germany.

 

● March 2015:

 

Vision Systems unveiled its SPD-Smart Opti-Visor electronically dimmable sun visor for the aircraft market at the Helicopter Association International Heli-Expo in Orlando, Florida.

 

 17 

 

 

● December 2014:

 

At the 2014 MEBA show in Dubai, U.A.E., Vision Systems unveiled a new generation of its Energia photovoltaic autonomous SPD-Smart dimmable window – the new product is capable of producing more energy than the prior generation.

 

● October 2014:

 

Epic Aircraft featured SPD-Smart windows in the mock-up of its upcoming E1000 aircraft. The mock-up was unveiled at 2014 NBAA in Orlando, Florida.

 

● May 2014:

 

At the 2014 EBACE show in Geneva, Switzerland, Vision Systems unveiled a new SPD-Smart dimmable window product that offers passengers the ability to independently control the tint of different “zones” within the same window. At the same show, Vision Systems announced an improvement in the optical performance of its Nuance SPD-Smart dimmable windows – a product offering wider amplitude between clear and dark.

 

● April 2014:

 

BAE Systems featured SPD-Smart electronically dimmable windows in its cabin management system mock-up at the 2014 Hamburg Airshow. The windows can be controlled by the BAE system.

 

Vaupell featured an SPD-Smart electronically dimmable window in its commercial airliner window assembly at the 2014 Hamburg Airshow.

 

● October 2013:

 

At the 2013 AIX Americas show, Vision Systems’ strategic partner Vaupell announced they are offering the industry a complete SPD-Smart light-control window system – Vision Systems’ SPD-Smart Noctis window and control system, integrated with Vaupell’s window assembly. This product offering was showcased at Vaupell’s AIX Americas booth. Vision Systems and Vaupell entered into a strategic partnership to develop and offer SPD-Smart Noctis and Nuance windows to OEMs, including Vaupell’s longstanding customer Boeing.

 

At the 2013 NBAA, Vision Systems unveiled Energia – the world’s first self-powered dimmable window for aircraft cabins. Energia adds the many practical, technical, and financial benefits of solar power to the instant switching speed, wide range of light transmission, and relief from light, glare and heat that SPD-Smart aircraft windows already provide. Energia operates without using the aircraft’s electrical system because it integrates a transparent photovoltaic layer that is capable of producing its own energy – from the sun, or from artificial light sources. Energia facilitates the installation of dimmable windows on new production and aftermarket aircraft. It is completely independent of the cabin’s wiring, and no modifications to the aircraft’s existing electrical system are required. Energia was developed in collaboration with Sunpartner Technologies, Vision Systems partner and the inventor and manufacturer of the transparent photovoltaic panel. In March 2014, Vision Systems announced that Energia had been selected as a finalist in the prestigious 2014 Crystal Cabin Award.

 

 18 

 

 

● June 2013:

 

At the Paris Air Show, Vision Systems announced it will open its first-ever U.S. SPD-SmartGlass factory, investing nearly $1.2 million in capital expenditures to serve customers with strong U.S. operations. The new factory was highlighted by Florida Governor Rick Scott and Vision Systems President and CEO Carl Putman, with Research Frontiers President and CEO Joseph M. Harary and others in attendance for this special announcement. This announcement of a further expansion to the United States indicates an acceleration of existing and projected business in North and South America where major aircraft OEMs and customers of Vision Systems are located, including HondaJet and Gulfstream.

 

● May 2013:

 

Eurocopter featured SPD-Smart windows, and SPD-Smart cabin partitions, in the mock-up of its EC175 helicopter. The mock-up was unveiled at EBACE 2013 in Geneva, Switzerland.

 

● April 2013:

 

Vision Systems debuted its new SPD-Smart window with integrated electronics and controls directly on the window at the 2013 Hamburg Air Show. Developed with strategic partner Vaupell, a world leader in the production of aircraft interior subassemblies for commercial aerospace applications, it became the first dimmable window with integrated electronics and control panel directly on the aesthetically attractive window reveal.

 

● October 2012:

 

Honda Aircraft Company featured HondaJet SPD-Smart cabin windows at the 2012 National Business Aviation Association (NBAA) Annual Meeting & Convention. The HondaJet’s passenger windows will use SPD technology as standard equipment. SPD-Smart Nuance windows for the HondaJet went into production at Vision Systems’ new Melbourne, Florida factory.

 

InspecTech announced enhancements to its electronics architecture used to control its iShade to enable the SPD-Smart electronically dimmable windows to switch to their clearest state in the event of a power loss – that was a request made by certain OEMs. InspecTech’s iShades now offer “the best of both worlds” - when unpowered on the ramp, the windows automatically switch to their darkest, maximum heat-rejecting state, and when in the air, they instantly switch to the clear state in the event of a loss of power.

 

InspecTech announced improvements to its iShadeiQ including a higher light transmission, greater contrast ratio, unprecedented optical clarity, superior acoustic and thermal insulation properties, and lighter weight.

 

● March 2012:

 

At the 2012 Aircraft Interiors Expo in Hamburg, Germany, Isoclima S.p.A. announced that Isoclima’s CromaLite brand of SPD-Smart aerospace windows made its world premiere. CromaLite is Isoclima’s SPD-Smart solar control glazing product and enables users to efficiently control the transmitted solar radiation in both the visible and the solar range. Dr. Alberto Bertolini, Executive Director of Isoclima, commented: “Our CromaLite brand of SPD-Smart window offers many valuable light-control benefits: instant shading, glare control, UV rejection, the desire for passenger comfort, and keeping aircraft cool when they are on the ground. We are very excited by the reactions we have received from OEMs and cabin designers who are here at the Aircraft Interiors Expo and are excited about our growing portfolio of SPD-Smart CromaLite solutions for the transportation and architectural markets.”

 

Vision Systems announced that the company has invested over $750,000 to expand its existing factory in France to add a production facility dedicated to the manufacture of its SPD-Smart Nuance and Noctis aerospace and transportation windows and cabin dividers.

 

 19 

 

 

● November 2011:

 

Bombardier Aerospace featured SPD-Smart aircraft windows in its CSeries aircraft cabin mock-up at the 2011 Dubai Airshow, equipping the business class windows in its mock-up with SPD-Smart aerospace windows.

 

Vision Systems exhibited its Nuance and Noctis brands of SPD-Smart aircraft cabin windows at the Dubai Airshow in Dubai, United Arab Emirates. Nuance and Noctis SPD-Smart aerospace windows offer instant and precise light-control at every level which provides OEMs and private aircraft owners a solar protection solution that enhances flying comfort and supports fuel efficiency. These electronically dimmable aircraft and helicopter window shades and cabin dividers are impact-resistant, completely silent, available in flat and curved surfaces, and can be controlled by the cabin management system or by passengers. Vision Systems’ Noctis SPD-Smart product line offers enhanced blackout solar protection and complete privacy. Also, at the November 2011 Dubai Airshow, Vision Systems announced that Bombardier Aerospace was featuring Vision Systems’ SPD-Smart aircraft windows in Bombardier’s CSeries aircraft cabin mock-up. Bombardier equipped the business class windows in its mock-up with Vision Systems’ SPD-Smart Noctis aerospace windows. Developed for the 100- to 149-seat market segment, the CSeries family of aircraft is Bombardier’s all new mainline transport solution.

 

● April 2011:

 

InspecTech announced a new model of its SPD-Smart iShade window, branded iShadeiQ. This model, in addition to the light, glare and heat control, also reduces noise levels in the cabin.

 

Key performance requirements for aircraft light-control windows:

 

● Level of darkness:
   
  Solar radiation onboard aircraft is extreme and requires a dimmable window that creates an environment dark enough for passengers to sleep, even during daylight hours. Research Frontiers licensees now offer SPD-Smart windows that can be set to block over 99.96% of incoming light, to meet the needs of OEMs and their customers.
   
● Switching speed:
   
  Whenever a passenger wants relief from glare, SPD-Smart aircraft windows offer immediate response. Due to instant switching, an infinite number of light-transmission states can be selected by the passenger or flight crew, from clear to blackout, and any level of view-preserving tint in between.
   
● Heat-blocking:
   
  Aircraft cabins can become hot when the aircraft is parked because of solar heat streaming through windows. The result is an uncomfortably warm cabin upon boarding or the need to use jet fuel or auxiliary power units before boarding to cool down the cabin. SPD-Smart aircraft windows automatically switch to their maximum heat-blocking state, even when the aircraft is parked unpowered, and the cabin remains cool.

 

Additional challenges stated by OEMs and their customers that have been successfully met by SPD-Smart dimmable aircraft windows include:

 

● Noise-blocking: the ability to reduce the amount of noise transmitted through windows
   
● Curved shapes: the ability to offer curved windows to meet interior design needs

 

 20 

 

 

● Weight-reduction: the ability to fabricate dimmable windows using lightweight plastics and thin chemically strengthened glass
   
● FAA and EASA certification: the ability to demonstrate full compliance with all FAA and EASA requirements

 

8. SPD-Smart Architectural Products:

 

Research Frontiers and its licensees are currently working with multiple architectural customers to introduce SPD-Smart products including windows, skylights, partitions and doors. The architectural markets for these products are highly fragmented and in general have a high sensitivity to price. In the near term, the Company expects SPD-SmartGlass products primarily will be commercialized in specialty applications and/or sectors that value its distinctive performance attributes including fast switching speed regardless of window size, a very wide range of visible light transmission, infinite light-control between its dark and clear states, and availability in unusual shapes and sizes. Research Frontiers’ end-product licensees in this sector include industry leaders such as: American Glass Products (AGP), Asahi Glass, CricursaCristalesCurvados, Gauzy, Glatic, Innovative Glass, Isoclima, LTI SmartGlass, NSG UMU Products Co., Ltd Prelco, Isoclima, Smartglass International and Traco (a business unit of Alcoa).

 

In December 2019, Research Frontiers licensed Seoul, South Korea based Glatic Co., Ltd. to produce and sell SPD-SmartGlass smart windows for the South Korean architectural market.

 

In January 2017, Research Frontiers and NSG UMU Products Co., Ltd. announced that UMU Products has acquired a license from Research Frontiers to produce and sell SPD-SmartGlass architectural intelligent products throughout the United States, Canada, Mexico, Japan, the People’s Republic of China and Taiwan. The non-exclusive license grants UMU Products, a subsidiary of world-leading glass manufacturer Nippon Sheet Glass, the right to manufacture and sell SPD-SmartGlass products including windows, doors, solar shading screens, curtainwalls, skylights and other intelligent smart glass architectural products.

 

In September 2016, Smartglass International announced that its Solar SmartGlass brand of SPD-SmartGlass has been selected for both new construction and retrofit projects. An example of a retrofit project is the University of Edinburgh’s historic McEwan Hall. The interior of this hall, built in 1897, is being refurbished. In an article on the Smartglass International website, the company indicates that its Solar SmartGlass “…will be retrofitted to the internal building walls to protect the beautiful paintings and features for many more years to come. The glass will increase the functionality of the space by allowing instant control over the amount of light entering the hall. Smartglass International will create bespoke solar switchable panels that will be fitted inside each of the 13 circular oculi, each more than 2 meters in diameter.”

 

At its annual stockholders meeting in June 2015, Research Frontiers announced a small strategic investment in Zuli Inc. a manufacturer of smartplugs. At this meeting, Joseph Harary demonstrated how the ZuliSmartplug integrates with SPD SmartGlass products. Mr. Harary indicated that “Using a ZuliSmartplug, you can walk into a room with your smartphone, and have the lights automatically turn on, temperature adjust, and the glass in your windows instantly go from an energy-saving dark tint, to clear so you can see the magnificent views outside your home. Now, walk into another room and have those lights and windows adjust too, while the ZuliSmartplug automatically shuts off your devices in the room you left to save energy.”

 

In March 2015, Research Frontiers’ patented SPD-SmartGlass technology was selected as the exclusive smart glass for the USA Pavilion at this year’s World’s Fair, Expo Milano 2015 from May through October 2015. The USA Pavilion 312 large panels of SPD-SmartGlass manufactured under license from Research Frontiers by Isoclima S.p.A. Each panel measures approximately 1 meter by 3 meters, making the total surface area in the roof more than 10,000 square feet. This is the largest known installation of smart glass in the world for a roof application and was seen by over six million people.

 

SPD-Smart windows, skylights, doors and partitions offer various benefits in architectural applications. During 2009, independent tests were conducted by DSET Laboratories, a division of Atlas Material Testing Technology, in accordance with ASTM and ASHRAE testing and calculation protocols. These test results demonstrate that SPD-Smart windows have excellent solar heat rejection and control capabilities. In January 2011 a study published by the Department of Engineering at the University of Cambridge concluded that SPD-Smart light-control windows are exceptionally energy efficient, reducing solar heat gain by as much as 90%. The Cambridge study indicated that the real-world testing “confirms theoretical predictions that SPD glass holds great energy saving potential and is a technology that can really help to reduce energy wastage of glass facades.” In addition to SPD-Smart technology, the Cambridge study discussed alternative dynamic glazing technologies that could be used in windows (e.g. electrochromics) and reported that SPD-Smart technology did not have the disadvantages that limited the potential of these alternative technologies. For example, the study cited that an electrochromic window that is 2.4 square meters can take up to 30 minutes to change from clear to dark.

 

 21 

 

 

In November 2011, Research Frontiers’ licensee Innovative Glass Corporation was awarded two 2010 Crystal Achievement Awards for its smart window product line using our SPD-Smart light-control technology. In October 2010, its SPD-SmartGlass product was awarded WFX’s (Worship Facilities Conference & Expo) New Product award for Best Building System Material Product/Window. Innovative Glass has completed or is working on a variety of SPD-SmartGlass projects in the commercial, residential and institutional markets. Innovative Glass also periodically exhibits its SPD-SmartGlass architectural products at Glass Expo Northeast in Hauppauge, New York. Glass Expo Northeast is the region’s largest conference and trade show dedicated to the architectural glass and metal industry.

 

Research Frontiers licensee SmartGlass International has announced completion of several high visibility SPD-SmartGlass installations. During February 2012, the company announced installation of SPD-SmartGlass at CERN, the European Organization for Nuclear Research, which is one of the world’s largest and most respected centers for scientific research. SmartGlass International installed SPD-SmartGlass in CERN’s Globe of Science and Innovation that will house a permanent exhibition and is intended to serve as a venue for a wide range of activities, conferences and other events, In February 2011, SmartGlass International announced it supplied retrofit SPD-SmartGlass to five London television studios of the Associated Press. The SPD-SmartGlass used in these projects harvests daylight when it’s needed, improves occupant comfort by providing controllable solar shading during peak light conditions, and preserves views. Just prior to this installation, it was announced that SmartGlass International installed retrofit SPD-SmartGlass panels at the set of “Daybreak,” the breakfast anchor program from ITV, one of the UK’s largest commercial television networks.

 

In 2014, Research Frontiers added Teknoglass Solutions LLP and Diamond Glass. Teknoglass Solutions LLP acquired a license from Research Frontiers Inc. to make and sell SPD-SmartGlass architectural smart window products in the United Kingdom and Republic of Ireland. Diamond Glass acquired a license from Research Frontiers Inc. to make and sell SPD-SmartGlass architectural smart window products throughout Europe. In November of 2013 Research Frontiers announced that it had a new licensee, MDV, who is targeting the architectural market in Brazil. In March of 2013 Research Frontiers announced that it had added two new licensees, Tint-It JSC and Advnanotech, both of whom are targeting the architectural market (in addition to the automotive aftermarket discussed previously) in Russia.

 

9. SPD-Smart Marine Products:

 

Research Frontiers and its licensees are currently working with marine customers to introduce SPD-Smart products including windows, doors and partitions. When our patented SPD-Smart light-control technology is used in yacht windows and other products, users can quickly and precisely control and “tune” the amount of light, glare and heat coming through their windows, while preserving their view. Diamond Sea Glaze Manufacturing commenced marketing activities for products using SPD technology during the second quarter of 2011 but did not renew its license for SPD-SmartGlass technology for the marine market which terminated at the end of December 2017.

 

In October 2022, at the NBAA trade show, Vision Systems discussed their SPD-SmartGlass contracts for marine platforms, which includes three sailing yacht contract, four yacht contracts, and 2 cruise ship contracts.

 

In June 2019, Vision Systems exhibited at the Cruise Ship Interiors Expo in Miami, Florida. Building upon its expertise in dimmable shading systems, Vision Systems exhibited its Electronically Dimmable Windows (EDWs) for solar protection and privacy, including a curved dimmable solution, a complete privacy solution, and a multizone Electronically Dimmable Window with integrated information display. Vision Systems’ innovative solutions make it possible to eliminate shades that clutter up the space, block the view and require regular maintenance. They also allow for a solar protection on windows where shades could not, or be difficult, to be installed.

 

In October 2016, Vision Systems announced at the Monaco Yacht Show and 2016 IBEX new relationships for offering SPD-SmartGlass products with Taylor Made Systems, ProCurve Glass, and Yachtglass. In addition, the Monaco Yacht Show hosted the world premiere of the “Edition 1” model of the “ARROW460 – Granturismo,” which has SPD-Smart dimmable glazing products throughout the Silver Arrows Marine motor yacht supplied by Vision Systems and designed by Mercedes-Benz Design.

 

 22 

 

 

In November 2015, Silver Arrows Marine in conjunction with Mercedes-Benz Style (a design arm of Mercedes-Benz) unveiled a new yacht called the ARROW460 – Granturismo featuring an SPD-SmartGlass electronically dimmable roof. The roof, which is supplied by licensee Vision Systems, will be able to be electrically risen, creating a “glass pergola” effect on the yacht. First customer deliveries of this production yacht are planned to start in early 2016. Vision Systems presented its products at the 2015 Marine Equipment Trade Show in Amsterdam in November 2015 and at the Monaco Yacht Show in September 2015.

 

In November 2013, Hatteras Yachts unveiled its new flagship motor yacht, the 100 Raised Pilothouse with dual SPD-SmartGlass skylights in the galley as standard equipment at the 2013 Fort Lauderdale Boat Show.

 

In February 2013, licensee Isoclima demonstrated its VebLite brand of SPD-SmartGlass for marine applications at SEATEC 2013 in Italy. SEATEC is a leading international exhibition of technology and design for boats, megayachts and ships.

 

In November 2012, licensee Isoclima exhibited its VebLite brand of SPD-SmartGlass for marine applications at the Marine Equipment Trade (METS) Show 2012 in The Netherlands. VebLite is Isoclima’s SPD-Smart solar control and privacy glazing product that functions like a venetian blind. It has multiple segments that provide instantly customizable shading fully controlled by the passenger that can be operated individually to create the effect of a shade being raised or lowered or moved to the side. This precisely controls where incoming heat and glare enter a yacht or boat through a window or rooflite, and also controls privacy levels.

 

In addition to exhibiting its SPD-Smart marine products at METS 2012, licensee Vision Systems’ SPD-Smart Nuance dimmable marine window was named the category winner in the prestigious METS 2012 Design Award METS (DAME) competition for interior equipment, furnishing, materials and electrical fittings used in cabins. DAME is considered the world’s most prestigious design competition for new marine equipment and accessories. In METS’ news release about the DAME award, it was noted “The Jury felt that Nuance is a major innovation that will benefit designers and owners greatly - with comparatively little increase in cost.”

 

In October 2011, Cheoy Lee Shipyards unveiled the Alpha 76 Express, its most advanced production yacht, which is fully equipped with the latest yacht design features including SPD-SmartGlass supplied by Research Frontiers licensee Diamond Sea Glaze. The Alpha has approximately 150 square feet of SPD-SmartGlass at various places throughout the vessel and it is the first large-scale production yacht to make such extensive use of SPD-SmartGlass. In October 2012, Cheoy Lee Shipyards exhibited two yachts – the Alpha 76 Express and the Alpha 76 Flybridge – at the 2012 Fort Lauderdale International Boat Show with SPD-SmartGlass.

 

10. VariGuard SmartGlass:

 

In May 2013, Research Frontiers announced the formation of its VariGuard SmartGlass business unit. This business unit allowed the Company to directly address market opportunities for SPD technology outside the scope of its current license agreements or the focus of its licensees. VariGuard SmartGlass was a developmental activity for the Company and its revenues are currently immaterial relative to the Company’s licensing activities.

 

The VariGuard SmartGlass business unit marketed and sold SPD-Smart products directly to customers for specialty uses such as the protection of artwork and light-sensitive documents in museums and private collections. The business uses an optimized fabrication designed specifically for its exhibition panels. The production of these panels is outsourced to current licensees that have experience producing SPD laminates.

 

Excessive light-exposure is a leading cause of irreversible damage to many precious objects, particularly works on paper, textiles and watercolor. Presently, no display system is able to provide these artifacts with any protection against visible light damage. VariGuard SmartGlass provides the world’s first and only display panels that limit an artifact’s light-exposure only to when the artifact is being viewed. This provides unequalled protection for light-sensitive artifacts by substantially reducing an artifact’s overall lux-hour exposure when compared to conventional display panels.

 

 23 

 

 

VariGuard SmartGlass marketing and exhibition activities include:

 

● October 2018: In an inauguration ceremony presided over by the King and Queen of Sweden, the country’s Nationalmuseum reopened after a five-year $132 million renovation. The Nationalmuseum selected ArtRatio’s display case, engineered using VariGuard SmartGlass, to allow visitors to experience these objects while at the same time providing unprecedented protection against irreversible damage from exposure to light.

 

Some of the works being protected by the ArtRatio display case include:

 

  ● Book of Hours, St. Christopher carrying the Christ Child, watercolor and gold on parchment, Spain, c1400.
  ● Book of Hours, Arrest of Christ, watercolor and gold on parchment, France, c1500.
  ● Ivory object, Christ on the Cross, France, c1350.
  ● Book of Hours, St. Catherine and Kneeling Donor, watercolor and gold on parchment, Netherlands, c1430.
  ● Book, The Hours of Giraldi-Guicciardini: The Rising of Lazarus; Death Carrying a Scythe; 1500-1525, Watercolor, gold on parchment, Italy.

 

Many objects in the collection date from the Middle Ages and are highly susceptible to permanent damage from exposure to UV, visible and infrared light.

 

Nationalmuseum Comments:

 

“The ArtRatio smart glass table works wonderfully, does its job of protecting our manuscripts and looks great in the room as well!” Carina Pia Fryklund – Curator, Department of Prints and Drawings, Nationalmuseum

 

“With VariGuard SmartGlass we can now show very light sensitive illuminations in a gallery where we also let daylight coming in.” Joakim Werning – Exhibition Designer, Nationalmuseum

 

●

January 2018: VariGuard SmartGlass showcased its SPD-SmartGlass products at the West Coast Art and Framing Expo at Omega Moulding’s booth #431.

 

● December 2017: To raise awareness of the unprecedented benefits of VariGuard SmartGlass, the Company has launched an advertising campaign targeting the display case and custom framing industries. The first phase of the campaign utilizes publications from leading conservation institutions in the US (Journal of the American Institute of Conservation) and the UK (Institute of Conservation) as well the leading institution for the picture framing industry (Picture Framing Magazine).
   
● May 2017: VariGuard SmartGlass showcased its SPD-SmartGlass products at the 45th annual meeting of the American Institute for Conservation of Historic and Artistic Works (AIC) in Chicago at booth #107.
   
● September 2015: The Church History Museum, operated by The Church of Jesus Christ of Latter-day Saints, installed 22 exhibit cases containing VariGuard SmartGlass panels to protect light sensitive documents and artifacts. VariGuard panels provide a better viewing experience (by allowing substantially higher gallery illumination levels), while simultaneously reducing damaging visible light-exposure to artifacts.
   
● August 2015: The Smithsonian’s National Postal Museum selected VariGuard SmartGlass panels to protect the 1856 British Guiana One Cent Magenta, the world’s most famous rare postage stamp.
   
● May 2015: VariGuard SmartGlass exhibited its products at the American Institute for Conservation of Historic and Artistic Works (“AIC”) 43rd annual meeting in Miami, FL. Seth Van Voorhees, President of the VariGuard SmartGlass business unit commented: “Our display panels offer the highest level of protection against UV and visible light damage in the industry and they are being used in cases, frames and wall cases to protect various light sensitive artifacts in museums internationally. Reinforcing the benefits of VariGuard panels and how they limit light exposure, the Smithsonian National Postal Museum presented a paper at this meeting entitled “(Year of Light) Lighten Up: Enhancing Visitor Experiences,” which will discuss the positive impact that VariGuard panels have in protecting valuable artifacts and enhancing the visitor experience.

 

 24 

 

 

● January 2015: VariGuard SmartGlass exhibited its display panels at a Washington Conservation Guild meeting focused on innovative new conservation technologies at the Smithsonian Institution’s S. Dillon Ripley Center in Washington, DC.

 

● November 2014: VariGuard SmartGlass was invited to present at a meeting of the Washington Conservation Guild which was entitled: “Outsmarting Light: SmartGlass Technology in Exhibitions”. At this meeting, results of the light conservation benefits of its light control panels at the National Postal Museum were reported. This study quantified the dramatic reduction (>86%) in light exposure that artifacts experienced in cases using VariGuard SmartGlass display panels versus traditional glass display panels.
   
● June 2014: VariGuard SmartGlass business unit announced that the Smithsonian’s National Postal Museum will use VariGuard SmartGlass panels based on SPD-SmartGlass technology at the “Behind the Badge” exhibition in Washington, DC. This exhibit showcases the work of one of the nation’s oldest federal law enforcement agencies and VariGuard panels are featured in display cases that showcase historic light-sensitive artifacts.
   
● January 2014: VariGuard SmartGlass announced that Omega Moulding will distribute its patented light control SmartGlass products for frames and display cases in the United States and Canada. That month Omega Moulding showcased the benefits of VariGuard SmartGlass products at the 15th Annual West Coast Art and Frame Expo and National Conference in Las Vegas, NV.
   
● May 2013: VariGuard SmartGlass featured its panels in several framing applications at Museum Expo 2013 at the Baltimore Convention Center in Baltimore, MD.

 

On March 14, 2019, the Company suspended its VariGuard SmartGlass business unit activities. Instead, the Company licensed a new entity to pursue the business opportunities previously pursued by the Company’s VariGuard SmartGlass business unit. This new licensee continues to use the VariGuard SmartGlass name. The non-exclusive license grants this new licensee the right to manufacture and sell: (i) SPD-SmartGlass products used in panels, frames, cases, wall cases, appliances or other similar products to protect light-sensitive documents, artwork or other objects, (ii) SPD-SmartGlass products used in panels, frames, cases, wall cases, appliances or other similar products to provide “hide and reveal” functionality, and (iii) SPD-SmartGlass products used in a medical device to provide control and management of visible light.

 

More information about VariGuard SmartGlass can be found on its independent website at www.VariGuard.com.

 

Marketing Activities and Licensee Support:

 

In addition to supporting the efforts of its licensees, the Company also recognizes the need to develop the SPD industry as a whole. As such, the Company continues to plan and execute complementary programs that build awareness and interest in smart glass generally and demand for SPD-Smart products specifically. In the last several years, these programs included presentations at various general industry conferences, participation in panel presentations and discussions hosted by academia, development of trade association educational materials, and presentations to architects, designers, and other influential specifiers.

 

In January 2020, the Company and Gauzy presented at the CES in Las Vegas the benefits of SPD-SmartGlass for the automotive, architectural and consumer electronics industries. Some examples on display were automotive sunroofs that could be controlled electronically with a variety of control systems including smart speakers, high definition and projection displays. The use of SPD-SmartGlass technology enhances the clarity and vibrancy of displayed images, and when used to control the tint of automotive windows, sunroofs and sun visors, reduces heat, light or glare on demand or automatically. This can increase the driving range of electric vehicles by up to 5.5% and reduce CO2 emissions by up to four grams per kilometer and reduce air conditioner compressor sizes by 40%.

 

 25 

 

 

In February 2019, Research Frontiers and its licensee Gauzy rang the opening bell at the Nasdaq Market Site in Times Square to announce Gauzy’s new SPD-Smart light control film factory in Stuttgart, Germany. In early December 2019, Research Frontiers, Gauzy and executives from the automotive and architectural smart glass industries, invited guests and government officials, celebrated the opening of Gauzy’s new state-of-the-art production facility in Stuttgart, Germany. In May 2019, Research Frontiers presented the benefits of SPD-SmartGlass to the Automotive Industry at the 5th International CTI Automotive Glazing USA conference in Novi, Michigan. In March 2019, the Company presented the benefits of SPD-SmartGlass to the Automotive Industry at the Automotive Glazing Summit in Berlin, Germany. Both of these presentations focused on a real-world analysis of the use, benefits and reliability of SPD-SmartGlass in automotive and other glazings. SPD-SmartGlass technology, which allows users to instantly vary the tint of glass or plastic, is currently being used in the automotive, aircraft, marine, architectural, museum and consumer electronics industries.

 

In 2018, the Company was invited to speak at the 12th International CTI Conference – Automotive Glazing Europe and at the 3rd Annual 2018 Disruptive Growth & Healthcare Conference on the subject of disruptive automotive technologies. In 2017 and 2016, the Company participated in clean tech, emerging growth and automotive glass conferences in Europe, and during 2016 the Company presented at the Autonomous Vehicle Interior Design & Technology Symposium in Novi, Michigan and was the keynote speaker, and event chairman, at the annual CTI Automotive Glazing USA Conference in Rochester, Michigan.

 

The Company’s market development department has a number of other initiatives in place. To help guide and prioritize its technical and marketing investments, the Company periodically retains outside strategic marketing and other consultants to help generate increased short- and medium-term market penetrations for each of the major markets for the Company’s light-control technology, and to provide support and guidance to the Company’s licensees worldwide.

 

The Company has emerged as a leading resource for market research information on the subject of smart glass. Research Frontiers lectures and presents at industry conferences in areas of energy efficiency, daylight harvesting and sustainability. The Company has published independent test data about SPD-SmartGlass, shared the results of its research studies and test data with industry and the media, posted various reference materials to the Company’s website for global dissemination, and published presentations, data and bylined articles.

 

Research Frontiers maintains an active role with various standards-setting organizations, including ASTM International, which has an active committee developing standards for smartglass.

 

In addition to Research Frontiers providing overarching support of licensees’ sales efforts by developing the SPD industry as a whole, leveraging its prominence as a leading resource on the topic of smart glass, and maintaining an active role with standards organizations, Research Frontiers also supports licensees’ marketing and sales efforts directly. Activities include advising and assisting with branding strategies and advertising campaigns, website development and other marketing materials, joint presentations to prospective customers, and additional support. As a focal point of interest in smart glass, resulting in many consumer and business inquiries, Research Frontiers has an active referral program to generate customer leads for its licensees.

 

As part of this mission to develop the industry and to support our licensees’ acquiring SPD projects, Research Frontiers completed the construction of the SPD-SmartGlass Design Center. This Center is also configured as an interactive and energy-efficient “smart” executive office and conference room and is located at the Company’s corporate headquarters in Woodbury, New York. The SPD-SmartGlass Design Center features leading-edge SPD-Smart windows of different sizes (some floor-to-ceiling) and framing materials. It has a multi-functional electronic controller system for manual, remote, and automatic SPD-SmartGlass switching, and windows that can be controlled remotely over the internet or using a smart phone. This interactive area also contains other types of smart glass, such as those using liquid crystal and electrochromic technologies, allowing users to operate and experience first-hand the differences in performance characteristics of different types of smart glass. Additional showcases of SPD-SmartGlass are being established in other geographic locations to make it convenient for even more people to experience the benefits of SPD-SmartGlass technology.

 

Research Frontiers’ Design Center is the only known public forum where designers, specifiers and end-users can compare performance between SPD-Smart technology and products using other light-control technologies. Research Frontiers believes that the growth of the smart glass industry will accelerate as more information is made available through direct comparisons. Research Frontiers believes that SPD products will be strongly preferred over competing technologies once a direct comparison is available to potential buyers. Research Frontiers continues to encourage its competitors to participate in public forums where consumers of electronically tintable products can see the relative performance of products that are available.

 

 26 

 

 

Licensees of Research Frontiers:

 

The Company’s licensees are currently categorized into four main areas: materials for making films (emulsions), film, lamination of film to glass or plastic, and end-products. Emulsion makers produce and combine the necessary materials (i.e. SPD particles and various liquids and special polymers) from which SPD-Smart films are made. The film makers coat a thin layer of emulsion between two sheets of plastic film, each of which has a transparent conductive coating. This emulsion is then partly solidified to form an SPD film that allows users to control the amount of light, glare and heat passing through this film. The end-product licensees then integrate this film into a variety of SPD-Smart products or make electronic systems to control such SPD-Smart products. Some of these end-product licensees do their own lamination of the SPD light-control film to glass or plastic, and some outsource this lamination to other companies. The names of Research Frontiers’ licensees, and the year that their license agreements were entered into, are available on the Company’s SmartGlass.com website and with its filings with the Securities and Exchange Commission.

 

Licensees of Research Frontiers that incorporate SPD technology into end-products will pay Research Frontiers a royalty of 5-15% of net sales of licensed products under license agreements currently in effect and may also be required to pay Research Frontiers fees and minimum annual royalties. Licensees that sell components (such as SPD emulsion or film) or lamination services to other licensees of Research Frontiers do not pay a royalty on such sale or service, and Research Frontiers will collect a royalty from the licensee incorporating these components into their own SPD-Smart end-products. Research Frontiers’ license agreements typically allow the licensee to terminate the license after some period of time and give Research Frontiers only limited rights to terminate before the license expires. The current licensees of Research Frontiers are listed on the Company’s website, and licenses granted by the Company are non-exclusive and generally last as long as Research Frontiers’ patents remain in effect. Due to their bankruptcy filings or other termination of their general business activities or for other reasons, the Company does not believe that Polaroid Corporation, Kerros Limited, ThermoView Industries, BRG Group, MDV, Hanamac, SPD Technologies, SPD Systems, and Film Technologies International are pursuing business activities with respect to SPD technology. The Company and SPD Control Systems agreed to terminate their license agreement in December 2014 which resulted in a grant back to Research Frontiers of certain rights in SPD Control Systems’ intellectual property. Some of the Company’s other licensees are currently inactive with respect to SPD technology, but may hereafter become active again. To date, the Company has not generated sufficient revenue from its licensees to profitably fund its operations other than a profit reported for the third quarter of 2021.

 

The Company plans to continue to exploit its SPD-Smart light-control technology by entering into additional license and other agreements with end-product manufacturers such as manufacturers of flat glass, flat panel displays and automotive products, and with other interested companies who may wish to acquire rights to manufacture and sell the Company’s proprietary emulsions and films. Although the Company believes based upon the status of current negotiations that additional license agreements with third parties will be entered into, there can be no assurance that any such additional license agreements will be consummated, or of the extent to which any current or future licensee of the Company will produce or sell commercial products using the Company’s technology or generate meaningful revenue from sales of such licensed products.

 

The Company’s plans also call for further development of its technology and the provision of additional technological and marketing assistance to its licensees to develop commercially viable SPD-Smart products and expand the markets for such products. The Company cannot predict when or if new license agreements will be entered into or the extent to which commercial products will result from its existing or future licensees because of general economic conditions and the risks inherent in the developmental process and because commercialization is dependent upon the efforts of its licensees as well as on the continuing research and development efforts of the Company.

 

In February 2022, Research Frontiers, and its licensee and strategic investor Gauzy Ltd. announced that, following successfully raising $60 million in a Series D financing, Gauzy has acquired Research Frontiers licensee, Vision Systems. With the consolidation of the two companies, the combined entity now has international subsidiaries on six continents, product availability through direct fulfillment and a distribution channel of over 70 certified industrial partners, five dedicated manufacturing sites, 14 global offices. The combined entity reports revenues of approximately $50 million in 2021, and holding over 60 patents, offering 20 unique product categories, and employing 480 people globally serving customers in over 50 countries.

 

Competitive Technologies:

 

The Company believes that SPD light-control technology, in which particles move under the influence of an electric field, has certain performance advantages over other “smart glass” technologies.

 

 27 

 

 

The Company believes that pricing and product performance are the two main factors critical to the adoption of smart glass products. Because the non-SPD smart glass technologies listed below do not have published, consistent pricing or cost data that can be relied upon, the Company cannot accurately report its price position relative to these other technologies. In terms of product performance, the Company believes that SPD-SmartGlass technology offers numerous advantages over other smart glass technologies as discussed below.

 

Variable light transmission technologies can be classified into two basic types: “active” technologies that can be controlled electrically by the user either automatically or manually, and “passive” technologies that can only react to ambient environmental conditions such as changes in lighting or temperature. One type of passive variable light transmission technology is photochromic technology; such devices change their level of transparency in reaction to external ultra-violet radiation. As compared to photochromic technology, the Company’s SPD technology permits the user to adjust the amount of light passing through the viewing area of the device, rather than the viewing area of the photochromic device merely reacting to external radiation without control by the user. In addition, the reaction time necessary to change from light to dark with SPD-Smart technology can be almost instantaneous, as compared to the much slower reaction time for photochromic devices. Also, unlike SPD technology, photochromic technology does not function well at the high and low ends of the temperature range in which smart windows and other devices are normally expected to operate, nor does photochromic technology perform well in vehicles or other enclosed settings where existing glass is blocking incoming ultra-violet light which is required for photochromic devices to operate.

 

Similarly, thermochromic smart windows are passive systems which change their light transmission properties as sunlight heats or cools the glass. Because the light transmission properties of thermochromic systems are not controlled by the user, their ability to adapt to the specific needs of occupants is very limited. For example, thermochromic glazings will remain tinted on hot days even when occupants desire more daylight to enter the building or when they want to preserve their views. SPD-Smart windows, which require very low amounts of power to operate, allow for much greater control of incoming light, glare and heat and can be adjusted to any level of light transmission from dark to clear at any time. In addition, SPD-Smart windows can block up to 99.5% of incoming light, a level many times darker than thermochromic systems. The added advantage offers much higher levels of privacy and control over incoming solar energy. Companies involved in thermochromic technology include Pleotint, Suntek and Ravenbrick.

 

Active, user-controllable technologies, sometimes referred to as “smart” technologies, are generally more useful than passive technologies because they allow the user to actually control the state of the window. This control is achieved with a manual adjustment, or automatically when coupled with a timer or sensing device such as a photocell, motion detector, thermostat or other intelligent building system.

 

There are three main types of active devices which are compared below:

 

● Electrochromic devices (EC)
   
● Liquid crystal devices (LC)
   
● Suspended-particle devices (SPD)

 

Electrochromic Technology:

 

Electrochromic windows and rear-view mirrors use a direct current voltage to alter the molecular structure of electrochromic materials (which can be in the form of either a liquid, gel or solid film) causing the material to darken. When compared to electrochromic devices, SPD technology is expected to have numerous potential performance and manufacturing advantages, including some or all of the following:

 

● significantly faster response time, especially compared to larger electrochromic glazings
   
● ability to precisely “tune” an infinite number of intermediate light-transmission states
   
● consistent and uniform switching speed regardless of size of glazing area
   
● more reliable performance over a wider temperature range
   
● higher contrast ratios and the capability of achieving darker shaded states for large area product applications

 

 28 

 

 

● unpowered state is dark, maximizing solar heat gain benefits when the room, office or vehicle is not in use
   
● lower electrical current drain
   
● higher estimated battery life in applications where batteries are used
   
● no “iris effect” (where light transmission changes first occur at the outer edges of a window or mirror and then work their way toward the center) when changing from clear to dark and back again
   
● SPD technology is a film-based technology that can be applied to plastic, acrylic, and chemically strengthened glass as well as glass, and which can be applied to curved as well as flat surfaces
   
● available in single panels for retrofitting existing windows, skylights and doors

 

Many companies with substantially greater resources than Research Frontiers such as 3M, Gentex Corp., Pilkington, PPG Industries, Saint-Gobain and other large corporations have pursued or are pursuing projects in the electrochromic area. While some of these companies have reportedly discontinued or substantially curtailed their work on electrochromics due to technical problems and issues relating to the expense of these technologies, at least four companies (Gentex, PPG Industries, View (formerly known as Soladigm), and Sage Electrochromics) are currently working to commercialize electrochromic window products. In May 2012, Saint-Gobain acquired Sage Electrochromics and combined all of their respective electrochromic manufacturing and developmental efforts. In late 2020, View announced that it was trying to become a public company by merging with a Special Purpose Acquisition Company (“SPAC”) CF Finance Acquisition Corp. II (Nasdaq: CFII).

 

Liquid Crystal Technology:

 

To date, the main types of liquid crystal smart windows have been produced by Taliq Corp. (a subsidiary of Raychem Corp. which has since discontinued its liquid crystal operations and licensed its technology to others), Asahi Glass Co., Gauzy, Nippon Sheet Glass, Saint-Gobain Glass, iGlass Projects Pty Limited, Polytronix, Inc., DMDisplays, and 3M (which has also reportedly discontinued its liquid crystal film making operations). The first four companies listed above are also licensees of Research Frontiers for SPD-Smart technology. Liquid crystal windows only change from a cloudy, opaque milky-white to a clear state, are hazy when viewed at an angle and have no useful intermediate states. As compared to liquid crystal windows, SPD smart windows are expected to have some or all of the following advantages:

 

● have less direct and off-angle haze
   
● in its intermediate tinted states provides shading without loss of view
   
● operates over a wider temperature range
   
● uses less power
   
● higher contrast ratios
   
● reduction in the amount of light transmitted rather than simply scatter it
   
● permits an infinite number of intermediate states between a transparent state and a dark blue state, rather than typically just two states
   
● offers superior solar heat gain control

 

 29 

 

 

In the flat panel display market, further development (such as the achievement of faster switching speeds sufficient for full-motion video applications) is required if the Company expects to compete against display technologies that are currently being used commercially such as liquid crystal displays (“LCDs”) and organic light-emitting diodes (“OLEDs”). Some of the advantages that SPD displays might have include the ability to make displays without using sheet polarizers or alignment layers, and lower light loss and a corresponding reduction in backlighting requirements. However, such products need additional product design, engineering or testing before an evaluation of the commercial potential of such SPD-SmartGlass products can be determined and when, or if, its licensees may begin to penetrate the flat panel display market.

 

LCDs and other types of displays, liquid crystal windows, as well as electrochromic self-dimmable rear-view mirrors, are already on the market, whereas products incorporating SPD technology (as well as electrochromic windows) have only begun to appear in the marketplace. Therefore, the long-term durability and performance of SPD-Smart displays have not yet been fully ascertained. The companies that manufacture LCD and other display devices, liquid crystal windows, and electrochromic self-dimmable rear-view mirrors and windows, have substantially greater financial resources and manufacturing experience than the Company. There is no assurance that comparable systems having the same advantages of the Company’s SPD technology could not be developed by competitors at a lower cost or that other products could not be developed which would render the Company’s products difficult to market or otherwise render our products obsolete.

 

Research and Development:

 

As a result of the Company’s research and development efforts, the Company believes that its SPD technology is now, or with additional development will become, usable in a number of commercial products. Such products may include one or more of the following fields: “smart” windows, doors, skylights and partitions; variable light transmission eyewear such as sunglasses and goggles; self-dimmable automotive sunroofs, windows, sun visors, and mirrors; display cases/frames; and instruments and other information displays that use digits, letters, graphic images, or other symbols to supply information, including scientific instruments, aviation instruments, automobile dashboard displays and, if certain improvements can be made in various features of the Company’s SPD technology that increases switching speed to the levels needed for video applications, portable computer displays and flat panel television displays.

 

Even though the Company’s SPD technology has much faster switching speeds than electrochromic technology, current switching speeds are not fast enough for such video applications. The Company believes that most of its research and development efforts have applicability to products that may incorporate the Company’s technology. At its current state of development, the Company’s technology has been judged sufficiently advanced by various of its licensees and their customers for them to proceed with the development, introduction and sale of SPD-Smart products. However, the Company is continuously investing in research and development because it believes that further improvements will result in accelerated and increased market penetration. The Company intends to continue its research and development efforts for the foreseeable future to improve its SPD light-control technology and thereby assist our licensees in the product development, sales and marketing of various existing and new SPD-Smart products.

 

During the past few years, the Company and/or its licensees have made significant advances relating to materials to enable (1) improved stability of SPD emulsions, (2) a wider range of light transmission, (3) improved film adhesion and cohesion and (4) increased durability of SPD films/laminates, and (5) cost reductions. These advances have resulted in patents being issued to the Company by the US Patent Office and by foreign patent offices between 2018-2022 in addition to other patents and patent applications that are pending worldwide.

 

The Company has devoted most of the resources it has heretofore expended to research and development activities with the goal of producing commercially viable SPD products and has developed working prototypes of SPD-Smart products for several different applications, with primary emphasis on smart windows for various industries. In addition to working with the Company’s licensees, Research Frontiers has also expanded its efforts to also work directly with some of our licensees’ major customers.

 

 30 

 

 

Research Frontiers’ main goals in its research and development include:

 

● developing wider ranges of light transmission and quicker switching speeds
   
● developing different colored particles
   
● reducing the voltage required to operate SPDs
   
● obtaining data and developing improved materials regarding environmental stability and longevity
   
● quantifying the degree of energy savings expected by users of the Company’s technology including the degree that SPD technology can control heat and its contribution to energy savings directly and through daylight harvesting strategies in sustainable building designs
   
● continually striving to improve the performance and reducing material/production costs associated with making SPD-Smart products

 

Excluding non-cash expenses of approximately $16,000 and $10,000, associated with the grant of stock options to the Company’s technical personnel, Research Frontiers incurred approximately $593,000 and $570,000 during the years ended December 31, 2022 and 2021, respectively, for research and development costs. Research Frontiers plans to engage in substantial continuing research and development activities to invest in future improvements in SPD light-control technology and to expand for its licensees the capabilities of SPD-Smart technology and the markets for SPD-Smart products.

 

Patents and Proprietary Information:

 

Research Frontiers continues to make substantial investments to develop, license and protect its intellectual property position. The Company has 14 United States and several hundred foreign patents in force. The Company’s United States patents expire at various dates from 2023 through 2037, while its foreign patents expire at various dates from 2023 through 2037.

 

The Company has current US and foreign patent applications that, if granted, would add a number of additional patents to its portfolio. The Company believes that its SPD light-control technology is adequately protected by its patent position and by its proprietary technological know-how. However, the validity of the Company’s patents has never been contested in any litigation. The Company also possesses know-how and relies on trade secrets and nondisclosure agreements to protect its technology. The Company generally requires any employee, consultant, or licensee having access to its confidential information to execute an agreement whereby such person agrees to keep such information confidential.

 

Rights Plan:

 

In February 2013, the Company’s Board of Directors adopted a Stockholders’ Rights Plan (the “Rights Plan”) and declared a dividend distribution of one right (a “Right”) for each outstanding share of Company common stock to stockholders of record at the close of business on March 3, 2003 (“Record Time”) and authorized the issuance of one Right in respect of each share of Common Stock issued after the Record Time and prior to the Separation Time. The Rights Plan was readopted and extended in December 2022 until February 11, 2033.

 

“Separation Time” shall mean the earlier of the Close of Business on the tenth Business Day (or such later date as the Board of Directors may from time to time fix by resolution adopted prior to the Separation Time that otherwise would have occurred) following but not including (i) the date on which any Person commences a tender or exchange offer that, if consummated, would result in such Person’s becoming an Acquiring Person, and (ii) the date of the first event causing a Flip-in Date to occur; provided that if any tender or exchange offer referred to in clause (i) of this paragraph is cancelled, terminated or otherwise withdrawn prior to the Separation Time without the purchase of any shares of Common Stock pursuant thereto, such offer shall be deemed, for purposes of this paragraph, never to have been made.

 

Subject to certain exceptions listed in the Rights Plan, if a person or group has acquired beneficial ownership of, or commences a tender or exchange offer for, 15% or more of the Company’s common stock, unless redeemed by the Company’s Board of Directors, each Right entitles the holder (other than the acquiring person) to purchase from the Company $80 worth of common stock for $40. If the Company is merged into, or 50% or more of its assets or earning power is sold to, the acquiring company, the Rights will also enable the holder (other than the acquiring person) to purchase $80 worth of common stock of the acquiring company for $40. During 2022, the Company extended the expiration of The Rights which will now expire at the close of business on February 11, 2033, unless the Rights Plan is extended by the Company’s Board of Directors or unless the Rights are earlier redeemed by the Company at a price of $.0001 per Right. The Rights are not exercisable during the time when they are redeemable by the Company.

 

 31 

 

 

The above description highlights some of the features of the Company’s Rights Plan and is not a complete description of the Rights Plan. A more detailed description and copy of the Rights Plan has been filed with the SEC and is available from the Company upon request.

 

Available Information:

 

Our principal executive offices are located at 240 Crossways Park Drive, Woodbury, New York 11797, our telephone number is (516) 364-1902, and our Internet website address is www.SmartGlass.com. We make available free of charge on or through our Internet website our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements on Schedule 14A, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 as soon as reasonably practicable after we electronically file such materials with, or furnish them to, the SEC.

 

ITEM 1A. RISK FACTORS

 

In addition to the other information in this Annual Report on Form 10-K, you should carefully consider the following factors in evaluating us and our business. This Annual Report contains, in addition to historical information, forward-looking statements that involve risks and uncertainties, some of which are beyond our control. Should one or more of these risks and uncertainties materialize or should underlying assumptions prove incorrect, our actual results could differ materially. Factors that could cause or contribute to such differences include, but are not limited to, those discussed below, as well as those discussed elsewhere in this Annual Report, including the documents incorporated by reference.

 

There are risks associated with investing in companies such as ours who are primarily engaged in research and development. In addition to risks which could apply to any company or business, you should also consider the business we are in and the following:

 

Source and Need for Capital.

 

As of December 31, 2022, we had approximately $4.2 million in cash and cash equivalents.

 

As we take steps in the commercialization and marketing of our technology or respond to potential opportunities and/or adverse events, our working capital needs may change. We anticipate that if our cash and cash equivalents are insufficient to satisfy our liquidity requirements, we will require additional funding to sustain our ongoing operations and to continue our SPD technology research and development activities.

 

We have funded most of our activities through sales of our common stock to investors, and upon the exercise of options and warrants. The eventual success of the Company and generation of positive cash flow will be dependent upon the extent of commercialization of products using the Company’s technology by the Company’s licensees and payments of continuing royalties on account thereof. We can give no assurances that we will generate sufficient cash in the future (through sales of our common stock, exercise of options and warrants, royalty fees, or otherwise) to satisfy our liquidity requirements or sustain future operations, or that additional funding, if required, will be available when needed or, if available, on favorable terms.

 

As of December 31, 2022, the Company had cash and cash equivalents of approximately $4.2 million, working capital of $4.6 million and total shareholders’ equity of $4.8 million. Our quarterly projected cash flow shortfall, based on our current operations, adjusted for any non-recurring cash expenses and adjusted for additional royalties expected to be received for use of our products in new production, for the next 12 months, is approximately $200,000 per quarter. We may eliminate some operating expenses in the future, which will further reduce our cash flow shortfall if needed. Based on these assumptions, we currently expect to have sufficient working capital for more than the next 5 years of operations.

 

 32 

 

 

History of Operating Losses.

 

We have experienced net losses from operations, and we may continue to incur net losses from operations in the future. We have incurred substantial costs and expenses in researching and developing our SPD technology. As of December 31, 2022, we had an accumulated deficit of $122.4 million since our inception. Our net loss was $2.7 million in 2022 and $1.8 million in 2021, (which includes non-cash accounting charges in 2022 and 2021 of $0.2 million and $0.2 million, respectively, resulting from the expensing of grants of stock options).

 

We may not generate sufficient cash flows to cover our operating expenses.

 

As noted above, we have incurred recurring losses since inception and expect to continue to incur losses as a result of costs and expenses related to our research and continued development of our SPD technology and our corporate general and administrative expenses. Our limited capital resources and operations to date have been substantially funded through sales of our common stock, exercise of options and warrants and royalty fees collected. As of December 31, 2022, we had working capital of approximately $4.6 million, cash and cash equivalents of approximately $4.2 million, shareholders’ equity of approximately $4.8 million and an accumulated deficit of $122.4 million. In the event that we are unable to generate sufficient cash from our operating activities or raise additional funds, we may be required to delay, reduce or severely curtail our operations or otherwise impede our on-going business efforts, which could have a material adverse effect on our business, operating results, financial condition and long-term prospects.

 

We have never declared a cash dividend and do not intend to declare a cash dividend in the foreseeable future.

 

We have never declared or paid cash dividends on our common stock. Payment of dividends on our common stock is within the discretion of our Board of Directors and will depend upon our future earnings, capital requirements, financial condition and other relevant factors. We do not anticipate declaring or paying any cash dividends on our common stock in the foreseeable future.

 

We do not directly manufacture products using SPD technology. We currently depend upon the activities of our licensees and their customers in order to be profitable.

 

We do not directly manufacture products using SPD technology. We currently depend upon the activities of our licensees in order to be profitable. Although a variety of products have been sold by our licensees, and because it is up to our licensees to decide when and if they will introduce products using SPD technology, we cannot predict when and if our licensees will generate substantial sales of such products. Our SPD technology is currently licensed to over 40 companies. Other companies are also evaluating SPD technology for use in various products. In the past, some companies have evaluated our technology without proceeding further. While we expect that our licensees would be primarily responsible for manufacturing and marketing SPD-Smart products and components, we are also engaging in market development activities to support our licensees and build the smart glass industry. We cannot control whether or not our licensees will develop SPD products. Some of our licensees appear to be more active than others, some appear to be better capitalized than others, and some licensees appear to be inactive. There is no guarantee when or if our licensees will successfully produce any commercial product using SPD technology in sufficient quantities to make the Company profitable.

 

SPD-Smart products have only recently been introduced.

 

Products using SPD technology have only recently begun to be introduced into the marketplace. Developing products using new technologies can be risky because problems, expenses and delays frequently occur, and costs may or may not come down quickly enough for such products using new technologies to rapidly penetrate mass market applications.

 

We have several large licensees that account for 10% or more of our annual fee income.

 

During 2022, four licensees accounted for 28%, 23%, 13% and 11%, respectively, of fee income recognized for the year. During 2021, four licensees accounted for 20%, 18%, 18% and 12%, respectively, of fee income recognized for the year. The loss of all or a substantial portion of the fee income from any of these customers (or certain other significant customers) could have a material adverse effect on our business, financial condition, and/or results of operations.

 

 33 

 

 

SPD-Smart products face intense competition, which could affect our ability to increase our revenues.

 

The market for SPD-Smart products is intensely competitive and we expect competition to increase in the future. We compete based on the functionality and the quality of our product. Many of our current and potential competitors have significantly greater financial, technical, marketing and other resources than we have. In addition, many of our competitors have well-established relationships with our current and potential customers and have extensive knowledge of our industry. If our competitors develop new technologies or new products, improve the functionality or quality of their current products, or reduce their prices, and if we are unable to respond to such competitive developments quickly either because our research and development efforts do not keep pace with our competitors or because of our lack of financial resources, we may be unable to compete effectively.

 

Declining production of automobiles, airplanes, trains, boats and real estate could harm our business.

 

Our licensees’ commercialization efforts of SPD-Smart products could be negatively impacted if the global production of automobiles, airplanes, trains, boats and real estate construction declines significantly. If such commercialization is reduced, our revenues, results of operations and financial condition could be negatively impacted.

 

Limited source of SPD film.

 

Our end-product licensees require a source of SPD film to manufacture finished products. Currently, Hitachi Chemical and Gauzy Ltd. are the only sources of commercial quantities of SPD-film. There are several other companies that are licensed to manufacture SPD-film, but they have not begun commercial production of this film. Our end-product licensees’ ability to sell SPD products could be negatively impacted if there was a prolonged disruption in SPD-film availability. Such a disruption could also negatively impact our revenues, results of operations and financial condition.

 

We are dependent on key personnel.

 

Our continued success will depend, to a significant extent, on the services of our directors, executive management team, key personnel and certain key scientists. If one or more of these individuals were to leave the Company, there is no guarantee that we could replace them with qualified individuals in a timely or economically satisfactory manner or at all. The loss or unavailability of any or all of these individuals could harm our ability to execute our business plan, maintain important business relationships and complete certain product development initiatives, which would have a material adverse effect on our business, results of operations and financial conditions.

 

Dependence on SPD-Smart technology.

 

Because SPD technology is the only technology we work with, our success depends upon the viability of SPD technology which has yet to be fully proven. We have not fully ascertained the performance and long-term reliability of our technology, and therefore there is no guarantee that our technology will successfully be incorporated into all of the products which we are targeting for use of SPD technology. We expect that different product applications for SPD technology will have different performance and reliability specifications. We expect that our licensees will primarily be responsible for reliability testing, but that we may also continue to do reliability testing so that we can more effectively focus our research and development efforts towards constantly improving the performance characteristics and reliability of products using SPD technology.

 

Our patents and other protective measures may not adequately protect our proprietary intellectual property, and we may be infringing on the rights of others.

 

Our intellectual property, particularly our proprietary rights in our SPD technology, is critical to our success. We have received various patents, and filed other patent applications, for various applications and aspects of our SPD technology. In addition, we generally enter into confidentiality and invention agreements with our employees and consultants. Such patents and agreements and various other measures we take to protect our intellectual property from use by others may not be effective for various reasons generally applicable to patents and their granting and enforcement. In addition, the costs associated with enforcing patents, confidentiality and invention agreements or other intellectual property rights may be expensive. Our inability to protect our proprietary intellectual property rights or gain a competitive advantage from such rights could harm our ability to generate revenues and, as a result, our business and operations.

 

If we fail to maintain an effective system of internal control over financial reporting, the accuracy and timing of our financial reporting may be adversely affected.

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Our management is likewise required, on a quarterly basis, to evaluate the effectiveness of our internal controls and to disclose any changes and material weaknesses identified through such evaluation of those internal controls. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

 

If we identify material weaknesses or significant deficiencies in our internal controls or disclosure controls, we may be unable to provide required financial information in a timely and reliable manner and we may incorrectly report financial information. If our financial statements are not filed on a timely basis, we could be subject to adverse action by shareholders, Nasdaq, the SEC or other regulatory authorities. The existence of material weaknesses or significant deficiencies in internal control over financial reporting could adversely affect our reputation or investor perceptions of us, which could have a negative effect on the trading price of our stock. In addition, we may incur additional costs to remediate material weaknesses or significant deficiencies in our internal control over financial reporting.

 

We cannot assure you that a material weakness will not arise in the future due to a failure to implement and maintain adequate internal control over financial reporting. In addition, even if we are successful in strengthening our controls and procedures, in the future those controls and procedures may not be adequate to prevent or identify irregularities or errors or to facilitate the fair presentation of our financial statements.

 

 34 

 

 

ITEM 1B. UNRESOLVED STAFF COMMENTS

 

None

 

ITEM 2. PROPERTIES

 

The Company currently occupies approximately 9,500 square feet of space at an annual rent which, in 2022 was approximately $183,000, for its executive office, research facility and SPD-Smart Glass Design Center at 240 Crossways Park Drive, Woodbury, New York 11797 under a lease expiring March 31, 2025. The Company believes that its space, including its laboratory facilities, is adequate for its present needs.

 

ITEM 3. LEGAL PROCEEDINGS

 

There are no legal proceedings pending by or against the Company required to be reported under this Item 3.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

N/A

 

PART II

 

ITEM 5. MARKET FOR THE REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

(a) Market Information

 

(1) The Company’s common stock is traded on the NASDAQ Capital Market under the symbol “REFR”. As of March 8, 2023, there were 33,509,287 shares of common stock outstanding.
   
(2) The following table sets forth the range of the high and low selling prices (as provided by the National Association of Securities Dealers) of the Company’s common stock for each quarterly period within the past two fiscal years:

 

Quarter Ended  Low   High 
         
March 31, 2021  $2.65   $5.66 
June 30, 2021   2.01    3.15 
September 30, 2021   1.76    3.18 
December 31, 2021   1.65    2.63 
           
March 31, 2022  $1.34   $2.45 
June 30, 2022   1.51    2.29 
September 30, 2022   1.55    2.85 
December 31, 2022   1.83    2.53 

 

These quotations may reflect inter-dealer prices, without retail mark-up, mark-down, or commission, and may not necessarily represent actual transactions.

 

 35 

 

 

(b) Approximate Number of Security Holders

 

As of March 8, 2023, there were approximately 312 holders of record of the Company’s common stock and the closing price of our common stock was $1.80 per share. The Company estimates that there are approximately 7,100 beneficial holders of the Company’s common stock.

 

(c) Dividends

 

The Company has not declared or paid cash dividends on its common stock for the two most recent fiscal years and does not expect to declare or pay any cash dividends in the foreseeable future. There are no restrictions on the payment of dividends.

 

(d) Issuer Purchases of Equity Securities

 

None.

 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Forward-Looking Statements

 

Information included in this Annual Report on Form 10-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical facts, but rather reflect our current expectations concerning future events and results. We generally use the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “will” and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, those factors set forth in this Annual Report on Form 10-K under “Item 1A. – Risk Factors” above. Except as required by applicable law, including the securities laws of the United States, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this Annual Report on Form 10-K.

 

In reviewing Management’s Discussion and Analysis of Financial Condition and Results of Operations, you should refer to our consolidated financial statements and the notes related thereto.

 

Critical Accounting Policies

 

The following accounting policies are important to understanding our financial condition and results of operations and should be read as an integral part of the discussion and analysis of the results of our operations and financial position. For additional accounting policies, see Note 2 to our Consolidated Financial Statements, “Summary of Significant Accounting Policies.”

 

The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers. The Company determined that its license agreements provide for three performance obligations: (i) Grant of Use, (ii) Technical Support, and (iii) New Improvements.

 

The best method for determining the standalone selling price of our Grant of Use performance obligation is through a comparison of the average royalty rate for comparable license agreements as compared to our license agreements. Based on the royalty rate comparison referred to above, any pricing above and beyond the average royalty rate would relate to the Technical Support and New Improvements performance obligations.

 

 36 

 

 

We recognize revenue when or as the performance obligations in the contract are satisfied. For performance obligations that are fulfilled at a point in time, revenue is recognized at the fulfillment of the performance obligation. Since the IP is determined to be a functional license, the value of the Grant of Use is recognized in the first period of the contract term in which the license agreement is in force. Since the costs incurred to satisfy the Technical Support and New Improvements performance obligations are incurred evenly throughout the year, the value of the Technical Support and New Improvements services are recognized throughout the contract period as these performance obligations are satisfied.

 

The Company has entered into license agreements covering products using the Company’s SPD technology. When royalties from the sales of licensed products by a licensee exceed its contractual minimum annual royalties, the excess amount is recognized by the Company as fee income in the period that it was earned. Certain of the fees are accrued by, or paid to, the Company in advance of the period in which they are earned resulting in deferred revenue.

 

Royalty receivables are stated less allowance for doubtful accounts. The allowance represents estimated uncollectible receivables usually due to licensees’ potential insolvency. The allowance includes amounts for certain licensees where risk of default has been specifically identified. The Company evaluates the collectability of its receivables on at least a quarterly basis and records appropriate allowances for uncollectible accounts when necessary.

 

The Company has historically used the Black-Scholes option-pricing model to determine the estimated fair value of each option grant. The Black-Scholes model includes assumptions regarding dividend yields, expected volatility, expected lives, and risk-free interest rates. These assumptions reflect our best estimates, but these items involve uncertainties based on market conditions generally outside of our control. As a result, if other assumptions had been used in the current period, stock-based compensation expense could have been materially impacted. Furthermore, if management uses different assumptions in future periods, stock-based compensation expense could be materially impacted in future years.

 

 37 

 

 

On occasion, the Company may issue to consultants either options or warrants to purchase shares of common stock of the Company at specified share prices. These options or warrants may vest based upon specific services being performed or performance criteria being met. In accounting for equity instruments that are issued to other than employees for acquiring, or in conjunction with selling, goods or services, the Company is required to record consulting expenses based upon the fair value of such options or warrants on the earlier of the service period or the period that such options or warrants vest as determined using a Black-Scholes option pricing model and are marked to market quarterly using the Black-Scholes option valuation model.

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent liabilities at the date of the financial statements, and reported amounts of revenues and expenses during the reporting periods. Actual results could differ from these estimates. An example of a critical estimate is the full valuation allowance for deferred taxes that was recorded based on the uncertainty that such tax benefits will be realized in future periods.

 

Recent Global Events

 

On March 11, 2020, the World Health Organization declared the novel strain of coronavirus (“COVID-19”) a global pandemic and recommended containment and mitigation measures worldwide.

 

Revenues were negatively impacted since 2020 due to delays in manufacture of products using our technology. Most of the products using our technology are manufactured by licensees overseas in Europe and Asia who have been similarly affected by the pandemic. The disruption caused by public health crises, such as COVID-19, could result in lower levels of sale activity for products using our technology resulting in lower level of royalties owed to us from the sale of these products. The duration of the potential business disruptions and related financial impact cannot be reasonably estimated at this time, but could materially adversely affect our business, financial condition, results of operations, and cash flows.

 

 38 

 

 

Results of Operations

 

Overview

 

The majority of the Company’s fee income comes from the activities of several licensees participating in the automotive market. The Company currently believes that the automotive market will be the largest source of its royalty income over the next several years. The Company’s royalty income from this market may be influenced by numerous factors including various trends affecting demand in the automotive industry and the rate of introduction of new technology in OEM product lines and the impact of COVID-19. In addition to these macro factors, the Company’s royalty income from the automotive market could also be influenced by specific factors such as whether the Company’s SPD-SmartGlass technology appears as standard equipment or as an option on a particular vehicle, the number of additional vehicle models that SPD-SmartGlass appears on, the size of each window on a vehicle and the number of windows on a vehicle that use SPD-SmartGlass, fluctuations in the total number of vehicles produced by a manufacturer, and in the percentage of cars within model like produced with SPD-SmartGlass, and changes in pricing or exchange rates. Certain license fees, which are paid to the Company in advance of the accounting period in which they are earned resulting in the recognition of deferred revenue for the current accounting period, which will be recognized as fee income in future periods. Also, licensees offset some or all of their royalty payments on sales of licensed products for a given period by applying these advance payments towards such earned royalty payments.

 

In 2022 and 2021, the Company received royalty revenues from sales of SPD-SmartGlass products for various car models that were accretive to the Company’s royalty revenue. Production efficiencies are expected to continue and accelerate with the introduction of the higher vehicle production volumes for various car models going forward, and the Company expects that lower pricing per square foot of the Company’s technology could expand the market opportunities, adoption rates, and revenues for its technology in automotive and non-automotive applications. The Company expects to generate additional royalty income from the near-term introduction of additional new car and aircraft models from other OEMs (original equipment manufacturers), continued growth of sales of products using the Company’s technology for the marine industry in yachts and other watercraft, in trains, in museums, and in larger architectural projects.

 

Because the Company’s license agreements typically provide for the payment of royalties by a licensee on product sales within 45 days after the end of the quarter in which a sale of a licensed product occurs (with some of the Company’s more recent license agreements providing for payments on a monthly basis), and because of the time period which typically will elapse between a customer order and the sale of the licensed product and installation in a home, office building, automobile, aircraft, boat or any other product, there could be a delay between when economic activity between a licensee and its customer occurs and when the Company gets paid its royalty resulting from such activity.

 

As discussed in Note 1 to our Consolidated Financial Statements, the Company’s financial results has been impacted by the COVID-19 pandemic. Most of the products using the Company’s technology are manufactured by licensees overseas in Europe and Asia who have been similarly affected by the pandemic. The disruption caused by COVID-19 could result in lower levels of sale activity for products using our technology resulting in lower level of royalties owed to us from the sale of these products. The duration of the potential business disruptions and related financial impact cannot be reasonably estimated at this time.

 

Year ended December 31, 2022 Compared to the Year ended December 31, 2021

 

The Company’s fee income from licensing activities for the year ended December 31, 2022 was $536,686 compared to $1,263,034 for the year ended December 31, 2021. This decrease in fee income was the result of the timing of payments and new and amended license agreements entered into in 2021 and was predominantly from one-time settlements from two licensees for royalty payments due, as well as for a current special government contract in the automotive area. Without these one-time events, fee income in 2022 would have been comparable to fee income in 2021. The Company expects revenue in all market segments to further increase as new car models and other products using the Company’s SPD-SmartGlass technology are introduced into the market.

 

Operating expenses increased by $33,840 for the year ended December 31, 2022 to $2,555,689 from $2,521,849 for the year ended December 31, 2021. The increase is the result of higher bad debt expense ($80,000) as well as higher payroll and related costs ($80,000) and higher insurance costs ($13,000) partially offset by lower legal ($80,000) and patent ($57,000) costs. Operating expenses include non-cash charges for options granted to employees and directors of $216,000 and $207,000 in 2022 and 2021, respectively

 

Research and development expenditures increased by $29,127 for the year ended December 31, 2022 to $609,127 from $580,000 for the year ended December 31, 2022. This increase was the result of higher allocated insurance costs ($12,000) as well as higher payroll and related costs ($10,000) and higher allocated facility costs ($3,000). Research and development costs include non-cash charges for options granted to employees of $16,000 and $10,000 in 2022 and 2021, respectively.

 

 39 

 

 

The Company’s net investment loss for the year ended December 31, 2022 was $44,219 as compared to $7,537 for the year ended December 31, 2021. This difference was primarily due to changes in market interest rates and the sale of marketable securities to convert them into cash and cash equivalents resulting in a loss.

 

No income tax benefit or expense was recorded for the years ended December 31, 2022 and 2021.

 

As a consequence of the factors discussed above, the Company’s net loss was $2,669,349 ($0.08 per common share) for the year ended December 31, 2022 as compared to $1,846,352 ($0.06 per common share) for the year ended December 31, 2021.

 

Financial Condition, Liquidity and Capital Resources

 

The Company has primarily utilized its cash, cash equivalents, marketable securities, and proceeds from sales of our common stock, proceeds from the exercise of options and warrants, and royalty fees collected to fund its research and development, for marketing initiatives, and for other working capital purposes. The Company’s working capital and capital requirements depend upon numerous factors, including, but not limited to, the results of research and development activities, competitive and technological developments, the timing and costs of patent filings, and the development of new licensees and changes in the Company’s relationship with existing licensees. The degree of dependence of the Company’s working capital requirements on each of the foregoing factors cannot be quantified; increased research and development activities and related costs would increase such requirements; the addition of new licensees may provide additional working capital or working capital requirements, and changes in relationships with existing licensees would have a favorable or negative impact depending upon the nature of such changes.

 

During 2022, the Company’s cash and cash equivalents balance increased by $3,960,952 principally as a result of cash generated from the sale of common stock and warrants of $3,450,000 as well as cash generated from the sale of marketable securities of $2,694,968 partially offset by cash used for operations of $2,182,745 and cash used for the purchase of property and equipment of $1,271. At December 31, 2022, the Company had cash and cash equivalents of $4.2 million, working capital of $4.6 million and total shareholders’ equity of $4.8 million. Our quarterly projected cash flow shortfall, based on our current operations, adjusted for any non-recurring cash expenses for the next 12 months and adjusted for additional royalties expected to be received for use of our products in new production, for the next 12 months, is approximately $200,000 per quarter. We may eliminate some operating expenses in the future, which will further reduce our cash flow shortfall if needed. Based on these assumptions, we currently expect to have sufficient working capital for more than the next 5 years of operations.

 

The Company expects to use its cash to fund its research and development of SPD light valves, its expanded marketing initiatives, and for other working capital purposes. The Company believes that its current cash and cash equivalents would fund its operations for more than the next five years. There can be no assurances that expenditures will not exceed the anticipated amounts or that additional financing, if required, will be available when needed or, if available, that its terms will be favorable or acceptable to the Company. The eventual success of the Company and generation of positive cash flow will be dependent upon the extent of commercialization of products using the Company’s technology by the Company’s licensees and payments of continuing royalties on account thereof. To date the Company has not generated sufficient revenue from its licensees to fully fund its operations.

 

During 2021, the Company’s cash and cash equivalents balance decreased by $4,502,741 principally as a result of cash used for the purchase of marketable securities of $3,433,633 and cash used for operations of $1,804,293 and cash used for the purchase of property and equipment of $1,077 partially offset by cash generated from the exercise of options and warrants of $86,262 and cash generated from the sale of marketable securities of $650,000. At December 31, 2021, the Company had cash and cash equivalents of $3.0 million, working capital of $3.7 million and total shareholders’ equity of $3.8 million.

 

 40 

 

 

Inflation

 

The Company does not believe that inflation has a significant impact on its business.

 

Contractual Obligations:

 

The Company has operating leases for certain facilities and equipment with a weighted average remaining lease term of 2.2 years as of December 31, 2022. The maturities over time of the operating lease obligations as of December 31, 2022 were as follows:

 

     
   December 31, 2022 
Year 1  $                         217,000 
Years 2-3   278,000 
Years 4-5   - 
Thereafter   - 
Total lease payments  $495,000 

 

See Note 8 to our Consolidated Financial Statements for further discussion of the Company’s lease obligations.

 

Off-Balance Sheet Arrangements

 

The Company has no variable interest entities or other off-balance sheet obligation arrangements.

 

Forward Looking Statements

 

The information set forth in this Report and in all publicly disseminated information about the Company, including the narrative contained in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” above, includes “forward-looking statements” within the meaning of 21E of the Securities Exchange Act of 1934, as amended, and is subject to the safe harbor created by that section. Readers are cautioned not to place undue reliance on these forward-looking statements as they speak only as of the date hereof and are not guaranteed.

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

The consolidated financial statements listed in Item 15(a)(1) and (2) are included in this report beginning on page F-1.

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

None

 

 41 

 

 

ITEM 9A. CONTROLS AND PROCEDURES

 

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

 

As of the end of the period covered by this Annual Report on Form 10-K, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and acting interim Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Exchange Act Rule 13a-15(e) and 15d-15(e). Based upon that evaluation, the Company’s Chief Executive Officer and acting interim Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective in timely alerting them to material information relating to the Company (including its consolidated subsidiary) required to be included in the Company’s periodic SEC filings. Our Chief Executive Officer and acting interim Chief Financial Officer has concluded that as of December 31, 2022 our disclosure controls and procedures are designed, and are effective, to ensure that information required to be disclosed by our Company in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the commission’s rules and forms, and are also effective to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and acting interim Chief Financial Officer, to allow timely decisions regarding required disclosure.

 

Management’s Annual Report on Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f). Our internal control system is designed to provide reasonable assurance to our management and Board of Directors regarding the preparation and fair presentation of published financial statements. Under the supervision and with the participation of our management, including our Chief Executive Officer and acting interim Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control-Integrated Framework, issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013), or the COSO Framework. Based on the evaluation of our disclosure controls and procedures as of December 31, 2022, our Chief Executive Officer and Acting Interim Chief Financial Officer concluded that, as of such date, our internal control over financial reporting was effective.

 

This Annual Report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting because such attestation report is not required by our independent registered public accounting firm pursuant to rules of the Securities and Exchange Commission.

 

Changes in Internal Control Over Financial Reporting

 

There were no changes to controls during the three months ended December 31, 2022 that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

 

ITEM 9B. OTHER INFORMATION

 

None.

 

PART III

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

The Company has adopted a Code of Ethics applicable to its Chief Executive Officer, Chief Operating Officer, Treasurer and Chief Financial Officer, Vice Presidents and other employees of the Company with important roles in the financial reporting process. This Code of Ethics was adopted by the entire Board of Directors of the Company, including all of its Audit Committee members, in March 2004 in accordance with the requirements of the Sarbanes Oxley Act. The Code of Ethics is available on the Company’s website at www.SmartGlass.com and was also filed as an exhibit to the Company’s Annual Report on Form 10-K for the year ended December 31, 2003. The Company intends to satisfy the disclosure requirement under Item 10 of Form 8-K regarding any amendment to, or waiver from, a provision of this Code of Ethics by posting such information on the website specified above.

 

The other information required by this Item 10 is incorporated by reference to the Company’s definitive Proxy Statement to be filed with the Commission on or before April 28, 2023.

 

 42 

 

 

ITEM 11. EXECUTIVE COMPENSATION

 

The information required by this Item 11 is incorporated by reference to the Company’s definitive Proxy Statement to be filed with the Commission on or before April 28, 2023. Notwithstanding anything to the contrary set forth herein or in any of the Company’s past or future filings with the SEC that might incorporate by reference the Company’s definitive Proxy Statement, in whole or in part, the report of the compensation committee and the stock price performance graph contained in such definitive Proxy Statement shall not be incorporated by reference into this Annual Report on Form 10-K or in any other such filings.

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

The information required by this Item 12 is incorporated by reference to the Company’s definitive Proxy Statement to be filed with the Commission on or before April 28, 2023.

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE.

 

The information required by this Item 13 is incorporated by reference to the Company’s definitive Proxy Statement to be filed with the Commission on or before April 28, 2023.

 

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

 

Our independent registered public accounting firm is CohnReznick LLP, Melville, NY, Auditor Firm ID No: 596. The information required by this Item 14 is incorporated by reference to the Company’s definitive Proxy Statement to be filed with the Commission on or before April 28, 2023.

 

PART IV

 

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND REPORTS ON FORM 8-K

 

(a)(1) and (2) Financial Statements and Financial Statement Schedules

 

The following consolidated financial statements of Research Frontiers Incorporated are filed under “Item 8. Financial Statements and Supplemental Data” of this Report.

 

  Page
   
Report of Independent Registered Public Accounting Firm F-1
   
Consolidated Financial Statements:  
   
Consolidated Balance Sheets, December 31, 2022 and 2021 F-2
   
Consolidated Statements of Operations, Years ended December 31, 2022 and 2021 F-3
   
Consolidated Statements of Shareholders’ Equity, Years ended December 31, 2022 and 2021 F-4
   
Consolidated Statements of Cash Flows, Years ended December 31, 2022 and 2021 F-5
   
Notes to Consolidated Financial Statements F-6

 

All other schedules have been omitted because they are not applicable, or not required, or the required information is disclosed elsewhere in this Annual Report.

 

43

 

 

(a)(3)   Exhibits
     
3.1   Restated Certificate of Incorporation of the Company. Previously filed as Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 1994, and incorporated herein by reference.
     
3.2   Amended and Restated Bylaws of the Company. Previously filed as Exhibit 99.2 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2007, and incorporated herein by reference.
     
4.1   Form of Common Stock Certificate. Previously filed as an Exhibit to the Company’s Registration Statement on Form S-18 (Reg. No. 33-5573NY), declared effective by the Commission on July 8, 1986, and incorporated herein by reference.
     
4.2   Restated and amended Stockholder Protection Rights Agreement between Research Frontiers Incorporated and Continental Stock Transfer & Trust Company, as Rights Agent, dated February 11, 2023 - Filed herewith.
     
4.3  

Rights Agreement dated as of February 18, 2003 between Research Frontiers Incorporated and Continental Stock Transfer & Trust Company, as Rights Agent, which includes as Exhibit A thereto the Form of Rights Certificate. Previously filed as an Exhibit to the Company’s Registration Statement on Form 8-A dated February 13, 2013, and incorporated herein by reference.

 

10.1A*   Employment Agreement effective as of January 1, 2009 between the Company and Joseph M. Harary. Previously filed as an Exhibit to the Company’s Current Report on Form 8-K dated April 30, 2009 and incorporated herein by reference.
     
10.1B*   Amendment to Employment Agreement effective as of June 12, 2014 between the Company and Joseph M. Harary. Previously filed as an Exhibit to the Company’s Current Report on Form 8-K dated June 13, 2014 and incorporated herein by reference.
     
10.1B*   Amendment to Employment Agreement effective as of September 26, 2019 between the Company and Joseph M. Harary. Previously filed as an Exhibit to the Company’s Current Report on Form 8-K dated September 26, 2019 and incorporated herein by reference.
     
10.1C*   Employment Agreement effective as of January 1, 2014 between the Company and Seth L. Van Voorhees Previously filed as an Exhibit to the Company’s Current Report on Form 10-K dated December 31, 2013 and incorporated herein by reference.
     
10.2*   Amended and Restated 1992 Stock Option Plan. Previously filed as Exhibit 4 to the Company’s Registration Statement on Form S-8 (Reg. No. 33-86910) filed with the Commission on November 30, 1994, and incorporated herein by reference.
     
10.3*   1998 Stock Option Plan, as amended. Previously filed as an Exhibit to the Company’s Definitive Proxy Statement dated April 30, 1998 filed with the Commission on April 29, 1998, 1994, and incorporated herein by reference.
     
10.31*   2008 Equity Incentive Plan. Previously filed as an Exhibit to the Company’s Definitive Proxy Statement dated April 30, 2008 filed with the Commission on April 29, 2008, and incorporated herein by reference.
     
10.32*   2019 Equity Incentive Plan. Previously filed as an Exhibit to the Company’s Definitive Proxy Statement dated April 29, 2019 filed with the Commission on April 29, 2019, and incorporated herein by reference.
     
10.4*   Form of Stock Option Agreement between the Company and recipients of stock options issued pursuant to the Company’s Stock Option Plans. Previously filed as part of Exhibits 4.1, 4.2, and 4.3 to the Company’s Registration Statement on Form S-8 (Reg. No. 33-53030) filed with the Commission on October 6, 1992, and incorporated herein by reference.
     
10.5   Lease Agreement dated November 7, 1986, between the Company and Industrial & Research Associates Co. Previously filed as an exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 1986 and incorporated herein by reference.

 

44

 

 

10.5.1   First Amendment to Lease dated November 26, 1991 between the Company and Industrial and Research Associates Co. Previously filed as an Exhibit to Amendment No. 1 to the Company’s Registration Statement on Form S-1 (Reg. No. 33-43768) declared effective by the Commission on December 17, 1991, and incorporated herein by reference.
     
10.5.2   Second Amendment to Lease dated March 11, 1994 between the Company and Industrial and Research Associates Co. Previously filed as an exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 1993 and incorporated herein by reference.
     
10.5.3   Third Amendment to Lease dated July 14, 1998 between the Company and Industrial and Research Associates Co. Previously filed as an exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 1998 and incorporated herein by reference.
     
10.5.4   Fourth Amendment to Lease dated January 13, 2004 between the Company and Industrial and Research Associates Co. Previously filed as an exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2003 and incorporated herein by reference.
     
10.5.5   Fifth Amendment to Lease dated February 21, 2014 between the Company and CLK-HP 230-240 CROSSWAYS PARK LLC and LAKE PARK 230-240 CROSSWAYS PARK LLC. Previously filed as an exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2013 and incorporated herein by reference.
     
10.6   License Agreement effective as of August 2, 1995 between the Company and General Electric Company. Previously filed as an Exhibit to the Company’s Current Report on Form 8-K dated August 2, 1995 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.7   License Agreement effective as of April 29, 1996 between the Company and Glaverbel, S.A. Previously filed as an Exhibit to the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 1996 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.8   License Agreement effective as of January 18, 1997 between the Company and Material Sciences Corporation. Previously filed as an Exhibit to the Company’s Current Report on Form 8-K dated March 3, 1997 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.9   License Agreement effective as of March 31, 1997 between the Company and Hankuk Glass Industries, Inc. Previously filed as an Exhibit to the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 1997 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.10   License Agreement effective as of August 8, 1997 between the Company and Orcolite, a Unit of Monsanto Company. Previously filed as an Exhibit to the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 1997 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.11   License Agreement effective as of June 25, 1999 between the Company and Dainippon Ink and Chemicals, Incorporated. Previously filed as an Exhibit to the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 1999 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.

 

45

 

 

10.12   License Agreement effective as of August 9, 1999 between the Company and Hitachi Chemical Co., Ltd. Previously filed as an Exhibit to the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 1999 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.13   License Agreement effective as of December 3, 1999 between the Company and Global Mirror GmbH & Co. KG. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 1999 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
 10.14   License Agreement effective as of December 13, 1999 between the Company and Global Mirror GmbH & Co. KG. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 1999 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.15   License Agreement effective as of March 21, 2000 between the Company and ThermoView Industries, Inc. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 1999 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.16   License Agreement effective as of May 23, 2000 between the Company and Polaroid Corporation. Previously filed as an Exhibit to the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2000 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.17   License Agreement effective as of February 16, 2001 between the Company and AP Technoglass Co. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2001 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.18   License Agreement effective as of March 21, 2001 between the Company and InspecTech Aero Service, Inc. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2001 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.19   License Agreement effective as of March 28, 2001 between the Company and Film Technologies International, Inc. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2001 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.20   License Agreement effective as of November 29, 2001 between the Company and Avery Dennison Corporation. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2001 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.21   License Agreement effective as of February 4, 2002 between the Company and BOS GmbH & Co. KG. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2001 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.

 

46

 

 

10.22   License Agreement effective as of March 11, 2002 between the Company and Isoclima S.p.A. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2001 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.23   License Agreement effective as of July 2, 2002 between the Company and Isoclima S.p.A. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2002 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.24   License Agreement effective as of August 19, 2002 between the Company and Razor’s Edge Technologies, Inc. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2002 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.25   License Agreement effective as of October 7, 2002 between the Company and American Glass Products (Glass Technology Investment Ltd.). Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2002 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.26   License Agreement effective as of October 7, 2002 between the Company and SPD Systems, Inc. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2002 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.27   License Agreement effective as of October 24, 2002 between the Company and CricursaCristalesCurvados S.A. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2002 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.28   License Agreement effective as of December 9, 2002 between the Company and BRG Group, Ltd. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2002 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.29   License Agreement effective as of December 13, 2002 between the Company and Laminated Technologies Inc. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2002 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.30   License Agreement effective as of April 17, 2003 between the Company and Custom Glass Corporation. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K/A for the fiscal year ended December 31, 2003 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.31   License Agreement effective as of May 2, 2003 between the Company and Air Products and Chemicals, Inc. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K/A for the fiscal year ended December 31, 2003 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.

 

47

 

 

10.32   License Agreement effective as of May 30, 2003 between the Company and Kerros Limited. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K/A for the fiscal year ended December 31, 2003 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.33   License Agreement effective as of June 6, 2003 between the Company and Traco, Inc. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K/A for the fiscal year ended December 31, 2003 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.34   License Agreement effective as of June 16, 2003 between the Company and Saint-Gobain Glass France S.A. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K/A for the fiscal year ended December 31, 2003 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.35   License Agreement effective as of August 1, 2003 between the Company and Vision (Environmental Innovation) Limited. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K/A for the fiscal year ended December 31, 2003 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.36   License Agreement effective as of November 13, 2003 between the Company and Innovative Glass Corporation. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K/A for the fiscal year ended December 31, 2003 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.37   License Agreement effective as of December 11, 2003 between the Company and Leminur Limited. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K/A for the fiscal year ended December 31, 2003 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.38   License Agreement effective as of March 25, 2004 between the Company and Pilkington plc. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.39   License Agreement effective as of April 5, 2004 between the Company and SmartGlass Ireland Ltd. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.40   License Agreement effective as of April 8, 2004 between the Company and Prelco Inc. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.41   License Agreement effective as of April 13, 2004 between the Company and E. I. Dupont De Nemours and Company. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.

 

48

 

 

10.42   License Agreement effective as of September 3, 2004 between the Company and Nippon Sheet Glass Co., Ltd. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.43   License Agreement effective as of October 25, 2005 between the Company and SPD Control Systems Corporation. Previously filed as an Exhibit to the Company’s Current Report on Form 8-K dated October 31, 2005 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.44   License Agreement effective as of March 30, 2006 between the Company and Dainippon Ink and Chemicals. Previously filed as an Exhibit to the Company’s Current Report on Form 8-K dated April 4, 2006 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.45   License Agreement effective as of May 11, 2006 between the Company and Asahi Glass Company. Previously filed as an Exhibit to the Company’s Current Report on Form 8-K dated May 15, 2006 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.46   License Agreement effective as of March 19, 2007 between the Company and SmartGlass International Ltd. Previously filed as an Exhibit to the Company’s Current Report on Form 8-K dated March 19, 2007 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.47   License Agreement effective as of October 16, 2007 between Research Frontiers Incorporated and Glass Wholesalers, Ltd. d/b/a Craftsman Fabricated Glass, Ltd. Previously filed as an Exhibit to the Company’s Current Report on Form 8-K dated October 18, 2007 and incorporated herein by reference.
     
10.48   License Agreement effective as of December 14, 2007 between Research Frontiers Incorporated and AGC Flat Glass Europe SA. Previously filed as an Exhibit to the Company’s Current Report on Form 8-K dated December 17, 2007 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.49   License Agreement effective as of February 21, 2008 between Research Frontiers Incorporated and GKN Aerospace Transparency Systems Inc. Previously filed as an Exhibit to the Company’s Current Report on Form 8-K dated March 5, 2008 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.50   License Agreement effective as of September 29, 2008 between Research Frontiers Incorporated and PPG Industries, Inc. (now known as Pittsburgh Glass Works, LLC). Previously filed as an Exhibit to the Company’s Current Report on Form 8-K dated October 6, 2008 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.51   License Agreement effective as of September 10, 2009 between Research Frontiers Incorporated and Pilkington Group Ltd. Previously filed as an Exhibit to the Company’s Current Report on Form 8-K dated September 15, 2009 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.52   License Agreement effective as of January 25, 2010 between Research Frontiers Incorporated and Vision Systems. Previously filed as an Exhibit to the Company’s Current Report on Form 8-K dated January 25, 2010 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.

 

49

 

 

10.53   License Agreement effective as of February 8, 2010 between Research Frontiers Incorporated and ID Research Pty Ltd. (iGlass). Previously filed as an Exhibit to the Company’s Current Report on Form 8-K dated February 16, 2010 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.54   License Agreement effective as of December 13, 2010 between Research Frontiers Incorporated and Diamond Sea-Glaze Manufacturing Ltd. Previously filed as an Exhibit to the Company’s Current Report on Form 8-K dated December 14, 2010 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.55   License Agreement effective as of December 22, 2010 between Daimler AG, Research Frontiers Incorporated and SPD Control Systems Corp. Previously filed as an Exhibit to the Company’s Current Report on Form 8-K dated February 9, 2011 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.56   License Agreement effective as of February 19, 2013 between Tint-It JSC and Research Frontiers Incorporated. Previously filed as an Exhibit to the Company’s Current Report on Form 8-K dated March 5, 2013 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
10.57   License Agreement effective as of August 6, 2012 between Advnanotech LLC and Research Frontiers Incorporated. Previously filed as an Exhibit to the Company’s Current Report on Form 8-K dated March 12, 2013 with portions omitted pursuant to the Registrant’s request for confidential treatment and filed separately with the Securities and Exchange Commission and incorporated herein by reference.
     
14   Code of Ethics of Research Frontiers Incorporated. Previously filed as an Exhibit to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2003 and incorporated herein by reference.
     
21   Subsidiary of the Registrant - SPD Enterprises, Inc.
     
23.1   Consent of CohnReznick LLP - Filed herewith.
     
31.1   Rule 13a-14(a)/15d-14(a) Certification of Joseph M. Harary - Filed herewith.
     
32.1   Section 1350 Certification of Joseph M. Harary - Filed herewith.

 

EX-101.INS   Inline XBRL INSTANCE DOCUMENT
     
EX-101.SCH   Inline XBRL TAXONOMY EXTENSION SCHEMA
     
EX-101.PRE   Inline XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
     
EX-101.LAB   Inline XBRL TAXONOMY EXTENSION LABEL LINKBASE
     
EX-101.CAL   Inline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
     
EX-101.DEF   Inline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Executive Compensation Plan or Arrangement.

 

ITEM 16. Form 10-K Summary

 

None.

 

50

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  RESEARCH FRONTIERS INCORPORATED
  (Registrant)
   
  /s/ Joseph M. Harary
  Joseph M. Harary, President, CEO and Acting Interim CFO
  (Principal Executive Officer and Principal Financial and Accounting Officer)

 

Dated: March 9, 2023

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:

 

Signature   Position   Date
         
/s/ Darryl Daigle   Director   March 9, 2023
Darryl Daigle        
         
/s/ Joseph M. Harary   Director, President, CEO and Acting Interim CFO   March 9, 2023
Joseph M. Harary        
         
/s/ Alexander Kaganowicz   Director   March 9, 2023
Alexander Kaganowicz        

 

51

 

 

Report of Independent Registered Public Accounting Firm

 

Board of Directors and Shareholders

Research Frontiers Incorporated

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Research Frontiers Incorporated (the “Company”) as of December 31, 2022 and 2021, and the related consolidated statements of operations, shareholders’ equity and cash flows for each of the two years in the period ended December 31, 2022, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2022 in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial report, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matter

 

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there were no critical matters.

 

/s/ CohnReznick LLP

 

We have served as Research Frontiers Incorporated’s auditor since 2019.

 

Melville, New York

March 9, 2023

 

F-1

 

 

RESEARCH FRONTIERS INCORPORATED

Consolidated Balance Sheets

December 31, 2022 and 2021

 

           
   December 31, 2022   December 31, 2021 
         
Assets          
Current assets:          
Cash and cash equivalents  $4,230,916   $269,964 
Marketable securities   -    2,755,111 
Royalties receivable, net of reserves of $1,158,450 in 2022 and $1,016,678 in 2021, respectively    589,599    831,636 
Prepaid expenses and other current assets   100,973    92,931 
Total current assets   4,921,488    3,949,642 
           
Fixed assets, net   65,388    92,954 
Operating lease ROU assets   323,509    469,824 
Deposits and other assets   56,066    33,567 
Total assets  $5,366,451   $4,545,987 
           
Liabilities and Shareholders’ Equity          
           
Current liabilities:          
Current portion of operating lease liability  $196,405   $182,091 
Accounts payable   71,079    66,460 
Accrued expenses and other   34,379    49,385 
Total current liabilities   301,863    297,936 
           
Operating lease liability, net of current portion   267,723    464,128 
Total liabilities   569,586    762,064 
           
Shareholders’ equity:          
Common stock, par value $0.0001 per share; authorized 100,000,000 shares, issued and outstanding 33,150,396 in 2022 and 31,650,396 in 2021   3,315    3,165 
Additional paid-in capital   127,150,027    123,467,886 
Accumulated deficit   (122,356,477)   (119,687,128)
Total shareholders’ equity   4,796,865    3,783,923 
           
Total liabilities and shareholders’ equity  $5,366,451   $4,545,987 

 

See accompanying notes to consolidated financial statements.

 

F-2

 

 

RESEARCH FRONTIERS INCORPORATED

Consolidated Statements of Operations

Years ended December 31, 2022 and 2021

 

           
   2022   2021 
         
Fee income  $539,686   $1,263,034 
           
Operating expenses   2,555,689    2,521,849 
Research and development   609,127    580,000 
Total expenses   3,164,816    3,101,849 
           
Operating loss   (2,625,130)   (1,838,815)
           
Net investment loss   (44,219)   (7,537)
           
Net loss  $(2,669,349)  $(1,846,352)
           
Basic and diluted net loss per common share  $(0.08)  $(0.06)
           
Weighted average number of common shares outstanding   32,070,233    31,646,520 

 

See accompanying notes to consolidated financial statements.

 

F-3

 

 

RESEARCH FRONTIERS INCORPORATED

Consolidated Statements of Shareholders’ Equity

Years ended December 31, 2022 and 2021

 

                          
   Common Stock   Additional
Paid-in		   Accumulated     
   Shares   Amount   Capital   Deficit   Total 
                     
Balance, January 1, 2021   31,575,786   $3,158   $123,164,623   $(117,840,776)  $5,327,005 
                          
Exercise of options   74,610    7    86,255    -    86,262 
Share-based compensation   -    -    217,008    -    217,008 
Net loss   -    -    -    (1,846,352)   (1,846,352)
Balance, December 31, 2021   31,650,396    3,165    123,467,886    (119,687,128)   3,783,923 
                          
Share based compensation   -    -    232,291    -    232,291 
Issuance of common stock and warrants   1,500,000    150    3,449,850    -    3,450,000 
Net loss   -    -    -    (2,669,349)   (2,669,349)
Balance, December 31, 2022   33,150,396   $3,315   $127,150,027   $(122,356,477)  $4,796,865 

 

See accompanying notes to consolidated financial statements.

 

F-4

 

 

RESEARCH FRONTIERS INCORPORATED

Consolidated Statements of Cash Flows

Years ended December 31, 2022 and 2021

 

           
   2022   2021 
Cash flows from operating activities:          
Net loss  $(2,669,349)  $(1,846,352)
Adjustments to reconcile net loss to net cash          
used in operating activities:          
Depreciation and amortization   28,837    29,895 
Realized loss on marketable securities   60,143    - 
Unrealized loss on marketable securities   -    28,522 
Share-based compensation   232,291    217,008 
Bad debts   141,772    44,476 
ROU asset amortization   146,315    146,618 
Change in assets and liabilities:          
Royalty receivables   100,266    (277,819)
Prepaid expenses and other assets   (30,542)   (36,420)
Accounts payable and accrued expenses   (10,387)   56,156 
Operating lease liability   (182,091)   (166,377)
Net cash used in operating activities   (2,182,745)   (1,804,293)
           
Cash flows from investing activities:          
Purchases of fixed assets   (1,271)   (1,077)
Purchases of marketable securities   -    (3,433,633)
Sales of marketable securities   2,694,968    650,000 
Net cash used in investing activities   2,693,697    (2,784,710)
           
Cash flows from financing activities:          
Net proceeds from exercise of options and warrants   -    86,262 
Proceeds from issuance of common stock and warrants   3,450,000    - 
Net cash provided by financing activities   3,450,000    86,262 
           
Net increase (decrease) in cash and cash equivalents   3,960,952    (4,502,741)
           
Cash and cash equivalents at beginning of year   269,964    4,772,705 
Cash and cash equivalents at end of year  $4,230,916   $269,964 

 

See accompanying notes to consolidated financial statements.

 

F-5

 

 

RESEARCH FRONTIERS INCORPORATED

Notes to Consolidated Financial Statements

 

(1) Business and Basis for Presentation

 

Research Frontiers Incorporated (“Research Frontiers” or the “Company”) operates in a single business segment which is engaged in the development and marketing of technology and devices to control the flow of light. Such devices, often referred to as “light valves” or suspended particle devices (“SPDs”), use colloidal particles that are either incorporated within a liquid suspension or a film, which is usually enclosed between two sheets of glass or plastic having transparent, electrically conductive coatings on the facing surfaces thereof. At least one of the two sheets is transparent. SPD technology, made possible by a flexible light-control film invented by Research Frontiers, allows the user to instantly and precisely control the shading of glass/plastic manually or automatically. SPD technology has numerous product applications, including SPD-Smart™ windows, sunshades, skylights and interior partitions for homes and buildings; automotive windows, sunroofs, sun visors, sunshades, rear-view mirrors, instrument panels, heads up displays and navigation systems; aircraft windows; museum display panels; eyewear products; and flat panel displays for electronic products. SPD-Smart light control film is now being developed for, or used in, architectural, automotive, marine, aerospace and appliance applications.

 

The Company has primarily utilized its cash, cash equivalents, and investments generated from sales of our common stock, proceeds from the exercise of options and warrants, and royalty fees collected to fund its research and development of SPD light valves, for marketing initiatives, and for other working capital purposes. The Company’s working capital and capital requirements depend upon numerous factors, including the results of research and development activities, competitive and technological developments, the timing and cost of patent filings, and the development of new licensees and changes in the Company’s relationships with its existing licensees. The degree of dependence of the Company’s working capital requirements on each of the foregoing factors cannot be quantified; increased research and development activities and related costs would increase such requirements; the addition of new licensees may provide additional working capital or working capital requirements, and changes in relationships with existing licensees would have a favorable or negative impact depending upon the nature of such changes. We have incurred recurring losses since inception and expect to continue to incur losses as a result of costs and expenses related to our research and continued development of our SPD technology and our corporate general and administrative expenses. Our limited capital resources and operations to date have been substantially funded through sales of our common stock, exercise of options and warrants and royalty fees collected. As of December 31, 2022, we had working capital of approximately $4.6 million, cash and cash equivalents of approximately $4.2 million, shareholders’ equity of approximately $4.8 million and an accumulated deficit of approximately $122.4 million. Our quarterly projected cash flow shortfall, based on our current operations, adjusted for any non-recurring cash expenses and adjusted for additional royalties expected to be received for use of our products in new production, for the next 12 months, is approximately $200,000 per quarter. We may eliminate some operating expenses in the future, which will further reduce our cash flow shortfall, if needed. Based on these assumptions, we currently expect to have sufficient working capital for at least 12 months from the issuance of these financial statements.

 

In the event that we are unable to generate sufficient cash from our operating activities or raise additional funds, we may be required to delay, reduce or severely curtail our operations or otherwise impede our on-going business efforts, which could have a material adverse effect on our business, operating results, financial condition and long-term prospects. The Company may seek to obtain additional funding through future equity issuances. There can be no assurance as to the availability or terms upon which such financing and capital might be available. The eventual success of the Company and generation of positive cash flow will be dependent upon the commercialization of products using the Company’s technology by the Company’s licensees and payments of continuing royalties on account thereof. To date, the Company has not generated sufficient revenue from its licensees to fund its operations.

 

Recent Global Events:

 

On March 11, 2020, the World Health Organization declared the novel strain of coronavirus (“COVID-19”) a global pandemic and recommended containment and mitigation measures worldwide.

 

F-6

 

 

Since 2020 revenues have been negatively impacted due to delays in manufacture of products using our technology. Most of the products using our technology are manufactured by licensees overseas in Europe and Asia who have been similarly affected by the pandemic. The disruption caused by public health crises, such as COVID-19, could result in lower levels of sale activity for products using our technology resulting in lower level of royalties owed to us from the sale of these products. The duration of the potential business disruptions and related financial impact cannot be reasonably estimated at this time, but could materially adversely affect our business, financial condition, results of operations, and cash flows.

 

Certain amounts in the accompanying December 31, 2021 statements of cash flows have been reclassified to conform with the December 31, 2022 presentation.

 

(2) Summary of Significant Accounting Policies

 

(a) Cash and Cash Equivalents

 

The Company considers securities purchased with original maturities of three months or less to be cash equivalents. Cash equivalents consist of short-term investments in money market accounts at December 31, 2022 and 2021.

 

Cash and cash equivalents are maintained at financial institutions and, at times, balances may exceed federally insured limits. We have never experienced any losses related to these balances. FDIC insurance coverage is $250,000 per depositor at each financial institution, and our non-interest bearing cash balances may again exceed federally insured limits. Amounts on deposit in excess of federally insured limits at December 31, 2022 and 2021 are approximately $2.7 million and $0, respectively.

 

(b) Marketable Securities

 

The Company classifies investments in marketable securities as trading, available-for-sale or held-to-maturity at the time of purchase and periodically re-evaluates such classification. Trading securities are carried at fair value, with unrealized holding gains and losses included in earnings. Held-to-maturity securities are recorded at cost and are adjusted for the amortization or accretion of premiums or discounts over the life of the related security. Unrealized holding gains and losses of available-for-sale securities are excluded from earnings and are reported as a separate component of accumulated other comprehensive income (loss) until realized. In determining realized gains and losses, the cost of the securities sold is based on the specific identification method. Interest and dividends on the investments are accrued at the balance sheet date.

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date. Fair value measurements are broken down into three levels based on the reliability of inputs as follows: Level 1 inputs are quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. An active market for the asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates and yield curves observable at commonly quoted intervals or current market) and contractual prices for the underlying financial instrument, as well as other relevant economic measures. Level 3 inputs are unobservable inputs for the asset or liability. Unobservable inputs are used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.

 

At December 31, 2022, the Company invested only in investments qualified as cash and cash equivalents. During the year ended December 31, 2022, the Company incurred a realized loss on the sale of marketable securities of $60,143. At December 31, 2021 all investments are Level 1 and were classified as trading and consisted of the following:

 

      December 31, 2021 
      Value of trading 
   Investment  Investments 
        
Mutual Funds  Putnam Short Duration Bond   $1,972,736 
   Putnam Ultra Short Duration Income    782,375 
         
      $2,755,111 
         
   Unrealized loss   $28,522 

 

(c) Royalties Receivable

 

Royalties receivable from licensees are recorded at the amounts specified within the license agreements when the collectability of the receivable is reasonably assured. The allowance for doubtful accounts is the Company’s best estimate of the amount of probable credit losses in the Company’s existing royalties receivable. The Company determines the allowance based on historical write-off experience as well as the current status of the Company’s customers. The Company reviews its allowance for doubtful accounts periodically. Past due accounts are reviewed individually for collectability. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. As of December 31, 2022, one company accounted for 14% of the Company’s outstanding receivables. As of December 31, 2021, two companies accounted for 14% and 11% of the Company’s outstanding receivables.

 

(d) Fixed Assets

 

Fixed assets are carried at cost less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the assets.

 

F-7

 

 

(e) Revenue Recognition/Fee Income

 

The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers (“ASC 606”). The standard provides a single comprehensive revenue recognition model for all contracts with customers and supersedes existing revenue recognition guidance. The revenue standard contains principles that an entity will apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to customers at an amount that the entity expects to be entitled to in exchange for those goods or services.

 

ASC 606 follows a five-step approach to determining revenue recognition including: 1) Identification of the contract; 2) Identification of the performance obligations; 3) Determination of the transaction price; 4) Allocation of the transaction price; and 5) Recognition of revenue.

 

The Company determined that its license agreements provide for three performance obligations which include: (i) the Grant of Use to its Patent Portfolio (“Grant of Use”), (ii) Stand-Ready Technical Support (“Technical Support”) including the transfer of trade secrets and other know-how, production of materials, scale-up support, analytical testing, etc., and (iii) access to new Intellectual Property (“IP”) that may be developed sometime during the course of the contract period (“New Improvements”). Given the nature of IP development, such New Improvements are on an unspecified basis and can occur and be made available to licensees at any time during the contract period.

 

When a contract includes more than one performance obligation, the Company needs to allocate the total consideration to each performance obligation based on its relative standalone selling price or estimate the standalone selling price if it is not observable. A standalone selling price is not available for our performance obligations since we do not sell any of the services separately and there is no competitor pricing that is available. As a consequence, the best method for determining standalone selling price of our Grant of Use performance obligation is through a comparison of the average royalty rate for comparable license agreements as compared to our license agreements. Comparable license agreements must consider several factors including: (i) the materials that are being licensed, (ii) the market application for the licensed materials, and (iii) the financial terms in the license agreements that can increase or decrease the risk/reward nature of the agreement.

 

Based on the royalty rate comparison referred to above, any pricing above and beyond the average royalty rate would relate to the Technical Support and New Improvements performance obligations. The Company focuses a significant portion of its time and resources to provide the Technical Support and New Improvements services to its licensees, which further supports the conclusions reached using the royalty rate analysis.

 

The Technical Support and New Improvements performance obligations are co-terminus over the term of the license agreement. For purposes of determining the transaction price, and recognizing revenue, the Company combined the Technical Support and New Improvements performance obligations because they have the same pattern of transfer and the same term. We maintain a staff of scientists and other professionals whose primary job responsibilities throughout the year are: (i) being available to respond to Technical Support needs of our licensees, and (ii) developing improvements to our technology which are offered to our licensees as New Improvements. Since the costs incurred to satisfy the Technical Support and New Improvements performance obligations are incurred evenly throughout the year, the value of the Technical Support and New Improvements services are recognized throughout the initial contract period as these performance obligations are satisfied. If the agreement is not terminated at the end of the initial contract period, it will renew on the same terms as the initial contract for a one-year period. Consequently, any fees or minimum annual royalty obligations relating to this renewal contract will be allocated similarly to the initial contract over the additional one-year period.

 

We recognize revenue when or as the performance obligations in the contract are satisfied. For performance obligations that are fulfilled at a point in time, revenue is recognized at the fulfillment of the performance obligation. Since the IP is determined to be a functional license, the value of the Grant of Use is recognized in the first period of the contract term in which the license agreement is in force. The value of the Technical Support and New Improvements obligations is allocated throughout the contract period based on the satisfaction of its performance obligations. If the agreement is not terminated at the end of the contract period, it will renew on the same terms as the original agreement for a one-year period. Consequently, any fees or minimum annual royalties (“MAR”) relating to this renewal contract will be allocated similarly over that additional year.

 

F-8

 

 

The Company’s license agreements have a variable royalty fee structure (meaning that royalties are a fixed percentage of sales that vary from period to period) and frequently include a minimum annual royalty commitment. In instances when sales of licensed products by its licensees exceed the MAR, the Company recognizes fee income as the amounts have been earned. Typically, the royalty rate for such sales is 10-15% of the selling price. While this is variable consideration, it is subject to the sales/usage royalty exception to recognition of variable consideration in ASC 606 10-55-65 and therefore is not recognized until the subsequent sales or usage occurs or the MAR period commences.

 

Because of the immediate recognition of the Grant of Use performance obligation: (i) the first period of the contract term will generally have a higher percent allocation of the transaction price under ASC 606 and (ii) the remaining periods will have less of the transaction price recognized under ASC 606. After the initial period in the contract term, the revenue for the remaining periods will be based on the satisfaction of the technical support and New Improvements obligations. Since most of our license agreements start as of January 1st, the revenue recognized for the contract under ASC 606 in our first quarter will tend to be higher subsequent quarters in the fiscal year.

 

Certain of the contract fees are accrued by, or paid to, the Company in advance of the period in which they are earned resulting in deferred revenue. Such excess amounts are recorded as deferred revenue and are recognized as revenue in future periods as earned.

 

The Company operates in a single business segment which is engaged in the development and marketing of technology and devices to control the flow of light. Our revenue source comes from the licensing of this technology and all of these license agreements have similar terms and provisions. The majority of the Company’s licensing fee income comes from the activities of several licensees participating in the automotive market. The Company currently believes that the automotive market will be the largest source of its royalty income over the next several years. The Company’s royalty income from this market may be influenced by numerous factors including various trends affecting demand in the automotive industry and the rate of introduction of new technology in OEM product lines. In addition to these macro factors, the Company’s royalty income from the automotive market could also be influenced by specific factors such as whether the Company’s SPD-SmartGlass technology appears as standard equipment or as an option on a particular vehicle, the number of additional vehicle models that SPD-SmartGlass appears on, the size of each window on a vehicle and the number of windows on a vehicle that use SPD SmartGlass, fluctuations in the total number of vehicles produced by a manufacturer, and in the percentage of cars within each model produced with SPD-SmartGlass, and changes in pricing or exchange rates.

 

As of December 31, 2022, the Company has one license agreement that are in its initial multiyear term (“Initial Term”) with continuing performance obligations going forward. The Initial Term of this agreement will end as of December 31, 2024, The Company currently expects this agreement will renew annually at the end of the Initial Term. As of December 31, 2022, the aggregate amount of the revenue to be recognized upon the satisfaction of the remaining performance obligations for this license agreements is $123,000. The revenue for the remaining performance obligations for this license agreement is expected to be recognized evenly throughout the remaining period of the Initial Term.

 

For the years ended December 31, 2022 and 2021, the Company entered into a number of license agreements covering its light control technology. The Company received minimum annual royalties under certain license agreements and recorded fee income based on ASC 606 revenue recognition each quarter. In instances when sales of licensed products by its licensees exceed minimum annual royalties, the Company recognized additional fee income as the amounts have been earned. Certain of the fees are accrued by, or paid to, the Company in advance of the period in which they are earned resulting in deferred revenue. Such excess amounts are recorded as deferred revenue and are typically recognized as fee income when earned. As of December 31, 2022 and 2021, there was no balance in deferred revenue.

 

Fee income represents amounts earned by the Company under various license and other agreements relating to technology developed by the Company. During 2022, four licensees accounted for 28%, 23%, 13% and 11% of fee income recognized during the year. During 2021, four licensees accounted for 20%, 18%, 18% and 12% of fee income recognized during the year.

 

F-9

 

 

(f) Basic and Diluted Loss Per Common Share

 

Basic loss per share excludes any dilution. It is based upon the weighted average number of common shares outstanding during the period. Dilutive loss per share reflects the potential dilution that would occur if securities or other contracts to issue common stock were exercised or converted into common stock. The Company’s dilutive loss per share equals basic loss per share for each of the years in the two-year period ended December 31, 2022 because all potentially dilutive securities (i.e., options and warrants) were antidilutive in those periods. The number of options and warrants that were not included because their effect is antidilutive was 4,146,951 and 2,599,701 for 2022 and 2021, respectively.

 

(g) Research and Development Costs

 

Research and development costs are charged to expense as incurred.

 

(h) Patent Costs

 

The Company expenses costs relating to the development or acquisition of patents due to the uncertainty of the recoverability of these items.

 

(i) Use of Estimates

 

The preparation of the Company’s consolidated financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during this period. Actual results could differ from those estimates.

 

(j) Income Taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to be recovered or settled.

 

In accordance with ASC Topic 740, we recognize tax benefits only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely to be realized upon ultimate settlement. Unrecognized tax benefits are tax benefits claimed in tax returns that do not meet these recognition and measurement standards. We classify accrued interest and penalties related to any unrecognized tax benefits in our income tax provision. At December 31, 2022 and 2021, we do not have accrued interest and penalties related to any unrecognized tax benefits. We do not believe we have any uncertain tax positions as of December 31, 2022 and 2021.

 

The tax years subject to examination by major tax jurisdictions include the years 2017 and forward by the U.S. Internal Revenue Service and certain states. The Company is not currently being audited by any tax jurisdiction.

 

(k) Equity-Based Compensation

 

We recognize all stock-based compensation as an expense in the consolidated financial statements and such costs are measured at the fair value of the award at the date of grant. In addition to reflecting compensation expense for new share-based payment awards, expense is also recognized to reflect the remaining vesting period of awards that had been granted in prior periods. Tax benefits related to stock option exercises are reflected as financing cash inflows.

 

The exercise prices for stock options granted are generally set at the average for the high and low trading prices of the Company’s common stock on the trading date immediately prior to the date of grant, and the related numbers of shares granted are fixed at the date of grant.

 

F-10

 

 

In order to determine the fair value of stock options on the date of grant, the Company uses the Black-Scholes option-pricing model. Inherent in this model are assumptions related to expected stock-price volatility, option term, risk-free interest rate and dividend yield. While the risk-free interest rate and dividend yield are less subjective assumptions that are based on factual data derived from public sources, the expected stock-price volatility and option term assumptions require a greater level of judgment.

 

In connection with employee and director stock options, the Company charged to compensation expense $232,291 and $217,008 during the years ended December 31, 2022 and 2021, respectively. As of December 31, 2022, these awards were fully vested. In lieu of higher cash compensation, the Company has granted warrants and non-employee options to consultants. These warrants and non-employee options vested fully on the date of grant. There were no such charges for the year ended December 31, 2022 and 2021.

 

(l) Restricted Stock

 

Compensation cost for restricted stock is measured using the quoted market price of the Company’s common stock at the date the common stock is granted. The compensation cost is recognized over the period between the issue date and the vesting period for such shares. Restricted stock is included in total common shares outstanding upon the lapse of any vesting conditions.

 

(m) Impairment of Long-Lived Assets

 

The Company reviews long-lived assets to determine whether an event or change in circumstances indicates the carrying value of the asset may not be recoverable. The Company bases its evaluation on such impairment indicators as the nature of the assets, the future economic benefit of the assets and any historical or future profitability measurements, as well as other external market conditions or factors that may be present. There was no impairment of long-lived assets recorded during 2022 and 2021.

 

(n) Fair Value Measurements

 

As of December 31, 2022 and 2021, the fair value of the Company’s financial assets and non-warrant liabilities including cash and cash equivalents, marketable securities, royalties receivable, accounts payable and accrued expenses approximated carrying value due to the short-term maturity of these instruments.

 

(o) Recent Accounting Pronouncements

 

New Accounting Standards

 

The Company believes that no new accounting standards that are not yet effective will have a material effect on the Company’s consolidated financial statements.

 

F-11

 

 

(3) Fixed Assets

 

Fixed assets and their estimated useful lives as of December 31, 2022 and 2021 are as follows:

 

   2022   2021   Estimated useful life
            
Equipment and furniture  $1,392,365   $1,391,094   5 years
Trade show materials   775,654    775,654   5 years
Autos   53,764    53,764   5 years
             Life of lease or estimated
Leasehold improvements   584,967    584,967   life of asset if shorter
    2,806,750    2,805,479    
              
Less accumulated depreciation             
and amortization   (2,741,362)   (2,712,525)   
   $65,388   $92,954    

 

(4) Accrued Expenses and Other

 

Accrued expenses consist of the following at December 31, 2022 and 2021:

 

   2022   2021 
Payroll, bonuses and related benefits  $29,219   $45,725 
Professional services   4,800    3,300 
Other   360    360 
Accrued expenses  $34,379   $49,385 

 

(5) Income Taxes

 

Since inception, the Company has incurred losses from operations and as a result has not recorded income tax expense. Benefits related to net operating loss carryforwards and deferred items have been fully reserved because it is not more likely than not that the Company will achieve profitable operations. The difference between the total income taxes at the federal statutory rate for each of the years ended December 31, 2022 and 2021 and the fact that no income tax benefit was recorded in each of these years is attributable to the change in the valuation allowance recorded in each year.

 

F-12

 

 

The Tax Cuts and Jobs Act of 2017 (“TCIA”) amended IRC Section 174 to require capitalization of all research and development (“R&D”) costs incurred in tax years beginning after December 31, 2021. These costs are required to be amortized over five years if the R&D activities are performed in the U.S., or over 15 years if the activities were performed outside the U.S. For tax reporting purposes, the Company capitalized $609,000 of R&D expenses incurred as of December 31, 2022.

 

On August 16, 2022, the Inflation Reduction Act (“IRA”) was signed into law in the United States. Among other provisions, the IRA includes a 15% corporate minimum tax rate which applies to certain large corporations and a 1% excise tax on corporate stock repurchases made after December 31, 2022. We do not expect the IRA to have a material impact on our consolidated financial statements.

 

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets at December 31, 2022 and 2021 are presented below:

 

   2022   2021 
Deferred tax assets:          
Depreciation  $109,000   $106,000 
Allowance for bad debts   248,000    218,000 
Net operating loss carry-forwards   13,561,000    14,114,000 
Stock option expense   334,000    355,000 
Research and other credits   891,000    945,000 
Lease liability   99,000    138,000 
Amortization   130,000    - 
Total gross deferred tax assets   15,372,000    15,876,000 
           
Deferred tax liabilities:          
Lease liability   69,000    101,000 
Other temporary differences   -    22,000 
Total gross deferred tax liabilities   69,000    123,000 
           
Valuation allowance   (15,303,000)   (15,753,000)
Net deferred tax  $-   $- 

 

The reconciliation of the income tax expense (benefit) computed at the federal statutory tax rates to income tax expense (benefit) is as follows:

 

   2022   2021 
         
Income tax provision at federal statutory rate  $(561,000)  $(388,000)
Expired carryforwards and other   1,011,000    1,079,000 
Valuation allowance   (450,000)   (691,000)
Total income tax provision  $-   $- 

 

In assessing the realizability of deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon future taxable income during the period in which those temporary differences become deductible. The Company considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Based upon its historical operating losses, utilization of deferred tax assets cannot currently be determined. Accordingly, the Company has recorded a full valuation allowance against the deferred tax assets due to the uncertainty regarding the future utilization of the deferred tax assets for all periods presented.

 

At December 31, 2022, the Company had net operating loss carryforwards for federal income tax purposes of approximately $63,370,000. Net operating loss carryforwards accumulated through December 31, 2017 of approximately $52,927,000 will expire in varying amounts from 2023 through 2037. Net operating losses generated since 2018, totaling approximately $10,443,000, will carry forward indefinitely, but cannot offset more than 80 percent of taxable income. Research and other credit carryforwards of approximately $891,000 are available to the Company to reduce income taxes payable in future years principally through 2040. The Company’s ability to utilize its net operating loss carryforwards and its current year tax credits in future periods could be subject to the 382 limitation. The Company will need to complete an analysis to determine whether its net operating losses are subject to the 382 limitation.

 

F-13

 

 

(6) Shareholders’ Equity

 

(a) Common Stock and Warrants

 

During 2021, the Company received proceeds of $86,262 and issued 74,610 shares of common stock in connection with the exercise of outstanding options and warrants. In addition, during February 2023, the Company received proceeds of $484,503 and issued 358,891common shares in connection with the exercise of outstanding warrants.

 

On September 16, 2022, the Company entered into subscription agreements from a group of private accredited investors to sell them 2.0 million shares of common stock of the Company at a price of $2.30 per share (which represents the closing market price of the Company’s common stock on September 14, 2022 which was the date that the transaction was agreed to). As of December 31, 2022, the Company received $3,450,000 under these subscription agreements and has issued 1,500,000 common shares and issued 1,500,000 warrants. In addition, the Company expects to receive the remaining $1,150,000 under these subscription agreements in March, 2023. The shares were issued to the investors in a private placement and, along with the shares issued in connection with the exercise of any warrants in the future, are not registered and therefore currently subject to at least a six-month holding period by the investor.

 

(b) Options and Warrants

 

(i) Employee Options

 

In 2019, the shareholders approved the Company’s 2019 Equity Incentive Plan, which provides for the granting of both incentive stock options at the fair market value at the date of grant and nonqualified stock options at the fair market value at the date of grant to employees or non-employees who, in the determination of the Board of Directors, have made or may make significant contributions to the Company in the future. The Company may also award stock appreciation rights, restricted stock, or restricted stock units under this plan. The Company initially reserved 1,400,000 shares of its common stock for issuance under this plan, and 307,500 options and other awards were available for issuance under this plan as of December 31, 2022.

 

At the discretion of the Board of Directors, options expire in ten years or less from the date of grant and are generally fully exercisable upon grant but in some cases may be subject to vesting in the future. Full payment of the exercise price may be made in cash or in shares of common stock valued at the fair market value thereof on the date of exercise, or by agreeing with the Company to cancel a portion of the exercised options.

 

The Company granted 178,000 fully vested options during 2022 and recorded share-based compensation of $232,291. The Company granted 198,000 fully vested options during 2021 and recorded share-based compensation of $217,008. The Company valued these grants using the Black-Scholes option pricing model with the following weighted average assumptions:

 

   2022   2021 
         
Fair value on grant date  $1.31   $1.10 
Expected dividend yield   -    - 
Expected volatility   81%   79%
Risk free interest rate   3.99%   1.26%
Expected term of the option   5 years    5 years 

 

 

F-14

 

 

Activity for stock options is summarized below:

 

   Number of Shares Subject to Option   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term (Years)   Aggregate Intrinsic Value 
                 
Balance at January 1, 2021   1,297,260   $4.09    5.8   $142,885 
                     
Granted   198,000   $1.72           
Cancelled   (155,050)  $5.38           
Exercised   (140,500)  $2.48           
Balance at December 31, 2021   1,199,710   $3.67    5.7   $21,870 
                     
Granted   178,000   $1.95           
Cancelled   (130,750)  $4.91           
Exercised   -   $-           
Balance at December 31, 2022   1,246,960   $3.35    5.8   $67,510 

 

All options are exercisable at December 31, 2022.

 

(ii) Warrants and Non-Employee Options

 

Activity in warrants is summarized below:

 

   Number of Shares Underlying Warrants Granted   Weighted Average Exercise Price 
       
         
Balance at January 1, 2021   1,399,991   $2.27 
           
Exercised   -      
Terminated   -      
Issued   -      
Balance at December 31, 2021   1,399,991   $2.27 
           
Exercised   -      
Terminated   -      
Issued   1,500,000    2.76 
Balance at December 31, 2022   2,899,991   $2.52 

 

In lieu of cash compensation, the Company has granted warrants to investors and non-employee options to consultants. These warrants and non-employee options vested ratably over various terms ranging from 12 to 59 months. The non-employee options are valued at fair value at the time that the related services are provided using the Black-Scholes option valuation model and marked to market quarterly using the Black-Scholes option valuation model. There are 2,899,991 warrants issued to investors that are outstanding that are accounted for as equity.

 

Warrants and non-employee options generally expire in five years from the date of issuance. At December 31, 2022, all warrants and non-employee options outstanding were exercisable.

 

F-15

 

 

(c) Restricted Stock Grants

 

During 2022 and 2021, the Company did not issue restricted stock to its directors and employees.

 

(7) License and Other Agreements

 

The Company has entered into a number of license agreements covering various products using the Company’s SPD technology. Some of these license agreements are limited to specific countries and/or markets. Licensees of Research Frontiers who incorporate SPD technology into end products pay Research Frontiers an earned royalty of 5-15% of net sales of licensed products under license agreements currently in effect and may also be required to pay Research Frontiers fees and minimum annual royalties. Licensees who sell products or components to other licensees of Research Frontiers do not pay a royalty on such sale; Research Frontiers will collect such royalty from the licensee incorporating such products or components into its own end-products. Research Frontiers’ license agreements typically allow the licensee to terminate the license after some period of time and give Research Frontiers only limited rights to terminate before the license expires. Most licenses are non-exclusive and generally last as long as our patents remain in effect.

 

On March 14, 2019, the Company suspended its VariGuard SmartGlass business unit activities. Instead, the Company licensed a new entity to pursue the business opportunities previously pursued by the Company’s VariGuard SmartGlass business unit. This new licensee continues to use the VariGuard SmartGlass name. In addition to other employees at VariGuard SmartGlass Inc., one of the Company’s officers (Michael R. LaPointe) and one former officer (Seth L. Van Voorhees) are shareholders of VariGuard SmartGlass Inc. and, as consequence, this transaction is a related party relationship which has been reviewed and approved by the Company’s Board of Directors pursuant to the requirements of Delaware corporate law and the Company’s Code of Ethics. Mr. LaPointe also remains a full-time employee at the Company. In October 2021, the Company entered into an amendment to the license agreement with VariGuard modifying its scope and terms.

 

(8) Commitments

 

The Company has an employment agreement with its chief executive officer which provides for an annual base salary of $500,000 for calendar year 2023. This employment agreement has an evergreen provision that extends the term by one year on the expiration date unless either the Company or the employee has given notice that they will not be renewing the agreement upon the expiration of its term.

 

The Company has a defined contribution profit sharing (401k) plan covering employees who have completed one year of service. Contributions are made at the discretion of the Company. The Company did not make any contributions to this plan for 2022 or 2021.

 

The Company determines if an arrangement is a lease at its inception. This determination generally depends on whether the arrangement conveys the right to control the use of an identified fixed asset explicitly or implicitly for a period of time in exchange for consideration. Control of an underlying asset is conveyed if the Company obtains the rights to direct the use of, and to obtain substantially all of the economic benefits from the use of, the underlying asset. Lease expense for variable leases and short-term leases is recognized when the obligation is incurred.

 

The Company has operating leases for certain facilities, vehicles and equipment with a weighted average remaining lease term of 2.2 years as of December 31, 2022. Operating leases are included in right of use lease assets, other current liabilities and long-term lease liabilities on the consolidated balance sheet. Right of use lease assets and liabilities are recognized at each lease’s commencement date based on the present value of its lease payments over its respective lease term. The Company does not have an established incremental borrowing rate as it does not have any debt. The Company uses the stated borrowing rate for a lease when readily determinable. When the interest rate implicit in its lease agreements is not readily determinable, the Company uses an interest rate based on the marketplace for public debt. The weighted average discount rate associated with operating leases as of December 31, 2022 is 5.5%.

 

F-16

 

 

Maturities of operating lease liabilities as of December 31, 2022 were as follows:

 

    December 31, 2022
Year 1   $                      217,000  
Years 2-3     278,000  
Years 4-5     -  
Thereafter     -  
Total lease payments     495,000  
Less: imputed lease interest     (30,872)  
Present value of lease liabilities   $ 464,128  

 

(9) Rights Plan

 

In February 2013, the Company’s Board of Directors adopted a Stockholders’ Rights Plan (the “Rights Plan”) and declared a dividend distribution of one right (a “Right”) for each outstanding share of Company common stock to stockholders of record at the close of business on March 3, 2003 (“Record Time”) and authorized the issuance of one Right in respect of each share of Common Stock issued after the Record Time and prior to the Separation Time. The Rights Plan was readopted and extended in December 2022 until February 11, 2033.

 

“Separation Time” shall mean the earlier of the Close of Business on the tenth Business Day (or such later date as the Board of Directors may from time to time fix by resolution adopted prior to the Separation Time that otherwise would have occurred) following but not including (i) the date on which any Person commences a tender or exchange offer that, if consummated, would result in such Person’s becoming an Acquiring Person, and (ii) the date of the first event causing a Flip-in Date to occur; provided that if any tender or exchange offer referred to in clause (i) of this paragraph is cancelled, terminated or otherwise withdrawn prior to the Separation Time without the purchase of any shares of Common Stock pursuant thereto, such offer shall be deemed, for purposes of this paragraph, never to have been made.

 

Subject to certain exceptions listed in the Rights Plan, if a person or group has acquired beneficial ownership of, or commences a tender or exchange offer for, 15% or more of the Company’s common stock, unless redeemed by the Company’s Board of Directors, each Right entitles the holder (other than the acquiring person) to purchase from the Company $80 worth of common stock for $40. If the Company is merged into, or 50% or more of its assets or earning power is sold to, the acquiring company, the Rights will also enable the holder (other than the acquiring person) to purchase $80 worth of common stock of the acquiring company for $40. During 2022, the Company extended to expiration of The Rights to the close of business on February 11, 2033, unless the Rights Plan is extended by the Company’s Board of Directors or unless the Rights are earlier redeemed by the Company at a price of $0.0001 per Right. The Rights are not exercisable during the time when they are redeemable by the Company.

 

The above description highlights some of the features of the Company’s Rights Plan and is not a complete description of the Rights Plan. A more detailed description and copy of the Rights Plan has been filed with the SEC and is available from the Company upon request.

 

F-17

 

 EX-4.2 2 ex4-2.htm

 

Exhibit 4.2

 

RESTATED AND AMENDED STOCKHOLDER PROTECTION RIGHTS AGREEMENT

 

RESTATED AND AMENDED STOCKHOLDER PROTECTION RIGHTS AGREEMENT (as further amended from time to time, this “Agreement”), dated as of February 11, 2023, between Research Frontiers Incorporated, a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York banking corporation, as Rights Agent (the “Rights Agent,” which term shall include any successor Rights Agent hereunder).

 

WITNESSETH:

 

WHEREAS, on February 18, 2003, the Board of Directors of the Company (a) authorized the adoption of the Rights Agreement, dated February 18, 2003, between the Company and the Rights Agent (the “2003 Agreement”), (b) authorized and declared a dividend of one right (“Right”) in respect of each share of Common Stock (as hereinafter defined) held of record as of the Close of Business (as hereinafter defined) on March 3, 2003 (the “Record Time”), and (c) authorized the issuance of one Right in respect of each share of Common Stock issued after the Record Time and prior to the Separation Time (as hereinafter defined);

 

WHEREAS, pursuant to Section 26 of the 2003 Agreement, on February 11, 2013, the Board of Directors of the Company authorized the adoption of this Agreement which restates and amends the 2003 Agreement to (a) extend the Final Expiration Time (as hereinafter defined), (b) decrease the Exercise Price (as hereinafter defined), and (c) make certain other changes as set forth herein.

 

WHEREAS, pursuant to Section 26 of the 2003 Agreement and the 2013 Agreement, on December 14, 2022, the Board of Directors of the Company authorized the adoption of this Agreement which restates and amends the 2003 Agreement to (a) extend the Final Expiration Time (as hereinafter defined), and (b) make certain other changes as set forth herein.

 

NOW THEREFORE, in consideration of the premises and the respective agreements set forth herein, the parties hereby agree as follows:

 

ARTICLE I

DEFINITIONS

 

1.1 Definitions. For purposes of this Agreement, the following terms have the meanings indicated:

 

“Acquiring Person” shall mean any Person who is or becomes the Beneficial Owner of 15% or more of the outstanding shares of Common Stock; provided, however, that the term “Acquiring Person” shall not include any Person (i) who becomes the Beneficial Owner of 15% or more of the outstanding shares of Common Stock but who (in the good faith determination of the Board of Directors) acquired Beneficial Ownership of shares of Common Stock without any plan or intention to obtain, change or influence the control of the Company if such Person promptly divests, or promptly enters into an agreement with, and satisfactory to, the Board of Directors, in the Board’s sole discretion, to divest, and subsequently divests in accordance with the terms of such agreement (without exercising or retaining any power, including, but not limited to, voting power, with respect to such shares), sufficient shares of Common Stock (or securities convertible into, exchangeable into or exercisable for Common Stock or otherwise deemed to be Beneficially Owned by such Person) so that such Person ceases to be the Beneficial Owner of 15% or more of the outstanding shares of Common Stock; (ii) who becomes the Beneficial Owner of 15% or more of the outstanding shares of Common Stock solely as a result of a reduction in the number of shares of Common Stock outstanding due to the repurchase of shares of Common Stock by the Company (or any Subsidiary of the Company, any employee benefit plan of the Company or of any Subsidiary of the Company, or any Person or entity organized, appointed or established by the Company for or pursuant to the terms of any such plan) unless and until such Person, after becoming aware that such Person has become the Beneficial Owner of 15% or more of the then outstanding shares of Common Stock, acquires Beneficial Ownership (other than by means of a stock dividend or stock split) of additional shares of Common Stock representing 1% or more of the shares of Common Stock then outstanding; or (iii) who Beneficially Owns shares of Common Stock consisting solely of one or more of (A) shares of Common Stock that are Beneficially Owned pursuant to the grant or exercise of an option granted to such Person (an “Option Holder”) by the Company in connection with an agreement to merge with, or acquire, the Company entered into prior to a Flip-in Date, (B) shares of Common Stock (or securities convertible into, exchangeable into or exercisable for Common Stock or otherwise deemed to be Beneficially Owned by such Person) Beneficially Owned by such Option Holder or its Affiliates or Associates at the time of grant of such option, and (C) shares of Common Stock (or securities convertible into, exchangeable into or exercisable for Common Stock or otherwise deemed to be Beneficially Owned by such Person) acquired by Affiliates or Associates of such Option Holder after the time of such grant that, in the aggregate, amount to less than 1% of the outstanding shares of Common Stock. Notwithstanding anything to the contrary in this Agreement, the Company, any Subsidiary of the Company, and any employee stock ownership or other employee benefit plan of the Company or a Subsidiary of the Company (or any Person, entity or trustee holding shares of Common Stock for or pursuant to the terms of any such plan or for the purpose of funding any such plan or funding other employee benefits for employees of the Company or of any Subsidiary of the Company) shall not be an Acquiring Person.

 

 1 

 

 

“Affiliate” and “Associate” shall have the respective meanings ascribed to such terms in Rule 12b-2 of the General Rules and Regulations under the Exchange Act, as such Rule is in effect on the Date of this Agreement.

 

“Agreement” shall have the meaning set forth in the Preamble.

 

“Applicable Expiration Date” shall have the meaning set forth in Section 5.19.

 

A Person shall be deemed the “Beneficial Owner”, and to have “Beneficial Ownership” of, and to “Beneficially Own”, any securities (i) as to which such Person or any of such Person’s Affiliates or Associates is or may be deemed to be the beneficial owner, directly or indirectly, pursuant to Rules 13d-3 and 13d-5 of the General Rules and Regulations under the Exchange Act, as such Rules are in effect on the Date of this Agreement; (ii) as to which such Person or any of such Person’s Affiliates or Associates has the right to become the Beneficial Owner (whether such right is exercisable immediately or only after the passage of time or the occurrence of conditions), directly or indirectly, pursuant to any agreement, arrangement or understanding, whether or not in writing (other than customary agreements with and between underwriters and selling group members with respect to a bona fide public offering of securities), or upon the exercise of conversion rights, exchange rights, rights (other than the Rights), warrants or options, or otherwise; (iii) which are Beneficially Owned, directly or indirectly, by any other Person or any of such other Person’s Affiliates or Associates with which such first Person or any of such first Person’s Affiliates or Associates has any agreement, arrangement or understanding, whether or not in writing, (x) for the purpose of acquiring, holding, voting (except pursuant to a revocable proxy as described in clause (B) of the proviso to this sentence) or disposing of any voting securities of the Company, or (y) to cooperate in obtaining, changing or influencing the control of the Company; and (iv) that such Person or any of such Person’s Affiliates or Associates are determined to Constructively Own; provided, however, that a Person shall not be deemed the “Beneficial Owner,” or to have “Beneficial Ownership” of, or to “Beneficially Own,” any security (A) solely because such security has been tendered pursuant to a tender or exchange offer made by such Person or any of such Person’s Affiliates or Associates until such tendered security is accepted for payment or exchange, or (B) solely because such Person or any of such Person’s Affiliates or Associates has or shares the power to vote or direct the voting of such security pursuant to a revocable proxy or consent given in response to a public proxy or consent solicitation made to more than ten holders of shares of a class of stock of the Company registered under Section 12 of the Exchange Act and pursuant to, and in accordance with, the applicable provisions of the General Rules and Regulations under the Exchange Act, except if such power (or the arrangements relating thereto (whether or not in writing)) is then reportable under Item 6 of Schedule 13D under the Exchange Act (or any similar provision of a comparable or successor statement). Notwithstanding the foregoing, no officer or director of the Company shall be deemed to Beneficially Own any securities of any other Person solely by virtue of any actions that such officer or director takes in such capacity. For purposes of this Agreement, in determining the percentage of the outstanding shares of Common Stock with respect to which a Person is the Beneficial Owner, all shares as to which such Person is deemed the Beneficial Owner shall be deemed to be outstanding.

 

 2 

 

 

“Board of Directors” shall mean the Board of Directors of the Company.

 

“Business Day” shall mean any day other than a Saturday, Sunday or a day on which banking institutions in the State of New York or the state in which the principal office of the Rights Agent is located are authorized or obligated by law or executive order to close.

 

“Close of Business” on any given date shall mean 5:00 p.m. New York City time on such date or, if such date is not a Business Day, 5:00 p.m. New York City time on the next succeeding Business Day.

 

“Common Stock” shall mean the shares of common stock, par value $0.0001 per share, of the Company.

 

“Company” shall have the meaning set forth in the Preamble.

 

A Person shall be deemed to “Constructively Own” shares of Common Stock in respect of which such Person has a Synthetic Long Position, calculated in the manner set forth below. The number of shares of Common Stock in respect of a Synthetic Long Position that shall be deemed to be Constructively Owned is the notional or other number of shares of Common Stock in respect of such Synthetic Long Position that is specified in a filing by such Person or any of such Person’s Affiliates or Associates with the SEC or in the documentation evidencing such Synthetic Long Position as the basis upon which the value or settlement amount of such right or derivative, or the opportunity of the holder of such right or derivative to profit or share in any profit, is to be calculated in whole or in part, and in any case (or if no such number of shares of Common Stock is specified in any filing or documentation), as determined by the Board of Directors in good faith to be the number of shares of Common Stock to which such Synthetic Long Position relates.

 

“Date of this Agreement” shall mean February 11, 2023.

 

“Election to Exercise” shall have the meaning set forth in Section 2.3(d).

 

“Exchange Act” shall mean the Securities Exchange Act of 1934, as amended.

 

“Exchange Ratio” shall have the meaning set forth in Section 3.1(c).

 

“Exchange Time” shall mean the time at which the right to exercise the Rights shall terminate pursuant to Section 3.1(c).

 

“Exercise Price” shall mean, as of any date, the price at which a holder may purchase the securities issuable upon exercise of one whole Right. Until adjustment thereof in accordance with the terms hereof, the Exercise Price shall equal $40.

 

“Expansion Factor” shall have the meaning set forth in Section 2.4(a).

 

“Expiration Time” shall mean the earliest of (i) the Exchange Time, (ii) the Redemption Time, (iii) the Final Expiration Time, unless, for purposes of this clause (iii), extended by action of the Board of Directors in accordance with Section 5.19 (in which case the applicable time shall be the time to which it has been so extended), and (iv) immediately prior to the effective time of a consolidation, merger or statutory share exchange that does not constitute a Flip-over Transaction or Event.

 

“Final Expiration Time” shall mean the Close of Business on February 11, 2033.

 

 3 

 

 

“Flip-in Date” shall mean any Stock Acquisition Date or such later date and time as the Board of Directors may from time to time fix by resolution adopted prior to the Flip-in Date that would otherwise have occurred.

 

“Flip-over Entity,” for purposes of Section 3.2, shall mean (i) in the case of a Flip-over Transaction or Event described in clause (i) of the definition thereof, the Person issuing any securities into which shares of Common Stock are being converted or exchanged and, if no such securities are being issued, the other Person that is a party to such Flip-over Transaction or Event, and (ii) in the case of a Flip-over Transaction or Event referred to in clause (ii) of the definition thereof, the Person receiving the greatest portion of the (A) assets or, if (A) is not readily determinable, (B) operating income or cash flow being transferred in such Flip-over Transaction or Event; provided, in all cases, that if such Person is a Subsidiary of another Person, the ultimate parent entity of such Person shall be the Flip-over Entity.

 

“Flip-over Stock” shall mean the capital stock (or similar equity interest) with the greatest voting power in respect of the election of directors (or other Persons similarly responsible for the direction of the business and affairs) of the Flip-over Entity.

 

“Flip-over Transaction or Event” shall mean a transaction or series of transactions, on or after a Flip-in Date, in which, directly or indirectly, (i) the Company shall consolidate or merge or participate in a statutory share exchange with any other Person if, at the time of consummation of the consolidation, merger or statutory share exchange or at the time the Company enters into any agreement with respect to any such consolidation, merger or statutory share exchange, the Acquiring Person is the Beneficial Owner of 90% or more of the outstanding shares of Common Stock or controls the Board of Directors and either (A) any term of or arrangement concerning the treatment of shares of capital stock in such consolidation, merger or statutory share exchange relating to the Acquiring Person is not identical to the terms and arrangements relating to other holders of the Common Stock, or (B) the Person with whom the transaction or series of transactions occurs is the Acquiring Person or an Affiliate or Associate of the Acquiring Person; or (ii) the Company shall sell or otherwise transfer (or one or more of its Subsidiaries shall sell or otherwise transfer) assets (A) aggregating more than 50% of the assets (measured by either book value or fair market value) or (B) generating more than 50% of the operating income or cash flow, in each case of the Company and its Subsidiaries (taken as a whole) to any Person (other than the Company or one or more of its wholly owned Subsidiaries) or to two or more such Persons that are Affiliates or Associates or are otherwise acting in concert, if, at the time of the entry by the Company (or any such Subsidiary) into an agreement with respect to such sale or transfer of assets, the Acquiring Person is the Beneficial Owner of 90% of more of the outstanding shares of Common Stock or controls the Board of Directors of the Company. For purposes of the foregoing definition, the term “Acquiring Person” shall include any Acquiring Person and its Affiliates and Associates, counted together as a single Person. An Acquiring Person shall be deemed to control the Board of Directors when, on or following a Stock Acquisition Date, a majority of the members of the Board of Directors do not consist of (i) persons who were members of the Board of Directors on the Stock Acquisition Date, other than any person who was or is an Acquiring Person, an Affiliate or Associate of an Acquiring Person or a representative or nominee of an Acquiring Person, and (ii) persons, the nomination for election or election to the Board of Directors of whom is recommended or approved by a majority of the members of the Board of Directors satisfying either clause (i) above or this clause (ii).

 

“Market Price” per share of any securities on any date shall mean the average of the daily closing prices per share of such securities (determined as described below) on each of the 20 consecutive Trading Days through and including the Trading Day immediately preceding, but not including, such date; provided, however, that if any event described in Section 2.4, or any analogous event, shall have caused the closing prices used to determine the Market Price on any Trading Days during such period of 20 Trading Days not to be fully comparable with the closing price on such date, each such closing price so used shall be appropriately adjusted by the Board of Directors in order to make it fully comparable with the closing price on such date. The closing price per share of any securities on any date shall be the last reported sale price, regular way, or, in case no such sale takes place or is quoted on such date, the average of the closing bid and asked prices, regular way, for each share of such securities, in either case, as reported in the principal consolidated transaction reporting system with respect to securities listed on the principal national securities exchange on which the securities are listed or admitted to trading or, if the securities are not listed or admitted to trading on any national securities exchange, as reported by NASDAQ or such other quotation system then in use, or, if on any such date the securities are not listed or admitted to trading on any national securities exchange or quoted by any such quotation system, the average of the closing bid and asked prices as furnished by a professional market maker making a market in the securities selected by the Board of Directors; provided, however, that if on any such date the securities are not listed or admitted to trading on a national securities exchange or traded in the over-the-counter market, the closing price per share of such securities on such date shall mean the fair value per share of such securities on such date as determined in good faith by the Board of Directors, after consultation with a nationally recognized investment banking firm, and set forth in a certificate delivered to the Rights Agent, which determination shall be binding on the Rights Agent, the holders of Rights and all other Persons.

 

 4 

 

 

“NASDAQ” shall mean the National Association of Securities Dealers, Inc. Automated Quotation System.

 

“Option Holder” shall have the meaning set forth in the definition of Acquiring Person.

 

“Person” shall mean any individual, firm, partnership, limited liability partnership, limited liability company, business trust, trust, association, syndicate, group (as such term is used in Rule 13d-5 of the General Rules and Regulations under the Exchange Act, as such Rule is in effect on the Date of this Agreement), corporation or other entity, including, in each case, any successor thereof and any unincorporated group of persons who, by formal or informal agreement or arrangement, have embarked on a common purpose or act.

 

“Record Time” shall have the meaning set forth in the Recitals.

 

“Redemption Price” shall mean an amount equal to $0.0001.

 

“Redemption Time” shall mean the time at which the right to exercise the Rights shall terminate pursuant to Section 5.1.

 

“Right” shall have the meaning set forth in the Recitals.

 

“Rights Agent” shall have the meaning set forth in the Preamble.

 

“Rights Certificate” shall have the meaning set forth in Section 2.3(c).

 

“Rights Register” shall have the meaning set forth in Section 2.7(a).

 

“SEC” shall mean the Securities and Exchange Commission.

 

“Separation Time” shall mean the earlier of the Close of Business on the tenth Business Day (or such later date as the Board of Directors may from time to time fix by resolution adopted prior to the Separation Time that otherwise would have occurred) following but not including (i) the date on which any Person commences a tender or exchange offer that, if consummated, would result in such Person’s becoming an Acquiring Person, and (ii) the date of the first event causing a Flip-in Date to occur; provided that if any tender or exchange offer referred to in clause (i) of this paragraph is cancelled, terminated or otherwise withdrawn prior to the Separation Time without the purchase of any shares of Common Stock pursuant thereto, such offer shall be deemed, for purposes of this paragraph, never to have been made.

 

“Stock Acquisition Date” shall mean the earlier of (i) the first date on which there shall be a public announcement by the Company (by any means) that a Person has become an Acquiring Person or (ii) the date on which any Acquiring Person becomes the Beneficial Owner of more than 50% of the outstanding shares of Common Stock.

 

 5 

 

 

“Subsidiary” of any specified Person shall mean any corporation or other entity of which a majority of the voting power of the equity securities or a majority of the equity or ownership interests are Beneficially Owned, directly or indirectly, by such Person.

 

“Synthetic Long Position” shall mean any option, warrant, convertible security, stock appreciation right, swap agreement or other security, contract right or derivative position, whether or not presently exercisable, that has an exercise or conversion privilege or a settlement payment or mechanism at a price related to the value of Common Stock or a value determined in whole or part with reference to, or derived in whole or in part from, the value of Common Stock and that increases in value as the value of Common Stock increases or that provides to the holder an opportunity, directly or indirectly, to profit or share in any profit derived from any increase in the value of Common Stock, in any case without regard to whether (i) such derivative conveys any voting rights in such securities to such Person or any of such Person’s Affiliates or Associates, (ii) such derivative is required to be, or capable of being, settled through delivery of such securities, or (iii) such Person or any of such Person’s Affiliates or Associates may have entered into other transactions that hedge the economic effect of such derivative. A Synthetic Long Position shall not include any interests, rights, options or other securities set forth in Rule 16a-1(c)(1)-(5) or (7) of the General Rules and Regulations under the Exchange Act.

 

“Trading Day,” when used with respect to any securities, shall mean a day on which the principal national securities exchange on which such securities are listed or admitted to trading is open for the transaction of business or, if such securities are not listed or admitted to trading on any national securities exchange, a Business Day.

 

“Trading Regulation” shall have the meaning set forth in Section 2.3(c).

 

“Trust” shall have the meaning set forth in Section 3.1(c).

 

“Trust Agreement” shall have the meaning set forth in Section 3.1(c).

 

“2003 Agreement” shall have the meaning set forth in the Recitals.

 

“2013 Agreement” shall have the meaning set forth in the Recitals.

 

ARTICLE II

THE RIGHTS

 

2.1 Summary of Rights. The Company will make a summary of the terms of the Rights available to any holder of Rights who may so request from time to time prior to the Expiration Time.

 

2.2 Legend on Common Stock Certificates. Certificates for the Common Stock issued (whether originally issued or from the Company’s treasury) on or after the Record Time but prior to the Separation Time shall evidence one Right for each share of Common Stock represented thereby. Certificates for the Common Stock issued (whether originally issued or from the Company’s treasury) on or after the Record Time but prior to the Date of this Agreement shall have impressed on, printed on, written on or otherwise affixed to them substantially the legend specified in Section 3(c) of the 2003 Agreement. Certificates for the Common Stock issued (whether originally issued or from the Company’s treasury) on or after the Date of this Agreement but prior to the Separation Time shall have impressed on, printed on, written on or otherwise affixed to them substantially the following legend:

 

Until the Separation Time (as defined in the Rights Agreement referred to below), this certificate also evidences and entitles the holder hereof to certain Rights as set forth in the Restated and Amended Stockholder Protection Rights Agreement, dated as of February 11, 2023 (as such may be further amended from time to time, the “Rights Agreement”), between Research Frontiers Incorporated (the “Company”) and Continental Stock Transfer & Trust Company, as Rights Agent, the terms of which are hereby incorporated herein by reference and a copy of which is on file at the principal executive offices of the Company. Under certain circumstances, as set forth in the Rights Agreement, such Rights may be redeemed, may become exercisable for securities or assets of the Company or securities of another entity, may be exchanged for shares of Common Stock or other securities or assets of the Company, may expire, may become null and void (including, if they are “Beneficially Owned” by an “Acquiring Person” or an “Affiliate” or “Associate” thereof (as such terms are defined in the Rights Agreement, or by any transferee of any of the foregoing)) or may be evidenced by separate certificates and may no longer be evidenced by this certificate. The Company will mail or arrange for the mailing of a copy of the Rights Agreement to the holder of this certificate without charge after the receipt of a written request therefor.

 

 6 

 

 

Certificates representing shares of Common Stock that were issued and outstanding at the Record Time shall evidence one Right for each share of Common Stock evidenced thereby notwithstanding the foregoing legends. Notwithstanding the foregoing, neither the omission of a legend nor the inclusion of a legend that makes reference to a rights agreement other than the Agreement shall affect the enforceability of any part of this Agreement or the rights of any holder of Rights.

 

If the Common Stock issued after the Record Time but prior to the Separation Time shall be uncertificated, the registration of such Common Stock on the stock transfer books of the Company shall evidence one Right for each share of Common Stock represented thereby. The Company shall mail or arrange for the mailing of a copy of this Agreement to any Person that holds Common Stock, as evidenced by the registration of the Common Stock in the name of such Person on the stock transfer books of the Company, without charge after the receipt of a written request therefor, and the Company shall cause the transfer agent for the Common Stock to include on each direct registration account statement with respect to the Common Stock issued prior to the Separation Time an appropriate notation to the reflect the issuance of the Rights.

 

2.3 Exercise of Rights; Separation of Rights. (a) Subject to Sections 3.1, 5.1 and 5.10 and subject to adjustment as herein set forth, each Right will entitle the holder thereof, at or after the Separation Time and prior to the Expiration Time, to purchase, for the Exercise Price, one share of Common Stock.

 

(b) Until the Separation Time, (i) no Right may be exercised and (ii) each Right will be evidenced by the certificate for the associated share of Common Stock (or, if the Common Stock shall be uncertificated, by the registration of the associated Common Stock on the stock transfer books of the Company and the confirmation thereof provided for in Section 2.2), and will be transferable only together with, and will be transferred by a transfer (whether with or without such letter or confirmation) of, such associated share.

 

(c) Subject to the terms and conditions hereof, at or after the Separation Time and prior to the Expiration Time, the Rights (i) may be exercised pursuant to Section 2.3(d) below and (ii) may be transferred independent of shares of Common Stock. Promptly following the Separation Time (provided that the Board of Directors has not elected to exchange all of the then outstanding Rights pursuant to Section 3.1(c)), then the Rights Agent or the transfer agent for the Common Stock, if requested by the Company and provided with the necessary information, will mail to each holder of record of Common Stock as of the Separation Time (other than any Person whose Rights have become null and void pursuant to Section 3.1(b)), at such holder’s address as shown by the records of the Company (and the Company hereby agrees to furnish copies of such records to the Rights Agent for this purpose), (x) a certificate (a “Rights Certificate”) in substantially the form of Exhibit A hereto appropriately completed, representing the number of Rights held by such holder at the Separation Time and having such marks of identification or designation and such legends, summaries or endorsements printed thereon as the Company may deem appropriate and as are not inconsistent with the provisions of this Agreement and as do not affect the rights, liabilities, responsibilities or duties of the Rights Agent, or as may be required to comply with any law or with any rule or regulation made pursuant thereto or with any rule or regulation of any national securities exchange or quotation system on which the Common Stock or the Rights may from time to time be listed or traded (“Trading Regulation”), or to conform to usage, and (y) a disclosure statement describing the Rights; provided, however, that the Company shall have no obligation to distribute Rights Certificates to any Acquiring Person or Affiliate or Associate of an Acquiring Person or any transferee of any of the foregoing. Receipt of a Rights Certificate by any Person shall not preclude a later determination that such Rights are null and void pursuant to Section 3.1(b). To the extent applicable, the Company may implement such procedures as it deems appropriate, in its sole discretion, to minimize the possibility that Rights are received by Persons with respect to whom Rights would be null and void under Section 3.1(b).

 7 

 

 

(d) Subject to the terms and conditions hereof, Rights may be exercised on any Business Day at or after the Separation Time and prior to the Expiration Time by submitting to the Rights Agent the Rights Certificate evidencing such Rights with an Election to Exercise (an “Election to Exercise”) substantially in the form attached to the Rights Certificate duly executed and properly completed, accompanied by payment by certified or official bank check payable to the order of the Company, of a sum equal to the Exercise Price multiplied by the number of Rights being exercised and a sum sufficient to cover any tax or charge that may be payable in respect of any transfer involved in the transfer or delivery of Rights Certificates or the issuance or delivery of certificates (or, if uncertificated, the registration on the stock transfer books of the Company) for shares or depositary receipts (or both) in a name other than that of the holder of the Rights being exercised.

 

(e) Upon receipt of a Rights Certificate, with a duly executed and properly completed Election to Exercise accompanied by payment as set forth in Section 2.3(d), and subject to the terms and conditions hereof, the Rights Agent will thereupon promptly (i)(A) requisition from the transfer agent for the Common Stock certificates evidencing such number of shares or other securities to be purchased or, in the case of uncertificated shares or other securities, requisition from the transfer agent a notice setting forth such number of shares or other securities to be purchased for which registration will be made on the stock transfer books of the Company (the Company hereby irrevocably authorizing the transfer agent to comply with all such requisitions), and (B) if the Company elects pursuant to Section 5.5 not to issue certificates (or effect registrations on the stock transfer books of the Company) representing fractional shares, requisition from the depositary selected by the Company depositary receipts representing the fractional shares to be purchased (the Company hereby irrevocably authorizes each depositary to comply with all such requisitions) or, requisition from the Company the amount of monies to be paid in lieu of fractional shares in accordance with Section 5.5; (ii) after receipt of such certificates, depositary receipts and/or notices, cause the same to be delivered to or upon the order of the registered holder of such Rights Certificate, registered in such name or names as may be designated by such holder; and (iii) when necessary to comply with this Agreement, after receipt, promptly deliver such monies to or upon the order of the registered holder of such Rights Certificate.

 

(f) In case the holder of any Rights shall exercise less than all of the Rights evidenced by such holder’s Rights Certificate, a new Rights Certificate evidencing the Rights remaining unexercised will be issued by the Rights Agent to such holder or to such holder’s duly authorized assigns.

 

(g) The Company covenants and agrees that it will (i) take all such action as may be necessary to ensure that all shares delivered (or evidenced by registration on the stock transfer books of the Company) upon exercise of Rights shall, at the time of delivery (or registration) of such shares (subject to payment of the Exercise Price), be duly and validly authorized, executed, issued and delivered (or registered) and fully paid and nonassessable; (ii) take all such action as may be necessary to comply with any applicable requirements of the Securities Act of 1933, as amended, or the Exchange Act, and the rules and regulations thereunder, and any other applicable law, rule or regulation, in connection with the issuance of any shares upon exercise of Rights; and (iii) pay when due and payable any and all taxes and charges that may be payable in respect of the original issuance or delivery of the Rights Certificates or of any shares issued upon the exercise of Rights; provided that the Company shall not be required to pay any tax or charge that may be payable in respect of any transfer involved in the transfer or delivery of Rights Certificates or the issuance or delivery (or registration) of shares in a name other than that of the holder of the Rights being transferred or exercised.

 

(h) Notwithstanding anything in this Agreement to the contrary, neither the Rights Agent nor the Company shall be obligated to undertake any action with respect to the exercise or assignment of a Rights Certificate unless the registered holder of such Rights Certificate shall have (i) duly executed and properly completed the certificate following the Form of Assignment or the Form of Election to Exercise, as applicable, set forth on the reverse side of the Rights Certificate surrendered for such exercise or assignment; (ii) provided such additional evidence of the identity of the Beneficial Owner (or former Beneficial Owner) thereof and of the Rights evidenced thereby, and the Affiliates and Associates of such Beneficial Owner or former Beneficial Owner, as the Company or the Rights Agent may reasonably request; and (iii) paid a sum sufficient to cover any tax or charge that may be imposed in connection with any transfer, split up, combination or exchange of Right Certificates as required under Section 2.3(d).

 

 8 

 

 

2.4 Adjustments to Exercise Price; Number of Rights. (a) In the event that the Company shall at any time after the Record Time and prior to the Separation Time (i) declare or pay a dividend on the Common Stock payable in Common Stock, (ii) subdivide the outstanding Common Stock or (iii) combine the outstanding Common Stock into a smaller number of shares of Common Stock, (x) the Exercise Price in effect after such adjustment will be equal to the Exercise Price in effect immediately prior to such adjustment divided by the number of shares of Common Stock, including any fractional shares in lieu of which such holder received payment by check (the “Expansion Factor”), that a holder of one share of Common Stock immediately prior to such dividend, subdivision or combination would hold thereafter as a result thereof, and (y) each Right held prior to such adjustment will become that number of Rights equal to the Expansion Factor, and the adjusted number of Rights will be deemed to be distributed among the shares of Common Stock with respect to which the original Rights were associated (if they remain outstanding) and the shares issued in respect of such dividend, subdivision or combination, so that each such share of Common Stock will have exactly one Right associated with it. Each adjustment made pursuant to this paragraph shall be made as of the payment or effective date for the applicable dividend, subdivision or combination.

 

In the event that the Company shall at any time after the Record Time and prior to the Separation Time issue any shares of Common Stock otherwise than in a transaction referred to in the preceding paragraph, each such share of Common Stock so issued shall automatically have one new Right associated with it, which Right shall be evidenced by the certificate representing such share (or, if the Common Stock shall be uncertificated, such Right shall be evidenced by the registration of such Common Stock on the stock transfer books of the Company and the confirmation thereof provided for in Section 2.2). Rights shall be issued by the Company in respect of shares of Common Stock that are issued or sold by the Company after the Separation Time only to the extent provided in Section 5.3.

 

(b) In the event that the Company shall at any time after the Record Time and prior to the Separation Time issue or distribute any securities or assets in respect of, in lieu of or in exchange for the Common Stock (other than pursuant to any non-extraordinary periodic cash dividend or a dividend paid solely in Common Stock), whether by dividend, in a reclassification or recapitalization (including, but not limited to, any such transaction involving a merger, consolidation or statutory share exchange), or otherwise, the Company shall make such adjustments, if any, in the Exercise Price, number of Rights and/or securities or other property purchasable upon exercise of Rights as the Board of Directors, in its sole discretion, may deem to be appropriate under the circumstances in order to adequately protect the interests of the holders of Rights generally, and the Company and the Rights Agent shall amend this Agreement as necessary to provide for such adjustments.

 

(c) Each adjustment to the Exercise Price made pursuant to this Section 2.4 shall be calculated to the nearest cent. Whenever an adjustment to the Exercise Price is made pursuant to this Section 2.4, the Company shall (i) promptly prepare a certificate setting forth such adjustment and a brief statement of the facts accounting for such adjustment, and (ii) promptly file with the Rights Agent and with the transfer agent for the Common Stock a copy of such certificate. The Rights Agent shall be fully protected in relying on any such certificate and on any adjustment or statement therein contained and shall have no duty or liability with respect to, and shall not be deemed to have knowledge of, any adjustment or any such event unless and until it shall have received such a certificate.

 

(d) Rights Certificates shall represent the right to purchase the securities purchasable under the terms of this Agreement, including any adjustment or change in the securities purchasable upon exercise of the Rights, even though such certificates may continue to express the securities purchasable at the time of issuance of the initial Rights Certificates.

 

2.5 Date on Which Exercise is Effective. Each Person in whose name any certificate for shares is issued (or registration on the stock transfer books is effected) upon the exercise of Rights shall for all purposes be deemed to have become the holder of record of the shares represented thereby on the date upon which the Rights Certificate evidencing such Rights was duly surrendered and payment of the Exercise Price for such Rights (and any applicable taxes and other governmental charges payable by the exercising holder hereunder) was made; provided, however, that if the date of such surrender and payment is a date upon which the stock transfer books of the Company are closed, such Person shall be deemed to have become the record holder of such shares on, and such certificate (or registration) shall be dated, the next succeeding Business Day on which the stock transfer books of the Company are open.

 

 9 

 

 

2.6 Execution, Authentication, Delivery and Dating of Rights Certificates. (a) The Rights Certificates shall be executed on behalf of the Company by its Chief Executive Officer or one of its Executive Vice Presidents and by its Secretary or one of its Assistant Secretaries. The signature of any of these officers on the Rights Certificates may be manual or facsimile.

 

Rights Certificates bearing the manual or facsimile signatures of individuals who were at any time the proper officers of the Company shall bind the Company, notwithstanding that such individuals or any of them have ceased to hold such offices prior to the countersignature and delivery of such Rights Certificates.

 

Promptly after the Separation Time, the Company will notify in writing the Rights Agent of such Separation Time (and if such notification is given orally, the Company shall confirm same in writing on or prior to the Business Day next following) and will deliver Rights Certificates executed by the Company to the Rights Agent for countersignature, and, subject to Section 3.1(b), the Rights Agent shall countersign (either manually or by facsimile) and deliver such Rights Certificates to the holders of the Rights pursuant to Section 2.3(c). Until the written notice provided for in this Section 2.6 is received by the Rights Agent, the Rights Agent may presume conclusively for all purposes that the Separation Time has not occurred. No Rights Certificate shall be valid for any purpose unless countersigned (either manually or by facsimile) by the Rights Agent.

 

(b) Each Rights Certificate shall be dated the date of countersignature thereof.

 

2.7 Registration, Registration of Transfer and Exchange. (a) After the Separation Time, the Company will cause to be kept a register (the “Rights Register”) in which, subject to such reasonable regulations as it may prescribe, the Company will provide for the registration and transfer of Rights. The Rights Agent is hereby appointed “Rights Registrar” for the purpose of maintaining the Rights Register for the Company and registering Rights and transfers of Rights after the Separation Time as herein provided. In the event that the Rights Agent shall cease to be the Rights Registrar, the Rights Agent will have the right to examine the Rights Register at all reasonable times after the Separation Time. The Rights Certificates are transferable only on the Rights Register maintained by the Rights Registrar.

 

After the Separation Time and prior to the Expiration Time, upon surrender for registration of transfer or exchange of any Rights Certificate, and subject to the provisions of Sections 2.7(c) and (d), the Company will execute, and the Rights Agent will countersign and, if requested and provided with all necessary information, deliver, in the name of the holder or the designated transferee or transferees, as required pursuant to the holder’s instructions, one or more new Rights Certificates evidencing the same aggregate number of Rights as did the Rights Certificate so surrendered.

 

(b) Except as otherwise provided in Section 3.1(b), all Rights issued upon any registration of transfer or exchange of Rights Certificates shall be the valid obligations of the Company, and such Rights shall be entitled to the same benefits under this Agreement as the Rights surrendered upon such registration of transfer or exchange.

 

(c) Every Rights Certificate surrendered for registration of transfer or exchange shall be duly endorsed, or be accompanied by a written instrument of transfer in form satisfactory to the Company or the Rights Agent, as the case may be, duly executed by the holder thereof or such holder’s attorney-in-fact duly authorized in writing. As a condition to the issuance of any new Rights Certificate under this Section 2.7, the Company may require the payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in relation thereto. The Rights Agent shall have no duty or obligation under any section of this Agreement that requires the payment of taxes or charges unless and until it is satisfied that all such taxes and/or charges have been paid.

 

 10 

 

 

(d) The Company shall not register the transfer or exchange of any Rights that have become null and void under Section 3.1(b), been exchanged under Section 3.1(c) or been redeemed under Section 5.1.

 

2.8 Mutilated, Destroyed, Lost and Stolen Rights Certificates. (a) If any mutilated Rights Certificate is surrendered to the Rights Agent prior to the Expiration Time, then, subject to Sections 3.1(b), 3.1(c) and 5.1, the Company shall execute and the Rights Agent shall countersign and deliver in exchange therefor a new Rights Certificate evidencing the same number of Rights as did the Rights Certificate so surrendered.

 

(b) If there shall be delivered to the Company and the Rights Agent prior to the Expiration Time (i) evidence to their satisfaction of the destruction, loss or theft of any Rights Certificate, and (ii) such security or indemnity as may be required by them to hold each of them and any of their agents harmless, then, subject to Sections 3.1(b), 3.1(c) and 5.1 and in the absence of written notice to the Company or the Rights Agent that such Rights Certificate has been acquired by a bona fide purchaser, the Company shall execute and upon its written request the Rights Agent shall countersign and, if requested and provided with all necessary information, deliver, in lieu of any such destroyed, lost or stolen Rights Certificate, a new Rights Certificate evidencing the same number of Rights as did the Rights Certificate so destroyed, lost or stolen.

 

(c) As a condition to the issuance of any new Rights Certificate under this Section 2.8, the Company may require the payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including the fees and expenses of the Rights Agent) connected therewith.

 

(d) Every new Rights Certificate issued pursuant to this Section 2.8 in lieu of any destroyed, lost or stolen Rights Certificate shall evidence an original additional contractual obligation of the Company, whether or not the destroyed, lost or stolen Rights Certificate shall be at any time enforceable by anyone, and, subject to Section 3.1(b) shall be entitled to all the benefits of this Agreement equally and proportionately with any and all other Rights duly issued hereunder.

 

2.9 Persons Deemed Owners. Prior to due presentment of a Rights Certificate (or, prior to the Separation Time, the associated Common Stock certificate or notice of transfer, if uncertificated) for registration of transfer, the Company, the Rights Agent and any agent of the Company or the Rights Agent may deem and treat the Person in whose name such Rights Certificate (or, prior to the Separation Time, such Common Stock certificate or Common Stock registration, if uncertificated) is registered as the absolute owner thereof and of the Rights evidenced thereby for all purposes whatsoever, including the payment of the Redemption Price, and neither the Company nor the Rights Agent shall be affected by any notice to the contrary. As used in this Agreement, unless the context otherwise requires, the term “holder” of any Rights shall mean the registered holder of such Rights (or, prior to the Separation Time, the associated shares of Common Stock).

 

2.10 Delivery and Cancellation of Certificates. All Rights Certificates surrendered upon exercise or for registration of transfer or exchange shall, if surrendered to any Person other than the Rights Agent, be delivered to the Rights Agent and, in any case, shall be promptly cancelled by the Rights Agent. The Company may at any time deliver to the Rights Agent for cancellation any Rights Certificates previously countersigned and delivered hereunder that the Company may have acquired in any manner whatsoever, and all Rights Certificates so delivered shall be promptly cancelled by the Rights Agent. No Rights Certificates shall be countersigned in lieu of or in exchange for any Rights Certificates cancelled as provided in this Section 2.10, except as expressly permitted by this Agreement. The Rights Agent shall destroy all cancelled Rights Certificates and deliver to the Company a certificate attesting to such destruction.

 

2.11 Agreement of Rights Holders. Every holder of Rights by accepting the Rights consents and agrees with the Company and the Rights Agent and with every other holder of Rights that:

 

 11 

 

 

(a) prior to the Separation Time, each Right will be transferable only together with, and will be transferred by a transfer of, the associated share of Common Stock;

 

(b) as of and after the Separation Time, the Rights Certificates will be transferable only on the Rights Register as provided herein;

 

(c) prior to due presentment of a Rights Certificate (or, prior to the Separation Time, the associated Common Stock certificate or Common Stock registration, if uncertificated) for registration of transfer, the Company, the Rights Agent and any agent of the Company or the Rights Agent may deem and treat the Person in whose name the Rights Certificate (or, prior to the Separation Time, the associated Common Stock certificate or Common Stock registration, if uncertificated) is registered as the absolute owner thereof and of the Rights evidenced thereby for all purposes whatsoever, and neither the Company nor the Rights Agent shall be affected by any notice to the contrary;

 

(d) Rights that are Beneficially Owned by certain Persons will, under the circumstances set forth in Section 3.1(b), become null and void;

 

(e) this Agreement may be supplemented or amended from time to time in accordance with its terms;

 

(f) the Board of Directors shall have the exclusive power and authority delegated to it pursuant to Section 5.14; and

 

(g) notwithstanding anything in this Agreement to the contrary, neither the Company nor the Rights Agent shall have any liability to any holder of a Right or other Person as a result of its inability to perform any of its obligations under this Agreement by reason of any preliminary or permanent injunction or other order, decree or ruling issued by a court of competent jurisdiction or by a governmental, regulatory or administrative agency or commission, or any statute, rule, regulation or executive order promulgated or enacted by any governmental authority, prohibiting or otherwise restraining performance of such obligation; provided, however, that the Company shall use its reasonable best efforts to have any such order, decree or ruling lifted or otherwise overturned as soon as possible.

 

ARTICLE III

ADJUSTMENTS TO THE RIGHTS IN

THE EVENT OF CERTAIN TRANSACTIONS

 

3.1 Flip-in. (a) In the event that prior to the Expiration Time a Flip-in Date shall occur, except as otherwise provided in this Section 3.1, each Right shall constitute the right to purchase from the Company, upon exercise thereof in accordance with the terms hereof (but subject to Section 5.10), that number of shares of Common Stock having an aggregate Market Price on the Stock Acquisition Date that gave rise to the Flip-in Date equal to twice the Exercise Price for a purchase price, payable as set forth in Section 2.3(c) equal to the Exercise Price (such right to be appropriately adjusted in order to protect the interests of the holders of Rights generally in the event that on or after such Stock Acquisition Date any of the events described in Section 2.4(a) or (b), or any analogous event, shall have occurred with respect to the Common Stock). The foregoing notwithstanding, Rights shall not be exercisable pursuant to this Section 3.1 unless and until the Separation Time shall have occurred.

 

(b) Notwithstanding the foregoing, any Rights that are or were Beneficially Owned on or after the Stock Acquisition Date by (i) an Acquiring Person or an Affiliate or Associate thereof, (ii) a transferee of an Acquiring Person or an Affiliate or Associate thereof who becomes a transferee after the Acquiring Person becomes such, or (iii) a transferee of an Acquiring Person or an Affiliate or Associate thereof who becomes a transferee prior to or concurrently with the Acquiring Person becoming such and receives such Rights pursuant to either (A) a transfer (whether or not for consideration) from the Acquiring Person to holders of equity interests in such Acquiring Person or to any Person with whom the Acquiring Person has any continuing agreement, arrangement or understanding, whether or not in writing, regarding the transferred Rights, or (B) a transfer which the Board of Directors has determined is part of a plan, arrangement or understanding which has as a primary purpose or effect the avoidance of this Section 3.1(b), shall become null and void and any holder of such Rights (including transferees, whether direct or indirect, of any such Persons) shall thereafter have no right to exercise or transfer such Rights under any provision of this Agreement. If any Rights Certificate is presented for assignment or exercise and the Person presenting the same will not complete the certification set forth at the end of the Form of Assignment or Form of Notice of Election to Exercise or, if requested, will not provide such additional evidence, including, but not limited to, the identity of the Beneficial Owners and their Affiliates and Associates (or former Beneficial Owners and their Affiliates and Associates) as the Company shall reasonably request in order to determine if such Rights are null and void, then the Company shall be entitled conclusively to deem the Rights to be Beneficially Owned by an Acquiring Person or an Affiliate or Associate thereof or a transferee of any of the foregoing and accordingly will deem the Rights evidenced thereby to be null and void and not transferable, exercisable or exchangeable. The Company shall use all reasonable efforts to insure that the provisions of this Section 3.1(b) are complied with, but shall have no liability to any holder of Rights or any other Person as a result of its failure to make any determinations with respect to an Acquiring Person or any of its Affiliates, Associates or their respective transferees hereunder.

 

 12 

 

 

(c) The Board of Directors may, at its option, at any time after a Flip-in Date and prior to the time that an Acquiring Person, together with all Affiliates and Associates of such Person, becomes the Beneficial Owner of more than 50% of the outstanding shares of Common Stock, elect to exchange all (but not less than all) of the then outstanding Rights (which shall not include Rights that have become null and void pursuant to the provisions of Section 3.1(b)) for shares of Common Stock at an exchange ratio of one share of Common Stock per Right, appropriately adjusted in order to protect the interests of holders of Rights generally in the event that after the Separation Time any of the events described in Section 2.4(a) or (b), or any analogous event, shall have occurred with respect to the Common Stock (such exchange ratio, as adjusted from time to time, being hereinafter referred to as the “Exchange Ratio”).

 

Immediately upon the action of the Board of Directors electing to exchange the Rights, without any further action and without any notice, the right to exercise the Rights will terminate and each Right (other than Rights that have become null and void pursuant to Section 3.1(b)), whether or not previously exercised, will thereafter represent only the right to receive a number of shares of Common Stock equal to the Exchange Ratio. The exchange of the Rights by the Board of Directors may be made effective at such time, on such basis and with such conditions as the Board of Directors in its sole discretion may establish. Promptly after the action of the Board of Directors electing to exchange the Rights, the Company shall give written notice thereof (specifying the steps to be taken to receive shares of Common Stock in exchange for Rights) to the Rights Agent and the holders of the Rights (other than Rights that have become null and void pursuant to Section 3.1(b)) outstanding immediately prior thereto by mailing such notice in accordance with Section 5.9; provided, however, that the failure to give, or any defect in, such notice shall not affect the validity of such exchange. Following the action of the Board of Directors ordering the exchange of any Rights pursuant to this Section 3.1(c), the Company may implement such procedures as it deems appropriate, in its sole discretion, for the purpose of ensuring that the Common Stock (or such other consideration) issuable upon an exchange pursuant to this Section 3.1(c) is not received by holders of Rights that have become null and void pursuant to Section 3.1(b). Before effecting an exchange pursuant to this Section 3.1(c), the Board of Directors may direct the Company to enter into a Trust Agreement in such form and with such terms as the Board of Directors shall then approve (the “Trust Agreement”). If the Board of Directors so directs, the Company shall enter into the Trust Agreement and shall issue to the trust created by such agreement (the “Trust”) all or a portion (as designated by the Board of Directors) of the shares of Common Stock (or other securities) issuable pursuant to the exchange, and all holders of Rights entitled to receive such shares or securities pursuant to the exchange shall be entitled to receive such shares or securities (and any dividends paid or distributions made thereon after the date on which such shares are deposited in the Trust) only from the Trust and solely upon compliance with the relevant terms and provisions of the Trust Agreement. Prior to effecting an exchange and registering shares of Common Stock (or other such securities) in any Person’s name, including any nominee or transferee of a Person, the Company may require (or cause the trustee of the Trust to require), as a condition thereof, that any holder of Rights provide evidence, including, but not limited to, the identity of the Beneficial Owners thereof and their Affiliates and Associates (or former Beneficial Owners thereof and their Affiliates and Associates) as the Company shall reasonably request in order to determine if such Rights are null and void. If any Person shall fail to comply with such request, the Company shall be entitled conclusively to deem the Rights formerly held by such Person to be null and void pursuant to Section 3.1(b) and not transferable or exercisable or exchangeable in connection herewith. Any shares of Common Stock or other securities issued at the direction of the Board of Directors in connection herewith shall be validly issued, fully paid and nonassessable shares of Common Stock or of such other securities (as the case may be), and the Company shall be deemed to have received as consideration for such issuance a benefit having a value that is at least equal to the aggregate par value of the shares so issued.

 

 13 

 

 

Each Person in whose name any certificate for such shares is issued (or for whom any registration on the stock transfer books of the Company is made) upon the exchange of Rights pursuant to Section 3.1(c) or (d) shall for all purposes be deemed to have become the holder of record of the shares represented thereby on, and such certificate (or registration on the stock transfer books of the Company) shall be dated (or registered) as of, the date upon which the Rights Certificate evidencing such Rights was duly exchanged (or deemed exchanged by the Company) and payment of any applicable taxes and other governmental charges payable by the holder was made; provided, however, that if the date of such exchange and payment is a date upon which the stock transfer books of the Company are closed, such Person shall be deemed to have become the record holder of such shares on, and such certificate (or registration on the stock transfer books of the Company) shall be dated (or registered) as of the next succeeding Business Day on which the stock transfer books of the Company are open.

 

(d) In the event that there shall not be sufficient treasury shares or authorized but unissued shares of Common Stock to permit the exercise in full of the Rights in accordance with Section 3.1(a) (or, if the Company so elects to make the exchange referred to in Section 3.1(c), to permit the issuance of all shares pursuant to the exchange), the Company shall either (i) call a meeting of stockholders seeking approval to cause sufficient additional shares to be authorized (provided that if such approval is not obtained the Company will take the action specified in clause (ii) of this sentence) or (ii) take such action as shall be necessary to ensure and provide, as and when and to the maximum extent permitted by applicable law and without exposing directors to personal liability in connection therewith (as determined by the Board of Directors) and any agreements or instruments in effect on the Stock Acquisition Date (and remaining in effect) to which it is a party, that each Right shall thereafter constitute the right to receive (x) in the case of any exercise in accordance with Section 3.1(a), at the Company’s option as determined by the Board of Directors, either (A) in return for the Exercise Price, debt or equity securities or other assets (or a combination thereof) having a fair value equal to twice the Exercise Price, or (B) without payment of consideration (except as may be required for the valid issuance of securities or otherwise required by applicable law), debt or equity securities or other assets (or a combination thereof) having a fair value equal to the Exercise Price, or (y) in the case of an exchange of Rights in accordance with Section 3.1(c), debt or equity securities or other assets (or a combination thereof) having a fair value equal to the product of the Market Price of a share of Common Stock on the Flip-in Date multiplied by the Exchange Ratio in effect on the Flip-in Date, where, in the case of (x) or (y) above, the fair value of such debt or equity securities or other assets (or a combination thereof) shall be as determined in good faith by the Board of Directors.

 

3.2 Flip-over. (a) Prior to the Expiration Time, the Company shall not enter into any agreement with respect to, consummate or permit to occur any Flip-over Transaction or Event unless and until it shall have entered into a supplemental agreement with the Flip-over Entity, for the benefit of the holders of the Rights (the terms of which shall be reflected in an amendment to this Agreement entered into with the Rights Agent), providing that, upon consummation or occurrence of the Flip-over Transaction or Event, (i) each Right shall thereafter constitute the right to purchase from the Flip-over Entity, upon exercise thereof in accordance with the terms hereof, that number of shares of Flip-over Stock of the Flip-over Entity having an aggregate Market Price on the date of consummation or occurrence of such Flip-over Transaction or Event equal to twice the Exercise Price for a purchase price, payable as set forth in Section 2.3(c), equal to the Exercise Price (such right to be appropriately adjusted in order to protect the interests of the holders of Rights generally in the event that after such date of consummation or occurrence any of the events described in Section 2.4(a) or (b), or any analogous event, shall have occurred with respect to the Flip-over Stock), and (ii) the Flip-over Entity shall thereafter be liable for, and shall assume, by virtue of such Flip-over Transaction or Event and such supplemental agreement, all the obligations and duties of the Company pursuant to this Agreement.

 

(b) Prior to the Expiration Time, unless the Rights are redeemed pursuant to Section 5.1 pursuant to an agreement entered into by the Company prior to a Flip-in Date, the Company shall not enter into any agreement with respect to, consummate or permit to occur any Flip-over Transaction or Event if (i) at the time thereof there are any rights, warrants or securities outstanding or any other arrangements, agreements or instruments that would eliminate or otherwise diminish in any material respect the benefits intended to be afforded by this Rights Agreement to the holders of Rights upon consummation of such transaction; (ii) prior to, simultaneously with or immediately after such Flip-over Transaction or Event, the stockholders of the Person who constitutes, or would constitute, the Flip-over Entity shall have received a distribution of Rights previously owned by such Person or any of its Affiliates or Associates; or (iii) the form or nature of organization of the Flip-over Entity would preclude or limit the exercisability of the Rights.

 

 14 

 

 

(c) The provisions of this Section 3.2 shall apply to successive Flip-over Transactions or Events.

 

ARTICLE IV

THE RIGHTS AGENT

 

4.1 General. (a) The Company hereby appoints the Rights Agent to act as agent for the Company in accordance with the express terms and conditions hereof (and no implied terms or conditions), and the Rights Agent hereby accepts such appointment. The Company agrees to pay to the Rights Agent reasonable compensation for all services rendered by it hereunder and, from time to time, on demand of the Rights Agent, including but not limited to reasonable fees and expenses of its counsel and other disbursements incurred in connection with the preparation, negotiation, delivery, amendment, administration and execution of this Agreement and the exercise and performance of its duties hereunder. The Company also agrees to indemnify the Rights Agent for, and to hold it harmless against, any loss, liability, damage, judgment, fine, penalty, claim, demand, settlement, cost or expense (including, but not limited to, the reasonable fees and expenses of legal counsel) incurred without gross negligence, bad faith or willful misconduct on the part of the Rights Agent for any action taken, suffered, or omitted to be taken by the Rights Agent in connection with the acceptance and administration of this Agreement, or in the exercise or performance of its duties hereunder, including, but not limited to, the costs and expenses of defending against any claim of liability. The costs and expenses of enforcing this right of indemnification shall also be paid by the Company. The provisions of this Section 4.1 and Section 4.3 (including the provisions relating to indemnification of the Rights Agent) shall survive the termination of this Agreement, the exercise or expiration of the Rights and the resignation, replacement or removal of the Rights Agent hereunder, including, but not limited to, the reasonable costs and expenses of defending against a claim of liability hereunder. Notwithstanding anything to the contrary in this Agreement, any references in this Agreement to the Rights Agent’s gross negligence, bad faith, or willful misconduct shall be deemed to be as determined by a final, non-appealable judgment of a court of competent jurisdiction.

 

(b) The Rights Agent may conclusively rely upon and shall be protected and shall incur no liability for or in respect of any action taken, suffered or omitted to be taken by it in connection with its acceptance and administration of this Agreement and the exercise and performance of its duties hereunder in reliance upon any certificate for securities (or registration on the stock transfer books of the Company) purchasable upon exercise of Rights, Rights Certificate, certificate for other securities of the Company, instrument of assignment or transfer, power of attorney, endorsement, affidavit, letter, notice, direction, consent, certificate, statement, or other paper or document believed by it to be genuine and to be signed, executed and, where necessary, verified or acknowledged, by the proper Person or Persons, or otherwise upon the advice of counsel as set forth in Section 4.3. The Rights Agent shall not be deemed to have knowledge of any event of which it was supposed to receive notice thereof hereunder, and the Rights Agent shall be fully protected and shall incur no liability for failing to take any action in connection therewith, unless and until it has received such notice.

 

4.2 Merger or Consolidation or Change of Name of Rights Agent. (a) Any Person into which the Rights Agent or any successor Rights Agent may be merged or with which it may be consolidated, or any Person resulting from any merger or consolidation to which the Rights Agent or any successor Rights Agent is a party, or any Person succeeding to the stockholder services business of the Rights Agent or any successor Rights Agent, will be the successor to the Rights Agent under this Agreement without the execution or filing of any paper or any further act on the part of any of the parties hereto, provided that such Person would be eligible for appointment as a successor Rights Agent under the provisions of Section 4.4. If at the time such successor Rights Agent succeeds to the agency created by this Agreement any of the Rights Certificates have been countersigned but not delivered, any such successor Rights Agent may adopt the countersignature of the predecessor Rights Agent and deliver such Rights Certificates so countersigned; and if at that time any of the Rights Certificates have not been countersigned, any successor Rights Agent may countersign such Rights Certificates either in the name of the predecessor Rights Agent or in the name of the successor Rights Agent, and in all such cases such Rights Certificates will have the full force and effect provided in the Rights Certificates and in this Agreement.

 

 15 

 

 

(b) If at any time the name of the Rights Agent is changed and at such time any of the Rights Certificates shall have been countersigned but not delivered, the Rights Agent may adopt the countersignature under its prior name and deliver Rights Certificates so countersigned, and if at that time any of the Rights Certificates shall not have been countersigned, the Rights Agent may countersign such Rights Certificates either in its prior name or in its changed name, and in all such cases such Rights Certificates shall have the full force and effect provided in the Rights Certificates and in this Agreement.

 

4.3 Duties of Rights Agent. The Rights Agent undertakes to perform only the duties and obligations expressly imposed by this Agreement (and no implied duties or obligations) upon the following terms and conditions, all of which the Company and the holders of Rights Certificates, by their acceptance thereof, shall be bound:

 

(a) The Rights Agent may consult with legal counsel (who may be legal counsel for the Company and/or an employee of the Rights Agent), and the advice or opinion of such counsel will be full and complete authorization and protection to the Rights Agent, and the Rights Agent shall incur no liability for or in respect of any action taken, suffered, or omitted to be taken by it in accordance with such advice or opinion.

 

(b) Whenever in the performance of its duties under this Agreement the Rights Agent deems it necessary or desirable that any fact or matter be proved or established by the Company prior to taking, suffering or omitting to take any action hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established by a certificate signed by a person believed by the Rights Agent to be the Chief Executive Officer or any Executive Vice President and by the Treasurer or any Assistant Treasurer or the Secretary or any Assistant Secretary of the Company and delivered to the Rights Agent, and such certificate will be full and complete authorization and protection to the Rights Agent, and the Rights Agent shall incur no liability for or in respect of any action taken, suffered or omitted to be taken by it under the provisions of this Agreement in reliance upon such certificate.

 

(c) The Rights Agent will be liable hereunder to the Company and any other Person only for its own gross negligence, bad faith or willful misconduct. Notwithstanding anything in this Agreement to the contrary, in no event shall the Rights Agent be liable for special, punitive, indirect, incidental or consequential loss or damage of any kind whatsoever (including but not limited to lost profits), even if the Rights Agent has been advised of the likelihood of such loss or damage and regardless of the form of the action.

 

(d) The Rights Agent will not be liable for or by reason of any of the statements of fact or recitals contained in this Agreement or in the certificates, if any, for securities purchasable upon exercise of Rights or the Rights Certificates (except its countersignature thereof) or be required to verify the same, and all such statements and recitals are and will be deemed to have been made by the Company only.

 

(e) The Rights Agent shall not have any liability for or be under any responsibility in respect of the validity of this Agreement or the execution and delivery hereof (except the due authorization, execution and delivery hereof by the Rights Agent) or in respect of the validity or execution of any certificate, if any, for securities purchasable upon exercise of Rights or Rights Certificate (except its countersignature thereof); nor will it be responsible for any breach by the Company of any covenant or failure by the Company to satisfy conditions contained in this Agreement or in any Rights Certificate; nor will it be responsible for any change in the exercisability or exchangeability of the Rights (including, but not limited to, the Rights becoming null and void pursuant to Section 3.1(b)) or any change or adjustment in the terms of the Rights (including, but not limited to, any adjustment required under the provisions of Section 2.4, 3.1 or 3.2) or responsible for the manner, method or amount of any such adjustment or the ascertaining of the existence of facts that would require any such adjustment (except with respect to the exercise of Rights evidenced by Right Certificates after receipt of a certificate furnished pursuant to Section 2.4, describing any such change or adjustment, upon which the Rights Agent may rely); nor will it by any act hereunder be deemed to make any representation or warranty as to the authorization or reservation of any securities purchasable upon exercise of Rights or any Rights Certificate or as to whether any securities purchasable upon exercise of Rights will, when issued, be duly and validly authorized, executed, issued and delivered and fully paid and nonassessable.

 

 16 

 

 

(f) The Company agrees that it will perform, execute, acknowledge and deliver, or cause to be performed, executed, acknowledged and delivered, all such further and other acts, instruments and assurances as may reasonably be required by the Rights Agent for the carrying out or performing by the Rights Agent of its duties under this Agreement.

 

(g) The Rights Agent is hereby authorized and directed to accept instructions with respect to the performance of its duties hereunder from any person believed by the Rights Agent to be the Chief Executive Officer, any Executive Vice President or the Secretary or any Assistant Secretary or the Treasurer or any Assistant Treasurer of the Company, and to apply to such persons for advice or instructions in connection with its duties, and such instructions shall be full authorization and protection to the Rights Agent and the Rights Agent shall not be liable for any action taken, suffered or omitted to be taken by it in accordance with instructions of any such person. The Rights Agent shall be fully authorized and protected in relying upon the most recent instructions received by any such officer. Any application by the Rights Agent for written instructions from the Company may, at the option of the Rights Agent, set forth in writing any action proposed to be taken, suffered or omitted to be taken by the Rights Agent under this Agreement and the date on or after which such action shall be taken, suffered or such omission shall be effective. The Rights Agent shall not be liable for any action taken or suffered by, or omission of, the Rights Agent in accordance with a proposal included in any such application on or after the date specified in such application (which date shall not be less than ten Business Days after, but not including, the date that any officer of the Company actually receives such application, unless any such officer shall have consented in writing to an earlier date) unless, prior to taking any such action (or the effective date in the case of an omission), the Rights Agent shall have received, in response to such application, written instructions with respect to the proposed action or omission specifying a different action to be taken, suffered or omitted to be taken.

 

(h) The Rights Agent and any stockholder, Affiliate, director, officer, agent or employee of the Rights Agent (in each case, other than an Acquiring Person) may buy, sell or deal in Common Stock, Rights or other securities of the Company or become pecuniarily interested in any transaction in which the Company may be interested, or contract with or lend money to the Company or otherwise act as fully and freely as though it were not Rights Agent under this Agreement. Nothing herein shall preclude the Rights Agent or any such stockholder, Affiliate, director, officer, agent or employee from acting in any other capacity for the Company or for any other Person.

 

(i) The Rights Agent may execute and exercise any of the rights or powers hereby vested in it or perform any duty hereunder either itself or by or through its attorneys or agents, and the Rights Agent will not be answerable or accountable for any act, default, neglect or misconduct of any such attorneys or agents or for any loss to the Company or any other Person resulting from any such act, default, neglect or misconduct, absent gross negligence, bad faith or willful misconduct in the selection and continued employment thereof.

 

(j) If, with respect to any Rights Certificate surrendered to the Rights Agent for exercise or transfer, the certificate attached to the form of assignment or form of election to purchase, as the case may be, has not been completed, the Rights Agent shall not take any further action with respect to such requested exercise or transfer without first consulting with the Company.

 

(k) No provision of this Agreement shall require the Rights Agent to expend or risk its own funds or otherwise incur any financial liability in the performance of any of its duties hereunder or in the exercise of its rights if it reasonably believes, after consultation with counsel, that repayment of such funds or adequate indemnification against such risk or liability is not assured to it.

 

 17 

 

 

4.4 Change of Rights Agent. The Rights Agent may resign and be discharged from its duties under this Agreement upon 60 days’ notice (or such lesser notice as is acceptable to the Company) in writing mailed to the Company and to each transfer agent of Common Stock known to the Rights Agent by registered or certified mail, and to the holders of the Rights in accordance with Section 5.9. The Company may remove the Rights Agent upon 30 days’ notice in writing, mailed to the Rights Agent and to each transfer agent of the Common Stock by registered or certified mail, and to the holders of the Rights in accordance with Section 5.9. If the Rights Agent should resign or be removed or otherwise become incapable of acting, the Company will appoint a successor to the Rights Agent. If the Company fails to make such appointment within a period of 30 days after giving notice of such removal or after it has been notified in writing of such resignation or incapacity by the resigning or incapacitated Rights Agent or by the holder of any Rights (which holder shall, with such notice, submit such holder’s Rights Certificate for inspection by the Company), then the holder of any Rights or the Rights Agent may apply to any court of competent jurisdiction for the appointment of a new Rights Agent. Any successor Rights Agent, whether appointed by the Company or by such a court, shall be (A) a Person organized and doing business under the laws of the United States or any state of the United States, in good standing, which is authorized under such laws to exercise the powers of the Rights Agent contemplated by this Agreement and is subject to supervision or examination by federal or state authority or (B) an Affiliate of a Person described in clause (A) of this sentence. After appointment, the successor Rights Agent will be vested with the same powers, rights, duties and responsibilities as if it had been originally named as Rights Agent without further act or deed, and the predecessor Rights Agent shall deliver and transfer to the successor Rights Agent any property at the time held by it hereunder, and execute and deliver any further assurance, conveyance, act or deed necessary for the purpose. Not later than the effective date of any such appointment, the Company will file notice thereof in writing with the predecessor Rights Agent and each transfer agent of the Common Stock. Failure to give any notice provided for in this Section 4.4, however, or any defect therein, shall not affect the legality or validity of the resignation or removal of the Rights Agent or the appointment of the successor Rights Agent, as the case may be.

 

ARTICLE V

MISCELLANEOUS

 

5.1 Redemption. (a) The Board of Directors may, at its option, at any time prior to the Separation Time elect to redeem all (but not less than all) of the then outstanding Rights at the Redemption Price and the Company, at its option, may pay the Redemption Price either by check or in shares of Common Stock or other securities of the Company deemed by the Board of Directors, in its sole discretion, to be at least equivalent in value to the Redemption Price.

 

(b) Immediately upon the action of the Board of Directors electing to redeem the Rights pursuant to Section 5.1(a) (or, if the resolution of the Board of Directors electing to redeem the Rights states that the redemption will not be effective until the occurrence of a specified future time or event, upon the occurrence of such future time or event), without any further action and without any notice, the right to exercise the Rights will terminate and each Right, whether or not previously exercised, will thereafter represent only the right to receive the Redemption Price by check or in securities, as determined by the Board of Directors. Promptly after the Rights are redeemed, the Company shall give notice of such redemption to the Rights Agent and the holders of the then outstanding Rights by mailing such notice in accordance with Section 5.9.

 

5.2 Expiration. The Rights and this Agreement shall expire at the Expiration Time and no Person shall have any rights pursuant to this Agreement or any Right after the Expiration Time, except, if the Rights have been exchanged or redeemed, as provided in Section 3.1 or 5.1, respectively.

 

5.3 Issuance of New Rights Certificates. Notwithstanding any of the provisions of this Agreement or of the Rights to the contrary, the Company may, at its option, issue new Rights Certificates evidencing Rights in such form as may be approved by the Board of Directors to reflect any adjustment or change in the number or kind or class of shares of stock purchasable upon exercise of Rights made in accordance with the provisions of this Agreement. In addition, in connection with the issuance or sale of shares of Common Stock by the Company following the Separation Time and prior to the Expiration Time pursuant to the terms of securities convertible or redeemable into shares of Common Stock (other than any securities issued or issuable in connection with the exercise or exchange of Rights) or to options, in each case issued or granted prior to, and outstanding at, the Separation Time, the Company shall issue to the holders of such shares of Common Stock, Rights Certificates representing the appropriate number of Rights in connection with the issuance or sale of such shares of Common Stock; provided, however, that, in each case, (i) no such Rights Certificate shall be issued if, and to the extent that, the Company shall be advised by counsel that such issuance would create a significant risk of material adverse tax consequences to the Company or to the Person to whom such Rights Certificates would be issued, (ii) no such Rights Certificates shall be issued if, and to the extent that, appropriate adjustment shall have otherwise been made in lieu of the issuance thereof, and (iii) the Company shall have no obligation to distribute Rights Certificates to any Acquiring Person or Affiliate or Associate of an Acquiring Person or any transferee of any of the foregoing.

 

 18 

 

 

5.4 Supplements and Amendments. The Company and the Rights Agent may from time to time supplement or amend this Agreement without the approval of any holders of Rights (i) prior to the Separation Time, in any respect, and (ii) on or after the Separation Time, to make any changes that the Company may deem necessary or desirable (x) that shall not materially adversely affect the interests of the holders of Rights generally (other than the Acquiring Person or any Affiliate or Associate thereof) or (y) in order to cure any ambiguity or to correct or supplement any provision contained herein that may be inconsistent with any other provisions herein or otherwise defective, including, but not limited to, any change in order to satisfy any applicable law, rule or regulation, including, but not limited to, any Trading Regulation on any applicable exchange so as to allow trading of the Company’s securities thereon. Any supplement or amendment authorized by this Section 5.4 will be evidenced by a writing signed by the Company and the Rights Agent. The Rights Agent will duly execute and deliver any supplement or amendment hereto requested by the Company in writing; provided that the Company has delivered to the Rights Agent a certificate from an appropriate officer of the Company that states that the proposed supplement or amendment complies with the terms of this Agreement. Notwithstanding anything in this Agreement to the contrary, the Rights Agent may, but shall not be obligated to enter into any supplement or amendment that affects the Rights Agent’s own rights, duties, immunities or obligations under this Agreement.

 

5.5 Fractional Shares. If the Company elects not to issue certificates representing (or register on the stock transfer books of the Company) fractional shares upon exercise, redemption or exchange of Rights, the Company shall, in lieu thereof, in the sole discretion of the Board of Directors, either (a) evidence such fractional shares by depositary receipts issued pursuant to an appropriate agreement between the Company and a depositary selected by it providing that each holder of a depositary receipt shall have all of the rights, privileges and preferences to which such holder would be entitled as a beneficial owner of such fractional share, or (b) pay to the registered holder of such Rights the appropriate fraction of the Market Price per share by check. Whenever a payment for fractional Rights or fractional shares of Common Stock is to be made by the Rights Agent, the Company shall promptly prepare and deliver to the Rights Agent a certificate setting forth in reasonable detail the facts related to such payments and the prices and/or formulas utilized in calculating such payments, and provide sufficient monies to the Rights Agent in the form of fully collected funds to make such payments. The Rights Agent shall be fully protected in relying upon such certificate and shall have no duty with respect to, and shall not be deemed to have knowledge of any payment for fractional Rights or fractional shares or Common Stock under any section of this Agreement relating to the payment of fractional Rights or fractional shares of Common Stock unless and until the Rights Agent shall have received such a certificate and sufficient monies.

 

5.6 Rights of Action. Subject to the terms of this Agreement, rights of action in respect of this Agreement, other than rights of action vested solely in the Rights Agent, the Board of Directors or the Company, are vested in the respective holders of the Rights; and any holder of any Rights, without the consent of the Rights Agent or of the holder of any other Rights, may, on such holder’s own behalf and for such holder’s own benefit and the benefit of other holders of Rights, enforce, and may institute and maintain any suit, action or proceeding against the Company to enforce, or otherwise act in respect of, such holder’s right to exercise such holder’s Rights in the manner provided in such holder’s Rights Certificate and in this Agreement. Without limiting the foregoing or any remedies available to the holders of Rights, it is specifically acknowledged that the holders of Rights would not have an adequate remedy at law for any breach of this Agreement and will be entitled to specific performance of the obligations under, and injunctive relief against actual or threatened violations of the obligations of any Person subject to, this Agreement.

 

 19 

 

 

5.7 Holder of Rights Not Deemed a Stockholder. No holder, as such, of any Rights shall be entitled to vote, receive dividends or be deemed for any purpose to be the holder of shares or any other securities that may at any time be issuable on the exercise of such Rights, nor shall anything contained herein or in any Rights Certificate be construed to confer upon the holder of any Rights, as such, any of the rights of a stockholder of the Company or any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof, or to give or withhold consent to any corporate action, or to receive notice of meetings or other actions affecting stockholders (except as provided in Section 5.8), or to receive dividends or subscription rights, or otherwise, until such Rights shall have been exercised or exchanged in accordance with the provisions hereof.

 

5.8 Notice of Proposed Actions. In case the Company shall propose at or after the Separation Time and prior to the Expiration Time (i) to effect or permit a Flip-over Transaction or Event or (ii) to effect the liquidation, dissolution or winding up of the Company, then, in each such case, the Company shall give to each holder of a Right, in accordance with Section 5.9, and to the Rights Agent a written notice of such proposed action, which shall specify the date on which such Flip-over Transaction or Event, liquidation, dissolution, or winding up is to take place, and such notice shall be so given at least 20 Business Days prior to, but not including, the date of the taking of such proposed action.

 

5.9 Notices. Notices or demands authorized or required by this Agreement to be given or made by the Rights Agent or by the holder of any Rights to or on the Company shall be sufficiently given or made if delivered or sent by recognized national overnight delivery service or first-class mail, postage prepaid, addressed (until another address is filed in writing with the Rights Agent) as follows:

 

Research Frontiers Incorporated

240 Crossways Park Drive

Woodbury NY 11797-2033

Attention: President

 

Subject to the provisions of Section 4.4, any notice or demand authorized or required by this Agreement to be given or made by the Company or by the holder of any Rights to or on the Rights Agent shall be sufficiently given or made if delivered or sent by recognized national overnight delivery service or first-class mail, postage prepaid, addressed (until another address is filed in writing with the Company) as follows:

 

Continental Stock Transfer & Trust Company

1 State Street, 30th Floor

New York, NY 10004

Attention: Compliance Department

(212) 509-4000

 

Notices or demands authorized or required by this Agreement to be given or made by the Company or the Rights Agent to or on the holder of any Rights shall be sufficiently given or made if delivered or sent by first-class mail, postage prepaid, addressed to such holder at the address of such holder as it appears upon the registry books of the Rights Agent or, prior to the Separation Time, on the registry books of the transfer agent for the Common Stock. Any notice that is mailed in the manner herein provided shall be deemed given, whether or not the holder receives the notice.

 

5.10 Suspension of Exercisability or Exchangeability. Notwithstanding any provisions in this Agreement to the contrary, to the extent that the Board of Directors determines in good faith that some action will or need be taken pursuant to, or in order to properly give effect to, Sections 2.3, 3.1 or 4.4 or to comply with federal or state securities laws or applicable Trading Regulations, the Company may suspend the exercisability or exchangeability of the Rights for a reasonable period sufficient to allow it to take such action or comply with such laws or Trading Regulations. In the event of any such suspension, the Company shall issue as promptly as practicable a public announcement (with prompt written notice to the Rights Agent) stating that the exercisability or exchangeability of the Rights has been temporarily suspended. Notice thereof pursuant to Section 5.9 shall not be required. Upon such suspension, any rights of action vested in a holder of Rights shall be similarly suspended.

 

 20 

 

 

Failure to give a notice pursuant to the provisions of this Agreement shall not affect the validity of any action taken hereunder.

 

5.11 Costs of Enforcement. The Company agrees that if the Company or any other Person the securities of which are purchasable upon exercise of Rights fails to fulfill any of its obligations pursuant to this Agreement, then the Company or such Person will reimburse the holder of any Rights for the costs and expenses (including legal fees) incurred by such holder in actions to enforce such holder’s rights pursuant to any Rights or this Agreement.

 

5.12 Successors. All the covenants and provisions of this Agreement by or for the benefit of the Company or the Rights Agent shall bind and inure to the benefit of their respective successors and assigns hereunder.

 

5.13 Benefits of this Agreement. Nothing in this Agreement shall be construed to give to any Person other than the Company, the Rights Agent and the holders of the Rights any legal or equitable right, remedy or claim under this Agreement and this Agreement shall be for the sole and exclusive benefit of the Company, the Rights Agent and the holders of the Rights.

 

5.14 Determination and Actions by the Company, etc. For all purposes of this Agreement, any calculation of the number of shares of Common Stock or any other class of capital stock outstanding at any particular time, including, but not limited to, for purposes of determining the particular percentage of such outstanding shares of Common Stock of which any Person is the Beneficial Owner, shall be made in accordance with the last sentence of Rule 13d-3(d)(1)(i) of the General Rules and Regulations under the Exchange Act. The Board of Directors shall have the exclusive power and authority to administer this Agreement and to exercise all rights and powers specifically granted to the Company, or as may be necessary or advisable in the administration of this Agreement, including, but not limited to, the right and power to (i) interpret the provisions of this Agreement and (ii) make all determinations and calculations deemed necessary or advisable for the administration or implementation of this Agreement, including, but not limited to, the right to determine the Rights to be null and voided pursuant to Section 3.1, after taking into account the purpose of this Agreement and the Company’s interest in maintaining an orderly trading market in the outstanding shares of Common Stock. All such actions, interpretations, calculations and determinations done or made by the Board of Directors shall (x) be final, conclusive and binding on the Company, the Rights Agent, the holders of the Rights and all other Persons, and (y) not subject the Board of Directors or any of the directors of the Company to any liability to the holders of the Rights.

 

5.15 Descriptive Headings; Section References. Descriptive headings appear herein for convenience only and shall not control or affect the meaning or construction of any of the provisions hereof. Where a reference in this Agreement is made to a Section, such reference shall be to a Section of this Agreement unless otherwise indicated.

 

5.16 GOVERNING LAW; EXCLUSIVE JURISDICTION. (a) THIS AGREEMENT AND EACH RIGHT ISSUED HEREUNDER SHALL BE DEEMED TO BE A CONTRACT MADE UNDER THE LAWS OF THE STATE OF DELAWARE AND FOR ALL PURPOSES SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF SUCH STATE APPLICABLE TO CONTRACTS TO BE MADE AND PERFORMED ENTIRELY WITHIN SUCH STATE; PROVIDED, HOWEVER, THAT ALL PROVISIONS REGARDING THE RIGHTS, DUTIES, OBLIGATIONS AND LIABILITIES OF THE RIGHTS AGENT SHALL BE GOVERNED AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO CONTRACTS MADE AND TO BE PERFORMED ENTIRELY WITHIN SUCH STATE.

 

(b) (i) THE COMPANY AND EACH HOLDER OF RIGHTS HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE COURT OF CHANCERY OF THE STATE OF DELAWARE, OR, IF SUCH COURT SHALL LACK SUBJECT MATTER JURISDICTION, THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE, OVER ANY SUIT, ACTION, OR PROCEEDING ARISING OUT OF OR RELATING TO OR CONCERNING THIS AGREEMENT. The Company and each holder of Rights acknowledge that the forum designated by this paragraph (b) has a reasonable relation to this Agreement, and to such Persons’ relationship with one another.

 

 21 

 

 

(ii) The Company and each holder of Rights hereby waive, to the fullest extent permitted by applicable law, any objection which they now or hereafter have to personal jurisdiction or to the laying of venue of any such suit, action or proceeding brought in any court referred to in paragraph (b)(i). The Company and each holder of Rights undertake not to commence any action subject to this Agreement in any forum other than the forum described in this paragraph (b). The Company and each holder of Rights agree that, to the fullest extent permitted by applicable law, a final and non-appealable judgment in any such suit, action, or proceeding brought in any such court shall be conclusive and binding upon such Persons.

 

5.17 Counterparts. This Agreement may be executed in counterparts and by each party hereto on a separate counterpart, both of which when so executed shall be deemed to be an original and both of which taken together shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this Agreement by facsimile or e-mail transmission shall be effective as delivery of a manually executed counterpart of this Agreement.

 

5.18 Severability. If any term, covenant, restriction or provision hereof or the application thereof to any circumstance shall, in any jurisdiction and to any extent, be invalid or unenforceable, such term, covenant, restriction or provision shall be ineffective as to such jurisdiction to the extent of such invalidity or unenforceability without invalidating or rendering unenforceable the remaining terms, covenants, restrictions and provisions hereof or the application of such term, covenant, restriction or provision to circumstances other than those as to which it is held invalid or unenforceable.

 

5.19 Renewal Amendment. Prior to the applicable date determined pursuant to clause (iii) of the definition of “Expiration Time” (the “Applicable Expiration Date”) (or, if the Applicable Expiration Date is hereafter amended to extend such date pursuant to this Section 5.19, then prior to the then Applicable Expiration Date), the Board of Directors may review this Agreement to determine whether extending the Applicable Expiration Date would be in the best interests of the Company and its stockholders. Upon the approval of the Board of Directors to extend the Applicable Expiration Date, the Company shall execute, and shall request (in accordance with Section 5.4) that the Rights Agent execute, an amendment to this Agreement pursuant to Section 5.4 giving effect to such extension.

 

5.20 USA PATRIOT Act. Each Person that is a party hereto acknowledges that the Rights Agent is subject to the customer identification program (“Customer Identification Program”) requirements under the USA PATRIOT Act and its implementing regulations, and that the Rights Agent must obtain, verify and record information that allows the Rights Agent to identify each such person or entity. Accordingly, prior to accepting an appointment hereunder, the Rights Agent may request information from any such person or entity that will help the Rights Agent to identify such person or entity, including, but not limited to, as applicable, such person or entity’s physical address, tax identification number, organizational documents, certificate of good standing, license to do business, or any other information that the Rights Agent deems necessary. Each Person that is a party hereto acknowledges that the Rights Agent cannot accept an appointment hereunder unless and until the Rights Agent verifies each such person or entity’s identity in accordance with the Customer Identification Program requirements.

 

[remainder of page intentionally left blank]

 

 22 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first above written.

 

  RESEARCH FRONTIERS INCORPORATED
   
  By: /s/ Joseph M. Harary                                      
  Name: Joseph M. Harary
  Title: President and CEO
   
  CONTINENTAL STOCK TRANSFER &
  TRUST COMPANY, as Rights Agent
   
  By:
  Name:
  Title:

 

[Signature Page to Stockholder Protection Rights Agreement]

 

 23 

 

 

EXHIBIT A

 

[Form of Rights Certificate]

 

Certificate No. W-   Rights

 

THE RIGHTS ARE SUBJECT TO REDEMPTION OR MANDATORY EXCHANGE, AT THE OPTION OF THE COMPANY, ON THE TERMS SET FORTH IN THE RIGHTS AGREEMENT. RIGHTS “BENEFICIALLY OWNED” BY “ACQUIRING PERSONS” OR “AFFILIATES” OR “ASSOCIATES” THEREOF (AS SUCH TERMS ARE DEFINED IN THE RIGHTS AGREEMENT) OR TRANSFEREES OF ANY OF THE FOREGOING WILL BE NULL AND VOID. [THE RIGHTS REPRESENTED BY THIS RIGHTS CERTIFICATE ARE OR WERE BENEFICIALLY OWNED BY A PERSON WHO WAS OR BECAME AN ACQUIRING PERSON OR AN AFFILIATE OR ASSOCIATE OF AN ACQUIRING PERSON (AS SUCH TERMS ARE DEFINED IN THE RIGHTS AGREEMENT). ACCORDINGLY, THIS RIGHTS CERTIFICATE AND THE RIGHTS REPRESENTED HEREBY MAY BECOME NULL AND VOID IN THE CIRCUMSTANCES SPECIFIED IN SECTION 3.1(b) OF SUCH AGREEMENT.]1

 

Rights Certificate

 

Research Frontiers Incorporated

 

This certifies that _____________, or registered assigns, is the registered holder of the number of Rights set forth above, each of which entitles the registered holder thereof, subject to the terms, provisions and conditions of the Restated and Amended Stockholder Protection Rights Agreement, dated as of February 11, 2023 (as amended from time to time, the “Rights Agreement”), between Research Frontiers Incorporated, a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York banking corporation, as Rights Agent (the “Rights Agent,” which term shall include any successor Rights Agent under the Rights Agreement), to purchase from the Company at any time after the Separation Time (as such term is defined in the Rights Agreement) and prior to the Expiration Time (as such term is defined in the Rights Agreement), one share of Common Stock, par value $0.0001 per share (the “Common Stock”), of the Company (subject to adjustment as provided in the Rights Agreement) at the Exercise Price referred to below, upon presentation and surrender of this Rights Certificate with the Form of Election to Exercise duly executed and properly completed at the office of the Rights Agent designated for such purpose. The Exercise Price shall initially be $40 per Right and shall be subject to adjustment in certain events as provided in the Rights Agreement.

 

In certain circumstances described in the Rights Agreement, the Rights evidenced hereby may entitle the registered holder thereof to purchase securities of an entity other than the Company or securities of the Company other than Common Stock or assets of the Company, all as provided in the Rights Agreement.

 

This Rights Certificate is subject to all of the terms, provisions and conditions of the Rights Agreement, which terms, provisions and conditions are hereby incorporated herein by reference and made a part hereof and to which Rights Agreement reference is hereby made for a full description of the rights, limitations of rights, obligations, duties and immunities hereunder of the Rights Agent, the Company and the holders of the Rights Certificates. Copies of the Rights Agreement are on file at the principal office of the Company and are available without cost upon written request.

 

This Rights Certificate, with or without other Rights Certificates, upon surrender at the office of the Rights Agent designated for such purpose, may be exchanged for another Rights Certificate or Rights Certificates of like tenor evidencing an aggregate number of Rights equal to the aggregate number of Rights evidenced by the Rights Certificate or Rights Certificates so surrendered. If this Rights Certificate shall be exercised in part, the registered holder shall be entitled to receive, upon surrender hereof, another Rights Certificate or Rights Certificates for the number of whole Rights not exercised.

 

 

1 The portion of the legend in brackets shall be inserted only if applicable and shall replace the preceding sentence.

 

 24 

 

 

Subject to the provisions of the Rights Agreement, each Right evidenced by this Certificate may be (a) redeemed by the Company under certain circumstances, at its option, at a redemption price of $0.0001 per Right, or (b) exchanged by the Company under certain circumstances, at its option, for one share of Common Stock per Right (or, in certain cases, other securities or assets of the Company), subject in each case to adjustment in certain events as provided in the Rights Agreement.

 

No holder of this Rights Certificate, as such, shall be entitled to vote or receive dividends or be deemed for any purpose the holder of any securities that may at any time be issuable on the exercise hereof, nor shall anything contained in the Rights Agreement or herein be construed to confer upon the holder hereof, as such, any of the rights of a stockholder of the Company or any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof, or to give or withhold consent to any corporate action, or to receive notice of meetings or other actions affecting stockholders (except as provided in the Rights Agreement), or to receive dividends or subscription rights, or otherwise, until the Rights evidenced by this Rights Certificate shall have been exercised or exchanged as provided in the Rights Agreement.

 

This Rights Certificate shall not be valid or obligatory for any purpose until it shall have been countersigned (either manually or by facsimile) by the Rights Agent.

 

WITNESS the facsimile signature of the proper officers of the Company and its corporate seal.

 

Date:  

 

 

ATTEST:   RESEARCH FRONTIERS
    INCORPORATED
     
    By:                          
Secretary   Name:  
    Title:  

 

Countersigned:

 

CONTINENTAL STOCK TRANSFER & TRUST

COMPANY, as Rights Agent

 

By:         
Name:    
Title:    

 

 25 

 

 

[Form of Reverse Side of Rights Certificate]

 

FORM OF ASSIGNMENT

 

(To be executed by the registered holder if such

holder desires to transfer this Rights Certificate.)

 

FOR VALUE RECEIVED _______________ hereby sells, assigns and transfers unto  

 

 
(Please print name and address of transferee)

this Rights Certificate, together with all right, title and interest therein, and does hereby irrevocably constitute and appoint _________ as Attorney-in-fact, to transfer the within Rights Certificate on the books of the within-named Company, with full power of substitution.

 

Dated:   ,    

 

Signature  
Guaranteed:  
  Signature
 
  (Signature must correspond to name as written upon the face of this Rights Certificate in every particular, without alteration or enlargement or any change whatsoever)

 

Signatures must be guaranteed by a participant in a Medallion Signature Guarantee Program at a guarantee level acceptable to the Company’s Rights Agent.

 

 

 

(To be completed if true)

 

The undersigned hereby represents, for the benefit of the Company and all holders of Rights and shares of Common Stock, that the Rights evidenced by this Rights Certificate are not, and, to the knowledge of the undersigned, have never been, Beneficially Owned by an Acquiring Person or an Affiliate or Associate thereof (as each such term is defined in the Rights Agreement).

 

   
 
Signature

 

NOTICE

 

In the event the certification set forth above is not completed in connection with a purported assignment, the Company will deem the Beneficial Owner of the Rights evidenced by the enclosed Rights Certificate to be an Acquiring Person or an Affiliate or Associate thereof (as each such term is defined in the Rights Agreement) or a transferee of any of the foregoing and accordingly will deem the Rights evidenced by such Rights Certificate to be null and void and not transferable or exercisable.

 

 26 

 

 

[To be attached to each Rights Certificate]

 

FORM OF ELECTION TO EXERCISE

 

(To be executed if holder desires to

exercise the Rights Certificate.)

 

TO: Research Frontiers Incorporated

 

The undersigned hereby irrevocably elects to exercise ______________________whole Rights represented by the attached Rights Certificate to purchase the shares of Common Stock or such other securities or assets as may then be issuable upon the exercise of such Rights and requests that certificates for such shares be issued in the name of:

 

Address:
 

Social Security or Other Taxpayer
Identification Number:

 

If such number of Rights shall not be all the Rights evidenced by this Rights Certificate, a new Rights Certificate for the balance of such Rights shall be registered in the name of and delivered to:

 

Address:  
   

 

Social Security or Other Taxpayer
Identification Number:

 

Dated:   ,    

 

Signature  
Guaranteed:  
  Signature
 
  (Signature must correspond to name as written upon the face of the attached Rights Certificate in every particular, without alteration or enlargement or any change whatsoever)

 

Signatures must be guaranteed by a participant in a Medallion Signature Guarantee Program at a guarantee level acceptable to the Company’s Rights Agent.

 

 

 

(To be completed if true)

 

The undersigned hereby represents, for the benefit of the Company and all holders of Rights and shares of Common Stock, that the Rights evidenced by the attached Rights Certificate are not, and, to the knowledge of the undersigned, have never been, Beneficially Owned by an Acquiring Person or an Affiliate or Associate thereof (as each such term is defined in the Rights Agreement).

 

 
  Signature

 

NOTICE

 

In the event the certification set forth above is not completed in connection with a purported exercise, the Company will deem the Beneficial Owner of the Rights evidenced by the attached Rights Certificate to be an Acquiring Person or an Affiliate or Associate thereof (as defined in the Rights Agreement) or a transferee of any of the foregoing and accordingly will deem the Rights evidenced by such Rights Certificate to be null and void and not transferable or exercisable.

 

 27 

 EX-21 3 ex21.htm

 

Exhibit 21

 

 

State or

Country of

Organization

Subsidiary of the Registrant:  
   
SPD Enterprises, Inc. Delaware

 

   

 

 

 EX-23.1 4 ex23-1.htm

 

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-184785, 333-179099, 333-133858, 333-40369, 333-115052, 333-65219 and 333-159093) and Form S-8 (Nos. 333-80575, 333-179097, 33-53030, 33-86910, 333-08623, 333-34163, 333-63374, 333-106754, 333-159094, 333-196746 and 333-237035) of Research Frontiers Incorporated of our report dated March 9, 2023, relating to the consolidated financial statements of Research Frontiers Incorporated as of December 31, 2022 and 2021 and the years then ended included in this Annual Report on Form 10-K of Research Frontiers Incorporated for the year ended December 31, 2022.

 

/s/ CohnReznick LLP  
   
March 9, 2023  
Melville, New York  

 

   

 EX-31.1 5 ex31-1.htm

 

EXHIBIT 31.1

 

CERTIFICATION

 

I, Joseph M. Harary, certify that:

 

1. I have reviewed this annual report on Form 10-K of Research Frontiers Incorporated (the “registrant”);

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the consolidated financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: March 9, 2023 /s/ Joseph M. Harary
  Joseph M. Harary
  President, Chief Executive Officer and Acting Interim Chief Financial Officer

 

   

 EX-32.1 6 ex32-1.htm

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Research Frontiers Incorporated (the “Company”) on Form 10-K for the year ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Joseph M. Harary, President, Chief Executive Officer, Acting Interim Chief Financial Officer and Principal Executive Officer and Principal Financial and Accounting Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and
   
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Joseph M. Harary  
Joseph M. Harary  

President, Chief Executive Officer, Acting Interim Chief Financial Officer and Principal Executive Officer and Principal Financial and Accounting Officer

  
   
March 9, 2023  

 

   

 EX-101.SCH 7 refr-20221231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Business and Basis for Presentation link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Fixed Assets link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Accrued Expenses and Other link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Shareholders’ Equity link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - License and Other Agreements link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Commitments link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Rights Plan link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Fixed Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Accrued Expenses and Other (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Shareholders’ Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Commitments (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Business and Basis for Presentation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Schedule of Unrealized Loss on Investments (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Schedule of Fixed Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Schedule of Accrued Expenses and Other (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Schedule of Deferred Tax Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Schedule of Reconciliation Income Tax Expenses Benefit (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Schedule of Assumptions Used to Value Options Granted to Employees (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Schedule of Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Schedule of Warrant Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Shareholders’ Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - License and Other Agreements (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Schedule of Minimum Annual Future Rental Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Commitments (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Rights Plan (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 refr-20221231_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 refr-20221231_def.xml XBRL DEFINITION FILE EX-101.LAB 10 refr-20221231_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer [Axis] Company One [Member] Company Two [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] License Agreement [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Product and Service [Axis] Licensee One [Member] License Two [Member] License Three [Member] License Four [Member] Antidilutive Securities [Axis] Options and Warrants [Member] Title of Individual [Axis] Employees and Directors [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Financial Instrument [Axis] Putnam Short Duration Bond [Member] Putnam Ultra Short Duration Income [Member] Long-Lived Tangible Asset [Axis] Equipment and Furniture [Member] Trade Show Materials [Member] Autos [Member] Leasehold Improvements [Member] Tax Period [Axis] Tax Year 2018 to 2022 [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Subscription Agreement [Member] Warrant [Member] Plan Name [Axis] 2019 Equity Incentive Plan [Member] Option Indexed to Issuer's Equity, Type [Axis] Non- Employee Stock Option [Member] Related Party [Axis] Investor [Member] Equity Option [Member] Chief Executive Officer [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] ICFR Auditor Attestation Flag Auditor Firm ID Auditor Name Auditor Location Statement of Financial Position [Abstract] Assets Current assets: Cash and cash equivalents Marketable securities Royalties receivable, net of reserves of $1,158,450 in 2022 and $1,016,678 in 2021, respectively Prepaid expenses and other current assets Total current assets Fixed assets, net Operating lease ROU assets Deposits and other assets Total assets Liabilities and Shareholders’ Equity Current liabilities: Current portion of operating lease liability Accounts payable Accrued expenses and other Total current liabilities Operating lease liability, net of current portion Total liabilities Shareholders’ equity: Common stock, par value $0.0001 per share; authorized 100,000,000 shares, issued and outstanding 33,150,396 in 2022 and 31,650,396 in 2021 Additional paid-in capital Accumulated deficit Total shareholders’ equity Total liabilities and shareholders’ equity Royalties receivables, reserves Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Fee income Operating expenses Research and development Total expenses Operating loss Net investment loss Net loss Basic and diluted net loss per common share Weighted average number of common shares outstanding Statement [Table] Statement [Line Items] Balance Balance, shares Exercise of options Exercise of options, shares Share based compensation Net loss Issuance of common stock and warrants Issuance of common stock and warrants, shares Balance Balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization Realized loss on marketable securities Unrealized loss on marketable securities Share-based compensation Bad debts ROU asset amortization Change in assets and liabilities: Royalty receivables Prepaid expenses and other assets Accounts payable and accrued expenses Operating lease liability Net cash used in operating activities Cash flows from investing activities: Purchases of fixed assets Purchases of marketable securities Sales of marketable securities Net cash used in investing activities Cash flows from financing activities: Net proceeds from exercise of options and warrants Proceeds from issuance of common stock and warrants Net cash provided by financing activities Net increase (decrease) in cash and cash equivalents Cash and cash equivalents at beginning of year Cash and cash equivalents at end of year Organization, Consolidation and Presentation of Financial Statements [Abstract] Business and Basis for Presentation Accounting Policies [Abstract] Summary of Significant Accounting Policies Property, Plant and Equipment [Abstract] Fixed Assets Payables and Accruals [Abstract] Accrued Expenses and Other Income Tax Disclosure [Abstract] Income Taxes Equity [Abstract] Shareholders’ Equity License And Other Agreements License and Other Agreements Commitments and Contingencies Disclosure [Abstract] Commitments Rights Plan Rights Plan Cash and Cash Equivalents Marketable Securities Royalties Receivable Fixed Assets Revenue Recognition/Fee Income Basic and Diluted Loss Per Common Share Research and Development Costs Patent Costs Use of Estimates Income Taxes Equity-Based Compensation Restricted Stock Impairment of Long-Lived Assets Fair Value Measurements Recent Accounting Pronouncements Schedule of Unrealized Loss on Investments Schedule of Fixed Assets Schedule of Accrued Expenses and Other Schedule of Deferred Tax Assets Schedule of Reconciliation Income Tax Expenses Benefit Schedule of Assumptions Used to Value Options Granted to Employees Schedule of Option Activity Schedule of Warrant Activity Schedule of Minimum Annual Future Rental Commitments Working capital Shareholders' equity Accumulated deficit Non-recurring cash expenses Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plan Disclosure [Line Items] Unrealized loss Schedule of Product Information [Table] Product Information [Line Items] FDIC insurance coverage Amounts on deposit in excess of federally insured limits Realized loss on sale of marketable securities Concentration risk, percentage Royalty rate on selling price Remaining performance obligations Antidilutive securities Recognized benefit measured Share based compensation Impairment of long-lived assets Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Fixed assets, gross Estimated useful life Less accumulated depreciation and amortization Payroll, bonuses and related benefits Professional services Other Accrued expenses Depreciation Allowance for bad debts Net operating loss carry-forwards Stock option expense Research and other credits Lease liability Amortization Total gross deferred tax assets Lease liability Other temporary differences Total gross deferred tax liabilities Valuation allowance Net deferred tax Income tax provision at federal statutory rate Expired carryforwards and other Valuation allowance Total income tax provision Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Line Items] Amortized cost term description Research and development expense Corporate minimum tax rate Excise tax on corporate stock Net operating loss carry-forward Net operating loss carry-forward with expiration Net operating loss carry-forward expiration description Income tax percentage Research and other credit carry-forwards Fair value on grant date Expected dividend yield Expected volatility Risk free interest rate Expected term of the option Option Indexed to Issuer's Equity [Table] Option Indexed to Issuer's Equity [Line Items] Number of Shares Subject to Option, Beginning Weighted Average Exercise Price, Beginning Weighted Average Remaining Contractual Term (Years), Ending Aggregate Intrinsic Value, Beginning Number of Shares Subject to Option, Granted Weighted Average Exercise Price, Granted Number of Shares Subject to Option, Cancelled Weighted Average Exercise Price, Cancelled Number of Shares Subject to Option, Exercised Weighted Average Exercise Price, Exercised Number of Shares Subject to Option, Ending Weighted Average Exercise Price, Ending Aggregate Intrinsic Value, Ending Number of Shares Underlying Warrants and Non-Employee Options Granted, Beginning Weighted Average Exercise Price, Beginning Number of Shares Underlying Warrants and Non-Employee Options Granted, Exercised Number of Shares Underlying Warrants and Non-Employee Options Granted, Terminated Number of Shares Underlying Warrants and Non-Employee Options Granted, Issued Weighted Average Exercise Price, Issued Number of Shares Underlying Warrants and Non-Employee Options Granted, Ending Weighted Average Exercise Price, Ending Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Proceeds from issuance of stock Stock issued during period shares Shares issued price per share Stock issued value Shares of common stock reserved for issuance Shares available for issuance Number of options vested Warrants and non-employee options vested term Warrants outstanding Option expiration period Royalty earned percentage Year 1 Years 2-3 Years 4-5 Thereafter Total lease payments Less: imputed lease interest Present value of lease liabilities Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table] Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] Annual base salary Lease expiration term Operating Lease, Weighted Average Remaining Lease Term Operating Lease, Weighted Average Discount Rate, Percent Percentage of acquisition threshold Value of stock covered by each right Discount price of stock Acquiring asset percent Rights plan expire date Redemption price Trade Show Materials [Member] Autos [Member] Royalties receivable net current. Net investment income loss. Issuance of common stock and warrants. Issuance of common stock and warrants, shares. Proceeds from stock options and warrants exercised. Proceeds from sale of common stock and warrants. Working capital. Non-recurring cash expenses. Royalty rate on selling price. License Agreement [Member] Net operating loss carry-forward expiration description. Licensee One [Member] License Two [Member] License Three [Member] License Four [Member] Options and Warrants [Member] Restricted stock [Policy Text Block] 2019 Equity Incentive Plan [Member] Recognized benefit measured. Weighted average price at which grantees can acquire the shares reserved for issuance under the non-option equity plan. Non- Employee Stock Option [Member] License and other agreements [Text Block] Royalty earned percentage. Lease expiration term. Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second and third fiscal year following latest fiscal year. Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fouth and fifth fiscal year following latest fiscal year. Rights plan disclosure [Text Block] Percentage of acquisition threshold in rights agreement. Rights plan expire date. Equipment and Furniture [Member] Increase decrease in royalty receivable. Deferred tax assets lease liability. Deferred tax assets amortization. Company One [Member] Company Two [Member] Tax Year 2018 to 2022 [Member] Employees and Directors [Member]. Share based compensation arrangement by share based payment award non option equity instruments issued in period weighted average exercise price. Warrants and non-employee options vested term. Putnam Short Duration Bond [Member] Putnam Ultra Short Duration Income [Member] Subscription Agreement [Member] Amortized cost term, description. Corporate minimum tax rate. Excise tax on corporate stock rate. Discount price of stock. Rights redemption price per share. Acquiring assets percent. Assets, Current Assets [Default Label] Liabilities, Current Liabilities Liabilities and Equity Operating Expenses Operating Income (Loss) Shares, Outstanding Marketable Securities, Realized Gain (Loss) IncreaseDecreaseInRoyaltyReceivable Increase (Decrease) in Prepaid Expense and Other Assets Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Payments to Acquire Marketable Securities Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations RightsPlanDisclosureTextBlock Property, Plant and Equipment, Policy [Policy Text Block] Income Tax, Policy [Policy Text Block] Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Deferred Tax Assets, Gross Deferred Tax Liabilities, Leasing Arrangements Deferred Tax Liabilities, Gross Deferred Tax Assets, Valuation Allowance Income Tax Expense (Benefit) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount EX-101.PRE 11 refr-20221231_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Cover - USD ($)
 12 Months Ended
Dec. 31, 2022
Mar. 09, 2023
Jun. 30, 2022
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2022    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2022    
Current Fiscal Year End Date --12-31    
Entity File Number 000-14893    
Entity Registrant Name RESEARCH FRONTIERS INCORPORATED    
Entity Central Index Key 0000793524    
Entity Tax Identification Number 11-2103466    
Entity Incorporation, State or Country Code DE    
Entity Address, Address Line One 240 CROSSWAYS PARK DRIVE    
Entity Address, City or Town WOODBURY    
Entity Address, State or Province NY    
Entity Address, Postal Zip Code 11797-2033    
City Area Code 516    
Local Phone Number 364-1902    
Title of 12(b) Security Common Stock, $0.0001 Par Value    
Trading Symbol REFR    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 49,488,280
Entity Common Stock, Shares Outstanding   33,509,287  
ICFR Auditor Attestation Flag false    
Auditor Firm ID 596    
Auditor Name CohnReznick LLP    
Auditor Location Melville, New York    
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 4,230,916 $ 269,964
Marketable securities 2,755,111
Royalties receivable, net of reserves of $1,158,450 in 2022 and $1,016,678 in 2021, respectively 589,599 831,636
Prepaid expenses and other current assets 100,973 92,931
Total current assets 4,921,488 3,949,642
Fixed assets, net 65,388 92,954
Operating lease ROU assets 323,509 469,824
Deposits and other assets 56,066 33,567
Total assets 5,366,451 4,545,987
Current liabilities:    
Current portion of operating lease liability 196,405 182,091
Accounts payable 71,079 66,460
Accrued expenses and other 34,379 49,385
Total current liabilities 301,863 297,936
Operating lease liability, net of current portion 267,723 464,128
Total liabilities 569,586 762,064
Shareholders’ equity:    
Common stock, par value $0.0001 per share; authorized 100,000,000 shares, issued and outstanding 33,150,396 in 2022 and 31,650,396 in 2021 3,315 3,165
Additional paid-in capital 127,150,027 123,467,886
Accumulated deficit (122,356,477) (119,687,128)
Total shareholders’ equity 4,796,865 3,783,923
Total liabilities and shareholders’ equity $ 5,366,451 $ 4,545,987
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets (Parenthetical) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Royalties receivables, reserves $ 1,158,450 $ 1,016,678
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 33,150,396 31,650,396
Common stock, shares outstanding 33,150,396 31,650,396
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
Fee income $ 539,686 $ 1,263,034
Operating expenses 2,555,689 2,521,849
Research and development 609,127 580,000
Total expenses 3,164,816 3,101,849
Operating loss (2,625,130) (1,838,815)
Net investment loss (44,219) (7,537)
Net loss $ (2,669,349) $ (1,846,352)
Basic and diluted net loss per common share $ (0.08) $ (0.06)
Weighted average number of common shares outstanding 32,070,233 31,646,520
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Shareholders' Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2020 $ 3,158 $ 123,164,623 $ (117,840,776) $ 5,327,005
Balance, shares at Dec. 31, 2020 31,575,786      
Exercise of options $ 7 86,255 86,262
Exercise of options, shares 74,610      
Share based compensation 217,008 217,008
Net loss (1,846,352) (1,846,352)
Balance at Dec. 31, 2021 $ 3,165 123,467,886 (119,687,128) 3,783,923
Balance, shares at Dec. 31, 2021 31,650,396      
Share based compensation 232,291 232,291
Net loss (2,669,349) (2,669,349)
Issuance of common stock and warrants $ 150 3,449,850 3,450,000
Issuance of common stock and warrants, shares 1,500,000      
Balance at Dec. 31, 2022 $ 3,315 $ 127,150,027 $ (122,356,477) $ 4,796,865
Balance, shares at Dec. 31, 2022 33,150,396      
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:    
Net loss $ (2,669,349) $ (1,846,352)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 28,837 29,895
Realized loss on marketable securities 60,143
Unrealized loss on marketable securities 28,522
Share-based compensation 232,291 217,008
Bad debts 141,772 44,476
ROU asset amortization 146,315 146,618
Change in assets and liabilities:    
Royalty receivables 100,266 (277,819)
Prepaid expenses and other assets (30,542) (36,420)
Accounts payable and accrued expenses (10,387) 56,156
Operating lease liability (182,091) (166,377)
Net cash used in operating activities (2,182,745) (1,804,293)
Cash flows from investing activities:    
Purchases of fixed assets (1,271) (1,077)
Purchases of marketable securities (3,433,633)
Sales of marketable securities 2,694,968 650,000
Net cash used in investing activities 2,693,697 (2,784,710)
Cash flows from financing activities:    
Net proceeds from exercise of options and warrants 86,262
Proceeds from issuance of common stock and warrants 3,450,000
Net cash provided by financing activities 3,450,000 86,262
Net increase (decrease) in cash and cash equivalents 3,960,952 (4,502,741)
Cash and cash equivalents at beginning of year 269,964 4,772,705
Cash and cash equivalents at end of year $ 4,230,916 $ 269,964
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Business and Basis for Presentation
 12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Business and Basis for Presentation

(1) Business and Basis for Presentation

 

Research Frontiers Incorporated (“Research Frontiers” or the “Company”) operates in a single business segment which is engaged in the development and marketing of technology and devices to control the flow of light. Such devices, often referred to as “light valves” or suspended particle devices (“SPDs”), use colloidal particles that are either incorporated within a liquid suspension or a film, which is usually enclosed between two sheets of glass or plastic having transparent, electrically conductive coatings on the facing surfaces thereof. At least one of the two sheets is transparent. SPD technology, made possible by a flexible light-control film invented by Research Frontiers, allows the user to instantly and precisely control the shading of glass/plastic manually or automatically. SPD technology has numerous product applications, including SPD-Smart™ windows, sunshades, skylights and interior partitions for homes and buildings; automotive windows, sunroofs, sun visors, sunshades, rear-view mirrors, instrument panels, heads up displays and navigation systems; aircraft windows; museum display panels; eyewear products; and flat panel displays for electronic products. SPD-Smart light control film is now being developed for, or used in, architectural, automotive, marine, aerospace and appliance applications.

 

The Company has primarily utilized its cash, cash equivalents, and investments generated from sales of our common stock, proceeds from the exercise of options and warrants, and royalty fees collected to fund its research and development of SPD light valves, for marketing initiatives, and for other working capital purposes. The Company’s working capital and capital requirements depend upon numerous factors, including the results of research and development activities, competitive and technological developments, the timing and cost of patent filings, and the development of new licensees and changes in the Company’s relationships with its existing licensees. The degree of dependence of the Company’s working capital requirements on each of the foregoing factors cannot be quantified; increased research and development activities and related costs would increase such requirements; the addition of new licensees may provide additional working capital or working capital requirements, and changes in relationships with existing licensees would have a favorable or negative impact depending upon the nature of such changes. We have incurred recurring losses since inception and expect to continue to incur losses as a result of costs and expenses related to our research and continued development of our SPD technology and our corporate general and administrative expenses. Our limited capital resources and operations to date have been substantially funded through sales of our common stock, exercise of options and warrants and royalty fees collected. As of December 31, 2022, we had working capital of approximately $4.6 million, cash and cash equivalents of approximately $4.2 million, shareholders’ equity of approximately $4.8 million and an accumulated deficit of approximately $122.4 million. Our quarterly projected cash flow shortfall, based on our current operations, adjusted for any non-recurring cash expenses and adjusted for additional royalties expected to be received for use of our products in new production, for the next 12 months, is approximately $200,000 per quarter. We may eliminate some operating expenses in the future, which will further reduce our cash flow shortfall, if needed. Based on these assumptions, we currently expect to have sufficient working capital for at least 12 months from the issuance of these financial statements.

 

In the event that we are unable to generate sufficient cash from our operating activities or raise additional funds, we may be required to delay, reduce or severely curtail our operations or otherwise impede our on-going business efforts, which could have a material adverse effect on our business, operating results, financial condition and long-term prospects. The Company may seek to obtain additional funding through future equity issuances. There can be no assurance as to the availability or terms upon which such financing and capital might be available. The eventual success of the Company and generation of positive cash flow will be dependent upon the commercialization of products using the Company’s technology by the Company’s licensees and payments of continuing royalties on account thereof. To date, the Company has not generated sufficient revenue from its licensees to fund its operations.

 

Recent Global Events:

 

On March 11, 2020, the World Health Organization declared the novel strain of coronavirus (“COVID-19”) a global pandemic and recommended containment and mitigation measures worldwide.

 

 

Since 2020 revenues have been negatively impacted due to delays in manufacture of products using our technology. Most of the products using our technology are manufactured by licensees overseas in Europe and Asia who have been similarly affected by the pandemic. The disruption caused by public health crises, such as COVID-19, could result in lower levels of sale activity for products using our technology resulting in lower level of royalties owed to us from the sale of these products. The duration of the potential business disruptions and related financial impact cannot be reasonably estimated at this time, but could materially adversely affect our business, financial condition, results of operations, and cash flows.

 

Certain amounts in the accompanying December 31, 2021 statements of cash flows have been reclassified to conform with the December 31, 2022 presentation.

 
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

(2) Summary of Significant Accounting Policies

 

(a) Cash and Cash Equivalents

 

The Company considers securities purchased with original maturities of three months or less to be cash equivalents. Cash equivalents consist of short-term investments in money market accounts at December 31, 2022 and 2021.

 

Cash and cash equivalents are maintained at financial institutions and, at times, balances may exceed federally insured limits. We have never experienced any losses related to these balances. FDIC insurance coverage is $250,000 per depositor at each financial institution, and our non-interest bearing cash balances may again exceed federally insured limits. Amounts on deposit in excess of federally insured limits at December 31, 2022 and 2021 are approximately $2.7 million and $0, respectively.

 

(b) Marketable Securities

 

The Company classifies investments in marketable securities as trading, available-for-sale or held-to-maturity at the time of purchase and periodically re-evaluates such classification. Trading securities are carried at fair value, with unrealized holding gains and losses included in earnings. Held-to-maturity securities are recorded at cost and are adjusted for the amortization or accretion of premiums or discounts over the life of the related security. Unrealized holding gains and losses of available-for-sale securities are excluded from earnings and are reported as a separate component of accumulated other comprehensive income (loss) until realized. In determining realized gains and losses, the cost of the securities sold is based on the specific identification method. Interest and dividends on the investments are accrued at the balance sheet date.

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date. Fair value measurements are broken down into three levels based on the reliability of inputs as follows: Level 1 inputs are quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. An active market for the asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates and yield curves observable at commonly quoted intervals or current market) and contractual prices for the underlying financial instrument, as well as other relevant economic measures. Level 3 inputs are unobservable inputs for the asset or liability. Unobservable inputs are used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.

 

At December 31, 2022, the Company invested only in investments qualified as cash and cash equivalents. During the year ended December 31, 2022, the Company incurred a realized loss on the sale of marketable securities of $60,143. At December 31, 2021 all investments are Level 1 and were classified as trading and consisted of the following:

 

      December 31, 2021 
      Value of trading 
   Investment  Investments 
        
Mutual Funds  Putnam Short Duration Bond   $1,972,736 
   Putnam Ultra Short Duration Income    782,375 
         
      $2,755,111 
         
   Unrealized loss   $28,522 

 

(c) Royalties Receivable

 

Royalties receivable from licensees are recorded at the amounts specified within the license agreements when the collectability of the receivable is reasonably assured. The allowance for doubtful accounts is the Company’s best estimate of the amount of probable credit losses in the Company’s existing royalties receivable. The Company determines the allowance based on historical write-off experience as well as the current status of the Company’s customers. The Company reviews its allowance for doubtful accounts periodically. Past due accounts are reviewed individually for collectability. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. As of December 31, 2022, one company accounted for 14% of the Company’s outstanding receivables. As of December 31, 2021, two companies accounted for 14% and 11% of the Company’s outstanding receivables.

 

(d) Fixed Assets

 

Fixed assets are carried at cost less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the assets.

 

 

(e) Revenue Recognition/Fee Income

 

The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers (“ASC 606”). The standard provides a single comprehensive revenue recognition model for all contracts with customers and supersedes existing revenue recognition guidance. The revenue standard contains principles that an entity will apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to customers at an amount that the entity expects to be entitled to in exchange for those goods or services.

 

ASC 606 follows a five-step approach to determining revenue recognition including: 1) Identification of the contract; 2) Identification of the performance obligations; 3) Determination of the transaction price; 4) Allocation of the transaction price; and 5) Recognition of revenue.

 

The Company determined that its license agreements provide for three performance obligations which include: (i) the Grant of Use to its Patent Portfolio (“Grant of Use”), (ii) Stand-Ready Technical Support (“Technical Support”) including the transfer of trade secrets and other know-how, production of materials, scale-up support, analytical testing, etc., and (iii) access to new Intellectual Property (“IP”) that may be developed sometime during the course of the contract period (“New Improvements”). Given the nature of IP development, such New Improvements are on an unspecified basis and can occur and be made available to licensees at any time during the contract period.

 

When a contract includes more than one performance obligation, the Company needs to allocate the total consideration to each performance obligation based on its relative standalone selling price or estimate the standalone selling price if it is not observable. A standalone selling price is not available for our performance obligations since we do not sell any of the services separately and there is no competitor pricing that is available. As a consequence, the best method for determining standalone selling price of our Grant of Use performance obligation is through a comparison of the average royalty rate for comparable license agreements as compared to our license agreements. Comparable license agreements must consider several factors including: (i) the materials that are being licensed, (ii) the market application for the licensed materials, and (iii) the financial terms in the license agreements that can increase or decrease the risk/reward nature of the agreement.

 

Based on the royalty rate comparison referred to above, any pricing above and beyond the average royalty rate would relate to the Technical Support and New Improvements performance obligations. The Company focuses a significant portion of its time and resources to provide the Technical Support and New Improvements services to its licensees, which further supports the conclusions reached using the royalty rate analysis.

 

The Technical Support and New Improvements performance obligations are co-terminus over the term of the license agreement. For purposes of determining the transaction price, and recognizing revenue, the Company combined the Technical Support and New Improvements performance obligations because they have the same pattern of transfer and the same term. We maintain a staff of scientists and other professionals whose primary job responsibilities throughout the year are: (i) being available to respond to Technical Support needs of our licensees, and (ii) developing improvements to our technology which are offered to our licensees as New Improvements. Since the costs incurred to satisfy the Technical Support and New Improvements performance obligations are incurred evenly throughout the year, the value of the Technical Support and New Improvements services are recognized throughout the initial contract period as these performance obligations are satisfied. If the agreement is not terminated at the end of the initial contract period, it will renew on the same terms as the initial contract for a one-year period. Consequently, any fees or minimum annual royalty obligations relating to this renewal contract will be allocated similarly to the initial contract over the additional one-year period.

 

We recognize revenue when or as the performance obligations in the contract are satisfied. For performance obligations that are fulfilled at a point in time, revenue is recognized at the fulfillment of the performance obligation. Since the IP is determined to be a functional license, the value of the Grant of Use is recognized in the first period of the contract term in which the license agreement is in force. The value of the Technical Support and New Improvements obligations is allocated throughout the contract period based on the satisfaction of its performance obligations. If the agreement is not terminated at the end of the contract period, it will renew on the same terms as the original agreement for a one-year period. Consequently, any fees or minimum annual royalties (“MAR”) relating to this renewal contract will be allocated similarly over that additional year.

 

 

The Company’s license agreements have a variable royalty fee structure (meaning that royalties are a fixed percentage of sales that vary from period to period) and frequently include a minimum annual royalty commitment. In instances when sales of licensed products by its licensees exceed the MAR, the Company recognizes fee income as the amounts have been earned. Typically, the royalty rate for such sales is 10-15% of the selling price. While this is variable consideration, it is subject to the sales/usage royalty exception to recognition of variable consideration in ASC 606 10-55-65 and therefore is not recognized until the subsequent sales or usage occurs or the MAR period commences.

 

Because of the immediate recognition of the Grant of Use performance obligation: (i) the first period of the contract term will generally have a higher percent allocation of the transaction price under ASC 606 and (ii) the remaining periods will have less of the transaction price recognized under ASC 606. After the initial period in the contract term, the revenue for the remaining periods will be based on the satisfaction of the technical support and New Improvements obligations. Since most of our license agreements start as of January 1st, the revenue recognized for the contract under ASC 606 in our first quarter will tend to be higher subsequent quarters in the fiscal year.

 

Certain of the contract fees are accrued by, or paid to, the Company in advance of the period in which they are earned resulting in deferred revenue. Such excess amounts are recorded as deferred revenue and are recognized as revenue in future periods as earned.

 

The Company operates in a single business segment which is engaged in the development and marketing of technology and devices to control the flow of light. Our revenue source comes from the licensing of this technology and all of these license agreements have similar terms and provisions. The majority of the Company’s licensing fee income comes from the activities of several licensees participating in the automotive market. The Company currently believes that the automotive market will be the largest source of its royalty income over the next several years. The Company’s royalty income from this market may be influenced by numerous factors including various trends affecting demand in the automotive industry and the rate of introduction of new technology in OEM product lines. In addition to these macro factors, the Company’s royalty income from the automotive market could also be influenced by specific factors such as whether the Company’s SPD-SmartGlass technology appears as standard equipment or as an option on a particular vehicle, the number of additional vehicle models that SPD-SmartGlass appears on, the size of each window on a vehicle and the number of windows on a vehicle that use SPD SmartGlass, fluctuations in the total number of vehicles produced by a manufacturer, and in the percentage of cars within each model produced with SPD-SmartGlass, and changes in pricing or exchange rates.

 

As of December 31, 2022, the Company has one license agreement that are in its initial multiyear term (“Initial Term”) with continuing performance obligations going forward. The Initial Term of this agreement will end as of December 31, 2024, The Company currently expects this agreement will renew annually at the end of the Initial Term. As of December 31, 2022, the aggregate amount of the revenue to be recognized upon the satisfaction of the remaining performance obligations for this license agreements is $123,000. The revenue for the remaining performance obligations for this license agreement is expected to be recognized evenly throughout the remaining period of the Initial Term.

 

For the years ended December 31, 2022 and 2021, the Company entered into a number of license agreements covering its light control technology. The Company received minimum annual royalties under certain license agreements and recorded fee income based on ASC 606 revenue recognition each quarter. In instances when sales of licensed products by its licensees exceed minimum annual royalties, the Company recognized additional fee income as the amounts have been earned. Certain of the fees are accrued by, or paid to, the Company in advance of the period in which they are earned resulting in deferred revenue. Such excess amounts are recorded as deferred revenue and are typically recognized as fee income when earned. As of December 31, 2022 and 2021, there was no balance in deferred revenue.

 

Fee income represents amounts earned by the Company under various license and other agreements relating to technology developed by the Company. During 2022, four licensees accounted for 28%, 23%, 13% and 11% of fee income recognized during the year. During 2021, four licensees accounted for 20%, 18%, 18% and 12% of fee income recognized during the year.

 

 

(f) Basic and Diluted Loss Per Common Share

 

Basic loss per share excludes any dilution. It is based upon the weighted average number of common shares outstanding during the period. Dilutive loss per share reflects the potential dilution that would occur if securities or other contracts to issue common stock were exercised or converted into common stock. The Company’s dilutive loss per share equals basic loss per share for each of the years in the two-year period ended December 31, 2022 because all potentially dilutive securities (i.e., options and warrants) were antidilutive in those periods. The number of options and warrants that were not included because their effect is antidilutive was 4,146,951 and 2,599,701 for 2022 and 2021, respectively.

 

(g) Research and Development Costs

 

Research and development costs are charged to expense as incurred.

 

(h) Patent Costs

 

The Company expenses costs relating to the development or acquisition of patents due to the uncertainty of the recoverability of these items.

 

(i) Use of Estimates

 

The preparation of the Company’s consolidated financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during this period. Actual results could differ from those estimates.

 

(j) Income Taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to be recovered or settled.

 

In accordance with ASC Topic 740, we recognize tax benefits only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely to be realized upon ultimate settlement. Unrecognized tax benefits are tax benefits claimed in tax returns that do not meet these recognition and measurement standards. We classify accrued interest and penalties related to any unrecognized tax benefits in our income tax provision. At December 31, 2022 and 2021, we do not have accrued interest and penalties related to any unrecognized tax benefits. We do not believe we have any uncertain tax positions as of December 31, 2022 and 2021.

 

The tax years subject to examination by major tax jurisdictions include the years 2017 and forward by the U.S. Internal Revenue Service and certain states. The Company is not currently being audited by any tax jurisdiction.

 

(k) Equity-Based Compensation

 

We recognize all stock-based compensation as an expense in the consolidated financial statements and such costs are measured at the fair value of the award at the date of grant. In addition to reflecting compensation expense for new share-based payment awards, expense is also recognized to reflect the remaining vesting period of awards that had been granted in prior periods. Tax benefits related to stock option exercises are reflected as financing cash inflows.

 

The exercise prices for stock options granted are generally set at the average for the high and low trading prices of the Company’s common stock on the trading date immediately prior to the date of grant, and the related numbers of shares granted are fixed at the date of grant.

 

 

In order to determine the fair value of stock options on the date of grant, the Company uses the Black-Scholes option-pricing model. Inherent in this model are assumptions related to expected stock-price volatility, option term, risk-free interest rate and dividend yield. While the risk-free interest rate and dividend yield are less subjective assumptions that are based on factual data derived from public sources, the expected stock-price volatility and option term assumptions require a greater level of judgment.

 

In connection with employee and director stock options, the Company charged to compensation expense $232,291 and $217,008 during the years ended December 31, 2022 and 2021, respectively. As of December 31, 2022, these awards were fully vested. In lieu of higher cash compensation, the Company has granted warrants and non-employee options to consultants. These warrants and non-employee options vested fully on the date of grant. There were no such charges for the year ended December 31, 2022 and 2021.

 

(l) Restricted Stock

 

Compensation cost for restricted stock is measured using the quoted market price of the Company’s common stock at the date the common stock is granted. The compensation cost is recognized over the period between the issue date and the vesting period for such shares. Restricted stock is included in total common shares outstanding upon the lapse of any vesting conditions.

 

(m) Impairment of Long-Lived Assets

 

The Company reviews long-lived assets to determine whether an event or change in circumstances indicates the carrying value of the asset may not be recoverable. The Company bases its evaluation on such impairment indicators as the nature of the assets, the future economic benefit of the assets and any historical or future profitability measurements, as well as other external market conditions or factors that may be present. There was no impairment of long-lived assets recorded during 2022 and 2021.

 

(n) Fair Value Measurements

 

As of December 31, 2022 and 2021, the fair value of the Company’s financial assets and non-warrant liabilities including cash and cash equivalents, marketable securities, royalties receivable, accounts payable and accrued expenses approximated carrying value due to the short-term maturity of these instruments.

 

(o) Recent Accounting Pronouncements

 

New Accounting Standards

 

The Company believes that no new accounting standards that are not yet effective will have a material effect on the Company’s consolidated financial statements.

 

 
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.22.4
Fixed Assets
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
Fixed Assets

(3) Fixed Assets

 

Fixed assets and their estimated useful lives as of December 31, 2022 and 2021 are as follows:

 

   2022   2021   Estimated useful life
            
Equipment and furniture  $1,392,365   $1,391,094   5 years
Trade show materials   775,654    775,654   5 years
Autos   53,764    53,764   5 years
             Life of lease or estimated
Leasehold improvements   584,967    584,967   life of asset if shorter
    2,806,750    2,805,479    
              
Less accumulated depreciation             
and amortization   (2,741,362)   (2,712,525)   
   $65,388   $92,954    

 
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.22.4
Accrued Expenses and Other
 12 Months Ended
Dec. 31, 2022
Payables and Accruals [Abstract]  
Accrued Expenses and Other

(4) Accrued Expenses and Other

 

Accrued expenses consist of the following at December 31, 2022 and 2021:

 

   2022   2021 
Payroll, bonuses and related benefits  $29,219   $45,725 
Professional services   4,800    3,300 
Other   360    360 
Accrued expenses  $34,379   $49,385 

 
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Income Taxes

(5) Income Taxes

 

Since inception, the Company has incurred losses from operations and as a result has not recorded income tax expense. Benefits related to net operating loss carryforwards and deferred items have been fully reserved because it is not more likely than not that the Company will achieve profitable operations. The difference between the total income taxes at the federal statutory rate for each of the years ended December 31, 2022 and 2021 and the fact that no income tax benefit was recorded in each of these years is attributable to the change in the valuation allowance recorded in each year.

 

 

The Tax Cuts and Jobs Act of 2017 (“TCIA”) amended IRC Section 174 to require capitalization of all research and development (“R&D”) costs incurred in tax years beginning after December 31, 2021. These costs are required to be amortized over five years if the R&D activities are performed in the U.S., or over 15 years if the activities were performed outside the U.S. For tax reporting purposes, the Company capitalized $609,000 of R&D expenses incurred as of December 31, 2022.

 

On August 16, 2022, the Inflation Reduction Act (“IRA”) was signed into law in the United States. Among other provisions, the IRA includes a 15% corporate minimum tax rate which applies to certain large corporations and a 1% excise tax on corporate stock repurchases made after December 31, 2022. We do not expect the IRA to have a material impact on our consolidated financial statements.

 

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets at December 31, 2022 and 2021 are presented below:

 

   2022   2021 
Deferred tax assets:          
Depreciation  $109,000   $106,000 
Allowance for bad debts   248,000    218,000 
Net operating loss carry-forwards   13,561,000    14,114,000 
Stock option expense   334,000    355,000 
Research and other credits   891,000    945,000 
Lease liability   99,000    138,000 
Amortization   130,000    - 
Total gross deferred tax assets   15,372,000    15,876,000 
           
Deferred tax liabilities:          
Lease liability   69,000    101,000 
Other temporary differences   -    22,000 
Total gross deferred tax liabilities   69,000    123,000 
           
Valuation allowance   (15,303,000)   (15,753,000)
Net deferred tax  $-   $- 

 

The reconciliation of the income tax expense (benefit) computed at the federal statutory tax rates to income tax expense (benefit) is as follows:

 

   2022   2021 
         
Income tax provision at federal statutory rate  $(561,000)  $(388,000)
Expired carryforwards and other   1,011,000    1,079,000 
Valuation allowance   (450,000)   (691,000)
Total income tax provision  $-   $- 

 

In assessing the realizability of deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon future taxable income during the period in which those temporary differences become deductible. The Company considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Based upon its historical operating losses, utilization of deferred tax assets cannot currently be determined. Accordingly, the Company has recorded a full valuation allowance against the deferred tax assets due to the uncertainty regarding the future utilization of the deferred tax assets for all periods presented.

 

At December 31, 2022, the Company had net operating loss carryforwards for federal income tax purposes of approximately $63,370,000. Net operating loss carryforwards accumulated through December 31, 2017 of approximately $52,927,000 will expire in varying amounts from 2023 through 2037. Net operating losses generated since 2018, totaling approximately $10,443,000, will carry forward indefinitely, but cannot offset more than 80 percent of taxable income. Research and other credit carryforwards of approximately $891,000 are available to the Company to reduce income taxes payable in future years principally through 2040. The Company’s ability to utilize its net operating loss carryforwards and its current year tax credits in future periods could be subject to the 382 limitation. The Company will need to complete an analysis to determine whether its net operating losses are subject to the 382 limitation.

 

 
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.22.4
Shareholders’ Equity
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Shareholders’ Equity

(6) Shareholders’ Equity

 

(a) Common Stock and Warrants

 

During 2021, the Company received proceeds of $86,262 and issued 74,610 shares of common stock in connection with the exercise of outstanding options and warrants. In addition, during February 2023, the Company received proceeds of $484,503 and issued 358,891common shares in connection with the exercise of outstanding warrants.

 

On September 16, 2022, the Company entered into subscription agreements from a group of private accredited investors to sell them 2.0 million shares of common stock of the Company at a price of $2.30 per share (which represents the closing market price of the Company’s common stock on September 14, 2022 which was the date that the transaction was agreed to). As of December 31, 2022, the Company received $3,450,000 under these subscription agreements and has issued 1,500,000 common shares and issued 1,500,000 warrants. In addition, the Company expects to receive the remaining $1,150,000 under these subscription agreements in March, 2023. The shares were issued to the investors in a private placement and, along with the shares issued in connection with the exercise of any warrants in the future, are not registered and therefore currently subject to at least a six-month holding period by the investor.

 

(b) Options and Warrants

 

(i) Employee Options

 

In 2019, the shareholders approved the Company’s 2019 Equity Incentive Plan, which provides for the granting of both incentive stock options at the fair market value at the date of grant and nonqualified stock options at the fair market value at the date of grant to employees or non-employees who, in the determination of the Board of Directors, have made or may make significant contributions to the Company in the future. The Company may also award stock appreciation rights, restricted stock, or restricted stock units under this plan. The Company initially reserved 1,400,000 shares of its common stock for issuance under this plan, and 307,500 options and other awards were available for issuance under this plan as of December 31, 2022.

 

At the discretion of the Board of Directors, options expire in ten years or less from the date of grant and are generally fully exercisable upon grant but in some cases may be subject to vesting in the future. Full payment of the exercise price may be made in cash or in shares of common stock valued at the fair market value thereof on the date of exercise, or by agreeing with the Company to cancel a portion of the exercised options.

 

The Company granted 178,000 fully vested options during 2022 and recorded share-based compensation of $232,291. The Company granted 198,000 fully vested options during 2021 and recorded share-based compensation of $217,008. The Company valued these grants using the Black-Scholes option pricing model with the following weighted average assumptions:

 

   2022   2021 
         
Fair value on grant date  $1.31   $1.10 
Expected dividend yield   -    - 
Expected volatility   81%   79%
Risk free interest rate   3.99%   1.26%
Expected term of the option   5 years    5 years 

 

 

 

Activity for stock options is summarized below:

 

   Number of Shares Subject to Option   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term (Years)   Aggregate Intrinsic Value 
                 
Balance at January 1, 2021   1,297,260   $4.09    5.8   $142,885 
                     
Granted   198,000   $1.72           
Cancelled   (155,050)  $5.38           
Exercised   (140,500)  $2.48           
Balance at December 31, 2021   1,199,710   $3.67    5.7   $21,870 
                     
Granted   178,000   $1.95           
Cancelled   (130,750)  $4.91           
Exercised   -   $-           
Balance at December 31, 2022   1,246,960   $3.35    5.8   $67,510 

 

All options are exercisable at December 31, 2022.

 

(ii) Warrants and Non-Employee Options

 

Activity in warrants is summarized below:

 

   Number of Shares Underlying Warrants Granted   Weighted Average Exercise Price 
       
         
Balance at January 1, 2021   1,399,991   $2.27 
           
Exercised   -      
Terminated   -      
Issued   -      
Balance at December 31, 2021   1,399,991   $2.27 
           
Exercised   -      
Terminated   -      
Issued   1,500,000    2.76 
Balance at December 31, 2022   2,899,991   $2.52 

 

In lieu of cash compensation, the Company has granted warrants to investors and non-employee options to consultants. These warrants and non-employee options vested ratably over various terms ranging from 12 to 59 months. The non-employee options are valued at fair value at the time that the related services are provided using the Black-Scholes option valuation model and marked to market quarterly using the Black-Scholes option valuation model. There are 2,899,991 warrants issued to investors that are outstanding that are accounted for as equity.

 

Warrants and non-employee options generally expire in five years from the date of issuance. At December 31, 2022, all warrants and non-employee options outstanding were exercisable.

 

 

(c) Restricted Stock Grants

 

During 2022 and 2021, the Company did not issue restricted stock to its directors and employees.

 
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.22.4
License and Other Agreements
 12 Months Ended
Dec. 31, 2022
License And Other Agreements  
License and Other Agreements

(7) License and Other Agreements

 

The Company has entered into a number of license agreements covering various products using the Company’s SPD technology. Some of these license agreements are limited to specific countries and/or markets. Licensees of Research Frontiers who incorporate SPD technology into end products pay Research Frontiers an earned royalty of 5-15% of net sales of licensed products under license agreements currently in effect and may also be required to pay Research Frontiers fees and minimum annual royalties. Licensees who sell products or components to other licensees of Research Frontiers do not pay a royalty on such sale; Research Frontiers will collect such royalty from the licensee incorporating such products or components into its own end-products. Research Frontiers’ license agreements typically allow the licensee to terminate the license after some period of time and give Research Frontiers only limited rights to terminate before the license expires. Most licenses are non-exclusive and generally last as long as our patents remain in effect.

 

On March 14, 2019, the Company suspended its VariGuard SmartGlass business unit activities. Instead, the Company licensed a new entity to pursue the business opportunities previously pursued by the Company’s VariGuard SmartGlass business unit. This new licensee continues to use the VariGuard SmartGlass name. In addition to other employees at VariGuard SmartGlass Inc., one of the Company’s officers (Michael R. LaPointe) and one former officer (Seth L. Van Voorhees) are shareholders of VariGuard SmartGlass Inc. and, as consequence, this transaction is a related party relationship which has been reviewed and approved by the Company’s Board of Directors pursuant to the requirements of Delaware corporate law and the Company’s Code of Ethics. Mr. LaPointe also remains a full-time employee at the Company. In October 2021, the Company entered into an amendment to the license agreement with VariGuard modifying its scope and terms.

 
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.22.4
Commitments
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments

(8) Commitments

 

The Company has an employment agreement with its chief executive officer which provides for an annual base salary of $500,000 for calendar year 2023. This employment agreement has an evergreen provision that extends the term by one year on the expiration date unless either the Company or the employee has given notice that they will not be renewing the agreement upon the expiration of its term.

 

The Company has a defined contribution profit sharing (401k) plan covering employees who have completed one year of service. Contributions are made at the discretion of the Company. The Company did not make any contributions to this plan for 2022 or 2021.

 

The Company determines if an arrangement is a lease at its inception. This determination generally depends on whether the arrangement conveys the right to control the use of an identified fixed asset explicitly or implicitly for a period of time in exchange for consideration. Control of an underlying asset is conveyed if the Company obtains the rights to direct the use of, and to obtain substantially all of the economic benefits from the use of, the underlying asset. Lease expense for variable leases and short-term leases is recognized when the obligation is incurred.

 

The Company has operating leases for certain facilities, vehicles and equipment with a weighted average remaining lease term of 2.2 years as of December 31, 2022. Operating leases are included in right of use lease assets, other current liabilities and long-term lease liabilities on the consolidated balance sheet. Right of use lease assets and liabilities are recognized at each lease’s commencement date based on the present value of its lease payments over its respective lease term. The Company does not have an established incremental borrowing rate as it does not have any debt. The Company uses the stated borrowing rate for a lease when readily determinable. When the interest rate implicit in its lease agreements is not readily determinable, the Company uses an interest rate based on the marketplace for public debt. The weighted average discount rate associated with operating leases as of December 31, 2022 is 5.5%.

 

 

Maturities of operating lease liabilities as of December 31, 2022 were as follows:

 

    December 31, 2022
Year 1   $                      217,000  
Years 2-3     278,000  
Years 4-5     -  
Thereafter     -  
Total lease payments     495,000  
Less: imputed lease interest     (30,872)  
Present value of lease liabilities   $ 464,128  

 
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.22.4
Rights Plan
 12 Months Ended
Dec. 31, 2022
Rights Plan  
Rights Plan

(9) Rights Plan

 

In February 2013, the Company’s Board of Directors adopted a Stockholders’ Rights Plan (the “Rights Plan”) and declared a dividend distribution of one right (a “Right”) for each outstanding share of Company common stock to stockholders of record at the close of business on March 3, 2003 (“Record Time”) and authorized the issuance of one Right in respect of each share of Common Stock issued after the Record Time and prior to the Separation Time. The Rights Plan was readopted and extended in December 2022 until February 11, 2033.

 

“Separation Time” shall mean the earlier of the Close of Business on the tenth Business Day (or such later date as the Board of Directors may from time to time fix by resolution adopted prior to the Separation Time that otherwise would have occurred) following but not including (i) the date on which any Person commences a tender or exchange offer that, if consummated, would result in such Person’s becoming an Acquiring Person, and (ii) the date of the first event causing a Flip-in Date to occur; provided that if any tender or exchange offer referred to in clause (i) of this paragraph is cancelled, terminated or otherwise withdrawn prior to the Separation Time without the purchase of any shares of Common Stock pursuant thereto, such offer shall be deemed, for purposes of this paragraph, never to have been made.

 

Subject to certain exceptions listed in the Rights Plan, if a person or group has acquired beneficial ownership of, or commences a tender or exchange offer for, 15% or more of the Company’s common stock, unless redeemed by the Company’s Board of Directors, each Right entitles the holder (other than the acquiring person) to purchase from the Company $80 worth of common stock for $40. If the Company is merged into, or 50% or more of its assets or earning power is sold to, the acquiring company, the Rights will also enable the holder (other than the acquiring person) to purchase $80 worth of common stock of the acquiring company for $40. During 2022, the Company extended to expiration of The Rights to the close of business on February 11, 2033, unless the Rights Plan is extended by the Company’s Board of Directors or unless the Rights are earlier redeemed by the Company at a price of $0.0001 per Right. The Rights are not exercisable during the time when they are redeemable by the Company.

 

The above description highlights some of the features of the Company’s Rights Plan and is not a complete description of the Rights Plan. A more detailed description and copy of the Rights Plan has been filed with the SEC and is available from the Company upon request.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Cash and Cash Equivalents

(a) Cash and Cash Equivalents

 

The Company considers securities purchased with original maturities of three months or less to be cash equivalents. Cash equivalents consist of short-term investments in money market accounts at December 31, 2022 and 2021.

 

Cash and cash equivalents are maintained at financial institutions and, at times, balances may exceed federally insured limits. We have never experienced any losses related to these balances. FDIC insurance coverage is $250,000 per depositor at each financial institution, and our non-interest bearing cash balances may again exceed federally insured limits. Amounts on deposit in excess of federally insured limits at December 31, 2022 and 2021 are approximately $2.7 million and $0, respectively.

 
Marketable Securities

(b) Marketable Securities

 

The Company classifies investments in marketable securities as trading, available-for-sale or held-to-maturity at the time of purchase and periodically re-evaluates such classification. Trading securities are carried at fair value, with unrealized holding gains and losses included in earnings. Held-to-maturity securities are recorded at cost and are adjusted for the amortization or accretion of premiums or discounts over the life of the related security. Unrealized holding gains and losses of available-for-sale securities are excluded from earnings and are reported as a separate component of accumulated other comprehensive income (loss) until realized. In determining realized gains and losses, the cost of the securities sold is based on the specific identification method. Interest and dividends on the investments are accrued at the balance sheet date.

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date. Fair value measurements are broken down into three levels based on the reliability of inputs as follows: Level 1 inputs are quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. An active market for the asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates and yield curves observable at commonly quoted intervals or current market) and contractual prices for the underlying financial instrument, as well as other relevant economic measures. Level 3 inputs are unobservable inputs for the asset or liability. Unobservable inputs are used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.

 

At December 31, 2022, the Company invested only in investments qualified as cash and cash equivalents. During the year ended December 31, 2022, the Company incurred a realized loss on the sale of marketable securities of $60,143. At December 31, 2021 all investments are Level 1 and were classified as trading and consisted of the following:

 

      December 31, 2021 
      Value of trading 
   Investment  Investments 
        
Mutual Funds  Putnam Short Duration Bond   $1,972,736 
   Putnam Ultra Short Duration Income    782,375 
         
      $2,755,111 
         
   Unrealized loss   $28,522 

 
Royalties Receivable

(c) Royalties Receivable

 

Royalties receivable from licensees are recorded at the amounts specified within the license agreements when the collectability of the receivable is reasonably assured. The allowance for doubtful accounts is the Company’s best estimate of the amount of probable credit losses in the Company’s existing royalties receivable. The Company determines the allowance based on historical write-off experience as well as the current status of the Company’s customers. The Company reviews its allowance for doubtful accounts periodically. Past due accounts are reviewed individually for collectability. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. As of December 31, 2022, one company accounted for 14% of the Company’s outstanding receivables. As of December 31, 2021, two companies accounted for 14% and 11% of the Company’s outstanding receivables.

 
Fixed Assets

(d) Fixed Assets

 

Fixed assets are carried at cost less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the assets.

 

 
Revenue Recognition/Fee Income

(e) Revenue Recognition/Fee Income

 

The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers (“ASC 606”). The standard provides a single comprehensive revenue recognition model for all contracts with customers and supersedes existing revenue recognition guidance. The revenue standard contains principles that an entity will apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to customers at an amount that the entity expects to be entitled to in exchange for those goods or services.

 

ASC 606 follows a five-step approach to determining revenue recognition including: 1) Identification of the contract; 2) Identification of the performance obligations; 3) Determination of the transaction price; 4) Allocation of the transaction price; and 5) Recognition of revenue.

 

The Company determined that its license agreements provide for three performance obligations which include: (i) the Grant of Use to its Patent Portfolio (“Grant of Use”), (ii) Stand-Ready Technical Support (“Technical Support”) including the transfer of trade secrets and other know-how, production of materials, scale-up support, analytical testing, etc., and (iii) access to new Intellectual Property (“IP”) that may be developed sometime during the course of the contract period (“New Improvements”). Given the nature of IP development, such New Improvements are on an unspecified basis and can occur and be made available to licensees at any time during the contract period.

 

When a contract includes more than one performance obligation, the Company needs to allocate the total consideration to each performance obligation based on its relative standalone selling price or estimate the standalone selling price if it is not observable. A standalone selling price is not available for our performance obligations since we do not sell any of the services separately and there is no competitor pricing that is available. As a consequence, the best method for determining standalone selling price of our Grant of Use performance obligation is through a comparison of the average royalty rate for comparable license agreements as compared to our license agreements. Comparable license agreements must consider several factors including: (i) the materials that are being licensed, (ii) the market application for the licensed materials, and (iii) the financial terms in the license agreements that can increase or decrease the risk/reward nature of the agreement.

 

Based on the royalty rate comparison referred to above, any pricing above and beyond the average royalty rate would relate to the Technical Support and New Improvements performance obligations. The Company focuses a significant portion of its time and resources to provide the Technical Support and New Improvements services to its licensees, which further supports the conclusions reached using the royalty rate analysis.

 

The Technical Support and New Improvements performance obligations are co-terminus over the term of the license agreement. For purposes of determining the transaction price, and recognizing revenue, the Company combined the Technical Support and New Improvements performance obligations because they have the same pattern of transfer and the same term. We maintain a staff of scientists and other professionals whose primary job responsibilities throughout the year are: (i) being available to respond to Technical Support needs of our licensees, and (ii) developing improvements to our technology which are offered to our licensees as New Improvements. Since the costs incurred to satisfy the Technical Support and New Improvements performance obligations are incurred evenly throughout the year, the value of the Technical Support and New Improvements services are recognized throughout the initial contract period as these performance obligations are satisfied. If the agreement is not terminated at the end of the initial contract period, it will renew on the same terms as the initial contract for a one-year period. Consequently, any fees or minimum annual royalty obligations relating to this renewal contract will be allocated similarly to the initial contract over the additional one-year period.

 

We recognize revenue when or as the performance obligations in the contract are satisfied. For performance obligations that are fulfilled at a point in time, revenue is recognized at the fulfillment of the performance obligation. Since the IP is determined to be a functional license, the value of the Grant of Use is recognized in the first period of the contract term in which the license agreement is in force. The value of the Technical Support and New Improvements obligations is allocated throughout the contract period based on the satisfaction of its performance obligations. If the agreement is not terminated at the end of the contract period, it will renew on the same terms as the original agreement for a one-year period. Consequently, any fees or minimum annual royalties (“MAR”) relating to this renewal contract will be allocated similarly over that additional year.

 

 

The Company’s license agreements have a variable royalty fee structure (meaning that royalties are a fixed percentage of sales that vary from period to period) and frequently include a minimum annual royalty commitment. In instances when sales of licensed products by its licensees exceed the MAR, the Company recognizes fee income as the amounts have been earned. Typically, the royalty rate for such sales is 10-15% of the selling price. While this is variable consideration, it is subject to the sales/usage royalty exception to recognition of variable consideration in ASC 606 10-55-65 and therefore is not recognized until the subsequent sales or usage occurs or the MAR period commences.

 

Because of the immediate recognition of the Grant of Use performance obligation: (i) the first period of the contract term will generally have a higher percent allocation of the transaction price under ASC 606 and (ii) the remaining periods will have less of the transaction price recognized under ASC 606. After the initial period in the contract term, the revenue for the remaining periods will be based on the satisfaction of the technical support and New Improvements obligations. Since most of our license agreements start as of January 1st, the revenue recognized for the contract under ASC 606 in our first quarter will tend to be higher subsequent quarters in the fiscal year.

 

Certain of the contract fees are accrued by, or paid to, the Company in advance of the period in which they are earned resulting in deferred revenue. Such excess amounts are recorded as deferred revenue and are recognized as revenue in future periods as earned.

 

The Company operates in a single business segment which is engaged in the development and marketing of technology and devices to control the flow of light. Our revenue source comes from the licensing of this technology and all of these license agreements have similar terms and provisions. The majority of the Company’s licensing fee income comes from the activities of several licensees participating in the automotive market. The Company currently believes that the automotive market will be the largest source of its royalty income over the next several years. The Company’s royalty income from this market may be influenced by numerous factors including various trends affecting demand in the automotive industry and the rate of introduction of new technology in OEM product lines. In addition to these macro factors, the Company’s royalty income from the automotive market could also be influenced by specific factors such as whether the Company’s SPD-SmartGlass technology appears as standard equipment or as an option on a particular vehicle, the number of additional vehicle models that SPD-SmartGlass appears on, the size of each window on a vehicle and the number of windows on a vehicle that use SPD SmartGlass, fluctuations in the total number of vehicles produced by a manufacturer, and in the percentage of cars within each model produced with SPD-SmartGlass, and changes in pricing or exchange rates.

 

As of December 31, 2022, the Company has one license agreement that are in its initial multiyear term (“Initial Term”) with continuing performance obligations going forward. The Initial Term of this agreement will end as of December 31, 2024, The Company currently expects this agreement will renew annually at the end of the Initial Term. As of December 31, 2022, the aggregate amount of the revenue to be recognized upon the satisfaction of the remaining performance obligations for this license agreements is $123,000. The revenue for the remaining performance obligations for this license agreement is expected to be recognized evenly throughout the remaining period of the Initial Term.

 

For the years ended December 31, 2022 and 2021, the Company entered into a number of license agreements covering its light control technology. The Company received minimum annual royalties under certain license agreements and recorded fee income based on ASC 606 revenue recognition each quarter. In instances when sales of licensed products by its licensees exceed minimum annual royalties, the Company recognized additional fee income as the amounts have been earned. Certain of the fees are accrued by, or paid to, the Company in advance of the period in which they are earned resulting in deferred revenue. Such excess amounts are recorded as deferred revenue and are typically recognized as fee income when earned. As of December 31, 2022 and 2021, there was no balance in deferred revenue.

 

Fee income represents amounts earned by the Company under various license and other agreements relating to technology developed by the Company. During 2022, four licensees accounted for 28%, 23%, 13% and 11% of fee income recognized during the year. During 2021, four licensees accounted for 20%, 18%, 18% and 12% of fee income recognized during the year.

 

 
Basic and Diluted Loss Per Common Share

(f) Basic and Diluted Loss Per Common Share

 

Basic loss per share excludes any dilution. It is based upon the weighted average number of common shares outstanding during the period. Dilutive loss per share reflects the potential dilution that would occur if securities or other contracts to issue common stock were exercised or converted into common stock. The Company’s dilutive loss per share equals basic loss per share for each of the years in the two-year period ended December 31, 2022 because all potentially dilutive securities (i.e., options and warrants) were antidilutive in those periods. The number of options and warrants that were not included because their effect is antidilutive was 4,146,951 and 2,599,701 for 2022 and 2021, respectively.

 
Research and Development Costs

(g) Research and Development Costs

 

Research and development costs are charged to expense as incurred.

 
Patent Costs

(h) Patent Costs

 

The Company expenses costs relating to the development or acquisition of patents due to the uncertainty of the recoverability of these items.

 
Use of Estimates

(i) Use of Estimates

 

The preparation of the Company’s consolidated financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during this period. Actual results could differ from those estimates.

 
Income Taxes

(j) Income Taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to be recovered or settled.

 

In accordance with ASC Topic 740, we recognize tax benefits only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely to be realized upon ultimate settlement. Unrecognized tax benefits are tax benefits claimed in tax returns that do not meet these recognition and measurement standards. We classify accrued interest and penalties related to any unrecognized tax benefits in our income tax provision. At December 31, 2022 and 2021, we do not have accrued interest and penalties related to any unrecognized tax benefits. We do not believe we have any uncertain tax positions as of December 31, 2022 and 2021.

 

The tax years subject to examination by major tax jurisdictions include the years 2017 and forward by the U.S. Internal Revenue Service and certain states. The Company is not currently being audited by any tax jurisdiction.

 
Equity-Based Compensation

(k) Equity-Based Compensation

 

We recognize all stock-based compensation as an expense in the consolidated financial statements and such costs are measured at the fair value of the award at the date of grant. In addition to reflecting compensation expense for new share-based payment awards, expense is also recognized to reflect the remaining vesting period of awards that had been granted in prior periods. Tax benefits related to stock option exercises are reflected as financing cash inflows.

 

The exercise prices for stock options granted are generally set at the average for the high and low trading prices of the Company’s common stock on the trading date immediately prior to the date of grant, and the related numbers of shares granted are fixed at the date of grant.

 

 

In order to determine the fair value of stock options on the date of grant, the Company uses the Black-Scholes option-pricing model. Inherent in this model are assumptions related to expected stock-price volatility, option term, risk-free interest rate and dividend yield. While the risk-free interest rate and dividend yield are less subjective assumptions that are based on factual data derived from public sources, the expected stock-price volatility and option term assumptions require a greater level of judgment.

 

In connection with employee and director stock options, the Company charged to compensation expense $232,291 and $217,008 during the years ended December 31, 2022 and 2021, respectively. As of December 31, 2022, these awards were fully vested. In lieu of higher cash compensation, the Company has granted warrants and non-employee options to consultants. These warrants and non-employee options vested fully on the date of grant. There were no such charges for the year ended December 31, 2022 and 2021.

 
Restricted Stock

(l) Restricted Stock

 

Compensation cost for restricted stock is measured using the quoted market price of the Company’s common stock at the date the common stock is granted. The compensation cost is recognized over the period between the issue date and the vesting period for such shares. Restricted stock is included in total common shares outstanding upon the lapse of any vesting conditions.

 
Impairment of Long-Lived Assets

(m) Impairment of Long-Lived Assets

 

The Company reviews long-lived assets to determine whether an event or change in circumstances indicates the carrying value of the asset may not be recoverable. The Company bases its evaluation on such impairment indicators as the nature of the assets, the future economic benefit of the assets and any historical or future profitability measurements, as well as other external market conditions or factors that may be present. There was no impairment of long-lived assets recorded during 2022 and 2021.

 
Fair Value Measurements

(n) Fair Value Measurements

 

As of December 31, 2022 and 2021, the fair value of the Company’s financial assets and non-warrant liabilities including cash and cash equivalents, marketable securities, royalties receivable, accounts payable and accrued expenses approximated carrying value due to the short-term maturity of these instruments.

 
Recent Accounting Pronouncements

(o) Recent Accounting Pronouncements

 

New Accounting Standards

 

The Company believes that no new accounting standards that are not yet effective will have a material effect on the Company’s consolidated financial statements.
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Schedule of Unrealized Loss on Investments

      December 31, 2021 
      Value of trading 
   Investment  Investments 
        
Mutual Funds  Putnam Short Duration Bond   $1,972,736 
   Putnam Ultra Short Duration Income    782,375 
         
      $2,755,111 
         
   Unrealized loss   $28,522 
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.22.4
Fixed Assets (Tables)
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
Schedule of Fixed Assets

Fixed assets and their estimated useful lives as of December 31, 2022 and 2021 are as follows:

 

   2022   2021   Estimated useful life
            
Equipment and furniture  $1,392,365   $1,391,094   5 years
Trade show materials   775,654    775,654   5 years
Autos   53,764    53,764   5 years
             Life of lease or estimated
Leasehold improvements   584,967    584,967   life of asset if shorter
    2,806,750    2,805,479    
              
Less accumulated depreciation             
and amortization   (2,741,362)   (2,712,525)   
   $65,388   $92,954    
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.22.4
Accrued Expenses and Other (Tables)
 12 Months Ended
Dec. 31, 2022
Payables and Accruals [Abstract]  
Schedule of Accrued Expenses and Other

Accrued expenses consist of the following at December 31, 2022 and 2021:

 

   2022   2021 
Payroll, bonuses and related benefits  $29,219   $45,725 
Professional services   4,800    3,300 
Other   360    360 
Accrued expenses  $34,379   $49,385 
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Deferred Tax Assets

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets at December 31, 2022 and 2021 are presented below:

 

   2022   2021 
Deferred tax assets:          
Depreciation  $109,000   $106,000 
Allowance for bad debts   248,000    218,000 
Net operating loss carry-forwards   13,561,000    14,114,000 
Stock option expense   334,000    355,000 
Research and other credits   891,000    945,000 
Lease liability   99,000    138,000 
Amortization   130,000    - 
Total gross deferred tax assets   15,372,000    15,876,000 
           
Deferred tax liabilities:          
Lease liability   69,000    101,000 
Other temporary differences   -    22,000 
Total gross deferred tax liabilities   69,000    123,000 
           
Valuation allowance   (15,303,000)   (15,753,000)
Net deferred tax  $-   $- 
Schedule of Reconciliation Income Tax Expenses Benefit

The reconciliation of the income tax expense (benefit) computed at the federal statutory tax rates to income tax expense (benefit) is as follows:

 

   2022   2021 
         
Income tax provision at federal statutory rate  $(561,000)  $(388,000)
Expired carryforwards and other   1,011,000    1,079,000 
Valuation allowance   (450,000)   (691,000)
Total income tax provision  $-   $- 
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.22.4
Shareholders’ Equity (Tables)
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Schedule of Assumptions Used to Value Options Granted to Employees

 

   2022   2021 
         
Fair value on grant date  $1.31   $1.10 
Expected dividend yield   -    - 
Expected volatility   81%   79%
Risk free interest rate   3.99%   1.26%
Expected term of the option   5 years    5 years 
Schedule of Option Activity

Activity for stock options is summarized below:

 

   Number of Shares Subject to Option   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term (Years)   Aggregate Intrinsic Value 
                 
Balance at January 1, 2021   1,297,260   $4.09    5.8   $142,885 
                     
Granted   198,000   $1.72           
Cancelled   (155,050)  $5.38           
Exercised   (140,500)  $2.48           
Balance at December 31, 2021   1,199,710   $3.67    5.7   $21,870 
                     
Granted   178,000   $1.95           
Cancelled   (130,750)  $4.91           
Exercised   -   $-           
Balance at December 31, 2022   1,246,960   $3.35    5.8   $67,510 
Schedule of Warrant Activity

Activity in warrants is summarized below:

 

   Number of Shares Underlying Warrants Granted   Weighted Average Exercise Price 
       
         
Balance at January 1, 2021   1,399,991   $2.27 
           
Exercised   -      
Terminated   -      
Issued   -      
Balance at December 31, 2021   1,399,991   $2.27 
           
Exercised   -      
Terminated   -      
Issued   1,500,000    2.76 
Balance at December 31, 2022   2,899,991   $2.52 
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.22.4
Commitments (Tables)
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Minimum Annual Future Rental Commitments

Maturities of operating lease liabilities as of December 31, 2022 were as follows:

 

    December 31, 2022
Year 1   $                      217,000  
Years 2-3     278,000  
Years 4-5     -  
Thereafter     -  
Total lease payments     495,000  
Less: imputed lease interest     (30,872)  
Present value of lease liabilities   $ 464,128  
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.22.4
Business and Basis for Presentation (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Working capital $ 4,600,000    
Cash and cash equivalents 4,230,916 $ 269,964  
Shareholders' equity 4,796,865 3,783,923 $ 5,327,005
Accumulated deficit 122,356,477 $ 119,687,128  
Non-recurring cash expenses $ 200,000    
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule of Unrealized Loss on Investments (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]    
Marketable securities $ 2,755,111
Unrealized loss (28,522)
Fair Value, Inputs, Level 1 [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Marketable securities   2,755,111
Unrealized loss   28,522
Fair Value, Inputs, Level 1 [Member] | Putnam Short Duration Bond [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Marketable securities   1,972,736
Fair Value, Inputs, Level 1 [Member] | Putnam Ultra Short Duration Income [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Marketable securities   $ 782,375
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Product Information [Line Items]    
FDIC insurance coverage $ 250,000  
Amounts on deposit in excess of federally insured limits 2,700,000 $ 0
Realized loss on sale of marketable securities 60,143
Remaining performance obligations $ 539,686 1,263,034
Recognized benefit measured greater than 50 percent  
Share based compensation $ 232,291 217,008
Impairment of long-lived assets 0 0
Employees and Directors [Member]    
Product Information [Line Items]    
Share based compensation $ 232,291 $ 217,008
Options and Warrants [Member]    
Product Information [Line Items]    
Antidilutive securities 4,146,951 2,599,701
License Agreement [Member]    
Product Information [Line Items]    
Remaining performance obligations $ 123,000  
Revenue Benchmark [Member] | License Agreement [Member] | Minimum [Member]    
Product Information [Line Items]    
Royalty rate on selling price 10.00%  
Revenue Benchmark [Member] | License Agreement [Member] | Maximum [Member]    
Product Information [Line Items]    
Royalty rate on selling price 15.00%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Licensee One [Member]    
Product Information [Line Items]    
Concentration risk, percentage 28.00% 20.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | License Two [Member]    
Product Information [Line Items]    
Concentration risk, percentage 23.00% 18.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | License Three [Member]    
Product Information [Line Items]    
Concentration risk, percentage 13.00% 18.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | License Four [Member]    
Product Information [Line Items]    
Concentration risk, percentage 11.00% 12.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Company One [Member]    
Product Information [Line Items]    
Concentration risk, percentage 14.00% 14.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Company Two [Member]    
Product Information [Line Items]    
Concentration risk, percentage   11.00%
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule of Fixed Assets (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Fixed assets, gross $ 2,806,750 $ 2,805,479
Less accumulated depreciation and amortization (2,741,362) (2,712,525)
Fixed assets, net 65,388 92,954
Equipment and Furniture [Member]    
Property, Plant and Equipment [Line Items]    
Fixed assets, gross $ 1,392,365 1,391,094
Estimated useful life 5 years  
Trade Show Materials [Member]    
Property, Plant and Equipment [Line Items]    
Fixed assets, gross $ 775,654 775,654
Estimated useful life 5 years  
Autos [Member]    
Property, Plant and Equipment [Line Items]    
Fixed assets, gross $ 53,764 53,764
Estimated useful life 5 years  
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Fixed assets, gross $ 584,967 $ 584,967
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule of Accrued Expenses and Other (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Payables and Accruals [Abstract]    
Payroll, bonuses and related benefits $ 29,219 $ 45,725
Professional services 4,800 3,300
Other 360 360
Accrued expenses $ 34,379 $ 49,385
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule of Deferred Tax Assets (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Depreciation $ 109,000 $ 106,000
Allowance for bad debts 248,000 218,000
Net operating loss carry-forwards 13,561,000 14,114,000
Stock option expense 334,000 355,000
Research and other credits 891,000 945,000
Lease liability 99,000 138,000
Amortization 130,000
Total gross deferred tax assets 15,372,000 15,876,000
Lease liability 69,000 101,000
Other temporary differences 22,000
Total gross deferred tax liabilities 69,000 123,000
Valuation allowance (15,303,000) (15,753,000)
Net deferred tax
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule of Reconciliation Income Tax Expenses Benefit (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Income tax provision at federal statutory rate $ (561,000) $ (388,000)
Expired carryforwards and other 1,011,000 1,079,000
Valuation allowance (450,000) (691,000)
Total income tax provision
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Aug. 16, 2022
Dec. 31, 2021
Operating Loss Carryforwards [Line Items]      
Amortized cost term description These costs are required to be amortized over five years if the R&D activities are performed in the U.S., or over 15 years if the activities were performed outside the U.S.    
Research and development expense $ 609,000    
Corporate minimum tax rate   15.00%  
Excise tax on corporate stock 1.00%    
Net operating loss carry-forward $ 63,370,000    
Net operating loss carry-forward with expiration $ 52,927,000    
Net operating loss carry-forward expiration description expire in varying amounts from 2023 through 2037    
Income tax percentage 80.00%    
Research and other credit carry-forwards $ 891,000   $ 945,000
Tax Year 2018 to 2022 [Member]      
Operating Loss Carryforwards [Line Items]      
Net operating loss carry-forward $ 10,443,000    
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule of Assumptions Used to Value Options Granted to Employees (Details) - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Equity [Abstract]    
Fair value on grant date $ 1.31 $ 1.10
Expected dividend yield
Expected volatility 81.00% 79.00%
Risk free interest rate 3.99% 1.26%
Expected term of the option 5 years 5 years
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule of Option Activity (Details) - Equity Option [Member] - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Option Indexed to Issuer's Equity [Line Items]      
Number of Shares Subject to Option, Beginning 1,199,710 1,297,260  
Weighted Average Exercise Price, Beginning $ 3.67 $ 4.09  
Weighted Average Remaining Contractual Term (Years), Ending 5 years 9 months 18 days 5 years 8 months 12 days 5 years 9 months 18 days
Aggregate Intrinsic Value, Beginning $ 21,870 $ 142,885  
Number of Shares Subject to Option, Granted 178,000 198,000  
Weighted Average Exercise Price, Granted $ 1.95 $ 1.72  
Number of Shares Subject to Option, Cancelled (130,750) (155,050)  
Weighted Average Exercise Price, Cancelled $ 4.91 $ 5.38  
Number of Shares Subject to Option, Exercised (140,500)  
Weighted Average Exercise Price, Exercised $ 2.48  
Number of Shares Subject to Option, Ending 1,246,960 1,199,710 1,297,260
Weighted Average Exercise Price, Ending $ 3.35 $ 3.67 $ 4.09
Aggregate Intrinsic Value, Ending $ 67,510 $ 21,870 $ 142,885
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule of Warrant Activity (Details) - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Equity [Abstract]    
Number of Shares Underlying Warrants and Non-Employee Options Granted, Beginning 1,399,991 1,399,991
Weighted Average Exercise Price, Beginning $ 2.27 $ 2.27
Number of Shares Underlying Warrants and Non-Employee Options Granted, Exercised
Number of Shares Underlying Warrants and Non-Employee Options Granted, Terminated
Number of Shares Underlying Warrants and Non-Employee Options Granted, Issued 1,500,000
Weighted Average Exercise Price, Issued $ 2.76  
Number of Shares Underlying Warrants and Non-Employee Options Granted, Ending 2,899,991 1,399,991
Weighted Average Exercise Price, Ending $ 2.52 $ 2.27
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.22.4
Shareholders’ Equity (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Sep. 16, 2022
Feb. 28, 2023
Dec. 31, 2022
Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Shares issued price per share     $ 80  
Number of options vested     178,000 198,000
Share based compensation     $ 232,291 $ 217,008
Investor [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Warrants outstanding     2,899,991  
2019 Equity Incentive Plan [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Shares of common stock reserved for issuance     1,400,000  
Shares available for issuance     307,500  
Subscription Agreement [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Proceeds from issuance of stock     $ 3,450,000  
Stock issued during period shares 2,000,000.0      
Shares issued price per share $ 2.30      
Stock issued value     $ 1,150,000  
Options and Warrants [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Proceeds from issuance of stock       $ 86,262
Stock issued during period shares       74,610
Options and Warrants [Member] | Subsequent Event [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Proceeds from issuance of stock   $ 484,503    
Stock issued during period shares   358,891    
Common Stock [Member] | Subscription Agreement [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Stock issued during period shares     1,500,000  
Warrant [Member] | Non- Employee Stock Option [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Option expiration period     5 years  
Warrant [Member] | Non- Employee Stock Option [Member] | Minimum [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Warrants and non-employee options vested term     12 months  
Warrant [Member] | Non- Employee Stock Option [Member] | Maximum [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Warrants and non-employee options vested term     59 months  
Warrant [Member] | Subscription Agreement [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Stock issued during period shares     1,500,000  
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.22.4
License and Other Agreements (Details Narrative)
 12 Months Ended
Dec. 31, 2022
Minimum [Member]  
Royalty earned percentage 5.00%
Maximum [Member]  
Royalty earned percentage 15.00%
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule of Minimum Annual Future Rental Commitments (Details)
Dec. 31, 2022
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Year 1 $ 217,000
Years 2-3 278,000
Years 4-5
Thereafter
Total lease payments 495,000
Less: imputed lease interest (30,872)
Present value of lease liabilities $ 464,128
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.22.4
Commitments (Details Narrative)
 12 Months Ended
Dec. 31, 2022
USD ($)
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]  
Lease expiration term 1 year
Operating Lease, Weighted Average Remaining Lease Term 2 years 2 months 12 days
Operating Lease, Weighted Average Discount Rate, Percent 5.50%
Chief Executive Officer [Member]  
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]  
Annual base salary $ 500,000
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.22.4
Rights Plan (Details Narrative)
 12 Months Ended
Dec. 31, 2022
$ / shares
Rights Plan  
Percentage of acquisition threshold 15.00%
Value of stock covered by each right $ 80
Discount price of stock $ 40
Acquiring asset percent 50.00%
Rights plan expire date Feb. 11, 2033
Redemption price $ 0.0001
XML 50 form10-k_htm.xml IDEA: XBRL DOCUMENT 0000793524 2022-01-01 2022-12-31 0000793524 2022-06-30 0000793524 2023-03-09 0000793524 2022-12-31 0000793524 2021-12-31 0000793524 2021-01-01 2021-12-31 0000793524 us-gaap:CommonStockMember 2020-12-31 0000793524 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000793524 us-gaap:RetainedEarningsMember 2020-12-31 0000793524 2020-12-31 0000793524 us-gaap:CommonStockMember 2021-12-31 0000793524 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000793524 us-gaap:RetainedEarningsMember 2021-12-31 0000793524 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000793524 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0000793524 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0000793524 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000793524 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0000793524 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0000793524 us-gaap:CommonStockMember 2022-12-31 0000793524 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000793524 us-gaap:RetainedEarningsMember 2022-12-31 0000793524 REFR:CompanyOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000793524 REFR:CompanyOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000793524 REFR:CompanyTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000793524 srt:MinimumMember us-gaap:SalesRevenueNetMember REFR:LicenseAgreementMember 2022-01-01 2022-12-31 0000793524 srt:MaximumMember us-gaap:SalesRevenueNetMember REFR:LicenseAgreementMember 2022-01-01 2022-12-31 0000793524 REFR:LicenseAgreementMember 2022-01-01 2022-12-31 0000793524 REFR:LicenseeOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000793524 REFR:LicenseeTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000793524 REFR:LicenseeThreeMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000793524 REFR:LicenseeFourMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000793524 REFR:LicenseeOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000793524 REFR:LicenseeTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000793524 REFR:LicenseeThreeMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000793524 REFR:LicenseeFourMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000793524 REFR:OptionsAndWarrantsMember 2022-01-01 2022-12-31 0000793524 REFR:OptionsAndWarrantsMember 2021-01-01 2021-12-31 0000793524 REFR:EmployeesAndDirectorsMember 2022-01-01 2022-12-31 0000793524 REFR:EmployeesAndDirectorsMember 2021-01-01 2021-12-31 0000793524 us-gaap:FairValueInputsLevel1Member REFR:PutnamShortDurationBondMember 2021-12-31 0000793524 us-gaap:FairValueInputsLevel1Member REFR:PutnamUltraShortDurationIncomeMember 2021-12-31 0000793524 us-gaap:FairValueInputsLevel1Member 2021-12-31 0000793524 us-gaap:FairValueInputsLevel1Member 2021-01-01 2021-12-31 0000793524 REFR:EquipmentAndFurnitureMember 2022-12-31 0000793524 REFR:EquipmentAndFurnitureMember 2021-12-31 0000793524 REFR:EquipmentAndFurnitureMember 2022-01-01 2022-12-31 0000793524 REFR:TradeShowMaterialsMember 2022-12-31 0000793524 REFR:TradeShowMaterialsMember 2021-12-31 0000793524 REFR:TradeShowMaterialsMember 2022-01-01 2022-12-31 0000793524 REFR:AutosMember 2022-12-31 0000793524 REFR:AutosMember 2021-12-31 0000793524 REFR:AutosMember 2022-01-01 2022-12-31 0000793524 us-gaap:LeaseholdImprovementsMember 2022-12-31 0000793524 us-gaap:LeaseholdImprovementsMember 2021-12-31 0000793524 2022-08-16 0000793524 REFR:TaxYear2018To2022Member 2022-12-31 0000793524 REFR:OptionsAndWarrantsMember 2021-01-01 2021-12-31 0000793524 REFR:OptionsAndWarrantsMember us-gaap:SubsequentEventMember 2023-02-01 2023-02-28 0000793524 REFR:SubscriptionAgreementMember 2022-09-14 2022-09-16 0000793524 REFR:SubscriptionAgreementMember 2022-09-16 0000793524 REFR:SubscriptionAgreementMember 2022-01-01 2022-12-31 0000793524 us-gaap:CommonStockMember REFR:SubscriptionAgreementMember 2022-01-01 2022-12-31 0000793524 us-gaap:WarrantMember REFR:SubscriptionAgreementMember 2022-01-01 2022-12-31 0000793524 REFR:TwoThousandNineteenEquityIncentivePlanMember 2022-12-31 0000793524 srt:MinimumMember REFR:NonEmployeeStockOptionMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0000793524 srt:MaximumMember REFR:NonEmployeeStockOptionMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0000793524 us-gaap:InvestorMember 2022-12-31 0000793524 REFR:NonEmployeeStockOptionMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0000793524 us-gaap:StockOptionMember 2020-12-31 0000793524 us-gaap:StockOptionMember 2020-01-01 2020-12-31 0000793524 us-gaap:StockOptionMember 2021-01-01 2021-12-31 0000793524 us-gaap:StockOptionMember 2021-12-31 0000793524 us-gaap:StockOptionMember 2022-01-01 2022-12-31 0000793524 us-gaap:StockOptionMember 2022-12-31 0000793524 srt:MinimumMember 2022-01-01 2022-12-31 0000793524 srt:MaximumMember 2022-01-01 2022-12-31 0000793524 srt:ChiefExecutiveOfficerMember 2022-01-01 2022-12-31 iso4217:USD shares iso4217:USD shares pure 0000793524 false FY true false REFR 10-K 2022-12-31 --12-31 2022 000-14893 RESEARCH FRONTIERS INCORPORATED DE 11-2103466 240 CROSSWAYS PARK DRIVE WOODBURY NY 11797-2033 516 364-1902 Common Stock, $0.0001 Par Value NASDAQ No No Yes Yes Non-accelerated Filer true false false false 49488280 33509287 596 CohnReznick LLP Melville, New York 4230916 269964 2755111 1158450 1016678 589599 831636 100973 92931 4921488 3949642 65388 92954 323509 469824 56066 33567 5366451 4545987 196405 182091 71079 66460 34379 49385 301863 297936 267723 464128 569586 762064 0.0001 0.0001 100000000 100000000 33150396 33150396 31650396 31650396 3315 3165 127150027 123467886 -122356477 -119687128 4796865 3783923 5366451 4545987 539686 1263034 2555689 2521849 609127 580000 3164816 3101849 -2625130 -1838815 -44219 -7537 -2669349 -1846352 -0.08 -0.06 32070233 31646520 31575786 3158 123164623 -117840776 5327005 74610 7 86255 86262 217008 217008 -1846352 -1846352 31650396 3165 123467886 -119687128 3783923 31650396 3165 123467886 -119687128 3783923 232291 232291 1500000 150 3449850 3450000 -2669349 -2669349 33150396 3315 127150027 -122356477 4796865 33150396 3315 127150027 -122356477 4796865 -2669349 -1846352 28837 29895 -60143 -28522 232291 217008 141772 44476 146315 146618 -100266 277819 30542 36420 -10387 56156 -182091 -166377 -2182745 -1804293 1271 1077 3433633 2694968 650000 2693697 -2784710 86262 3450000 3450000 86262 3960952 -4502741 269964 4772705 4230916 269964 <p id="xdx_80E_eus-gaap--BasisOfAccounting_zhsaiWcApDph" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) <span style="text-decoration: underline"><span id="xdx_82D_z8IWaDEOMno6">Business and Basis for Presentation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research Frontiers Incorporated (“Research Frontiers” or the “Company”) operates in a single business segment which is engaged in the development and marketing of technology and devices to control the flow of light. Such devices, often referred to as “light valves” or suspended particle devices (“SPDs”), use colloidal particles that are either incorporated within a liquid suspension or a film, which is usually enclosed between two sheets of glass or plastic having transparent, electrically conductive coatings on the facing surfaces thereof. At least one of the two sheets is transparent. SPD technology, made possible by a flexible light-control film invented by Research Frontiers, allows the user to instantly and precisely control the shading of glass/plastic manually or automatically. SPD technology has numerous product applications, including SPD-Smart™ windows, sunshades, skylights and interior partitions for homes and buildings; automotive windows, sunroofs, sun visors, sunshades, rear-view mirrors, instrument panels, heads up displays and navigation systems; aircraft windows; museum display panels; eyewear products; and flat panel displays for electronic products. SPD-Smart light control film is now being developed for, or used in, architectural, automotive, marine, aerospace and appliance applications.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has primarily utilized its cash, cash equivalents, and investments generated from sales of our common stock, proceeds from the exercise of options and warrants, and royalty fees collected to fund its research and development of SPD light valves, for marketing initiatives, and for other working capital purposes. The Company’s working capital and capital requirements depend upon numerous factors, including the results of research and development activities, competitive and technological developments, the timing and cost of patent filings, and the development of new licensees and changes in the Company’s relationships with its existing licensees. The degree of dependence of the Company’s working capital requirements on each of the foregoing factors cannot be quantified; increased research and development activities and related costs would increase such requirements; the addition of new licensees may provide additional working capital or working capital requirements, and changes in relationships with existing licensees would have a favorable or negative impact depending upon the nature of such changes. We have incurred recurring losses since inception and expect to continue to incur losses as a result of costs and expenses related to our research and continued development of our SPD technology and our corporate general and administrative expenses. Our limited capital resources and operations to date have been substantially funded through sales of our common stock, exercise of options and warrants and royalty fees collected. As of December 31, 2022, we had working capital of approximately $<span id="xdx_90B_ecustom--WorkingCapital_iI_pn5n6_c20221231_zPY0fp3Kvsre" title="Working capital">4.6</span> million, cash and cash equivalents of approximately $<span id="xdx_903_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn5n6_c20221231_zhZaxDNSZMu8" title="Cash and cash equivalents">4.2</span> million, shareholders’ equity of approximately $<span id="xdx_908_eus-gaap--StockholdersEquity_iI_pn5n6_c20221231_z6OebV8lexAb" title="Shareholders' equity">4.8</span> million and an accumulated deficit of approximately $<span id="xdx_905_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn5n6_di_c20221231_zCl6Hmi5q0M3" title="Accumulated deficit">122.4</span> million. Our quarterly projected cash flow shortfall, based on our current operations, adjusted for any non-recurring cash expenses and adjusted for additional royalties expected to be received for use of our products in new production, for the next 12 months, is approximately $<span id="xdx_90C_ecustom--NonrecurringCashExpenses_c20220101__20221231_zof9bbPDwZfh" title="Non-recurring cash expenses">200,000</span> per quarter. We may eliminate some operating expenses in the future, which will further reduce our cash flow shortfall, if needed. Based on these assumptions, we currently expect to have sufficient working capital for at least 12 months from the issuance of these financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event that we are unable to generate sufficient cash from our operating activities or raise additional funds, we may be required to delay, reduce or severely curtail our operations or otherwise impede our on-going business efforts, which could have a material adverse effect on our business, operating results, financial condition and long-term prospects. The Company may seek to obtain additional funding through future equity issuances. There can be no assurance as to the availability or terms upon which such financing and capital might be available. The eventual success of the Company and generation of positive cash flow will be dependent upon the commercialization of products using the Company’s technology by the Company’s licensees and payments of continuing royalties on account thereof. To date, the Company has not generated sufficient revenue from its licensees to fund its operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent Global Events:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 11, 2020, the World Health Organization declared the novel strain of coronavirus (“COVID-19”) a global pandemic and recommended containment and mitigation measures worldwide.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since 2020 revenues have been negatively impacted due to delays in manufacture of products using our technology. Most of the products using our technology are manufactured by licensees overseas in Europe and Asia who have been similarly affected by the pandemic. The disruption caused by public health crises, such as COVID-19, could result in lower levels of sale activity for products using our technology resulting in lower level of royalties owed to us from the sale of these products. The duration of the potential business disruptions and related financial impact cannot be reasonably estimated at this time, but could materially adversely affect our business, financial condition, results of operations, and cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain amounts in the accompanying December 31, 2021 statements of cash flows have been reclassified to conform with the December 31, 2022 presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 4600000 4200000 4800000 -122400000 200000 <p id="xdx_80A_eus-gaap--SignificantAccountingPoliciesTextBlock_z59DahKBRXa1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) <span style="text-decoration: underline"><span id="xdx_824_zNUxjfDmrnO5">Summary of Significant Accounting Policies</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zcEvXlxfzuni" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span id="xdx_860_zZiZmeirRQsd">Cash and Cash Equivalents</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers securities purchased with original maturities of three months or less to be cash equivalents. Cash equivalents consist of short-term investments in money market accounts at December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents are maintained at financial institutions and, at times, balances may exceed federally insured limits. We have never experienced any losses related to these balances. FDIC insurance coverage is $<span id="xdx_907_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20221231_zEOdoDoXv9sa" title="FDIC insurance coverage">250,000</span> per depositor at each financial institution, and our non-interest bearing cash balances may again exceed federally insured limits. Amounts on deposit in excess of federally insured limits at December 31, 2022 and 2021 are approximately $<span id="xdx_909_eus-gaap--CashUninsuredAmount_iI_pn5n6_c20221231_zHVcHdsPBS53" title="Amounts on deposit in excess of federally insured limits">2.7</span> million and $<span id="xdx_907_eus-gaap--CashUninsuredAmount_c20211231_pp0p0" title="Amounts on deposit in excess of federally insured limits">0</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--MarketableSecuritiesPolicy_z2okwA1AqxE6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span id="xdx_867_zoMlc9xX0Ns6">Marketable Securities</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company classifies investments in marketable securities as trading, available-for-sale or held-to-maturity at the time of purchase and periodically re-evaluates such classification. Trading securities are carried at fair value, with unrealized holding gains and losses included in earnings. Held-to-maturity securities are recorded at cost and are adjusted for the amortization or accretion of premiums or discounts over the life of the related security. Unrealized holding gains and losses of available-for-sale securities are excluded from earnings and are reported as a separate component of accumulated other comprehensive income (loss) until realized. In determining realized gains and losses, the cost of the securities sold is based on the specific identification method. Interest and dividends on the investments are accrued at the balance sheet date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date. Fair value measurements are broken down into three levels based on the reliability of inputs as follows: Level 1 inputs are quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. An active market for the asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates and yield curves observable at commonly quoted intervals or current market) and contractual prices for the underlying financial instrument, as well as other relevant economic measures. Level 3 inputs are unobservable inputs for the asset or liability. Unobservable inputs are used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022, the Company invested only in investments qualified as cash and cash equivalents. During the year ended December 31, 2022, the Company incurred a realized loss on the sale of marketable securities of $<span id="xdx_90E_eus-gaap--MarketableSecuritiesRealizedGainLoss_iN_di_c20220101__20221231_zpztVr8kqoHb" title="Realized loss on sale of marketable securities">60,143</span>. At December 31, 2021 all investments are Level 1 and were classified as trading and consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eus-gaap--ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_zHzbmn0Vdfj9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zzjjYZNd7e2i" style="display: none">Schedule of Unrealized Loss on Investments</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td> </td> <td colspan="2" style="text-align: center">December 31, 2021</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td> </td> <td colspan="2" style="text-align: center">Value of trading</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center">Investment</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Investments</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 50%; text-align: left">Mutual Funds</td><td style="width: 2%"> </td> <td style="width: 28%; text-align: left">Putnam Short Duration Bond </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--MarketableSecuritiesCurrent_iI_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--PutnamShortDurationBondMember_zI3BuHln3kO" style="width: 16%; text-align: right" title="Mutual Funds Putnam Short Duration Bond">1,972,736</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">Putnam Ultra Short Duration Income </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--MarketableSecuritiesCurrent_iI_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--PutnamUltraShortDurationIncomeMember_zPnekEUTPnkh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Mutual Funds Putnam Ultra Short Duration Income">782,375</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--MarketableSecuritiesCurrent_iI_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zZf3G5nbcvZ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Marketable securities">2,755,111</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">Unrealized loss </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6EAxQIVxFv5" style="border-bottom: Black 2.5pt double; text-align: right" title="Unrealized loss">28,522</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_z7amfonhzWVj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ReceivablesPolicyTextBlock_zkhCGP6qniD8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span id="xdx_863_zcQZnIRmkIl5">Royalties Receivable</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Royalties receivable from licensees are recorded at the amounts specified within the license agreements when the collectability of the receivable is reasonably assured. The allowance for doubtful accounts is the Company’s best estimate of the amount of probable credit losses in the Company’s existing royalties receivable. The Company determines the allowance based on historical write-off experience as well as the current status of the Company’s customers. The Company reviews its allowance for doubtful accounts periodically. Past due accounts are reviewed individually for collectability. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. As of December 31, 2022, one company accounted for <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CompanyOneMember_zGWGgoqJQkTf" title="Concentration risk percentage">14</span>% of the Company’s outstanding receivables. As of December 31, 2021, two companies accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CompanyOneMember_zplsw9FYmGnc" title="Concentration risk percentage">14</span>% and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--CompanyTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zb3NS0oiOnj7">11</span>% of the Company’s outstanding receivables.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z9PzNSpqkHZc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span id="xdx_86E_zT6X47cqF5K2">Fixed Assets</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed assets are carried at cost less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_848_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zQSBpEogyFQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)<span id="xdx_864_zv315qZwraw4"> Revenue Recognition/Fee Income</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers (“ASC 606”). The standard provides a single comprehensive revenue recognition model for all contracts with customers and supersedes existing revenue recognition guidance. The revenue standard contains principles that an entity will apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to customers at an amount that the entity expects to be entitled to in exchange for those goods or services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 606 follows a five-step approach to determining revenue recognition including: 1) Identification of the contract; 2) Identification of the performance obligations; 3) Determination of the transaction price; 4) Allocation of the transaction price; and 5) Recognition of revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company determined that its license agreements provide for three performance obligations which include: (i) the Grant of Use to its Patent Portfolio (“Grant of Use”), (ii) Stand-Ready Technical Support (“Technical Support”) including the transfer of trade secrets and other know-how, production of materials, scale-up support, analytical testing, etc., and (iii) access to new Intellectual Property (“IP”) that may be developed sometime during the course of the contract period (“New Improvements”). Given the nature of IP development, such New Improvements are on an unspecified basis and can occur and be made available to licensees at any time during the contract period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When a contract includes more than one performance obligation, the Company needs to allocate the total consideration to each performance obligation based on its relative standalone selling price or estimate the standalone selling price if it is not observable. A standalone selling price is not available for our performance obligations since we do not sell any of the services separately and there is no competitor pricing that is available. As a consequence, the best method for determining standalone selling price of our Grant of Use performance obligation is through a comparison of the average royalty rate for comparable license agreements as compared to our license agreements. Comparable license agreements must consider several factors including: (i) the materials that are being licensed, (ii) the market application for the licensed materials, and (iii) the financial terms in the license agreements that can increase or decrease the risk/reward nature of the agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on the royalty rate comparison referred to above, any pricing above and beyond the average royalty rate would relate to the Technical Support and New Improvements performance obligations. The Company focuses a significant portion of its time and resources to provide the Technical Support and New Improvements services to its licensees, which further supports the conclusions reached using the royalty rate analysis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Technical Support and New Improvements performance obligations are co-terminus over the term of the license agreement. For purposes of determining the transaction price, and recognizing revenue, the Company combined the Technical Support and New Improvements performance obligations because they have the same pattern of transfer and the same term. We maintain a staff of scientists and other professionals whose primary job responsibilities throughout the year are: (i) being available to respond to Technical Support needs of our licensees, and (ii) developing improvements to our technology which are offered to our licensees as New Improvements. Since the costs incurred to satisfy the Technical Support and New Improvements performance obligations are incurred evenly throughout the year, the value of the Technical Support and New Improvements services are recognized throughout the initial contract period as these performance obligations are satisfied. If the agreement is not terminated at the end of the initial contract period, it will renew on the same terms as the initial contract for a one-year period. Consequently, any fees or minimum annual royalty obligations relating to this renewal contract will be allocated similarly to the initial contract over the additional one-year period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We recognize revenue when or as the performance obligations in the contract are satisfied. For performance obligations that are fulfilled at a point in time, revenue is recognized at the fulfillment of the performance obligation. Since the IP is determined to be a functional license, the value of the Grant of Use is recognized in the first period of the contract term in which the license agreement is in force. The value of the Technical Support and New Improvements obligations is allocated throughout the contract period based on the satisfaction of its performance obligations. If the agreement is not terminated at the end of the contract period, it will renew on the same terms as the original agreement for a one-year period. Consequently, any fees or minimum annual royalties (“MAR”) relating to this renewal contract will be allocated similarly over that additional year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s license agreements have a variable royalty fee structure (meaning that royalties are a fixed percentage of sales that vary from period to period) and frequently include a minimum annual royalty commitment. In instances when sales of licensed products by its licensees exceed the MAR, the Company recognizes fee income as the amounts have been earned. Typically, the royalty rate for such sales is <span id="xdx_90E_ecustom--RoyaltyRateOnSellingPrice_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--TypeOfArrangementAxis__custom--LicenseAgreementMember__srt--RangeAxis__srt--MinimumMember_z9KrNWWMezWd" title="Royalty rate on selling price">10</span>-<span id="xdx_902_ecustom--RoyaltyRateOnSellingPrice_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--TypeOfArrangementAxis__custom--LicenseAgreementMember__srt--RangeAxis__srt--MaximumMember_z0dmO1XuIqS" title="Royalty rate on selling price">15</span>% of the selling price. While this is variable consideration, it is subject to the sales/usage royalty exception to recognition of variable consideration in ASC 606 10-55-65 and therefore is not recognized until the subsequent sales or usage occurs or the MAR period commences.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because of the immediate recognition of the Grant of Use performance obligation: (i) the first period of the contract term will generally have a higher percent allocation of the transaction price under ASC 606 and (ii) the remaining periods will have less of the transaction price recognized under ASC 606. After the initial period in the contract term, the revenue for the remaining periods will be based on the satisfaction of the technical support and New Improvements obligations. Since most of our license agreements start as of January 1st, the revenue recognized for the contract under ASC 606 in our first quarter will tend to be higher subsequent quarters in the fiscal year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain of the contract fees are accrued by, or paid to, the Company in advance of the period in which they are earned resulting in deferred revenue. Such excess amounts are recorded as deferred revenue and are recognized as revenue in future periods as earned.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company operates in a single business segment which is engaged in the development and marketing of technology and devices to control the flow of light. Our revenue source comes from the licensing of this technology and all of these license agreements have similar terms and provisions. The majority of the Company’s licensing fee income comes from the activities of several licensees participating in the automotive market. The Company currently believes that the automotive market will be the largest source of its royalty income over the next several years. The Company’s royalty income from this market may be influenced by numerous factors including various trends affecting demand in the automotive industry and the rate of introduction of new technology in OEM product lines. In addition to these macro factors, the Company’s royalty income from the automotive market could also be influenced by specific factors such as whether the Company’s SPD-SmartGlass technology appears as standard equipment or as an option on a particular vehicle, the number of additional vehicle models that SPD-SmartGlass appears on, the size of each window on a vehicle and the number of windows on a vehicle that use SPD SmartGlass, fluctuations in the total number of vehicles produced by a manufacturer, and in the percentage of cars within each model produced with SPD-SmartGlass, and changes in pricing or exchange rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, the Company has one license agreement that are in its initial multiyear term (“Initial Term”) with continuing performance obligations going forward. The Initial Term of this agreement will end as of December 31, 2024, The Company currently expects this agreement will renew annually at the end of the Initial Term. As of December 31, 2022, the aggregate amount of the revenue to be recognized upon the satisfaction of the remaining performance obligations for this license agreements is $<span id="xdx_907_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--LicenseAgreementMember_zSEo2YImeES6" title="Remaining performance obligations">123,000</span>. The revenue for the remaining performance obligations for this license agreement is expected to be recognized evenly throughout the remaining period of the Initial Term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2022 and 2021, the Company entered into a number of license agreements covering its light control technology. The Company received minimum annual royalties under certain license agreements and recorded fee income based on ASC 606 revenue recognition each quarter. In instances when sales of licensed products by its licensees exceed minimum annual royalties, the Company recognized additional fee income as the amounts have been earned. Certain of the fees are accrued by, or paid to, the Company in advance of the period in which they are earned resulting in deferred revenue. Such excess amounts are recorded as deferred revenue and are typically recognized as fee income when earned. As of December 31, 2022 and 2021, there was no balance in deferred revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee income represents amounts earned by the Company under various license and other agreements relating to technology developed by the Company. During 2022, four licensees accounted for <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--ProductOrServiceAxis__custom--LicenseeOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z5D4VCYPDNX2" title="Concentration risk, percentage">28</span>%, <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--ProductOrServiceAxis__custom--LicenseeTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zschEjYlelY5" title="Concentration risk, percentage">23</span>%, <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--ProductOrServiceAxis__custom--LicenseeThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zyohmyui28u5" title="Concentration risk, percentage">13</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--ProductOrServiceAxis__custom--LicenseeFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zoVI9FEameHg" title="Concentration risk, percentage">11</span>% of fee income recognized during the year. During 2021, four licensees accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--ProductOrServiceAxis__custom--LicenseeOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zRsFeWRcVXSe" title="Concentration risk, percentage">20</span>%, <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--ProductOrServiceAxis__custom--LicenseeTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z7JZZngWMtQe" title="Concentration risk, percentage">18</span>%, <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--ProductOrServiceAxis__custom--LicenseeThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zNK9RzmN4TIi" title="Concentration risk, percentage">18</span>% and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--ProductOrServiceAxis__custom--LicenseeFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zdEeq6Yvofv3" title="Concentration risk, percentage">12</span>% of fee income recognized during the year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_zkBX0ySF3JK7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <span id="xdx_861_zu7dMVK1JMte">Basic and Diluted Loss Per Common Share</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic loss per share excludes any dilution. It is based upon the weighted average number of common shares outstanding during the period. Dilutive loss per share reflects the potential dilution that would occur if securities or other contracts to issue common stock were exercised or converted into common stock. The Company’s dilutive loss per share equals basic loss per share for each of the years in the two-year period ended December 31, 2022 because all potentially dilutive securities (i.e<i>., </i>options and warrants) were antidilutive in those periods. The number of options and warrants that were not included because their effect is antidilutive was <span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--OptionsAndWarrantsMember_zAnc26xC6HOj" title="Antidilutive securities">4,146,951</span> and <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--OptionsAndWarrantsMember_zvbPF0oOKi5a" title="Antidilutive securities">2,599,701</span> for 2022 and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ResearchAndDevelopmentExpensePolicy_zffRFvjoOw4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <span id="xdx_869_zlRxhawFZES5">Research and Development Costs</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development costs are charged to expense as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zXzKqzojutCd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <span id="xdx_86C_zQde0eeKGMgf">Patent Costs</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company expenses costs relating to the development or acquisition of patents due to the uncertainty of the recoverability of these items.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--UseOfEstimates_zia28vczuL28" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <span id="xdx_86A_zHsGxw7Wd0W">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the Company’s consolidated financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during this period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--IncomeTaxPolicyTextBlock_znxFYlz14eo3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) <span id="xdx_869_zRto8lKebDr1">Income Taxes</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to be recovered or settled.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC Topic 740, we recognize tax benefits only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is <span id="xdx_90C_ecustom--RecognizedBenefitMeasured_c20220101__20221231_zIWelzBy9Vg2" title="Recognized benefit measured">greater than 50 percent</span> likely to be realized upon ultimate settlement. Unrecognized tax benefits are tax benefits claimed in tax returns that do not meet these recognition and measurement standards. We classify accrued interest and penalties related to any unrecognized tax benefits in our income tax provision. At December 31, 2022 and 2021, we do not have accrued interest and penalties related to any unrecognized tax benefits. We do not believe we have any uncertain tax positions as of December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The tax years subject to examination by major tax jurisdictions include the years 2017 and forward by the U.S. Internal Revenue Service and certain states. The Company is not currently being audited by any tax jurisdiction.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zgjISkwyGVWc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) <span id="xdx_860_zf086JEsrHP5">Equity-Based Compensation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We recognize all stock-based compensation as an expense in the consolidated financial statements and such costs are measured at the fair value of the award at the date of grant. In addition to reflecting compensation expense for new share-based payment awards, expense is also recognized to reflect the remaining vesting period of awards that had been granted in prior periods. Tax benefits related to stock option exercises are reflected as financing cash inflows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The exercise prices for stock options granted are generally set at the average for the high and low trading prices of the Company’s common stock on the trading date immediately prior to the date of grant, and the related numbers of shares granted are fixed at the date of grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to determine the fair value of stock options on the date of grant, the Company uses the Black-Scholes option-pricing model. Inherent in this model are assumptions related to expected stock-price volatility, option term, risk-free interest rate and dividend yield. While the risk-free interest rate and dividend yield are less subjective assumptions that are based on factual data derived from public sources, the expected stock-price volatility and option term assumptions require a greater level of judgment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with employee and director stock options, the Company charged to compensation expense $<span id="xdx_906_eus-gaap--ShareBasedCompensation_pp0p0_c20220101__20221231__srt--TitleOfIndividualAxis__custom--EmployeesAndDirectorsMember_zXopPVnR1iE8" title="Share based compensation">232,291</span> and $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_pp0p0_c20210101__20211231__srt--TitleOfIndividualAxis__custom--EmployeesAndDirectorsMember_zeQovMhes87g" title="Share based compensation">217,008</span> during the years ended December 31, 2022 and 2021, respectively. As of December 31, 2022, these awards were fully vested. In lieu of higher cash compensation, the Company has granted warrants and non-employee options to consultants. These warrants and non-employee options vested fully on the date of grant. There were no such charges for the year ended December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_ecustom--RestrictedStockPolicyTextBlock_z60R2QwyzXhh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) <span id="xdx_862_zcqBFHqKaIl9">Restricted Stock</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation cost for restricted stock is measured using the quoted market price of the Company’s common stock at the date the common stock is granted. The compensation cost is recognized over the period between the issue date and the vesting period for such shares. Restricted stock is included in total common shares outstanding upon the lapse of any vesting conditions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zOrD8my09cr" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) <span id="xdx_868_zyjVpdFbz33k">Impairment of Long-Lived Assets</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reviews long-lived assets to determine whether an event or change in circumstances indicates the carrying value of the asset may not be recoverable. The Company bases its evaluation on such impairment indicators as the nature of the assets, the future economic benefit of the assets and any historical or future profitability measurements, as well as other external market conditions or factors that may be present. There was <span id="xdx_908_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_do_c20220101__20221231_zYulNRfMoOja" title="Impairment of long-lived assets"><span id="xdx_90A_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_do_c20210101__20211231_zYSxFcQArMch" title="Impairment of long-lived assets">no</span></span> impairment of long-lived assets recorded during 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z3313bhEhgYl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) <span id="xdx_863_z0ve9i2f6xI7">Fair Value Measurements</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022 and 2021, the fair value of the Company’s financial assets and non-warrant liabilities including cash and cash equivalents, marketable securities, royalties receivable, accounts payable and accrued expenses approximated carrying value due to the short-term maturity of these instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zOxRqIpOohag" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) <span id="xdx_860_zchWk7DfOP7i">Recent Accounting Pronouncements</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>New Accounting Standards</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company believes that no new accounting standards that are not yet effective will have a material effect on the Company’s consolidated financial statements.</span></p> <p id="xdx_857_zKmORhLfsPve" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_841_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zcEvXlxfzuni" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span id="xdx_860_zZiZmeirRQsd">Cash and Cash Equivalents</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers securities purchased with original maturities of three months or less to be cash equivalents. Cash equivalents consist of short-term investments in money market accounts at December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents are maintained at financial institutions and, at times, balances may exceed federally insured limits. We have never experienced any losses related to these balances. FDIC insurance coverage is $<span id="xdx_907_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20221231_zEOdoDoXv9sa" title="FDIC insurance coverage">250,000</span> per depositor at each financial institution, and our non-interest bearing cash balances may again exceed federally insured limits. Amounts on deposit in excess of federally insured limits at December 31, 2022 and 2021 are approximately $<span id="xdx_909_eus-gaap--CashUninsuredAmount_iI_pn5n6_c20221231_zHVcHdsPBS53" title="Amounts on deposit in excess of federally insured limits">2.7</span> million and $<span id="xdx_907_eus-gaap--CashUninsuredAmount_c20211231_pp0p0" title="Amounts on deposit in excess of federally insured limits">0</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 250000 2700000 0 <p id="xdx_846_eus-gaap--MarketableSecuritiesPolicy_z2okwA1AqxE6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span id="xdx_867_zoMlc9xX0Ns6">Marketable Securities</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company classifies investments in marketable securities as trading, available-for-sale or held-to-maturity at the time of purchase and periodically re-evaluates such classification. Trading securities are carried at fair value, with unrealized holding gains and losses included in earnings. Held-to-maturity securities are recorded at cost and are adjusted for the amortization or accretion of premiums or discounts over the life of the related security. Unrealized holding gains and losses of available-for-sale securities are excluded from earnings and are reported as a separate component of accumulated other comprehensive income (loss) until realized. In determining realized gains and losses, the cost of the securities sold is based on the specific identification method. Interest and dividends on the investments are accrued at the balance sheet date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date. Fair value measurements are broken down into three levels based on the reliability of inputs as follows: Level 1 inputs are quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. An active market for the asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates and yield curves observable at commonly quoted intervals or current market) and contractual prices for the underlying financial instrument, as well as other relevant economic measures. Level 3 inputs are unobservable inputs for the asset or liability. Unobservable inputs are used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022, the Company invested only in investments qualified as cash and cash equivalents. During the year ended December 31, 2022, the Company incurred a realized loss on the sale of marketable securities of $<span id="xdx_90E_eus-gaap--MarketableSecuritiesRealizedGainLoss_iN_di_c20220101__20221231_zpztVr8kqoHb" title="Realized loss on sale of marketable securities">60,143</span>. At December 31, 2021 all investments are Level 1 and were classified as trading and consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eus-gaap--ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_zHzbmn0Vdfj9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zzjjYZNd7e2i" style="display: none">Schedule of Unrealized Loss on Investments</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td> </td> <td colspan="2" style="text-align: center">December 31, 2021</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td> </td> <td colspan="2" style="text-align: center">Value of trading</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center">Investment</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Investments</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 50%; text-align: left">Mutual Funds</td><td style="width: 2%"> </td> <td style="width: 28%; text-align: left">Putnam Short Duration Bond </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--MarketableSecuritiesCurrent_iI_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--PutnamShortDurationBondMember_zI3BuHln3kO" style="width: 16%; text-align: right" title="Mutual Funds Putnam Short Duration Bond">1,972,736</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">Putnam Ultra Short Duration Income </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--MarketableSecuritiesCurrent_iI_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--PutnamUltraShortDurationIncomeMember_zPnekEUTPnkh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Mutual Funds Putnam Ultra Short Duration Income">782,375</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--MarketableSecuritiesCurrent_iI_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zZf3G5nbcvZ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Marketable securities">2,755,111</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">Unrealized loss </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6EAxQIVxFv5" style="border-bottom: Black 2.5pt double; text-align: right" title="Unrealized loss">28,522</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_z7amfonhzWVj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> -60143 <p id="xdx_893_eus-gaap--ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_zHzbmn0Vdfj9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zzjjYZNd7e2i" style="display: none">Schedule of Unrealized Loss on Investments</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td> </td> <td colspan="2" style="text-align: center">December 31, 2021</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td> </td> <td colspan="2" style="text-align: center">Value of trading</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center">Investment</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Investments</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 50%; text-align: left">Mutual Funds</td><td style="width: 2%"> </td> <td style="width: 28%; text-align: left">Putnam Short Duration Bond </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--MarketableSecuritiesCurrent_iI_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--PutnamShortDurationBondMember_zI3BuHln3kO" style="width: 16%; text-align: right" title="Mutual Funds Putnam Short Duration Bond">1,972,736</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">Putnam Ultra Short Duration Income </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--MarketableSecuritiesCurrent_iI_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--PutnamUltraShortDurationIncomeMember_zPnekEUTPnkh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Mutual Funds Putnam Ultra Short Duration Income">782,375</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--MarketableSecuritiesCurrent_iI_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zZf3G5nbcvZ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Marketable securities">2,755,111</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">Unrealized loss </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6EAxQIVxFv5" style="border-bottom: Black 2.5pt double; text-align: right" title="Unrealized loss">28,522</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1972736 782375 2755111 28522 <p id="xdx_840_eus-gaap--ReceivablesPolicyTextBlock_zkhCGP6qniD8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span id="xdx_863_zcQZnIRmkIl5">Royalties Receivable</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Royalties receivable from licensees are recorded at the amounts specified within the license agreements when the collectability of the receivable is reasonably assured. The allowance for doubtful accounts is the Company’s best estimate of the amount of probable credit losses in the Company’s existing royalties receivable. The Company determines the allowance based on historical write-off experience as well as the current status of the Company’s customers. The Company reviews its allowance for doubtful accounts periodically. Past due accounts are reviewed individually for collectability. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. As of December 31, 2022, one company accounted for <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CompanyOneMember_zGWGgoqJQkTf" title="Concentration risk percentage">14</span>% of the Company’s outstanding receivables. As of December 31, 2021, two companies accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CompanyOneMember_zplsw9FYmGnc" title="Concentration risk percentage">14</span>% and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--CompanyTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zb3NS0oiOnj7">11</span>% of the Company’s outstanding receivables.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.14 0.14 0.11 <p id="xdx_848_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z9PzNSpqkHZc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span id="xdx_86E_zT6X47cqF5K2">Fixed Assets</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed assets are carried at cost less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_848_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zQSBpEogyFQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)<span id="xdx_864_zv315qZwraw4"> Revenue Recognition/Fee Income</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers (“ASC 606”). The standard provides a single comprehensive revenue recognition model for all contracts with customers and supersedes existing revenue recognition guidance. The revenue standard contains principles that an entity will apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to customers at an amount that the entity expects to be entitled to in exchange for those goods or services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 606 follows a five-step approach to determining revenue recognition including: 1) Identification of the contract; 2) Identification of the performance obligations; 3) Determination of the transaction price; 4) Allocation of the transaction price; and 5) Recognition of revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company determined that its license agreements provide for three performance obligations which include: (i) the Grant of Use to its Patent Portfolio (“Grant of Use”), (ii) Stand-Ready Technical Support (“Technical Support”) including the transfer of trade secrets and other know-how, production of materials, scale-up support, analytical testing, etc., and (iii) access to new Intellectual Property (“IP”) that may be developed sometime during the course of the contract period (“New Improvements”). Given the nature of IP development, such New Improvements are on an unspecified basis and can occur and be made available to licensees at any time during the contract period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When a contract includes more than one performance obligation, the Company needs to allocate the total consideration to each performance obligation based on its relative standalone selling price or estimate the standalone selling price if it is not observable. A standalone selling price is not available for our performance obligations since we do not sell any of the services separately and there is no competitor pricing that is available. As a consequence, the best method for determining standalone selling price of our Grant of Use performance obligation is through a comparison of the average royalty rate for comparable license agreements as compared to our license agreements. Comparable license agreements must consider several factors including: (i) the materials that are being licensed, (ii) the market application for the licensed materials, and (iii) the financial terms in the license agreements that can increase or decrease the risk/reward nature of the agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on the royalty rate comparison referred to above, any pricing above and beyond the average royalty rate would relate to the Technical Support and New Improvements performance obligations. The Company focuses a significant portion of its time and resources to provide the Technical Support and New Improvements services to its licensees, which further supports the conclusions reached using the royalty rate analysis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Technical Support and New Improvements performance obligations are co-terminus over the term of the license agreement. For purposes of determining the transaction price, and recognizing revenue, the Company combined the Technical Support and New Improvements performance obligations because they have the same pattern of transfer and the same term. We maintain a staff of scientists and other professionals whose primary job responsibilities throughout the year are: (i) being available to respond to Technical Support needs of our licensees, and (ii) developing improvements to our technology which are offered to our licensees as New Improvements. Since the costs incurred to satisfy the Technical Support and New Improvements performance obligations are incurred evenly throughout the year, the value of the Technical Support and New Improvements services are recognized throughout the initial contract period as these performance obligations are satisfied. If the agreement is not terminated at the end of the initial contract period, it will renew on the same terms as the initial contract for a one-year period. Consequently, any fees or minimum annual royalty obligations relating to this renewal contract will be allocated similarly to the initial contract over the additional one-year period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We recognize revenue when or as the performance obligations in the contract are satisfied. For performance obligations that are fulfilled at a point in time, revenue is recognized at the fulfillment of the performance obligation. Since the IP is determined to be a functional license, the value of the Grant of Use is recognized in the first period of the contract term in which the license agreement is in force. The value of the Technical Support and New Improvements obligations is allocated throughout the contract period based on the satisfaction of its performance obligations. If the agreement is not terminated at the end of the contract period, it will renew on the same terms as the original agreement for a one-year period. Consequently, any fees or minimum annual royalties (“MAR”) relating to this renewal contract will be allocated similarly over that additional year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s license agreements have a variable royalty fee structure (meaning that royalties are a fixed percentage of sales that vary from period to period) and frequently include a minimum annual royalty commitment. In instances when sales of licensed products by its licensees exceed the MAR, the Company recognizes fee income as the amounts have been earned. Typically, the royalty rate for such sales is <span id="xdx_90E_ecustom--RoyaltyRateOnSellingPrice_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--TypeOfArrangementAxis__custom--LicenseAgreementMember__srt--RangeAxis__srt--MinimumMember_z9KrNWWMezWd" title="Royalty rate on selling price">10</span>-<span id="xdx_902_ecustom--RoyaltyRateOnSellingPrice_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--TypeOfArrangementAxis__custom--LicenseAgreementMember__srt--RangeAxis__srt--MaximumMember_z0dmO1XuIqS" title="Royalty rate on selling price">15</span>% of the selling price. While this is variable consideration, it is subject to the sales/usage royalty exception to recognition of variable consideration in ASC 606 10-55-65 and therefore is not recognized until the subsequent sales or usage occurs or the MAR period commences.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because of the immediate recognition of the Grant of Use performance obligation: (i) the first period of the contract term will generally have a higher percent allocation of the transaction price under ASC 606 and (ii) the remaining periods will have less of the transaction price recognized under ASC 606. After the initial period in the contract term, the revenue for the remaining periods will be based on the satisfaction of the technical support and New Improvements obligations. Since most of our license agreements start as of January 1st, the revenue recognized for the contract under ASC 606 in our first quarter will tend to be higher subsequent quarters in the fiscal year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain of the contract fees are accrued by, or paid to, the Company in advance of the period in which they are earned resulting in deferred revenue. Such excess amounts are recorded as deferred revenue and are recognized as revenue in future periods as earned.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company operates in a single business segment which is engaged in the development and marketing of technology and devices to control the flow of light. Our revenue source comes from the licensing of this technology and all of these license agreements have similar terms and provisions. The majority of the Company’s licensing fee income comes from the activities of several licensees participating in the automotive market. The Company currently believes that the automotive market will be the largest source of its royalty income over the next several years. The Company’s royalty income from this market may be influenced by numerous factors including various trends affecting demand in the automotive industry and the rate of introduction of new technology in OEM product lines. In addition to these macro factors, the Company’s royalty income from the automotive market could also be influenced by specific factors such as whether the Company’s SPD-SmartGlass technology appears as standard equipment or as an option on a particular vehicle, the number of additional vehicle models that SPD-SmartGlass appears on, the size of each window on a vehicle and the number of windows on a vehicle that use SPD SmartGlass, fluctuations in the total number of vehicles produced by a manufacturer, and in the percentage of cars within each model produced with SPD-SmartGlass, and changes in pricing or exchange rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, the Company has one license agreement that are in its initial multiyear term (“Initial Term”) with continuing performance obligations going forward. The Initial Term of this agreement will end as of December 31, 2024, The Company currently expects this agreement will renew annually at the end of the Initial Term. As of December 31, 2022, the aggregate amount of the revenue to be recognized upon the satisfaction of the remaining performance obligations for this license agreements is $<span id="xdx_907_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--LicenseAgreementMember_zSEo2YImeES6" title="Remaining performance obligations">123,000</span>. The revenue for the remaining performance obligations for this license agreement is expected to be recognized evenly throughout the remaining period of the Initial Term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2022 and 2021, the Company entered into a number of license agreements covering its light control technology. The Company received minimum annual royalties under certain license agreements and recorded fee income based on ASC 606 revenue recognition each quarter. In instances when sales of licensed products by its licensees exceed minimum annual royalties, the Company recognized additional fee income as the amounts have been earned. Certain of the fees are accrued by, or paid to, the Company in advance of the period in which they are earned resulting in deferred revenue. Such excess amounts are recorded as deferred revenue and are typically recognized as fee income when earned. As of December 31, 2022 and 2021, there was no balance in deferred revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee income represents amounts earned by the Company under various license and other agreements relating to technology developed by the Company. During 2022, four licensees accounted for <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--ProductOrServiceAxis__custom--LicenseeOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z5D4VCYPDNX2" title="Concentration risk, percentage">28</span>%, <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--ProductOrServiceAxis__custom--LicenseeTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zschEjYlelY5" title="Concentration risk, percentage">23</span>%, <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--ProductOrServiceAxis__custom--LicenseeThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zyohmyui28u5" title="Concentration risk, percentage">13</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--ProductOrServiceAxis__custom--LicenseeFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zoVI9FEameHg" title="Concentration risk, percentage">11</span>% of fee income recognized during the year. During 2021, four licensees accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--ProductOrServiceAxis__custom--LicenseeOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zRsFeWRcVXSe" title="Concentration risk, percentage">20</span>%, <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--ProductOrServiceAxis__custom--LicenseeTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z7JZZngWMtQe" title="Concentration risk, percentage">18</span>%, <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--ProductOrServiceAxis__custom--LicenseeThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zNK9RzmN4TIi" title="Concentration risk, percentage">18</span>% and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--ProductOrServiceAxis__custom--LicenseeFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zdEeq6Yvofv3" title="Concentration risk, percentage">12</span>% of fee income recognized during the year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> 0.10 0.15 123000 0.28 0.23 0.13 0.11 0.20 0.18 0.18 0.12 <p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_zkBX0ySF3JK7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <span id="xdx_861_zu7dMVK1JMte">Basic and Diluted Loss Per Common Share</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic loss per share excludes any dilution. It is based upon the weighted average number of common shares outstanding during the period. Dilutive loss per share reflects the potential dilution that would occur if securities or other contracts to issue common stock were exercised or converted into common stock. The Company’s dilutive loss per share equals basic loss per share for each of the years in the two-year period ended December 31, 2022 because all potentially dilutive securities (i.e<i>., </i>options and warrants) were antidilutive in those periods. The number of options and warrants that were not included because their effect is antidilutive was <span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--OptionsAndWarrantsMember_zAnc26xC6HOj" title="Antidilutive securities">4,146,951</span> and <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--OptionsAndWarrantsMember_zvbPF0oOKi5a" title="Antidilutive securities">2,599,701</span> for 2022 and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 4146951 2599701 <p id="xdx_840_eus-gaap--ResearchAndDevelopmentExpensePolicy_zffRFvjoOw4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <span id="xdx_869_zlRxhawFZES5">Research and Development Costs</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development costs are charged to expense as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zXzKqzojutCd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <span id="xdx_86C_zQde0eeKGMgf">Patent Costs</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company expenses costs relating to the development or acquisition of patents due to the uncertainty of the recoverability of these items.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--UseOfEstimates_zia28vczuL28" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <span id="xdx_86A_zHsGxw7Wd0W">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the Company’s consolidated financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during this period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--IncomeTaxPolicyTextBlock_znxFYlz14eo3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) <span id="xdx_869_zRto8lKebDr1">Income Taxes</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to be recovered or settled.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC Topic 740, we recognize tax benefits only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is <span id="xdx_90C_ecustom--RecognizedBenefitMeasured_c20220101__20221231_zIWelzBy9Vg2" title="Recognized benefit measured">greater than 50 percent</span> likely to be realized upon ultimate settlement. Unrecognized tax benefits are tax benefits claimed in tax returns that do not meet these recognition and measurement standards. We classify accrued interest and penalties related to any unrecognized tax benefits in our income tax provision. At December 31, 2022 and 2021, we do not have accrued interest and penalties related to any unrecognized tax benefits. We do not believe we have any uncertain tax positions as of December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The tax years subject to examination by major tax jurisdictions include the years 2017 and forward by the U.S. Internal Revenue Service and certain states. The Company is not currently being audited by any tax jurisdiction.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> greater than 50 percent <p id="xdx_841_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zgjISkwyGVWc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) <span id="xdx_860_zf086JEsrHP5">Equity-Based Compensation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We recognize all stock-based compensation as an expense in the consolidated financial statements and such costs are measured at the fair value of the award at the date of grant. In addition to reflecting compensation expense for new share-based payment awards, expense is also recognized to reflect the remaining vesting period of awards that had been granted in prior periods. Tax benefits related to stock option exercises are reflected as financing cash inflows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The exercise prices for stock options granted are generally set at the average for the high and low trading prices of the Company’s common stock on the trading date immediately prior to the date of grant, and the related numbers of shares granted are fixed at the date of grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to determine the fair value of stock options on the date of grant, the Company uses the Black-Scholes option-pricing model. Inherent in this model are assumptions related to expected stock-price volatility, option term, risk-free interest rate and dividend yield. While the risk-free interest rate and dividend yield are less subjective assumptions that are based on factual data derived from public sources, the expected stock-price volatility and option term assumptions require a greater level of judgment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with employee and director stock options, the Company charged to compensation expense $<span id="xdx_906_eus-gaap--ShareBasedCompensation_pp0p0_c20220101__20221231__srt--TitleOfIndividualAxis__custom--EmployeesAndDirectorsMember_zXopPVnR1iE8" title="Share based compensation">232,291</span> and $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_pp0p0_c20210101__20211231__srt--TitleOfIndividualAxis__custom--EmployeesAndDirectorsMember_zeQovMhes87g" title="Share based compensation">217,008</span> during the years ended December 31, 2022 and 2021, respectively. As of December 31, 2022, these awards were fully vested. In lieu of higher cash compensation, the Company has granted warrants and non-employee options to consultants. These warrants and non-employee options vested fully on the date of grant. There were no such charges for the year ended December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 232291 217008 <p id="xdx_849_ecustom--RestrictedStockPolicyTextBlock_z60R2QwyzXhh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) <span id="xdx_862_zcqBFHqKaIl9">Restricted Stock</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation cost for restricted stock is measured using the quoted market price of the Company’s common stock at the date the common stock is granted. The compensation cost is recognized over the period between the issue date and the vesting period for such shares. Restricted stock is included in total common shares outstanding upon the lapse of any vesting conditions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zOrD8my09cr" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) <span id="xdx_868_zyjVpdFbz33k">Impairment of Long-Lived Assets</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reviews long-lived assets to determine whether an event or change in circumstances indicates the carrying value of the asset may not be recoverable. The Company bases its evaluation on such impairment indicators as the nature of the assets, the future economic benefit of the assets and any historical or future profitability measurements, as well as other external market conditions or factors that may be present. There was <span id="xdx_908_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_do_c20220101__20221231_zYulNRfMoOja" title="Impairment of long-lived assets"><span id="xdx_90A_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_do_c20210101__20211231_zYSxFcQArMch" title="Impairment of long-lived assets">no</span></span> impairment of long-lived assets recorded during 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 0 <p id="xdx_849_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z3313bhEhgYl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) <span id="xdx_863_z0ve9i2f6xI7">Fair Value Measurements</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022 and 2021, the fair value of the Company’s financial assets and non-warrant liabilities including cash and cash equivalents, marketable securities, royalties receivable, accounts payable and accrued expenses approximated carrying value due to the short-term maturity of these instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zOxRqIpOohag" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) <span id="xdx_860_zchWk7DfOP7i">Recent Accounting Pronouncements</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>New Accounting Standards</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company believes that no new accounting standards that are not yet effective will have a material effect on the Company’s consolidated financial statements.</span></p> <p id="xdx_80C_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zjvMlkjDg6Ri" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3) <span style="text-decoration: underline"><span id="xdx_824_zmzwJawVw32e">Fixed Assets</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--PropertyPlantAndEquipmentTextBlock_z5q40ajlqI2e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed assets and their estimated useful lives as of December 31, 2022 and 2021 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8BB_zACsGOhkeAgh" style="display: none">Schedule of Fixed Assets</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center">Estimated useful life</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Equipment and furniture</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--EquipmentAndFurnitureMember_zms1D6X4mJGh" title="Fixed assets, gross">1,392,365</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--EquipmentAndFurnitureMember_z24KIkUcdNaj" title="Fixed assets, gross">1,391,094</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="text-align: center; width: 20%"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_pp0p0_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--EquipmentAndFurnitureMember_zDfXYGyxbdxi" title="Estimated useful life">5</span> years</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Trade show materials</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeShowMaterialsMember_z7myTHjSwdNc">775,654</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeShowMaterialsMember_zLKmhTSmvpbd">775,654</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_pp0p0_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeShowMaterialsMember_zkcSTlNqtV8g" title="Estimated useful life">5</span> years</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Autos</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--AutosMember_z4h8HrJPqmv2">53,764</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--AutosMember_zvxp7sHAmXi5">53,764</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_pp0p0_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--AutosMember_zIQvkQX1ok36" title="Estimated useful life">5</span> years</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">Life of lease or estimated</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Leasehold improvements</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zBwV8eb25RM">584,967</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zyXf9DlB4wj9">584,967</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center">life of asset if shorter</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231_znXCg2N90Ztg" title="Fixed assets, gross">2,806,750</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentGross_c20211231_pp0p0" title="Fixed assets, gross">2,805,479</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Less accumulated depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">and amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_901_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20221231_zKvXfeHORbLe" title="Less accumulated depreciation and amortization">(2,741,362</span></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_909_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20211231_zlDPD3e7LEll" title="Less accumulated depreciation and amortization">(2,712,525</span></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20221231_zsXyeKxUE55a" title="Fixed assets, net">65,388</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentNet_c20211231_pp0p0" title="Fixed assets, net">92,954</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: center"> </td></tr> </table> <p id="xdx_8AC_zdaCWrCvxn7h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_899_eus-gaap--PropertyPlantAndEquipmentTextBlock_z5q40ajlqI2e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed assets and their estimated useful lives as of December 31, 2022 and 2021 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8BB_zACsGOhkeAgh" style="display: none">Schedule of Fixed Assets</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center">Estimated useful life</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Equipment and furniture</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--EquipmentAndFurnitureMember_zms1D6X4mJGh" title="Fixed assets, gross">1,392,365</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--EquipmentAndFurnitureMember_z24KIkUcdNaj" title="Fixed assets, gross">1,391,094</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="text-align: center; width: 20%"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_pp0p0_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--EquipmentAndFurnitureMember_zDfXYGyxbdxi" title="Estimated useful life">5</span> years</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Trade show materials</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeShowMaterialsMember_z7myTHjSwdNc">775,654</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeShowMaterialsMember_zLKmhTSmvpbd">775,654</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_pp0p0_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeShowMaterialsMember_zkcSTlNqtV8g" title="Estimated useful life">5</span> years</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Autos</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--AutosMember_z4h8HrJPqmv2">53,764</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--AutosMember_zvxp7sHAmXi5">53,764</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_pp0p0_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--AutosMember_zIQvkQX1ok36" title="Estimated useful life">5</span> years</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">Life of lease or estimated</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Leasehold improvements</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zBwV8eb25RM">584,967</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zyXf9DlB4wj9">584,967</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center">life of asset if shorter</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231_znXCg2N90Ztg" title="Fixed assets, gross">2,806,750</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentGross_c20211231_pp0p0" title="Fixed assets, gross">2,805,479</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Less accumulated depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">and amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_901_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20221231_zKvXfeHORbLe" title="Less accumulated depreciation and amortization">(2,741,362</span></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_909_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20211231_zlDPD3e7LEll" title="Less accumulated depreciation and amortization">(2,712,525</span></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20221231_zsXyeKxUE55a" title="Fixed assets, net">65,388</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentNet_c20211231_pp0p0" title="Fixed assets, net">92,954</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: center"> </td></tr> </table> 1392365 1391094 P5Y 775654 775654 P5Y 53764 53764 P5Y 584967 584967 2806750 2805479 2741362 2712525 65388 92954 <p id="xdx_809_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zbURYGn59W8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4) <span style="text-decoration: underline"><span id="xdx_826_znBzyna3FIlb">Accrued Expenses and Other</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zi7xe7SlnF5a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses consist of the following at December 31, 2022 and 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8BD_z007JgCRuJJ7" style="display: none">Schedule of Accrued Expenses and Other</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20221231_zS8Q4gKHeZzj" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20211231_z45lgFhdBps2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pp0p0_maAEAOCzZhA_zuEUSdXDHKh7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left">Payroll, bonuses and related benefits</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">29,219</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">45,725</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0_maAEAOCzZhA_zRyHwZE0E5g7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Professional services</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,300</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maAEAOCzZhA_z7qmiG9y9idi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">360</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">360</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AccruedLiabilitiesCurrent_iTI_pp0p0_mtAEAOCzZhA_zm4AcUAV1Uy9" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">34,379</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">49,385</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zcZJx2oZB1Ae" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_89A_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zi7xe7SlnF5a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses consist of the following at December 31, 2022 and 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8BD_z007JgCRuJJ7" style="display: none">Schedule of Accrued Expenses and Other</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20221231_zS8Q4gKHeZzj" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20211231_z45lgFhdBps2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pp0p0_maAEAOCzZhA_zuEUSdXDHKh7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left">Payroll, bonuses and related benefits</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">29,219</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">45,725</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0_maAEAOCzZhA_zRyHwZE0E5g7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Professional services</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,300</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maAEAOCzZhA_z7qmiG9y9idi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">360</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">360</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AccruedLiabilitiesCurrent_iTI_pp0p0_mtAEAOCzZhA_zm4AcUAV1Uy9" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">34,379</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">49,385</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 29219 45725 4800 3300 360 360 34379 49385 <p id="xdx_801_eus-gaap--IncomeTaxDisclosureTextBlock_zSiT1SjFscof" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5) <span style="text-decoration: underline"><span id="xdx_829_zpAdE6Hgh9ib">Income Taxes</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since inception, the Company has incurred losses from operations and as a result has not recorded income tax expense. Benefits related to net operating loss carryforwards and deferred items have been fully reserved because it is not more likely than not that the Company will achieve profitable operations. The difference between the total income taxes at the federal statutory rate for each of the years ended December 31, 2022 and 2021 and the fact that no income tax benefit was recorded in each of these years is attributable to the change in the valuation allowance recorded in each year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Tax Cuts and Jobs Act of 2017 (“TCIA”) amended IRC Section 174 to require capitalization of all research and development (“R&amp;D”) costs incurred in tax years beginning after December 31, 2021. <span id="xdx_90A_ecustom--AmortizedCostTermDescription_c20220101__20221231_zAq1pvZmhGV" title="Amortized cost term description">These costs are required to be amortized over five years if the R&amp;D activities are performed in the U.S., or over 15 years if the activities were performed outside the U.S.</span> For tax reporting purposes, the Company capitalized $<span id="xdx_902_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_iI_c20221231_zbOOPViSvASd" title="Research and development expense">609,000</span> of R&amp;D expenses incurred as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 16, 2022, the Inflation Reduction Act (“IRA”) was signed into law in the United States. Among other provisions, the IRA includes a <span id="xdx_90A_ecustom--CorporateMinimumTaxRate_iI_pid_dp_c20220816_zzLaLSPjk709" title="Corporate minimum tax rate">15</span>% corporate minimum tax rate which applies to certain large corporations and a <span id="xdx_90A_ecustom--ExciseTaxOnCorporateStockRate_iI_pid_dp_c20221231_zG2do6NuDM37" title="Excise tax on corporate stock">1</span>% excise tax on corporate stock repurchases made after December 31, 2022. We do not expect the IRA to have a material impact on our consolidated financial statements. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z08aHzSVpnUl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The tax effects of temporary differences that give rise to significant portions of the deferred tax assets at December 31, 2022 and 2021 are presented below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span id="xdx_8BA_zmW6w8TK4MUk" style="display: none">Schedule of Deferred Tax Assets</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20221231_zBOEL0GXtVyk" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20211231_z5ChT0MI8Jbd" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsPropertyPlantAndEquipment_iI_pp0p0_maDTAGzSKS_zSqKU8GSjmVe" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 62%">Depreciation</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">109,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">106,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_iI_pp0p0_maDTAGzSKS_zWuP9JHre7i3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Allowance for bad debts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">248,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">218,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTAGzSKS_zXucFnKQo3D7" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Net operating loss carry-forwards</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,561,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14,114,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pp0p0_maDTAGzSKS_zGj3Y7ba3efk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Stock option expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">334,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">355,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_iI_pp0p0_maDTAGzSKS_z8MtmgKY7nyl" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Research and other credits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">891,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">945,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--DeferredTaxAssetsLeaseLiability_iI_pp0p0_maDTAGzSKS_ziM6fY7DE4b9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Lease liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">99,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">138,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--DeferredTaxAssetsAmortization_iI_pp0p0_maDTAGzSKS_zvnwPXiRpL98" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">Amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">130,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0506">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzSKS_maDTANzkep_maDTANzdu4_zVf4dwEwUw2l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Total gross deferred tax assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,372,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,876,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred tax liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--DeferredTaxLiabilitiesLeasingArrangements_iI_maDITLz6F0_zjo4cImB98s4" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Lease liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">69,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">101,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxLiabilitiesOther_iI_maDITLz6F0_zMdEamcZQyD5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Other temporary differences</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0514">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">22,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredIncomeTaxLiabilities_iTI_mtDITLz6F0_msDTANzdu4_z4XPktvalnwa" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Total gross deferred tax liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">69,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">123,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzkep_msDTANzdu4_z1pkJKCyAgM8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(15,303,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(15,753,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_zRpPHUajMRfi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Net deferred tax</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0523">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0524">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zkkKWbh7ukB6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zMVwiaEu4cQf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The reconciliation of the income tax expense (benefit) computed at the federal statutory tax rates to income tax expense (benefit) is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B1_zJg9RwnCTm59" style="display: none">Schedule of Reconciliation Income Tax Expenses Benefit</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220101__20221231_zAd4OHQ9XMOj" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20210101__20211231_zpfVqw9yZGf2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBza9v_zmivi0IzLQJd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left">Income tax provision at federal statutory rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">(561,000</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">(388,000</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--IncomeTaxReconciliationOtherAdjustments_maITEBza9v_zHlNJeOtZtPh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expired carryforwards and other</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,011,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,079,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBza9v_zGsKNwHJeU3a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(450,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(691,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBza9v_zhKPmRXmN4hb" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total income tax provision</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0537">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0538">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zhDUEdmjyfo3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In assessing the realizability of deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon future taxable income during the period in which those temporary differences become deductible. The Company considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Based upon its historical operating losses, utilization of deferred tax assets cannot currently be determined. Accordingly, the Company has recorded a full valuation allowance against the deferred tax assets due to the uncertainty regarding the future utilization of the deferred tax assets for all periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022, the Company had net operating loss carryforwards for federal income tax purposes of approximately $<span id="xdx_900_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20221231_zc5TegVYMwra" title="Net operating loss carry-forward">63,370,000</span>. Net operating loss carryforwards accumulated through December 31, 2017 of approximately $<span id="xdx_900_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20221231_zKXgOXfZWZEb" title="Net operating loss carry-forward with expiration">52,927,000</span> will <span id="xdx_907_ecustom--OperatingLossCarryforwardsExpirationDescription_c20220101__20221231_zHUrfflTgzs8" title="Net operating loss carry-forward expiration description">expire in varying amounts from 2023 through 2037</span>. Net operating losses generated since 2018, totaling approximately $<span id="xdx_904_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20221231__us-gaap--TaxPeriodAxis__custom--TaxYear2018To2022Member_z7K8AYXAgo1" title="Net operating loss carry-forward">10,443,000</span>, will carry forward indefinitely, but cannot offset more than <span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20220101__20221231_zRSy4J03qRNk" title="Income tax percentage">80</span> percent of taxable income. Research and other credit carryforwards of approximately $<span id="xdx_90E_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_iI_pp0p0_c20221231_z8gZ2lyV7iR9" title="Research and other credit carry-forwards">891,000</span> are available to the Company to reduce income taxes payable in future years principally through 2040. The Company’s ability to utilize its net operating loss carryforwards and its current year tax credits in future periods could be subject to the 382 limitation. The Company will need to complete an analysis to determine whether its net operating losses are subject to the 382 limitation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> These costs are required to be amortized over five years if the R&D activities are performed in the U.S., or over 15 years if the activities were performed outside the U.S. 609000 0.15 0.01 <p id="xdx_89A_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z08aHzSVpnUl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The tax effects of temporary differences that give rise to significant portions of the deferred tax assets at December 31, 2022 and 2021 are presented below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span id="xdx_8BA_zmW6w8TK4MUk" style="display: none">Schedule of Deferred Tax Assets</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20221231_zBOEL0GXtVyk" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20211231_z5ChT0MI8Jbd" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsPropertyPlantAndEquipment_iI_pp0p0_maDTAGzSKS_zSqKU8GSjmVe" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 62%">Depreciation</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">109,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">106,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_iI_pp0p0_maDTAGzSKS_zWuP9JHre7i3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Allowance for bad debts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">248,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">218,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTAGzSKS_zXucFnKQo3D7" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Net operating loss carry-forwards</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,561,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14,114,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pp0p0_maDTAGzSKS_zGj3Y7ba3efk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Stock option expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">334,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">355,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_iI_pp0p0_maDTAGzSKS_z8MtmgKY7nyl" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Research and other credits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">891,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">945,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--DeferredTaxAssetsLeaseLiability_iI_pp0p0_maDTAGzSKS_ziM6fY7DE4b9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Lease liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">99,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">138,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--DeferredTaxAssetsAmortization_iI_pp0p0_maDTAGzSKS_zvnwPXiRpL98" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">Amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">130,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0506">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzSKS_maDTANzkep_maDTANzdu4_zVf4dwEwUw2l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Total gross deferred tax assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,372,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,876,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred tax liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--DeferredTaxLiabilitiesLeasingArrangements_iI_maDITLz6F0_zjo4cImB98s4" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Lease liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">69,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">101,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxLiabilitiesOther_iI_maDITLz6F0_zMdEamcZQyD5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Other temporary differences</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0514">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">22,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredIncomeTaxLiabilities_iTI_mtDITLz6F0_msDTANzdu4_z4XPktvalnwa" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Total gross deferred tax liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">69,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">123,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzkep_msDTANzdu4_z1pkJKCyAgM8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(15,303,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(15,753,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_zRpPHUajMRfi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Net deferred tax</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0523">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0524">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 109000 106000 248000 218000 13561000 14114000 334000 355000 891000 945000 99000 138000 130000 15372000 15876000 69000 101000 22000 69000 123000 15303000 15753000 <p id="xdx_899_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zMVwiaEu4cQf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The reconciliation of the income tax expense (benefit) computed at the federal statutory tax rates to income tax expense (benefit) is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B1_zJg9RwnCTm59" style="display: none">Schedule of Reconciliation Income Tax Expenses Benefit</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220101__20221231_zAd4OHQ9XMOj" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20210101__20211231_zpfVqw9yZGf2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBza9v_zmivi0IzLQJd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left">Income tax provision at federal statutory rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">(561,000</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">(388,000</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--IncomeTaxReconciliationOtherAdjustments_maITEBza9v_zHlNJeOtZtPh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expired carryforwards and other</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,011,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,079,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBza9v_zGsKNwHJeU3a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(450,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(691,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBza9v_zhKPmRXmN4hb" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total income tax provision</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0537">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0538">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> -561000 -388000 1011000 1079000 -450000 -691000 63370000 52927000 expire in varying amounts from 2023 through 2037 10443000 0.80 891000 <p id="xdx_802_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z8CvpScbIjo2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6) <span style="text-decoration: underline"><span id="xdx_82D_zdgtlViyjGsi">Shareholders’ Equity</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Common Stock and Warrants</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2021, the Company received proceeds of $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--OptionsAndWarrantsMember_zW1M00KCBuZe" title="Proceeds from issuance of stock">86,262</span> and issued <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--OptionsAndWarrantsMember_zm2ywlG0y22" title="Number of shares issued during the period">74,610</span> shares of common stock in connection with the exercise of outstanding options and warrants. In addition, during February 2023, the Company received proceeds of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230201__20230228__us-gaap--StatementEquityComponentsAxis__custom--OptionsAndWarrantsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zEpkn0duJNi6" title="Proceeds from issuance of stock">484,503</span> and issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230201__20230228__us-gaap--StatementEquityComponentsAxis__custom--OptionsAndWarrantsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1KYUKgyU1H7" title="Number of shares issued during the period">358,891</span>common shares in connection with the exercise of outstanding warrants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 16, 2022, the Company entered into subscription agreements from a group of private accredited investors to sell them <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pn5n6_c20220914__20220916__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zG2ss2HrRhz4" title="New Issues">2.0</span> million shares of common stock of the Company at a price of $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_c20220916__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zVZI5v005ale" title="Shares issued price per share">2.30</span> per share (which represents the closing market price of the Company’s common stock on September 14, 2022 which was the date that the transaction was agreed to). As of December 31, 2022, the Company received $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_z4STq2KXYGF1" title="Proceeds from issuance of stock">3,450,000</span> under these subscription agreements and has issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsDSi0ZEDO7k" title="Stock issued during period shares">1,500,000</span> common shares and issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zWAuNlgYx6bd" title="Stock issued during period shares">1,500,000</span> warrants. In addition, the Company expects to receive the remaining $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zfrfynHlr4D2" title="Stock issued value">1,150,000</span> under these subscription agreements in March, 2023. </span>The shares were issued to the investors in a private placement and, along with the shares issued in connection with the exercise of any warrants in the future, are not registered and therefore currently subject to at least a six-month holding period by the investor.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Options and Warrants</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.4in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <span style="text-decoration: underline">Employee Options</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.4in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2019, the shareholders approved the Company’s 2019 Equity Incentive Plan, which provides for the granting of both incentive stock options at the fair market value at the date of grant and nonqualified stock options at the fair market value at the date of grant to employees or non-employees who, in the determination of the Board of Directors, have made or may make significant contributions to the Company in the future. The Company may also award stock appreciation rights, restricted stock, or restricted stock units under this plan. The Company initially reserved <span id="xdx_90E_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20221231__us-gaap--PlanNameAxis__custom--TwoThousandNineteenEquityIncentivePlanMember_zjytmi3Pu1yj" title="Shares of common stock reserved for issuance">1,400,000</span> shares of its common stock for issuance under this plan, and <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20221231__us-gaap--PlanNameAxis__custom--TwoThousandNineteenEquityIncentivePlanMember_z4e33Rrr9cQb" title="Shares available for issuance">307,500</span> options and other awards were available for issuance under this plan as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.4in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At the discretion of the Board of Directors, options expire in ten years or less from the date of grant and are generally fully exercisable upon grant but in some cases may be subject to vesting in the future. Full payment of the exercise price may be made in cash or in shares of common stock valued at the fair market value thereof on the date of exercise, or by agreeing with the Company to cancel a portion of the exercised options.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.4in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company granted <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220101__20221231_zrTU7QeD6aUh" title="Number of options vested">178,000</span> fully vested options during 2022 and recorded share-based compensation of $<span id="xdx_900_eus-gaap--ShareBasedCompensation_pp0p0_c20220101__20221231_zgKFVtQOjmk3" title="Share based compensation">232,291</span>. The Company granted <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20210101__20211231_z1rPlkKS5fe8" title="Number of options vested">198,000</span> fully vested options during 2021 and recorded share-based compensation of $<span id="xdx_905_eus-gaap--ShareBasedCompensation_pp0p0_c20210101__20211231_zWlATjIlghoh" title="Share based compensation">217,008</span>. The Company valued these grants using the Black-Scholes option pricing model with the following weighted average assumptions:</span></p> <p id="xdx_894_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zxKinBytb43f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.4in; text-align: justify; text-indent: 0in"><span id="xdx_8B2_zRRxWBdqpYwa" style="display: none">Schedule of Assumptions Used to Value Options Granted to Employees</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left">Fair value on grant date</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220101__20221231_zpfXGbsBSjOa" title="Fair value on grant date">1.31</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231_zsz7ziylXsb5" title="Fair value on grant date">1.10</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20220101__20221231_zis6kl9qIsja" title="Expected dividend yield"><span style="-sec-ix-hidden: xdx2ixbrl0592">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20210101__20211231_zIMKSnyWgO34" title="Expected dividend yield"><span style="-sec-ix-hidden: xdx2ixbrl0594">-</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20220101__20221231_z5k8zUiDzyQb" title="Expected volatility">81</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20210101__20211231_zgIs1ecTLKye" title="Expected volatility">79</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20220101__20221231_zXA7kenwZIsa" title="Risk free interest rate">3.99</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20210101__20211231_zQQaPgxlprP7" title="Risk free interest rate">1.26</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected term of the option</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231_zZLbqgw8hIZa" title="Expected term of the option">5</span> years</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231_zrsMaS5qQxPc" title="Expected term of the option">5</span> years</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A0_zOYUGD2t9bpi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zdY2H07lf6sh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Activity for stock options is summarized below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B1_zqAtZT8AZuYg" style="display: none">Schedule of Option Activity</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number of Shares Subject to Option</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted Average Remaining Contractual Term (Years)</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Aggregate Intrinsic Value</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; padding-bottom: 1.5pt">Balance at January 1, 2021</td><td style="width: 3%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_z5wbqwBzMtK4" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Number of Shares Subject to Option, Beginning">1,297,260</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 3%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zLUBtoSetQ15" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Weighted Average Exercise Price, Beginning">4.09</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 3%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200101__20201231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zaHu61h0J9wi" title="Weighted Average Remaining Contractual Term (Years), Beginning">5.8</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 3%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20210101__20211231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zm2mntsilY6i" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Aggregate Intrinsic Value, Beginning">142,885</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zz67lZIR61Ie" style="text-align: right" title="Number of Shares Subject to Option, Granted">198,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zUKNekXFNIRh" style="text-align: right" title="Weighted Average Exercise Price, Granted">1.72</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20210101__20211231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zHv56EiUNHNi" style="text-align: right" title="Number of Shares Subject to Option, Cancelled">(155,050</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210101__20211231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zEMDqDzFAYpc" style="text-align: right" title="Weighted Average Exercise Price, Cancelled">5.38</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210101__20211231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_z2YKL0yB9M94" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares Subject to Option, Exercised">(140,500</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210101__20211231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zCD1Xvns7zI2" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Exercised">2.48</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Balance at December 31, 2021</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zprcNBTdUCY5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares Subject to Option, Beginning">1,199,710</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zQfRMCx2pUog" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Beginning">3.67</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zhqSmWW6mx33" title="Weighted Average Remaining Contractual Term (Years), Beginning">5.7</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_z4fNAuYmldCk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Beginning">21,870</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_ziDo9yJjOHCf" style="text-align: right" title="Number of Shares Subject to Option, Granted">178,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zO85rcKfcXNf" style="text-align: right" title="Weighted Average Exercise Price, Granted">1.95</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zMptucb9IICl" style="text-align: right" title="Number of Shares Subject to Option, Cancelled">(130,750</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_ztan0dJJ9POg" style="text-align: right" title="Weighted Average Exercise Price, Cancelled">4.91</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zOIzxWjsfjJb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares Subject to Option, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0646">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zUaFrZSHa5Ja" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0648">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Balance at December 31, 2022</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_z69pM44beFv6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares Subject to Option, Ending">1,246,960</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zJFXR8YgkHFd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Ending">3.35</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zZTdtZ7tdtfg" title="Weighted Average Remaining Contractual Term (Years), Ending">5.8</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zwS1QEmpV7V9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Ending">67,510</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_z7XzRNApZlB5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All options are exercisable at December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) Warrants and Non-Employee Options</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zjgnJWTRllPk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Activity in warrants is summarized below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span id="xdx_8BA_zvdOF62J9Dd1" style="display: none">Schedule of Warrant Activity</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 93%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number of Shares Underlying Warrants Granted</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"/><td> </td><td> </td> <td colspan="2" style="text-align: center"/><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; width: 62%">Balance at January 1, 2021</td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20210101__20211231_zNy0jUWDW8cd" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right" title="Number of Shares Underlying Warrants and Non-Employee Options Granted, Beginning">1,399,991</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_zPLKfmjrbvi4" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right" title="Weighted Average Exercise Price, Beginning">2.27</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20210101__20211231_zKqoO9yT4hEe" style="text-align: right" title="Number of Shares Underlying Warrants and Non-Employee Options Granted, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0664">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Terminated</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20210101__20211231_zbW94To0KIt1" style="text-align: right" title="Number of Shares Underlying Warrants and Non-Employee Options Granted, Terminated"><span style="-sec-ix-hidden: xdx2ixbrl0666">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Issued</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20210101__20211231_ztAkQ84asl7j" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares Underlying Warrants and Non-Employee Options Granted, Issued"><span style="-sec-ix-hidden: xdx2ixbrl0668">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Balance at December 31, 2021</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20220101__20221231_zFEI88Y4yaa6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares Underlying Warrants and Non-Employee Options Granted, Beginning">1,399,991</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231_zyELW3ixBuNj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Beginning">2.27</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20220101__20221231_zIJtaZe1nd67" style="text-align: right" title="Number of Shares Underlying Warrants and Non-Employee Options Granted, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0674">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Terminated</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20220101__20221231_zPqcT2Jyclpl" style="text-align: right" title="Number of Shares Underlying Warrants and Non-Employee Options Granted, Terminated"><span style="-sec-ix-hidden: xdx2ixbrl0676">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Issued</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20220101__20221231_zEnkUJonb0Cd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares Underlying Warrants and Non-Employee Options Granted, Issued">1,500,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssuedInPeriodWeightedAverageExercisePrice_c20220101__20221231_z7DumOUiTNJ7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Issued">2.76</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Balance at December 31, 2022</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20220101__20221231_zUYganO2w457" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares Underlying Warrants and Non-Employee Options Granted, Ending">2,899,991</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231_zJ6iUVusOmUd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Ending">2.52</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zr9nh9M5Jsk6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In lieu of cash compensation, the Company has granted warrants to investors and non-employee options to consultants. These warrants and non-employee options vested ratably over various terms ranging from <span id="xdx_90E_ecustom--WarrantsAndNonemployeeOptionsVestedTerm_dtM_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__custom--NonEmployeeStockOptionMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zAt2B4NUUe28" title="Warrants and non-employee options vested term">12</span> to <span id="xdx_901_ecustom--WarrantsAndNonemployeeOptionsVestedTerm_dtM_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__custom--NonEmployeeStockOptionMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zx81tMqTgMhc" title="Warrants and non-employee options vested term">59</span> months. The non-employee options are valued at fair value at the time that the related services are provided using the Black-Scholes option valuation model and marked to market quarterly using the Black-Scholes option valuation model. There are <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_z0WcyDEgiV96" title="Warrants outstanding">2,899,991</span> warrants issued to investors that are outstanding that are accounted for as equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants and non-employee options generally expire in <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dc_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__custom--NonEmployeeStockOptionMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zIvJsY8G8TI1" title="Option expiration period">five years</span> from the date of issuance. At December 31, 2022, all warrants and non-employee options outstanding were exercisable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Restricted Stock Grants</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2022 and 2021, the Company did not issue restricted stock to its directors and employees.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 86262 74610 484503 358891 2000000.0 2.30 3450000 1500000 1500000 1150000 1400000 307500 178000 232291 198000 217008 <p id="xdx_894_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zxKinBytb43f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.4in; text-align: justify; text-indent: 0in"><span id="xdx_8B2_zRRxWBdqpYwa" style="display: none">Schedule of Assumptions Used to Value Options Granted to Employees</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left">Fair value on grant date</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220101__20221231_zpfXGbsBSjOa" title="Fair value on grant date">1.31</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231_zsz7ziylXsb5" title="Fair value on grant date">1.10</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20220101__20221231_zis6kl9qIsja" title="Expected dividend yield"><span style="-sec-ix-hidden: xdx2ixbrl0592">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20210101__20211231_zIMKSnyWgO34" title="Expected dividend yield"><span style="-sec-ix-hidden: xdx2ixbrl0594">-</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20220101__20221231_z5k8zUiDzyQb" title="Expected volatility">81</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20210101__20211231_zgIs1ecTLKye" title="Expected volatility">79</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20220101__20221231_zXA7kenwZIsa" title="Risk free interest rate">3.99</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20210101__20211231_zQQaPgxlprP7" title="Risk free interest rate">1.26</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected term of the option</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231_zZLbqgw8hIZa" title="Expected term of the option">5</span> years</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231_zrsMaS5qQxPc" title="Expected term of the option">5</span> years</span></td><td style="text-align: left"> </td></tr> </table> 1.31 1.10 0.81 0.79 0.0399 0.0126 P5Y P5Y <p id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zdY2H07lf6sh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Activity for stock options is summarized below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B1_zqAtZT8AZuYg" style="display: none">Schedule of Option Activity</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number of Shares Subject to Option</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted Average Remaining Contractual Term (Years)</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Aggregate Intrinsic Value</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; padding-bottom: 1.5pt">Balance at January 1, 2021</td><td style="width: 3%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_z5wbqwBzMtK4" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Number of Shares Subject to Option, Beginning">1,297,260</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 3%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zLUBtoSetQ15" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Weighted Average Exercise Price, Beginning">4.09</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 3%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200101__20201231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zaHu61h0J9wi" title="Weighted Average Remaining Contractual Term (Years), Beginning">5.8</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 3%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20210101__20211231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zm2mntsilY6i" style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right" title="Aggregate Intrinsic Value, Beginning">142,885</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zz67lZIR61Ie" style="text-align: right" title="Number of Shares Subject to Option, Granted">198,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zUKNekXFNIRh" style="text-align: right" title="Weighted Average Exercise Price, Granted">1.72</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20210101__20211231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zHv56EiUNHNi" style="text-align: right" title="Number of Shares Subject to Option, Cancelled">(155,050</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210101__20211231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zEMDqDzFAYpc" style="text-align: right" title="Weighted Average Exercise Price, Cancelled">5.38</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210101__20211231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_z2YKL0yB9M94" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares Subject to Option, Exercised">(140,500</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210101__20211231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zCD1Xvns7zI2" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Exercised">2.48</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Balance at December 31, 2021</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zprcNBTdUCY5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares Subject to Option, Beginning">1,199,710</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zQfRMCx2pUog" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Beginning">3.67</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zhqSmWW6mx33" title="Weighted Average Remaining Contractual Term (Years), Beginning">5.7</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_z4fNAuYmldCk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Beginning">21,870</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_ziDo9yJjOHCf" style="text-align: right" title="Number of Shares Subject to Option, Granted">178,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zO85rcKfcXNf" style="text-align: right" title="Weighted Average Exercise Price, Granted">1.95</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zMptucb9IICl" style="text-align: right" title="Number of Shares Subject to Option, Cancelled">(130,750</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_ztan0dJJ9POg" style="text-align: right" title="Weighted Average Exercise Price, Cancelled">4.91</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zOIzxWjsfjJb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares Subject to Option, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0646">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zUaFrZSHa5Ja" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0648">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Balance at December 31, 2022</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_z69pM44beFv6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares Subject to Option, Ending">1,246,960</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zJFXR8YgkHFd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Ending">3.35</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zZTdtZ7tdtfg" title="Weighted Average Remaining Contractual Term (Years), Ending">5.8</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20220101__20221231__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--StockOptionMember_zwS1QEmpV7V9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Ending">67,510</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 1297260 4.09 P5Y9M18D 142885 198000 1.72 155050 5.38 140500 2.48 1199710 3.67 P5Y8M12D 21870 178000 1.95 130750 4.91 1246960 3.35 P5Y9M18D 67510 <p id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zjgnJWTRllPk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Activity in warrants is summarized below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span id="xdx_8BA_zvdOF62J9Dd1" style="display: none">Schedule of Warrant Activity</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 93%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number of Shares Underlying Warrants Granted</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"/><td> </td><td> </td> <td colspan="2" style="text-align: center"/><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; width: 62%">Balance at January 1, 2021</td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20210101__20211231_zNy0jUWDW8cd" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right" title="Number of Shares Underlying Warrants and Non-Employee Options Granted, Beginning">1,399,991</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_zPLKfmjrbvi4" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right" title="Weighted Average Exercise Price, Beginning">2.27</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20210101__20211231_zKqoO9yT4hEe" style="text-align: right" title="Number of Shares Underlying Warrants and Non-Employee Options Granted, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0664">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Terminated</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20210101__20211231_zbW94To0KIt1" style="text-align: right" title="Number of Shares Underlying Warrants and Non-Employee Options Granted, Terminated"><span style="-sec-ix-hidden: xdx2ixbrl0666">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Issued</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20210101__20211231_ztAkQ84asl7j" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares Underlying Warrants and Non-Employee Options Granted, Issued"><span style="-sec-ix-hidden: xdx2ixbrl0668">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Balance at December 31, 2021</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20220101__20221231_zFEI88Y4yaa6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares Underlying Warrants and Non-Employee Options Granted, Beginning">1,399,991</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231_zyELW3ixBuNj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Beginning">2.27</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20220101__20221231_zIJtaZe1nd67" style="text-align: right" title="Number of Shares Underlying Warrants and Non-Employee Options Granted, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0674">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Terminated</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20220101__20221231_zPqcT2Jyclpl" style="text-align: right" title="Number of Shares Underlying Warrants and Non-Employee Options Granted, Terminated"><span style="-sec-ix-hidden: xdx2ixbrl0676">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Issued</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20220101__20221231_zEnkUJonb0Cd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares Underlying Warrants and Non-Employee Options Granted, Issued">1,500,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssuedInPeriodWeightedAverageExercisePrice_c20220101__20221231_z7DumOUiTNJ7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Issued">2.76</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Balance at December 31, 2022</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20220101__20221231_zUYganO2w457" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Shares Underlying Warrants and Non-Employee Options Granted, Ending">2,899,991</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231_zJ6iUVusOmUd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Ending">2.52</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 1399991 2.27 1399991 2.27 1500000 2.76 2899991 2.52 P12M P59M 2899991 P5Y <p id="xdx_80A_ecustom--LicenseAndOtherAgreementsTextBlock_zhyEZLx1UHHi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7) <span style="text-decoration: underline"><span id="xdx_822_zIiINBFpuIp1">License and Other Agreements</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has entered into a number of license agreements covering various products using the Company’s SPD technology. Some of these license agreements are limited to specific countries and/or markets. Licensees of Research Frontiers who incorporate SPD technology into end products pay Research Frontiers an earned royalty of <span id="xdx_90D_ecustom--RoyaltyEarnedPercentage_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z8DHpMnzzT9g" title="Royalty earned percentage">5</span>-<span id="xdx_90C_ecustom--RoyaltyEarnedPercentage_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_z0Ilt6OEzny5" title="Royalty earned percentage">15</span>% of net sales of licensed products under license agreements currently in effect and may also be required to pay Research Frontiers fees and minimum annual royalties. Licensees who sell products or components to other licensees of Research Frontiers do not pay a royalty on such sale; Research Frontiers will collect such royalty from the licensee incorporating such products or components into its own end-products. Research Frontiers’ license agreements typically allow the licensee to terminate the license after some period of time and give Research Frontiers only limited rights to terminate before the license expires. Most licenses are non-exclusive and generally last as long as our patents remain in effect.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 14, 2019, the Company suspended its VariGuard SmartGlass business unit activities. Instead, the Company licensed a new entity to pursue the business opportunities previously pursued by the Company’s VariGuard SmartGlass business unit. This new licensee continues to use the VariGuard SmartGlass name. In addition to other employees at VariGuard SmartGlass Inc., one of the Company’s officers (Michael R. LaPointe) and one former officer (Seth L. Van Voorhees) are shareholders of VariGuard SmartGlass Inc. and, as consequence, this transaction is a related party relationship which has been reviewed and approved by the Company’s Board of Directors pursuant to the requirements of Delaware corporate law and the Company’s Code of Ethics. Mr. LaPointe also remains a full-time employee at the Company. In October 2021, the Company entered into an amendment to the license agreement with VariGuard modifying its scope and terms.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.05 0.15 <p id="xdx_80C_eus-gaap--CommitmentsDisclosureTextBlock_z3dspWkVj8th" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8) <span style="text-decoration: underline"><span id="xdx_82B_zTfhx2TlHLrd">Commitments</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has an employment agreement with its chief executive officer which provides for an annual base salary of $<span id="xdx_905_eus-gaap--OfficersCompensation_pp0p0_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zxmihk8i5w8a" title="Annual base salary">500,000</span> for calendar year 2023. This employment agreement has an evergreen provision that extends the term by <span id="xdx_90C_ecustom--LeaseExpirationTerm_dc_c20220101__20221231_zyGqkkf3NyN1" title="Lease expiration term">one year</span> on the expiration date unless either the Company or the employee has given notice that they will not be renewing the agreement upon the expiration of its term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has a defined contribution profit sharing (401k) plan covering employees who have completed one year of service. Contributions are made at the discretion of the Company. The Company did not make any contributions to this plan for 2022 or 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company determines if an arrangement is a lease at its inception. This determination generally depends on whether the arrangement conveys the right to control the use of an identified fixed asset explicitly or implicitly for a period of time in exchange for consideration. Control of an underlying asset is conveyed if the Company obtains the rights to direct the use of, and to obtain substantially all of the economic benefits from the use of, the underlying asset. Lease expense for variable leases and short-term leases is recognized when the obligation is incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has operating leases for certain facilities, vehicles and equipment with a weighted average remaining lease term of <span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20221231_zD4UpuKR7IFa">2.2</span> years as of December 31, 2022. Operating leases are included in right of use lease assets, other current liabilities and long-term lease liabilities on the consolidated balance sheet. Right of use lease assets and liabilities are recognized at each lease’s commencement date based on the present value of its lease payments over its respective lease term. The Company does not have an established incremental borrowing rate as it does not have any debt. The Company uses the stated borrowing rate for a lease when readily determinable. When the interest rate implicit in its lease agreements is not readily determinable, the Company uses an interest rate based on the marketplace for public debt. The weighted average discount rate associated with operating leases as of December 31, 2022 is <span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_uPure_c20221231_z3BLzuiRynja">5.5</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zAx0h0drVRNa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturities of operating lease liabilities as of December 31, 2022 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B3_zXUm8AnDarm7" style="display: none">Schedule of Minimum Annual Future Rental Commitments</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_493_20221231_zJG65TUiQvwl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzBsY_zgckmM6UgQ" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 78%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year 1</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">                     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">217,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree_iI_pp0p0_maLOLLPzBsY_z0JykXCQXiK3" style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Years 2-3</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">278,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndFive_iI_pp0p0_maLOLLPzBsY_zfFsHJT1Pfw7" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Years 4-5</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0714">-</span> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_maLOLLPzBsY_zMj7hOlsYq27" style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0716">-</span> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzBsY_zIXcah0G4amj" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total lease payments</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">495,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zbZ0tgrMymV6" style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: imputed lease interest</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(30,872)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseLiability_iI_pp0p0_zMyTkeoZJQ82" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of lease liabilities</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">464,128</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AA_zONChAzOoeEj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 500000 P1Y P2Y2M12D 0.055 <p id="xdx_890_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zAx0h0drVRNa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturities of operating lease liabilities as of December 31, 2022 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B3_zXUm8AnDarm7" style="display: none">Schedule of Minimum Annual Future Rental Commitments</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_493_20221231_zJG65TUiQvwl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzBsY_zgckmM6UgQ" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 78%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year 1</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">                     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">217,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree_iI_pp0p0_maLOLLPzBsY_z0JykXCQXiK3" style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Years 2-3</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">278,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndFive_iI_pp0p0_maLOLLPzBsY_zfFsHJT1Pfw7" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Years 4-5</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0714">-</span> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_maLOLLPzBsY_zMj7hOlsYq27" style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0716">-</span> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzBsY_zIXcah0G4amj" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total lease payments</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">495,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zbZ0tgrMymV6" style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: imputed lease interest</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(30,872)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseLiability_iI_pp0p0_zMyTkeoZJQ82" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of lease liabilities</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">464,128</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 217000 278000 495000 30872 464128 <p id="xdx_803_ecustom--RightsPlanDisclosureTextBlock_zb1X99w90a8c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9) <span style="text-decoration: underline"><span id="xdx_828_zv8Pl00K0brd">Rights Plan</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2013, the Company’s Board of Directors adopted a Stockholders’ Rights Plan (the “Rights Plan”) and declared a dividend distribution of one right (a “Right”) for each outstanding share of Company common stock to stockholders of record at the close of business on March 3, 2003 (“Record Time”) and authorized the issuance of one Right in respect of each share of Common Stock issued after the Record Time and prior to the Separation Time. The Rights Plan was readopted and extended in December 2022 until February 11, 2033.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">“Separation Time” shall mean the earlier of the Close of Business on the tenth Business Day (or such later date as the Board of Directors may from time to time fix by resolution adopted prior to the Separation Time that otherwise would have occurred) following but not including (i) the date on which any Person commences a tender or exchange offer that, if consummated, would result in such Person’s becoming an Acquiring Person, and (ii) the date of the first event causing a Flip-in Date to occur; provided that if any tender or exchange offer referred to in clause (i) of this paragraph is cancelled, terminated or otherwise withdrawn prior to the Separation Time without the purchase of any shares of Common Stock pursuant thereto, such offer shall be deemed, for purposes of this paragraph, never to have been made.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to certain exceptions listed in the Rights Plan, if a person or group has acquired beneficial ownership of, or commences a tender or exchange offer for, <span id="xdx_909_ecustom--PercentageOfAcquisitionThresholdInRightsAgreement_dp_uPure_c20220101__20221231_z3UhI6bYBMma" title="Percentage of acquisition threshold">15</span>% or more of the Company’s common stock, unless redeemed by the Company’s Board of Directors, each Right entitles the holder (other than the acquiring person) to purchase from the Company $<span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_pp0p0_c20221231_zyR9tzqoa225" title="Value of stock covered by each right">80</span> worth of common stock for $<span id="xdx_90C_ecustom--DiscountPriceOfStock_iI_c20221231_zQXEYT7TmOea" title="Discount price of stock">40</span>. If the Company is merged into, or <span id="xdx_90C_ecustom--AcquiringAssetsPercent_iI_dp_uPure_c20221231_zTN8cEDlk8O6" title="Acquiring asset percent">50</span>% or more of its assets or earning power is sold to, the acquiring company, the Rights will also enable the holder (other than the acquiring person) to purchase $<span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_pp0p0_c20221231_zFXjWhl1hzZd" title="Value of stock covered by each right">80</span> worth of common stock of the acquiring company for $<span id="xdx_90C_ecustom--DiscountPriceOfStock_iI_c20221231_zvyBX36ClgL8" title="Discount price of stock">40</span>. During 2022, the Company extended to expiration of The Rights to the close of business on <span id="xdx_90A_ecustom--RightsPlanExpireDate_dd_c20220101__20221231_z0JDZkHp81qc" title="Rights plan expire date">February 11, 2033</span>, unless the Rights Plan is extended by the Company’s Board of Directors or unless the Rights are earlier redeemed by the Company at a price of $<span id="xdx_90C_ecustom--RightsRedemptionPricePerShare_iI_c20221231_zahL2hiLipG4" title="Redemption price">0.0001</span> per Right. The Rights are not exercisable during the time when they are redeemable by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The above description highlights some of the features of the Company’s Rights Plan and is not a complete description of the Rights Plan. A more detailed description and copy of the Rights Plan has been filed with the SEC and is available from the Company upon request.</span></p> 0.15 80 40 0.50 80 40 2033-02-11 0.0001 EXCEL 51 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 52 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 53 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 54 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 78 216 1 false 33 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://smartglass.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://smartglass.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://smartglass.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations Sheet http://smartglass.com/role/StatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Shareholders' Equity Sheet http://smartglass.com/role/StatementsOfShareholdersEquity Consolidated Statements of Shareholders' Equity Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://smartglass.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - Business and Basis for Presentation Sheet http://smartglass.com/role/BusinessAndBasisForPresentation Business and Basis for Presentation Notes 7 false false R8.htm 00000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://smartglass.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Fixed Assets Sheet http://smartglass.com/role/FixedAssets Fixed Assets Notes 9 false false R10.htm 00000010 - Disclosure - Accrued Expenses and Other Sheet http://smartglass.com/role/AccruedExpensesAndOther Accrued Expenses and Other Notes 10 false false R11.htm 00000011 - Disclosure - Income Taxes Sheet http://smartglass.com/role/IncomeTaxes Income Taxes Notes 11 false false R12.htm 00000012 - Disclosure - Shareholders??? Equity Sheet http://smartglass.com/role/ShareholdersEquity Shareholders??? Equity Notes 12 false false R13.htm 00000013 - Disclosure - License and Other Agreements Sheet http://smartglass.com/role/LicenseAndOtherAgreements License and Other Agreements Notes 13 false false R14.htm 00000014 - Disclosure - Commitments Sheet http://smartglass.com/role/Commitments Commitments Notes 14 false false R15.htm 00000015 - Disclosure - Rights Plan Sheet http://smartglass.com/role/RightsPlan Rights Plan Notes 15 false false R16.htm 00000016 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://smartglass.com/role/SummaryOfSignificantAccountingPolicies 16 false false R17.htm 00000017 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://smartglass.com/role/SummaryOfSignificantAccountingPolicies 17 false false R18.htm 00000018 - Disclosure - Fixed Assets (Tables) Sheet http://smartglass.com/role/FixedAssetsTables Fixed Assets (Tables) Tables http://smartglass.com/role/FixedAssets 18 false false R19.htm 00000019 - Disclosure - Accrued Expenses and Other (Tables) Sheet http://smartglass.com/role/AccruedExpensesAndOtherTables Accrued Expenses and Other (Tables) Tables http://smartglass.com/role/AccruedExpensesAndOther 19 false false R20.htm 00000020 - Disclosure - Income Taxes (Tables) Sheet http://smartglass.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://smartglass.com/role/IncomeTaxes 20 false false R21.htm 00000021 - Disclosure - Shareholders??? Equity (Tables) Sheet http://smartglass.com/role/ShareholdersEquityTables Shareholders??? Equity (Tables) Tables http://smartglass.com/role/ShareholdersEquity 21 false false R22.htm 00000022 - Disclosure - Commitments (Tables) Sheet http://smartglass.com/role/CommitmentsTables Commitments (Tables) Tables http://smartglass.com/role/Commitments 22 false false R23.htm 00000023 - Disclosure - Business and Basis for Presentation (Details Narrative) Sheet http://smartglass.com/role/BusinessAndBasisForPresentationDetailsNarrative Business and Basis for Presentation (Details Narrative) Details http://smartglass.com/role/BusinessAndBasisForPresentation 23 false false R24.htm 00000024 - Disclosure - Schedule of Unrealized Loss on Investments (Details) Sheet http://smartglass.com/role/ScheduleOfUnrealizedLossOnInvestmentsDetails Schedule of Unrealized Loss on Investments (Details) Details 24 false false R25.htm 00000025 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesTables 25 false false R26.htm 00000026 - Disclosure - Schedule of Fixed Assets (Details) Sheet http://smartglass.com/role/ScheduleOfFixedAssetsDetails Schedule of Fixed Assets (Details) Details 26 false false R27.htm 00000027 - Disclosure - Schedule of Accrued Expenses and Other (Details) Sheet http://smartglass.com/role/ScheduleOfAccruedExpensesAndOtherDetails Schedule of Accrued Expenses and Other (Details) Details 27 false false R28.htm 00000028 - Disclosure - Schedule of Deferred Tax Assets (Details) Sheet http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails Schedule of Deferred Tax Assets (Details) Details 28 false false R29.htm 00000029 - Disclosure - Schedule of Reconciliation Income Tax Expenses Benefit (Details) Sheet http://smartglass.com/role/ScheduleOfReconciliationIncomeTaxExpensesBenefitDetails Schedule of Reconciliation Income Tax Expenses Benefit (Details) Details 29 false false R30.htm 00000030 - Disclosure - Income Taxes (Details Narrative) Sheet http://smartglass.com/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) Details http://smartglass.com/role/IncomeTaxesTables 30 false false R31.htm 00000031 - Disclosure - Schedule of Assumptions Used to Value Options Granted to Employees (Details) Sheet http://smartglass.com/role/ScheduleOfAssumptionsUsedToValueOptionsGrantedToEmployeesDetails Schedule of Assumptions Used to Value Options Granted to Employees (Details) Details 31 false false R32.htm 00000032 - Disclosure - Schedule of Option Activity (Details) Sheet http://smartglass.com/role/ScheduleOfOptionActivityDetails Schedule of Option Activity (Details) Details 32 false false R33.htm 00000033 - Disclosure - Schedule of Warrant Activity (Details) Sheet http://smartglass.com/role/ScheduleOfWarrantActivityDetails Schedule of Warrant Activity (Details) Details 33 false false R34.htm 00000034 - Disclosure - Shareholders??? Equity (Details Narrative) Sheet http://smartglass.com/role/ShareholdersEquityDetailsNarrative Shareholders??? Equity (Details Narrative) Details http://smartglass.com/role/ShareholdersEquityTables 34 false false R35.htm 00000035 - Disclosure - License and Other Agreements (Details Narrative) Sheet http://smartglass.com/role/LicenseAndOtherAgreementsDetailsNarrative License and Other Agreements (Details Narrative) Details http://smartglass.com/role/LicenseAndOtherAgreements 35 false false R36.htm 00000036 - Disclosure - Schedule of Minimum Annual Future Rental Commitments (Details) Sheet http://smartglass.com/role/ScheduleOfMinimumAnnualFutureRentalCommitmentsDetails Schedule of Minimum Annual Future Rental Commitments (Details) Details 36 false false R37.htm 00000037 - Disclosure - Commitments (Details Narrative) Sheet http://smartglass.com/role/CommitmentsDetailsNarrative Commitments (Details Narrative) Details http://smartglass.com/role/CommitmentsTables 37 false false R38.htm 00000038 - Disclosure - Rights Plan (Details Narrative) Sheet http://smartglass.com/role/RightsPlanDetailsNarrative Rights Plan (Details Narrative) Details http://smartglass.com/role/RightsPlan 38 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 3 fact(s) appearing in ix:hidden were eligible for transformation: dei:DocumentAnnualReport, dei:DocumentTransitionReport, dei:TradingSymbol - form10-k.htm 28, 29, 30 form10-k.htm ex21.htm ex23-1.htm ex31-1.htm ex32-1.htm ex4-2.htm refr-20221231.xsd refr-20221231_cal.xml refr-20221231_def.xml refr-20221231_lab.xml refr-20221231_pre.xml http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 57 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-k.htm": { "axisCustom": 0, "axisStandard": 17, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 339, "http://xbrl.sec.gov/dei/2022": 36 }, "contextCount": 78, "dts": { "calculationLink": { "local": [ "refr-20221231_cal.xml" ] }, "definitionLink": { "local": [ "refr-20221231_def.xml" ] }, "inline": { "local": [ "form10-k.htm" ] }, "labelLink": { "local": [ "refr-20221231_lab.xml" ] }, "presentationLink": { "local": [ "refr-20221231_pre.xml" ] }, "schema": { "local": [ "refr-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 348, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 28, "http://smartglass.com/20221231": 5, "http://xbrl.sec.gov/dei/2022": 6, "total": 39 }, "keyCustom": 32, "keyStandard": 184, "memberCustom": 18, "memberStandard": 14, "nsprefix": "REFR", "nsuri": "http://smartglass.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://smartglass.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Accrued Expenses and Other", "menuCat": "Notes", "order": "10", "role": "http://smartglass.com/role/AccruedExpensesAndOther", "shortName": "Accrued Expenses and Other", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Income Taxes", "menuCat": "Notes", "order": "11", "role": "http://smartglass.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Shareholders\u2019 Equity", "menuCat": "Notes", "order": "12", "role": "http://smartglass.com/role/ShareholdersEquity", "shortName": "Shareholders\u2019 Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "REFR:LicenseAndOtherAgreementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - License and Other Agreements", "menuCat": "Notes", "order": "13", "role": "http://smartglass.com/role/LicenseAndOtherAgreements", "shortName": "License and Other Agreements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "REFR:LicenseAndOtherAgreementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Commitments", "menuCat": "Notes", "order": "14", "role": "http://smartglass.com/role/Commitments", "shortName": "Commitments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "REFR:RightsPlanDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Rights Plan", "menuCat": "Notes", "order": "15", "role": "http://smartglass.com/role/RightsPlan", "shortName": "Rights Plan", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "REFR:RightsPlanDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Summary of Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "16", "role": "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:MarketableSecuritiesPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Summary of Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "17", "role": "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:MarketableSecuritiesPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Fixed Assets (Tables)", "menuCat": "Tables", "order": "18", "role": "http://smartglass.com/role/FixedAssetsTables", "shortName": "Fixed Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Accrued Expenses and Other (Tables)", "menuCat": "Tables", "order": "19", "role": "http://smartglass.com/role/AccruedExpensesAndOtherTables", "shortName": "Accrued Expenses and Other (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://smartglass.com/role/BalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "lang": null, "name": "REFR:RoyaltiesReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Income Taxes (Tables)", "menuCat": "Tables", "order": "20", "role": "http://smartglass.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - Shareholders\u2019 Equity (Tables)", "menuCat": "Tables", "order": "21", "role": "http://smartglass.com/role/ShareholdersEquityTables", "shortName": "Shareholders\u2019 Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:CommitmentsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - Commitments (Tables)", "menuCat": "Tables", "order": "22", "role": "http://smartglass.com/role/CommitmentsTables", "shortName": "Commitments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CommitmentsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BasisOfAccounting", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-5", "first": true, "lang": null, "name": "REFR:WorkingCapital", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - Business and Basis for Presentation (Details Narrative)", "menuCat": "Details", "order": "23", "role": "http://smartglass.com/role/BusinessAndBasisForPresentationDetailsNarrative", "shortName": "Business and Basis for Presentation (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BasisOfAccounting", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-5", "first": true, "lang": null, "name": "REFR:WorkingCapital", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:MarketableSecuritiesCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - Schedule of Unrealized Loss on Investments (Details)", "menuCat": "Details", "order": "24", "role": "http://smartglass.com/role/ScheduleOfUnrealizedLossOnInvestmentsDetails", "shortName": "Schedule of Unrealized Loss on Investments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock", "us-gaap:MarketableSecuritiesPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31_us-gaap_FairValueInputsLevel1Member", "decimals": "0", "lang": null, "name": "us-gaap:MarketableSecuritiesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)", "menuCat": "Details", "order": "25", "role": "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "Summary of Significant Accounting Policies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - Schedule of Fixed Assets (Details)", "menuCat": "Details", "order": "26", "role": "http://smartglass.com/role/ScheduleOfFixedAssetsDetails", "shortName": "Schedule of Fixed Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - Schedule of Accrued Expenses and Other (Details)", "menuCat": "Details", "order": "27", "role": "http://smartglass.com/role/ScheduleOfAccruedExpensesAndOtherDetails", "shortName": "Schedule of Accrued Expenses and Other (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - Schedule of Deferred Tax Assets (Details)", "menuCat": "Details", "order": "28", "role": "http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails", "shortName": "Schedule of Deferred Tax Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - Schedule of Reconciliation Income Tax Expenses Benefit (Details)", "menuCat": "Details", "order": "29", "role": "http://smartglass.com/role/ScheduleOfReconciliationIncomeTaxExpensesBenefitDetails", "shortName": "Schedule of Reconciliation Income Tax Expenses Benefit (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://smartglass.com/role/BalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "REFR:AmortizedCostTermDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - Income Taxes (Details Narrative)", "menuCat": "Details", "order": "30", "role": "http://smartglass.com/role/IncomeTaxesDetailsNarrative", "shortName": "Income Taxes (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "REFR:AmortizedCostTermDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - Schedule of Assumptions Used to Value Options Granted to Employees (Details)", "menuCat": "Details", "order": "31", "role": "http://smartglass.com/role/ScheduleOfAssumptionsUsedToValueOptionsGrantedToEmployeesDetails", "shortName": "Schedule of Assumptions Used to Value Options Granted to Employees (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31_us-gaap_StockOptionMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - Schedule of Option Activity (Details)", "menuCat": "Details", "order": "32", "role": "http://smartglass.com/role/ScheduleOfOptionActivityDetails", "shortName": "Schedule of Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_StockOptionMember", "decimals": null, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - Schedule of Warrant Activity (Details)", "menuCat": "Details", "order": "33", "role": "http://smartglass.com/role/ScheduleOfWarrantActivityDetails", "shortName": "Schedule of Warrant Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "span", "p", "REFR:RightsPlanDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharesIssuedPricePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - Shareholders\u2019 Equity (Details Narrative)", "menuCat": "Details", "order": "34", "role": "http://smartglass.com/role/ShareholdersEquityDetailsNarrative", "shortName": "Shareholders\u2019 Equity (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "span", "p", "REFR:LicenseAndOtherAgreementsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_srt_MinimumMember", "decimals": "INF", "first": true, "lang": null, "name": "REFR:RoyaltyEarnedPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - License and Other Agreements (Details Narrative)", "menuCat": "Details", "order": "35", "role": "http://smartglass.com/role/LicenseAndOtherAgreementsDetailsNarrative", "shortName": "License and Other Agreements (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "REFR:LicenseAndOtherAgreementsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_srt_MinimumMember", "decimals": "INF", "first": true, "lang": null, "name": "REFR:RoyaltyEarnedPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:CommitmentsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - Schedule of Minimum Annual Future Rental Commitments (Details)", "menuCat": "Details", "order": "36", "role": "http://smartglass.com/role/ScheduleOfMinimumAnnualFutureRentalCommitmentsDetails", "shortName": "Schedule of Minimum Annual Future Rental Commitments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:CommitmentsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "REFR:LeaseExpirationTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - Commitments (Details Narrative)", "menuCat": "Details", "order": "37", "role": "http://smartglass.com/role/CommitmentsDetailsNarrative", "shortName": "Commitments (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "REFR:LeaseExpirationTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "span", "p", "REFR:RightsPlanDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "REFR:PercentageOfAcquisitionThresholdInRightsAgreement", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - Rights Plan (Details Narrative)", "menuCat": "Details", "order": "38", "role": "http://smartglass.com/role/RightsPlanDetailsNarrative", "shortName": "Rights Plan (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "REFR:RightsPlanDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "REFR:PercentageOfAcquisitionThresholdInRightsAgreement", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Consolidated Statements of Operations", "menuCat": "Statements", "order": "4", "role": "http://smartglass.com/role/StatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:OtherGeneralExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Consolidated Statements of Shareholders' Equity", "menuCat": "Statements", "order": "5", "role": "http://smartglass.com/role/StatementsOfShareholdersEquity", "shortName": "Consolidated Statements of Shareholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "6", "role": "http://smartglass.com/role/StatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:DepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccounting", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - Business and Basis for Presentation", "menuCat": "Notes", "order": "7", "role": "http://smartglass.com/role/BusinessAndBasisForPresentation", "shortName": "Business and Basis for Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccounting", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "8", "role": "http://smartglass.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Fixed Assets", "menuCat": "Notes", "order": "9", "role": "http://smartglass.com/role/FixedAssets", "shortName": "Fixed Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 33, "tag": { "REFR_AcquiringAssetsPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acquiring assets percent.", "label": "Acquiring asset percent" } } }, "localname": "AcquiringAssetsPercent", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/RightsPlanDetailsNarrative" ], "xbrltype": "percentItemType" }, "REFR_AmortizedCostTermDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amortized cost term, description.", "label": "Amortized cost term description" } } }, "localname": "AmortizedCostTermDescription", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "REFR_AutosMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Autos [Member]", "label": "Autos [Member]" } } }, "localname": "AutosMember", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/ScheduleOfFixedAssetsDetails" ], "xbrltype": "domainItemType" }, "REFR_CompanyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Company One [Member]", "label": "Company One [Member]" } } }, "localname": "CompanyOneMember", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "REFR_CompanyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Company Two [Member]", "label": "Company Two [Member]" } } }, "localname": "CompanyTwoMember", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "REFR_CorporateMinimumTaxRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corporate minimum tax rate.", "label": "Corporate minimum tax rate" } } }, "localname": "CorporateMinimumTaxRate", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "percentItemType" }, "REFR_DeferredTaxAssetsAmortization": { "auth_ref": [], "calculation": { "http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails": { "order": 7.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets amortization.", "label": "Amortization" } } }, "localname": "DeferredTaxAssetsAmortization", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "REFR_DeferredTaxAssetsLeaseLiability": { "auth_ref": [], "calculation": { "http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets lease liability.", "label": "Lease liability" } } }, "localname": "DeferredTaxAssetsLeaseLiability", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "REFR_DisclosureLicenseAndOtherAgreementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "License And Other Agreements" } } }, "localname": "DisclosureLicenseAndOtherAgreementsAbstract", "nsuri": "http://smartglass.com/20221231", "xbrltype": "stringItemType" }, "REFR_DisclosureRightsPlanAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Rights Plan" } } }, "localname": "DisclosureRightsPlanAbstract", "nsuri": "http://smartglass.com/20221231", "xbrltype": "stringItemType" }, "REFR_DiscountPriceOfStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Discount price of stock.", "label": "Discount price of stock" } } }, "localname": "DiscountPriceOfStock", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/RightsPlanDetailsNarrative" ], "xbrltype": "perShareItemType" }, "REFR_EmployeesAndDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employees and Directors [Member].", "label": "Employees and Directors [Member]" } } }, "localname": "EmployeesAndDirectorsMember", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "REFR_EquipmentAndFurnitureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment and Furniture [Member]", "label": "Equipment and Furniture [Member]" } } }, "localname": "EquipmentAndFurnitureMember", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/ScheduleOfFixedAssetsDetails" ], "xbrltype": "domainItemType" }, "REFR_ExciseTaxOnCorporateStockRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Excise tax on corporate stock rate.", "label": "Excise tax on corporate stock" } } }, "localname": "ExciseTaxOnCorporateStockRate", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "percentItemType" }, "REFR_IncreaseDecreaseInRoyaltyReceivable": { "auth_ref": [], "calculation": { "http://smartglass.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in royalty receivable.", "label": "IncreaseDecreaseInRoyaltyReceivable", "negatedLabel": "Royalty receivables" } } }, "localname": "IncreaseDecreaseInRoyaltyReceivable", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "REFR_LeaseExpirationTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease expiration term.", "label": "Lease expiration term" } } }, "localname": "LeaseExpirationTerm", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/CommitmentsDetailsNarrative" ], "xbrltype": "durationItemType" }, "REFR_LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndFive": { "auth_ref": [], "calculation": { "http://smartglass.com/role/ScheduleOfMinimumAnnualFutureRentalCommitmentsDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fouth and fifth fiscal year following latest fiscal year.", "label": "Years 4-5" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndFive", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/ScheduleOfMinimumAnnualFutureRentalCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "REFR_LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree": { "auth_ref": [], "calculation": { "http://smartglass.com/role/ScheduleOfMinimumAnnualFutureRentalCommitmentsDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second and third fiscal year following latest fiscal year.", "label": "Years 2-3" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/ScheduleOfMinimumAnnualFutureRentalCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "REFR_LicenseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "License Agreement [Member]", "label": "License Agreement [Member]" } } }, "localname": "LicenseAgreementMember", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "REFR_LicenseAndOtherAgreementsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "License and other agreements [Text Block]", "label": "License and Other Agreements" } } }, "localname": "LicenseAndOtherAgreementsTextBlock", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/LicenseAndOtherAgreements" ], "xbrltype": "textBlockItemType" }, "REFR_LicenseeFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "License Four [Member]", "label": "License Four [Member]" } } }, "localname": "LicenseeFourMember", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "REFR_LicenseeOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Licensee One [Member]", "label": "Licensee One [Member]" } } }, "localname": "LicenseeOneMember", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "REFR_LicenseeThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "License Three [Member]", "label": "License Three [Member]" } } }, "localname": "LicenseeThreeMember", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "REFR_LicenseeTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "License Two [Member]", "label": "License Two [Member]" } } }, "localname": "LicenseeTwoMember", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "REFR_NetInvestmentIncomeLoss": { "auth_ref": [], "calculation": { "http://smartglass.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net investment income loss.", "label": "Net investment loss" } } }, "localname": "NetInvestmentIncomeLoss", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "REFR_NonEmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non- Employee Stock Option [Member]", "label": "Non- Employee Stock Option [Member]" } } }, "localname": "NonEmployeeStockOptionMember", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "REFR_NonrecurringCashExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Non-recurring cash expenses.", "label": "Non-recurring cash expenses" } } }, "localname": "NonrecurringCashExpenses", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/BusinessAndBasisForPresentationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "REFR_OperatingLossCarryforwardsExpirationDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net operating loss carry-forward expiration description.", "label": "Net operating loss carry-forward expiration description" } } }, "localname": "OperatingLossCarryforwardsExpirationDescription", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "REFR_OptionsAndWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Options and Warrants [Member]", "label": "Options and Warrants [Member]" } } }, "localname": "OptionsAndWarrantsMember", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative", "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "REFR_PercentageOfAcquisitionThresholdInRightsAgreement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of acquisition threshold in rights agreement.", "label": "Percentage of acquisition threshold" } } }, "localname": "PercentageOfAcquisitionThresholdInRightsAgreement", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/RightsPlanDetailsNarrative" ], "xbrltype": "percentItemType" }, "REFR_ProceedsFromSaleOfCommonStockAndWarrants": { "auth_ref": [], "calculation": { "http://smartglass.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from sale of common stock and warrants.", "label": "Proceeds from issuance of common stock and warrants" } } }, "localname": "ProceedsFromSaleOfCommonStockAndWarrants", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "REFR_ProceedsFromStockOptionsAndWarrantsExercised": { "auth_ref": [], "calculation": { "http://smartglass.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from stock options and warrants exercised.", "label": "Net proceeds from exercise of options and warrants" } } }, "localname": "ProceedsFromStockOptionsAndWarrantsExercised", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "REFR_PutnamShortDurationBondMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Putnam Short Duration Bond [Member]", "label": "Putnam Short Duration Bond [Member]" } } }, "localname": "PutnamShortDurationBondMember", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/ScheduleOfUnrealizedLossOnInvestmentsDetails" ], "xbrltype": "domainItemType" }, "REFR_PutnamUltraShortDurationIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Putnam Ultra Short Duration Income [Member]", "label": "Putnam Ultra Short Duration Income [Member]" } } }, "localname": "PutnamUltraShortDurationIncomeMember", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/ScheduleOfUnrealizedLossOnInvestmentsDetails" ], "xbrltype": "domainItemType" }, "REFR_RecognizedBenefitMeasured": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Recognized benefit measured.", "label": "Recognized benefit measured" } } }, "localname": "RecognizedBenefitMeasured", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "REFR_RestrictedStockPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted stock [Policy Text Block]", "label": "Restricted Stock" } } }, "localname": "RestrictedStockPolicyTextBlock", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "REFR_RightsPlanDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rights plan disclosure [Text Block]", "label": "RightsPlanDisclosureTextBlock", "verboseLabel": "Rights Plan" } } }, "localname": "RightsPlanDisclosureTextBlock", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/RightsPlan" ], "xbrltype": "textBlockItemType" }, "REFR_RightsPlanExpireDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rights plan expire date.", "label": "Rights plan expire date" } } }, "localname": "RightsPlanExpireDate", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/RightsPlanDetailsNarrative" ], "xbrltype": "dateItemType" }, "REFR_RightsRedemptionPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rights redemption price per share.", "label": "Redemption price" } } }, "localname": "RightsRedemptionPricePerShare", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/RightsPlanDetailsNarrative" ], "xbrltype": "perShareItemType" }, "REFR_RoyaltiesReceivableNetCurrent": { "auth_ref": [], "calculation": { "http://smartglass.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Royalties receivable net current.", "label": "Royalties receivable, net of reserves of $1,158,450 in 2022 and $1,016,678 in 2021, respectively" } } }, "localname": "RoyaltiesReceivableNetCurrent", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "REFR_RoyaltyEarnedPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Royalty earned percentage.", "label": "Royalty earned percentage" } } }, "localname": "RoyaltyEarnedPercentage", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/LicenseAndOtherAgreementsDetailsNarrative" ], "xbrltype": "percentItemType" }, "REFR_RoyaltyRateOnSellingPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Royalty rate on selling price.", "label": "Royalty rate on selling price" } } }, "localname": "RoyaltyRateOnSellingPrice", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "REFR_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssuedInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award non option equity instruments issued in period weighted average exercise price.", "label": "Weighted Average Exercise Price, Issued" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssuedInPeriodWeightedAverageExercisePrice", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "REFR_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the non-option equity plan.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice", "periodEndLabel": "Weighted Average Exercise Price, Ending", "periodStartLabel": "Weighted Average Exercise Price, Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "REFR_StockIssuedDuringPeriodSharesCommonStockAndWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of common stock and warrants, shares.", "label": "Issuance of common stock and warrants, shares" } } }, "localname": "StockIssuedDuringPeriodSharesCommonStockAndWarrants", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/StatementsOfShareholdersEquity" ], "xbrltype": "sharesItemType" }, "REFR_StockIssuedDuringPeriodValueCommonStockAndWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of common stock and warrants.", "label": "Issuance of common stock and warrants" } } }, "localname": "StockIssuedDuringPeriodValueCommonStockAndWarrants", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/StatementsOfShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "REFR_SubscriptionAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subscription Agreement [Member]", "label": "Subscription Agreement [Member]" } } }, "localname": "SubscriptionAgreementMember", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "REFR_TaxYear2018To2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax Year 2018 to 2022 [Member]", "label": "Tax Year 2018 to 2022 [Member]" } } }, "localname": "TaxYear2018To2022Member", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "REFR_TradeShowMaterialsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trade Show Materials [Member]", "label": "Trade Show Materials [Member]" } } }, "localname": "TradeShowMaterialsMember", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/ScheduleOfFixedAssetsDetails" ], "xbrltype": "domainItemType" }, "REFR_TwoThousandNineteenEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2019 Equity Incentive Plan [Member]", "label": "2019 Equity Incentive Plan [Member]" } } }, "localname": "TwoThousandNineteenEquityIncentivePlanMember", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "REFR_WarrantsAndNonemployeeOptionsVestedTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants and non-employee options vested term.", "label": "Warrants and non-employee options vested term" } } }, "localname": "WarrantsAndNonemployeeOptionsVestedTerm", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "durationItemType" }, "REFR_WorkingCapital": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Working capital.", "label": "Working capital" } } }, "localname": "WorkingCapital", "nsuri": "http://smartglass.com/20221231", "presentation": [ "http://smartglass.com/role/BusinessAndBasisForPresentationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r401" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r401" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r398", "r400", "r401" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r398", "r400", "r401" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r398", "r400", "r401" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r398", "r400", "r401" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r399" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r387" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r390" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r393" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r403" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r401" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r404" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r398", "r400", "r401" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r394" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r395" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r388" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r392" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r391" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r396" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r397" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r405" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://smartglass.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://smartglass.com/role/CommitmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r166", "r377", "r431", "r480" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r182", "r183", "r184", "r185", "r230", "r331", "r353", "r364", "r365", "r375", "r381", "r386", "r430", "r472", "r473", "r474", "r475", "r476", "r477" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://smartglass.com/role/LicenseAndOtherAgreementsDetailsNarrative", "http://smartglass.com/role/ShareholdersEquityDetailsNarrative", "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r182", "r183", "r184", "r185", "r230", "r331", "r353", "r364", "r365", "r375", "r381", "r386", "r430", "r472", "r473", "r474", "r475", "r476", "r477" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://smartglass.com/role/LicenseAndOtherAgreementsDetailsNarrative", "http://smartglass.com/role/ShareholdersEquityDetailsNarrative", "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r166", "r377", "r431", "r480" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r164", "r335", "r376", "r385", "r426", "r427", "r431", "r479" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r164", "r335", "r376", "r385", "r426", "r427", "r431", "r479" ], "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r182", "r183", "r184", "r185", "r222", "r230", "r242", "r243", "r244", "r307", "r331", "r353", "r364", "r365", "r375", "r381", "r386", "r425", "r430", "r473", "r474", "r475", "r476", "r477" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://smartglass.com/role/LicenseAndOtherAgreementsDetailsNarrative", "http://smartglass.com/role/ShareholdersEquityDetailsNarrative", "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r182", "r183", "r184", "r185", "r222", "r230", "r242", "r243", "r244", "r307", "r331", "r353", "r364", "r365", "r375", "r381", "r386", "r425", "r430", "r473", "r474", "r475", "r476", "r477" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://smartglass.com/role/LicenseAndOtherAgreementsDetailsNarrative", "http://smartglass.com/role/ShareholdersEquityDetailsNarrative", "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r416", "r468" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://smartglass.com/role/CommitmentsDetailsNarrative", "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://smartglass.com/role/CommitmentsDetailsNarrative", "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "Accrued Expenses and Other" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/AccruedExpensesAndOther" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r9", "r384" ], "calculation": { "http://smartglass.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r12" ], "calculation": { "http://smartglass.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://smartglass.com/role/ScheduleOfAccruedExpensesAndOtherDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued expenses and other", "totalLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheets", "http://smartglass.com/role/ScheduleOfAccruedExpensesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r12" ], "calculation": { "http://smartglass.com/role/ScheduleOfAccruedExpensesAndOtherDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Professional services" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfAccruedExpensesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r46", "r107" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less accumulated depreciation and amortization" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfFixedAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r115", "r116", "r285", "r286", "r287", "r288", "r289", "r290" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r4" ], "calculation": { "http://smartglass.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r246", "r247", "r248", "r412", "r413", "r414", "r462" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r75", "r76", "r231" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Share based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r110", "r167", "r172" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Royalties receivables, reserves" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r145" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive securities" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative", "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r89", "r95", "r109", "r123", "r155", "r158", "r162", "r170", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r274", "r276", "r284", "r384", "r428", "r429", "r470" ], "calculation": { "http://smartglass.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets [Default Label]", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r103", "r111", "r123", "r170", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r274", "r276", "r284", "r384", "r428", "r429", "r470" ], "calculation": { "http://smartglass.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccounting": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Business and Basis for Presentation" } } }, "localname": "BasisOfAccounting", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BusinessAndBasisForPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r26", "r105", "r366" ], "calculation": { "http://smartglass.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheets", "http://smartglass.com/role/BusinessAndBasisForPresentationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r21", "r26", "r28" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash and cash equivalents at end of year", "periodStartLabel": "Cash and cash equivalents at beginning of year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r21", "r88" ], "calculation": { "http://smartglass.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "FDIC insurance coverage" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashUninsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.", "label": "Amounts on deposit in excess of federally insured limits" } } }, "localname": "CashUninsuredAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Warrants outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsDisclosureTextBlock": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.", "label": "Commitments" } } }, "localname": "CommitmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/Commitments" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Shares of common stock reserved for issuance" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r412", "r413", "r462" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative", "http://smartglass.com/role/StatementsOfShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r3", "r52" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r3", "r384" ], "calculation": { "http://smartglass.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, par value $0.0001 per share; authorized 100,000,000 shares, issued and outstanding 33,150,396 in 2022 and 31,650,396 in 2021" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r33", "r34", "r86", "r87", "r166", "r360" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r33", "r34", "r86", "r87", "r166", "r359", "r360" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r33", "r34", "r86", "r87", "r166", "r360", "r481" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r33", "r34", "r86", "r87", "r166" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration risk, percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r33", "r34", "r86", "r87", "r166", "r360" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r32", "r166" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]" } } }, "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/CommitmentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r0", "r1", "r90", "r94", "r258" ], "calculation": { "http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "totalLabel": "Total gross deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r259" ], "calculation": { "http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Total gross deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": { "auth_ref": [ "r82", "r460" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.", "label": "Research and development expense" } } }, "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r459" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Net deferred tax" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r82", "r460" ], "calculation": { "http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Net operating loss carry-forwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.", "label": "Net operating loss carry-forward with expiration" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": { "auth_ref": [], "calculation": { "http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.", "label": "Depreciation" } } }, "localname": "DeferredTaxAssetsPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": { "auth_ref": [ "r80", "r82", "r460" ], "calculation": { "http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.", "label": "Research and other credits", "verboseLabel": "Research and other credit carry-forwards" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/IncomeTaxesDetailsNarrative", "http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r82", "r460" ], "calculation": { "http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "Stock option expense" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": { "auth_ref": [ "r82", "r460" ], "calculation": { "http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.", "label": "Allowance for bad debts" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r260" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": { "auth_ref": [ "r82", "r460" ], "calculation": { "http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.", "label": "Deferred Tax Liabilities, Leasing Arrangements", "verboseLabel": "Lease liability" } } }, "localname": "DeferredTaxLiabilitiesLeasingArrangements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesOther": { "auth_ref": [ "r82", "r460" ], "calculation": { "http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.", "label": "Other temporary differences" } } }, "localname": "DeferredTaxLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfUnrealizedLossOnInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r24", "r44" ], "calculation": { "http://smartglass.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r118", "r131", "r132", "r133", "r134", "r135", "r139", "r140", "r142", "r143", "r144", "r146", "r281", "r282", "r349", "r351", "r369" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Basic and diluted net loss per common share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r30", "r31" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Basic and Diluted Loss Per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r124", "r254", "r268" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Income tax percentage" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r12" ], "calculation": { "http://smartglass.com/role/ScheduleOfAccruedExpensesAndOtherDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Payroll, bonuses and related benefits" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfAccruedExpensesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r52", "r101", "r115", "r116", "r117", "r126", "r127", "r128", "r130", "r136", "r138", "r147", "r171", "r210", "r246", "r247", "r248", "r264", "r265", "r280", "r285", "r286", "r287", "r288", "r289", "r290", "r297", "r354", "r355", "r356" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative", "http://smartglass.com/role/StatementsOfShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r195", "r223", "r224", "r225", "r226", "r227", "r228", "r283", "r304", "r305", "r306", "r373", "r374", "r378", "r379", "r380" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfUnrealizedLossOnInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r195", "r223", "r228", "r283", "r304", "r378", "r379", "r380" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfUnrealizedLossOnInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r195", "r223", "r224", "r225", "r226", "r227", "r228", "r304", "r305", "r306", "r373", "r374", "r378", "r379", "r380" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfUnrealizedLossOnInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r168", "r169", "r173", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r196", "r208", "r278", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r372", "r421", "r422", "r423", "r482", "r483", "r484", "r485", "r486", "r487", "r488" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfUnrealizedLossOnInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": { "auth_ref": [ "r24", "r43" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.", "label": "Impairment of long-lived assets" } } }, "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r42", "r48" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment of Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r124", "r255", "r256", "r262", "r266", "r269", "r271", "r272", "r273" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r125", "r137", "r138", "r154", "r253", "r267", "r270", "r352" ], "calculation": { "http://smartglass.com/role/ScheduleOfReconciliationIncomeTaxExpensesBenefitDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "totalLabel": "Total income tax provision" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfReconciliationIncomeTaxExpensesBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r114", "r251", "r252", "r256", "r257", "r261", "r263" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "verboseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r458" ], "calculation": { "http://smartglass.com/role/ScheduleOfReconciliationIncomeTaxExpensesBenefitDetails": { "order": 3.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Valuation allowance" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfReconciliationIncomeTaxExpensesBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r254" ], "calculation": { "http://smartglass.com/role/ScheduleOfReconciliationIncomeTaxExpensesBenefitDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Income tax provision at federal statutory rate" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfReconciliationIncomeTaxExpensesBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherAdjustments": { "auth_ref": [ "r458" ], "calculation": { "http://smartglass.com/role/ScheduleOfReconciliationIncomeTaxExpensesBenefitDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Expired carryforwards and other" } } }, "localname": "IncomeTaxReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfReconciliationIncomeTaxExpensesBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r23" ], "calculation": { "http://smartglass.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Change in assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r409", "r464" ], "calculation": { "http://smartglass.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Operating lease liability" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r23" ], "calculation": { "http://smartglass.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "auth_ref": [ "r41", "r332", "r333", "r334", "r336", "r367" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.", "label": "Patent Costs" } } }, "localname": "IntangibleAssetsFiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestorMember": { "auth_ref": [ "r466", "r467" ], "lang": { "en-us": { "role": { "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value.", "label": "Investor [Member]" } } }, "localname": "InvestorMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r45" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfFixedAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r465" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Schedule of Minimum Annual Future Rental Commitments" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/CommitmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r296" ], "calculation": { "http://smartglass.com/role/ScheduleOfMinimumAnnualFutureRentalCommitmentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfMinimumAnnualFutureRentalCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r296" ], "calculation": { "http://smartglass.com/role/ScheduleOfMinimumAnnualFutureRentalCommitmentsDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfMinimumAnnualFutureRentalCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r296" ], "calculation": { "http://smartglass.com/role/ScheduleOfMinimumAnnualFutureRentalCommitmentsDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Year 1" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfMinimumAnnualFutureRentalCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r296" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: imputed lease interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfMinimumAnnualFutureRentalCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r11", "r123", "r170", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r275", "r276", "r277", "r284", "r370", "r428", "r470", "r471" ], "calculation": { "http://smartglass.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r8", "r91", "r97", "r384", "r411", "r424", "r463" ], "calculation": { "http://smartglass.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and shareholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Shareholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r13", "r104", "r123", "r170", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r275", "r276", "r277", "r284", "r384", "r428", "r470", "r471" ], "calculation": { "http://smartglass.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_MarketableSecuritiesCurrent": { "auth_ref": [], "calculation": { "http://smartglass.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security, classified as current.", "label": "Marketable securities" } } }, "localname": "MarketableSecuritiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheets", "http://smartglass.com/role/ScheduleOfUnrealizedLossOnInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesPolicy": { "auth_ref": [ "r93" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment classified as marketable security.", "label": "Marketable Securities" } } }, "localname": "MarketableSecuritiesPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_MarketableSecuritiesRealizedGainLoss": { "auth_ref": [], "calculation": { "http://smartglass.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI).", "label": "Marketable Securities, Realized Gain (Loss)", "negatedLabel": "Realized loss on marketable securities", "negatedTerseLabel": "Realized loss on sale of marketable securities" } } }, "localname": "MarketableSecuritiesRealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfCashFlows", "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesUnrealizedGainLoss": { "auth_ref": [ "r17" ], "calculation": { "http://smartglass.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment in marketable security.", "label": "Unrealized loss", "negatedLabel": "Unrealized loss on marketable securities" } } }, "localname": "MarketableSecuritiesUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfUnrealizedLossOnInvestmentsDetails", "http://smartglass.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r120" ], "calculation": { "http://smartglass.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r120" ], "calculation": { "http://smartglass.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r21", "r22", "r25" ], "calculation": { "http://smartglass.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r16", "r25", "r92", "r99", "r102", "r112", "r113", "r117", "r123", "r129", "r131", "r132", "r133", "r134", "r137", "r138", "r141", "r155", "r157", "r161", "r163", "r170", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r282", "r284", "r371", "r428" ], "calculation": { "http://smartglass.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://smartglass.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfCashFlows", "http://smartglass.com/role/StatementsOfOperations", "http://smartglass.com/role/StatementsOfShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OfficersCompensation": { "auth_ref": [ "r408" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.", "label": "Annual base salary" } } }, "localname": "OfficersCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/CommitmentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://smartglass.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r155", "r157", "r161", "r163", "r371" ], "calculation": { "http://smartglass.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r293" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Present value of lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfMinimumAnnualFutureRentalCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r293" ], "calculation": { "http://smartglass.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Current portion of operating lease liability" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r293" ], "calculation": { "http://smartglass.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating lease liability, net of current portion" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r292" ], "calculation": { "http://smartglass.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating lease ROU assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r410" ], "calculation": { "http://smartglass.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "ROU asset amortization" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r295", "r383" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/CommitmentsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r294", "r383" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/CommitmentsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r80" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Net operating loss carry-forward" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Loss Carryforwards [Line Items]" } } }, "localname": "OperatingLossCarryforwardsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsTable": { "auth_ref": [ "r81" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Operating Loss Carryforwards [Table]" } } }, "localname": "OperatingLossCarryforwardsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OptionIndexedToIssuersEquityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Option Indexed to Issuer's Equity [Line Items]" } } }, "localname": "OptionIndexedToIssuersEquityLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OptionIndexedToIssuersEquityTable": { "auth_ref": [ "r51", "r83", "r84", "r85" ], "lang": { "en-us": { "role": { "documentation": "Freestanding contracts issued by an Entity that are indexed to, and potentially settled in, an Entity's own stock by the different attributes of these freestanding contracts, including the strike price, number of shares, and settlement dates.", "label": "Option Indexed to Issuer's Equity [Table]" } } }, "localname": "OptionIndexedToIssuersEquityTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OptionIndexedToIssuersEquityTypeAxis": { "auth_ref": [ "r51", "r83", "r84", "r85" ], "lang": { "en-us": { "role": { "documentation": "Information by type of freestanding contracts issued by an entity that are indexed to, and potentially settled in, an entity's own stock.", "label": "Option Indexed to Issuer's Equity, Type [Axis]" } } }, "localname": "OptionIndexedToIssuersEquityTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfOptionActivityDetails", "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OptionIndexedToIssuersEquityTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding." } } }, "localname": "OptionIndexedToIssuersEquityTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfOptionActivityDetails", "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r12" ], "calculation": { "http://smartglass.com/role/ScheduleOfAccruedExpensesAndOtherDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfAccruedExpensesAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r108" ], "calculation": { "http://smartglass.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Deposits and other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherGeneralExpense": { "auth_ref": [ "r18" ], "calculation": { "http://smartglass.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of general expenses not normally included in Other Operating Costs and Expenses.", "label": "Operating expenses" } } }, "localname": "OtherGeneralExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "auth_ref": [ "r39" ], "calculation": { "http://smartglass.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for purchase of marketable security.", "label": "Payments to Acquire Marketable Securities", "negatedLabel": "Purchases of marketable securities" } } }, "localname": "PaymentsToAcquireMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r19" ], "calculation": { "http://smartglass.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of fixed assets" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r407" ], "calculation": { "http://smartglass.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "auth_ref": [ "r20" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.", "label": "Proceeds from issuance of stock" } } }, "localname": "ProceedsFromIssuanceOrSaleOfEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": { "auth_ref": [], "calculation": { "http://smartglass.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.", "label": "Sales of marketable securities" } } }, "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r47" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfFixedAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r49", "r361", "r362", "r363" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Fixed Assets" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/FixedAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r45", "r106" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Fixed assets, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfFixedAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfFixedAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r47", "r98", "r350", "r384" ], "calculation": { "http://smartglass.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Fixed assets, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheets", "http://smartglass.com/role/ScheduleOfFixedAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r47", "r361", "r362" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "verboseLabel": "Fixed Assets" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r47" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Schedule of Fixed Assets" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/FixedAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r45" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfFixedAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Estimated useful life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfFixedAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r119", "r174" ], "calculation": { "http://smartglass.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Bad debts" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesPolicyTextBlock": { "auth_ref": [ "r417", "r418", "r419", "r420" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.", "label": "Royalties Receivable" } } }, "localname": "ReceivablesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r229", "r298", "r299" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r229", "r298", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r469" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r77", "r100", "r478" ], "calculation": { "http://smartglass.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r77" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Costs" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r5", "r53", "r96", "r357", "r358", "r384" ], "calculation": { "http://smartglass.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit", "negatedLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheets", "http://smartglass.com/role/BusinessAndBasisForPresentationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r101", "r126", "r127", "r128", "r130", "r136", "r138", "r171", "r246", "r247", "r248", "r264", "r265", "r280", "r354", "r356" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r152", "r153", "r156", "r159", "r160", "r164", "r165", "r166", "r219", "r220", "r335" ], "calculation": { "http://smartglass.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Fee income", "verboseLabel": "Remaining performance obligations" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfOperations", "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r221", "r368" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue Recognition/Fee Income" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r166", "r415" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule of Accrued Expenses and Other" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/AccruedExpensesAndOtherTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": { "auth_ref": [ "r56", "r57" ], "lang": { "en-us": { "role": { "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.", "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]" } } }, "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/CommitmentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r79" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r58", "r59", "r60", "r61", "r62" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfUnrealizedLossOnInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r78" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Reconciliation Income Tax Expenses Benefit" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r47" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfFixedAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r64", "r70", "r71" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule of Option Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r73" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Assumptions Used to Value Options Granted to Employees" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r54", "r63" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule of Warrant Activity" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock": { "auth_ref": [ "r40" ], "lang": { "en-us": { "role": { "documentation": "For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value).", "label": "Schedule of Unrealized Loss on Investments" } } }, "localname": "ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r23" ], "calculation": { "http://smartglass.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based compensation", "verboseLabel": "Share based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative", "http://smartglass.com/role/StatementsOfCashFlows", "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r243" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Expected dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfAssumptionsUsedToValueOptionsGrantedToEmployeesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r242" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfAssumptionsUsedToValueOptionsGrantedToEmployeesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r244" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Risk free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfAssumptionsUsedToValueOptionsGrantedToEmployeesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "Number of non-option equity instruments exercised by participants.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised", "negatedLabel": "Number of Shares Underlying Warrants and Non-Employee Options Granted, Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": { "auth_ref": [ "r69" ], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.", "label": "Number of Shares Underlying Warrants and Non-Employee Options Granted, Terminated" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "auth_ref": [ "r67" ], "lang": { "en-us": { "role": { "documentation": "Net number of non-option equity instruments granted to participants.", "label": "Number of Shares Underlying Warrants and Non-Employee Options Granted, Issued" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "auth_ref": [ "r65", "r66" ], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "periodEndLabel": "Number of Shares Underlying Warrants and Non-Employee Options Granted, Ending", "periodStartLabel": "Number of Shares Underlying Warrants and Non-Employee Options Granted, Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r74" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Shares available for issuance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r237" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Number of Shares Subject to Option, Cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r235" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Number of Shares Subject to Option, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r238" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Fair value on grant date" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfAssumptionsUsedToValueOptionsGrantedToEmployeesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r74" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "periodEndLabel": "Aggregate Intrinsic Value, Ending", "periodStartLabel": "Aggregate Intrinsic Value, Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r233", "r234" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Number of Shares Subject to Option, Ending", "periodStartLabel": "Number of Shares Subject to Option, Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r233", "r234" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Exercise Price, Ending", "periodStartLabel": "Weighted Average Exercise Price, Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r236" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Weighted Average Exercise Price, Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r237" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Weighted Average Exercise Price, Cancelled" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r235" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Weighted Average Exercise Price, Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r232", "r239", "r240", "r241", "r242", "r245", "r249", "r250" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Equity-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r382" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Option expiration period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r241" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Expected term of the option" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfAssumptionsUsedToValueOptionsGrantedToEmployeesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r72" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted Average Remaining Contractual Term (Years), Ending" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "Number of options vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares issued price per share", "verboseLabel": "Value of stock covered by each right" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/RightsPlanDetailsNarrative", "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r29", "r121" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r15", "r52", "r101", "r115", "r116", "r117", "r126", "r127", "r128", "r130", "r136", "r138", "r147", "r171", "r210", "r246", "r247", "r248", "r264", "r265", "r280", "r285", "r286", "r287", "r288", "r289", "r290", "r297", "r354", "r355", "r356" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative", "http://smartglass.com/role/StatementsOfShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/LicenseAndOtherAgreementsDetailsNarrative", "http://smartglass.com/role/StatementsOfShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r126", "r127", "r128", "r147", "r335" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/LicenseAndOtherAgreementsDetailsNarrative", "http://smartglass.com/role/StatementsOfShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r2", "r3", "r52", "r53" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock issued during period shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r2", "r3", "r52", "r53", "r236" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Exercise of options, shares", "negatedLabel": "Number of Shares Subject to Option, Exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfOptionActivityDetails", "http://smartglass.com/role/StatementsOfShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r2", "r3", "r52", "r53" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock issued value" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r15", "r52", "r53" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Exercise of options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).", "label": "Equity Option [Member]" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfOptionActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r3", "r6", "r7", "r38", "r384", "r411", "r424", "r463" ], "calculation": { "http://smartglass.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Shareholders' equity", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total shareholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheets", "http://smartglass.com/role/BusinessAndBasisForPresentationDetailsNarrative", "http://smartglass.com/role/StatementsOfShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shareholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r55", "r122", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r209", "r210", "r279" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Shareholders\u2019 Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r291", "r300" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r291", "r300" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r291", "r300" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TaxPeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information about the period subject to enacted tax laws.", "label": "Tax Period [Axis]" } } }, "localname": "TaxPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_TaxPeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identified tax period." } } }, "localname": "TaxPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r168", "r169", "r196", "r208", "r278", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r421", "r422", "r423", "r482", "r483", "r484", "r485", "r486", "r487", "r488" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ScheduleOfUnrealizedLossOnInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r461" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative", "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r35", "r36", "r37", "r148", "r149", "r150", "r151" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r139", "r144" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average number of common shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://smartglass.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(c))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.6)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(b)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r387": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r388": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r389": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r391": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r392": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r393": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r394": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r395": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r396": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r397": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r398": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r399": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r401": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r402": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r403": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r404": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r405": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r406": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2611-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r482": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r483": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r484": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r485": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r486": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r487": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r488": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r49": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "63", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=126970277&loc=d3e23176-110880", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90193-114008", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90198-114008", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62652-112803", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 58 0001493152-23-007116-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-007116-xbrl.zip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end